DrugA,DrugB,Interaction,Mechanism,risk_level
Raxibacumab,Ublituximab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Ublituximab.,increase,risk
Raxibacumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Raxibacumab.,increase,risk
Raxibacumab,Vedolizumab,The risk or severity of adverse effects can be increased when Raxibacumab is combined with Vedolizumab.,increase,risk
"Sar9, Met (O2)11-Substance P",Benzonatate,"The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Benzonatate.",increase,no risk
"Sar9, Met (O2)11-Substance P",Betaine,"Betaine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Galantamine,"Galantamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Gallamine triethiodide,"Gallamine triethiodide may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Ginkgo biloba,"Ginkgo biloba may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Hexafluronium,"Hexafluronium may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Huperzine A,"Huperzine A may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Ketamine,"Ketamine may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P.",increase,no risk
"Sar9, Met (O2)11-Substance P",Oxybuprocaine,"The serum concentration of Sar9, Met (O2)11-Substance P can be increased when it is combined with Oxybuprocaine.",increase,no risk
Seletracetam,Galantamine,Galantamine may increase the bradycardic activities of Seletracetam.,increase,no risk
Seletracetam,Gallamine triethiodide,Seletracetam may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Seletracetam,Gliclazide,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Gliclazide.,increase,risk
Seletracetam,Glimepiride,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Glimepiride.,increase,risk
Seletracetam,Glipizide,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Glipizide.,increase,risk
Seletracetam,Gliquidone,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Gliquidone.,increase,risk
Seletracetam,Glofitamab,The serum concentration of Seletracetam can be increased when it is combined with Glofitamab.,increase,no risk
Seletracetam,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Seletracetam.,decrease,no risk
Seletracetam,Glyburide,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Glyburide.,increase,risk
Seletracetam,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Seletracetam.,decrease,no risk
Seletracetam,Glymidine,The risk or severity of hypoglycemia can be increased when Seletracetam is combined with Glymidine.,increase,risk
Seletracetam,Guanfacine,Guanfacine may increase the bradycardic activities of Seletracetam.,increase,no risk
Seletracetam,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Seletracetam.,increase,no risk
Inotuzumab ozogamicin,Galcanezumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Galcanezumab.,increase,risk
Inotuzumab ozogamicin,Gemcitabine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Gemcitabine.,increase,no risk
Inotuzumab ozogamicin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Gilteritinib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Gilteritinib.,increase,no risk
Inotuzumab ozogamicin,Glasdegib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Glasdegib.,increase,no risk
Inotuzumab ozogamicin,Glecaprevir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Glecaprevir.,increase,no risk
Inotuzumab ozogamicin,Glofitamab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Glofitamab.,increase,risk
Inotuzumab ozogamicin,Golimumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Golimumab.,increase,risk
Inotuzumab ozogamicin,Grazoprevir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Grazoprevir.,increase,no risk
Inotuzumab ozogamicin,Guselkumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Guselkumab.,increase,risk
Inotuzumab ozogamicin,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Human cytomegalovirus immune globulin.,increase,risk
Inotuzumab ozogamicin,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Human Rho(D) immune globulin.,increase,risk
Inotuzumab ozogamicin,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Human varicella-zoster immune globulin.,increase,risk
Inotuzumab ozogamicin,Ketoconazole,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Ketoconazole.,increase,no risk
Inotuzumab ozogamicin,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Obinutuzumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Obinutuzumab.,increase,risk
Inotuzumab ozogamicin,Ocrelizumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Ocrelizumab.,increase,risk
Inotuzumab ozogamicin,Odesivimab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Odesivimab.,increase,risk
Inotuzumab ozogamicin,Ofatumumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Ofatumumab.,increase,risk
Inotuzumab ozogamicin,Olaratumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Olaratumab.,increase,risk
Inotuzumab ozogamicin,Omadacycline,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Omadacycline.,increase,no risk
Inotuzumab ozogamicin,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Ombitasvir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Ombitasvir.,increase,no risk
Inotuzumab ozogamicin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Inotuzumab ozogamicin.,increase,no risk
Inotuzumab ozogamicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Inotuzumab ozogamicin is combined with Oxetacaine.,increase,risk
Inotuzumab ozogamicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Inotuzumab ozogamicin is combined with Oxybuprocaine.,increase,risk
Inotuzumab ozogamicin,Quinestrol,Quinestrol may increase the thrombogenic activities of Inotuzumab ozogamicin.,increase,no risk
Inotuzumab ozogamicin,Quinidine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Quinidine.,increase,no risk
Inotuzumab ozogamicin,Quinine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Quinine.,increase,no risk
Inotuzumab ozogamicin,Quizartinib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Quizartinib.,increase,no risk
Inotuzumab ozogamicin,Ublituximab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Ublituximab.,increase,risk
Inotuzumab ozogamicin,Ubrogepant,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Ubrogepant.,increase,no risk
Inotuzumab ozogamicin,Umbralisib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Umbralisib.,increase,no risk
Inotuzumab ozogamicin,Umeclidinium,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Umeclidinium.,increase,no risk
Inotuzumab ozogamicin,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Inotuzumab ozogamicin.,increase,risk
Inotuzumab ozogamicin,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Inotuzumab ozogamicin.,decrease,no risk
Inotuzumab ozogamicin,Vandetanib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vandetanib.,increase,no risk
Inotuzumab ozogamicin,Vardenafil,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vardenafil.,increase,no risk
Inotuzumab ozogamicin,Vedolizumab,The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with Vedolizumab.,increase,risk
Inotuzumab ozogamicin,Velpatasvir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Velpatasvir.,increase,no risk
Inotuzumab ozogamicin,Vemurafenib,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vemurafenib.,increase,no risk
Inotuzumab ozogamicin,Venetoclax,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Venetoclax.,increase,no risk
Inotuzumab ozogamicin,Verapamil,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Verapamil.,increase,no risk
Inotuzumab ozogamicin,Vinblastine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vinblastine.,increase,no risk
Inotuzumab ozogamicin,Vincristine,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vincristine.,increase,no risk
Inotuzumab ozogamicin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Inotuzumab ozogamicin.,increase,no risk
Inotuzumab ozogamicin,Voclosporin,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Voclosporin.,increase,no risk
Inotuzumab ozogamicin,Vorapaxar,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Vorapaxar.,increase,no risk
Inotuzumab ozogamicin,Voxilaprevir,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Voxilaprevir.,increase,no risk
Inotuzumab ozogamicin,Zonisamide,The serum concentration of Inotuzumab ozogamicin can be increased when it is combined with Zonisamide.,increase,no risk
RI 624,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with RI 624.,increase,risk
RI 624,Obinutuzumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Obinutuzumab.,increase,risk
RI 624,Ocrelizumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Ocrelizumab.,increase,risk
RI 624,Odesivimab,The risk or severity of adverse effects can be increased when RI 624 is combined with Odesivimab.,increase,risk
RI 624,Ofatumumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Ofatumumab.,increase,risk
RI 624,Olaratumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Olaratumab.,increase,risk
RI 624,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with RI 624.,increase,risk
RI 624,Quinestrol,Quinestrol may increase the thrombogenic activities of RI 624.,increase,no risk
RI 624,Ublituximab,The risk or severity of adverse effects can be increased when RI 624 is combined with Ublituximab.,increase,risk
RI 624,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with RI 624.,increase,risk
RI 624,Vedolizumab,The risk or severity of adverse effects can be increased when RI 624 is combined with Vedolizumab.,increase,risk
KOS-1584,Gepirone,The serum concentration of Gepirone can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Olaparib,The serum concentration of Olaparib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Ouabain,The serum concentration of Ouabain can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Oxetacaine,The risk or severity of methemoglobinemia can be increased when KOS-1584 is combined with Oxetacaine.,increase,risk
KOS-1584,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when KOS-1584 is combined with Oxybuprocaine.,increase,risk
KOS-1584,Quinidine,The serum concentration of Quinidine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Quinine,The serum concentration of Quinine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vardenafil,The metabolism of Vardenafil can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with KOS-1584.,decrease,no risk
KOS-1584,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vincristine,The serum concentration of Vincristine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vindesine,The serum concentration of Vindesine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Warfarin,The serum concentration of Warfarin can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with KOS-1584.,increase,no risk
KOS-1584,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Zopiclone,The metabolism of Zopiclone can be decreased when combined with KOS-1584.,decrease,no risk
KOS-1584,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with KOS-1584.,decrease,no risk
Betulinic Acid,Balsalazide,The risk or severity of adverse effects can be increased when Balsalazide is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Bendazac,The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Bendazac.,increase,risk
Betulinic Acid,Benorilate,The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Benorilate.,increase,risk
Betulinic Acid,Benoxaprofen,The risk or severity of adverse effects can be increased when Benoxaprofen is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Benzydamine,The risk or severity of adverse effects can be increased when Benzydamine is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Bromfenac,The risk or severity of adverse effects can be increased when Bromfenac is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Bufexamac,The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Bufexamac.,increase,risk
Betulinic Acid,Bumadizone,The risk or severity of adverse effects can be increased when Betulinic Acid is combined with Bumadizone.,increase,risk
Betulinic Acid,Butriptyline,The risk or severity of gastrointestinal bleeding can be increased when Butriptyline is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Glycol salicylate,The risk or severity of adverse effects can be increased when Glycol salicylate is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Oxaprozin,The risk or severity of adverse effects can be increased when Oxaprozin is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Oxyphenbutazone,The risk or severity of adverse effects can be increased when Oxyphenbutazone is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Quinupramine,The risk or severity of gastrointestinal bleeding can be increased when Quinupramine is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Valdecoxib,The risk or severity of adverse effects can be increased when Valdecoxib is combined with Betulinic Acid.,increase,risk
Betulinic Acid,Valproic acid,The protein binding of Valproic acid can be decreased when combined with Betulinic Acid.,decrease,no risk
Betulinic Acid,Voriconazole,The serum concentration of Betulinic Acid can be increased when it is combined with Voriconazole.,increase,no risk
Stamulumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with MYO-029.,increase,risk
Stamulumab,Obinutuzumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Obinutuzumab.,increase,risk
Stamulumab,Ocrelizumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Ocrelizumab.,increase,risk
Stamulumab,Odesivimab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Odesivimab.,increase,risk
Stamulumab,Ofatumumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Ofatumumab.,increase,risk
Stamulumab,Olaratumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Olaratumab.,increase,risk
Stamulumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with MYO-029.,increase,risk
Stamulumab,Quinestrol,Quinestrol may increase the thrombogenic activities of MYO-029.,increase,no risk
Stamulumab,Ublituximab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Ublituximab.,increase,risk
Stamulumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with MYO-029.,increase,risk
Stamulumab,Vedolizumab,The risk or severity of adverse effects can be increased when MYO-029 is combined with Vedolizumab.,increase,risk
CT-011,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when CT-011 is combined with Human varicella-zoster immune globulin.,increase,risk
CT-011,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with CT-011.,increase,risk
CT-011,Obinutuzumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Obinutuzumab.,increase,risk
CT-011,Ocrelizumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Ocrelizumab.,increase,risk
CT-011,Odesivimab,The risk or severity of adverse effects can be increased when CT-011 is combined with Odesivimab.,increase,risk
CT-011,Ofatumumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Ofatumumab.,increase,risk
CT-011,Olaratumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Olaratumab.,increase,risk
CT-011,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with CT-011.,increase,risk
CT-011,Oxetacaine,The risk or severity of methemoglobinemia can be increased when CT-011 is combined with Oxetacaine.,increase,risk
CT-011,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when CT-011 is combined with Oxybuprocaine.,increase,risk
CT-011,Quinestrol,Quinestrol may increase the thrombogenic activities of CT-011.,increase,no risk
CT-011,Ublituximab,The risk or severity of adverse effects can be increased when CT-011 is combined with Ublituximab.,increase,risk
CT-011,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with CT-011.,increase,risk
CT-011,Vedolizumab,The risk or severity of adverse effects can be increased when CT-011 is combined with Vedolizumab.,increase,risk
Macimorelin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Macimorelin.,increase,risk
Macimorelin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Macimorelin.,increase,risk
Macimorelin,Gallamine triethiodide,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Macimorelin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Macimorelin.,increase,risk
Macimorelin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Macimorelin.,increase,risk
Macimorelin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Macimorelin.,increase,risk
Macimorelin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Macimorelin.,increase,risk
Macimorelin,Glasdegib,The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Glasdegib.,increase,risk
Macimorelin,Glofitamab,The serum concentration of Macimorelin can be increased when it is combined with Glofitamab.,increase,no risk
Macimorelin,Glycol salicylate,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Macimorelin,Glycopyrronium,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Macimorelin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Macimorelin.,increase,risk
Macimorelin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Macimorelin.,increase,risk
Macimorelin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Macimorelin.,increase,risk
Macimorelin,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Macimorelin.,increase,risk
Macimorelin,Haloperidol,The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Haloperidol.,increase,risk
Macimorelin,Hexocyclium,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Hexocyclium.,decrease,no risk
Macimorelin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Macimorelin.,increase,risk
Macimorelin,Homatropine methylbromide,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Macimorelin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Macimorelin.,increase,risk
Macimorelin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Macimorelin.,increase,risk
Macimorelin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Hydroxyzine.,increase,risk
Macimorelin,Hyoscyamine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Macimorelin,Ketoconazole,The metabolism of Macimorelin can be decreased when combined with Ketoconazole.,decrease,no risk
Macimorelin,Ketoprofen,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Ketoprofen.,decrease,no risk
Macimorelin,Ketorolac,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Ketorolac.,decrease,no risk
Macimorelin,Octreotide,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Octreotide.,decrease,no risk
Macimorelin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Macimorelin.,increase,risk
Macimorelin,Olanzapine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Olanzapine.,decrease,no risk
Macimorelin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Macimorelin.,increase,risk
Macimorelin,Omaveloxolone,The serum concentration of Macimorelin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Macimorelin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Macimorelin.,increase,risk
Macimorelin,Orphenadrine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Orphenadrine.,decrease,no risk
Macimorelin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Macimorelin.,increase,risk
Macimorelin,Oxaprozin,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxaprozin.,decrease,no risk
Macimorelin,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Macimorelin.,increase,risk
Macimorelin,Oxybutynin,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxybutynin.,decrease,no risk
Macimorelin,Oxyphenbutazone,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Macimorelin,Oxyphencyclimine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Macimorelin,Oxyphenonium,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Macimorelin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Macimorelin.,increase,risk
Macimorelin,Quetiapine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Quetiapine.,decrease,no risk
Macimorelin,Quinidine,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Quinidine.,decrease,no risk
Macimorelin,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Macimorelin.,increase,risk
Macimorelin,Quizartinib,The risk or severity of QTc prolongation can be increased when Macimorelin is combined with Quizartinib.,increase,risk
Macimorelin,Umeclidinium,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Umeclidinium.,decrease,no risk
Macimorelin,Vadadustat,The serum concentration of Macimorelin can be increased when it is combined with Vadadustat.,increase,no risk
Macimorelin,Valdecoxib,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Valdecoxib.,decrease,no risk
Macimorelin,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Macimorelin.,increase,risk
Macimorelin,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Macimorelin.,increase,risk
Macimorelin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Macimorelin.,increase,risk
Macimorelin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Macimorelin.,increase,risk
Macimorelin,Venetoclax,The metabolism of Macimorelin can be decreased when combined with Venetoclax.,decrease,no risk
Macimorelin,Verapamil,The metabolism of Macimorelin can be decreased when combined with Verapamil.,decrease,no risk
Macimorelin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Macimorelin.,increase,risk
Macimorelin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Macimorelin.,increase,risk
Macimorelin,Viloxazine,The metabolism of Macimorelin can be decreased when combined with Viloxazine.,decrease,no risk
Macimorelin,Voriconazole,The metabolism of Macimorelin can be decreased when combined with Voriconazole.,decrease,no risk
Macimorelin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Macimorelin.,increase,risk
Macimorelin,Zimelidine,The metabolism of Macimorelin can be decreased when combined with Zimelidine.,decrease,no risk
Macimorelin,Ziprasidone,The therapeutic efficacy of Macimorelin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Macimorelin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Macimorelin.,increase,risk
Macimorelin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Macimorelin.,increase,risk
Abexinostat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Abexinostat.,increase,risk
Abexinostat,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Abexinostat.,increase,risk
Abexinostat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Abexinostat.,increase,risk
Abexinostat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Abexinostat.,increase,risk
Abexinostat,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Abexinostat.,increase,risk
Abexinostat,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Abexinostat.,increase,risk
Abexinostat,Glasdegib,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Glasdegib.,increase,risk
Abexinostat,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Abexinostat.,increase,risk
Abexinostat,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Abexinostat.,increase,risk
Abexinostat,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Grepafloxacin.,increase,risk
Abexinostat,Halofantrine,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Halofantrine.,increase,risk
Abexinostat,Haloperidol,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Haloperidol.,increase,risk
Abexinostat,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Abexinostat.,increase,risk
Abexinostat,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Abexinostat.,increase,risk
Abexinostat,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Abexinostat.,increase,risk
Abexinostat,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Hydroxyzine.,increase,risk
Abexinostat,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Abexinostat.,increase,risk
Abexinostat,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Abexinostat.,increase,risk
Abexinostat,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Abexinostat.,increase,risk
Abexinostat,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Abexinostat.,increase,risk
Abexinostat,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Abexinostat.,increase,risk
Abexinostat,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Abexinostat.,increase,risk
Abexinostat,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Abexinostat.,increase,risk
Abexinostat,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Abexinostat.,increase,risk
Abexinostat,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Abexinostat.,increase,risk
Abexinostat,Oxatomide,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Oxatomide.,increase,risk
Abexinostat,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Abexinostat is combined with Oxetacaine.,increase,risk
Abexinostat,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Abexinostat is combined with Oxybuprocaine.,increase,risk
Abexinostat,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Abexinostat.,increase,risk
Abexinostat,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Abexinostat.,increase,risk
Abexinostat,Quinidine,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Quinidine.,increase,risk
Abexinostat,Quinine,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Quinine.,increase,risk
Abexinostat,Quizartinib,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Quizartinib.,increase,risk
Abexinostat,Valproic acid,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Valproic acid.,increase,risk
Abexinostat,Vandetanib,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Vandetanib.,increase,risk
Abexinostat,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Abexinostat.,increase,risk
Abexinostat,Vemurafenib,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Vemurafenib.,increase,risk
Abexinostat,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Abexinostat.,increase,risk
Abexinostat,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Abexinostat.,increase,risk
Abexinostat,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Abexinostat.,increase,risk
Abexinostat,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Abexinostat is combined with Vorinostat.,increase,risk
Abexinostat,Ziprasidone,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Ziprasidone.,increase,risk
Abexinostat,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Abexinostat.,increase,risk
Abexinostat,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Abexinostat is combined with Zuclopenthixol.,increase,risk
Dovitinib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Gefitinib,Dovitinib may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Dovitinib,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Glasdegib,Dovitinib may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Dovitinib,Glecaprevir,Dovitinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Dovitinib,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Glyburide,Dovitinib may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Dovitinib,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Guanabenz,The metabolism of Guanabenz can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Olanzapine,The metabolism of Olanzapine can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Olaparib,The metabolism of Olaparib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Ombitasvir,Dovitinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Dovitinib,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Ondansetron,The metabolism of Ondansetron can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Ouabain,The excretion of Ouabain can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Oxaliplatin,Dovitinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Dovitinib,Oxazepam,The metabolism of Oxazepam can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Ozanimod,Dovitinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Dovitinib,Quinidine,The metabolism of Quinidine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Quinine,The metabolism of Quinine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Vadadustat,The metabolism of Vadadustat can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Valsartan,The excretion of Valsartan can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Velpatasvir,Dovitinib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Dovitinib,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Verapamil,The metabolism of Verapamil can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vincristine,The metabolism of Vincristine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vindesine,The metabolism of Vindesine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Voriconazole,The serum concentration of Dovitinib can be increased when it is combined with Voriconazole.,increase,no risk
Dovitinib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Voxilaprevir,Dovitinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Dovitinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Dovitinib.,increase,no risk
Dovitinib,Zidovudine,Dovitinib may decrease the excretion rate of Zidovudine which could result in a higher serum level.,decrease,no risk
Dovitinib,Zileuton,The metabolism of Zileuton can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Dovitinib.,decrease,no risk
Dovitinib,Zotepine,The metabolism of Zotepine can be increased when combined with Dovitinib.,increase,no risk
Dovitinib,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Dovitinib.,decrease,no risk
Olaparib,Boceprevir,The metabolism of Olaparib can be decreased when combined with Boceprevir.,decrease,no risk
Olaparib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Olaparib.",decrease,no risk
Olaparib,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Bosentan,The metabolism of Olaparib can be increased when combined with Bosentan.,increase,no risk
Olaparib,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Brodalumab,The risk or severity of adverse effects can be increased when Olaparib is combined with Brodalumab.,increase,risk
Olaparib,Budesonide,The metabolism of Olaparib can be increased when combined with Budesonide.,increase,no risk
Olaparib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Bupivacaine.,increase,risk
Olaparib,Buprenorphine,The metabolism of Olaparib can be decreased when combined with Buprenorphine.,decrease,no risk
Olaparib,Buspirone,The metabolism of Olaparib can be decreased when combined with Buspirone.,decrease,no risk
Olaparib,Busulfan,The metabolism of Busulfan can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Butacaine,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Butacaine.,increase,risk
Olaparib,Butalbital,The metabolism of Olaparib can be increased when combined with Butalbital.,increase,no risk
Olaparib,Butamben,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Butamben.,increase,risk
Olaparib,Gefitinib,The metabolism of Olaparib can be decreased when combined with Gefitinib.,decrease,no risk
Olaparib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Olaparib.,increase,risk
Olaparib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Olaparib.,increase,risk
Olaparib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Olaparib.,increase,no risk
Olaparib,Gilteritinib,The metabolism of Olaparib can be decreased when combined with Gilteritinib.,decrease,no risk
Olaparib,Ginkgo biloba,The metabolism of Olaparib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Olaparib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Olaparib.,increase,risk
Olaparib,Glecaprevir,The metabolism of Olaparib can be decreased when combined with Glecaprevir.,decrease,no risk
Olaparib,Glofitamab,The serum concentration of Olaparib can be increased when it is combined with Glofitamab.,increase,no risk
Olaparib,Glyburide,The metabolism of Olaparib can be decreased when combined with Glyburide.,decrease,no risk
Olaparib,Glycerol phenylbutyrate,The metabolism of Olaparib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Olaparib,Golimumab,The metabolism of Olaparib can be increased when combined with Golimumab.,increase,no risk
Olaparib,Grapefruit,The serum concentration of Olaparib can be increased when it is combined with Grapefruit.,increase,no risk
Olaparib,Griseofulvin,The metabolism of Olaparib can be increased when combined with Griseofulvin.,increase,no risk
Olaparib,Guselkumab,The risk or severity of adverse effects can be increased when Olaparib is combined with Guselkumab.,increase,risk
Olaparib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Halofantrine,The metabolism of Olaparib can be decreased when combined with Halofantrine.,decrease,no risk
Olaparib,Haloperidol,The metabolism of Olaparib can be decreased when combined with Haloperidol.,decrease,no risk
Olaparib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Olaparib.,increase,risk
Olaparib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Olaparib.,increase,risk
Olaparib,Hydralazine,The serum concentration of Olaparib can be increased when it is combined with Hydralazine.,increase,no risk
Olaparib,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Olaparib.,increase,risk
Olaparib,Hydrocortamate,The metabolism of Olaparib can be increased when combined with Hydrocortamate.,increase,no risk
Olaparib,Hydrocortisone,The metabolism of Olaparib can be increased when combined with Hydrocortisone.,increase,no risk
Olaparib,Hydrocortisone acetate,The metabolism of Olaparib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Olaparib,Hydrocortisone butyrate,The metabolism of Olaparib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Olaparib,Hydrocortisone cypionate,The metabolism of Olaparib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Olaparib,Hydrocortisone phosphate,The metabolism of Olaparib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Olaparib,Hydrocortisone succinate,The metabolism of Olaparib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Olaparib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Olaparib.,increase,risk
Olaparib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Olaparib.,increase,risk
Olaparib,Hydroxyprogesterone caproate,The metabolism of Olaparib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Olaparib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Olaparib.,increase,risk
Olaparib,Hydroxyzine,The metabolism of Olaparib can be decreased when combined with Hydroxyzine.,decrease,no risk
Olaparib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Ketazolam,The serum concentration of Olaparib can be increased when it is combined with Ketazolam.,increase,no risk
Olaparib,Ketoconazole,The metabolism of Olaparib can be decreased when combined with Ketoconazole.,decrease,no risk
Olaparib,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Olaparib.,increase,risk
Olaparib,Ocrelizumab,The risk or severity of adverse effects can be increased when Olaparib is combined with Ocrelizumab.,increase,risk
Olaparib,Octreotide,The serum concentration of Olaparib can be increased when it is combined with Octreotide.,increase,no risk
Olaparib,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Olaparib.,increase,risk
Olaparib,Olutasidenib,The metabolism of Olaparib can be increased when combined with Olutasidenib.,increase,no risk
Olaparib,Omaveloxolone,The serum concentration of Olaparib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Olaparib,Ondansetron,The metabolism of Olaparib can be decreased when combined with Ondansetron.,decrease,no risk
Olaparib,Oritavancin,The metabolism of Olaparib can be increased when combined with Oritavancin.,increase,no risk
Olaparib,Orphenadrine,The metabolism of Olaparib can be decreased when combined with Orphenadrine.,decrease,no risk
Olaparib,Osilodrostat,The metabolism of Olaparib can be decreased when combined with Osilodrostat.,decrease,no risk
Olaparib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Olaparib.,increase,risk
Olaparib,Oxcarbazepine,The metabolism of Olaparib can be increased when combined with Oxcarbazepine.,increase,no risk
Olaparib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Oxetacaine.,increase,risk
Olaparib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Olaparib is combined with Oxybuprocaine.,increase,risk
Olaparib,Oxybutynin,The serum concentration of Olaparib can be increased when it is combined with Oxybutynin.,increase,no risk
Olaparib,Oxycodone,The metabolism of Olaparib can be decreased when combined with Oxycodone.,decrease,no risk
Olaparib,Ozanimod,The risk or severity of adverse effects can be increased when Olaparib is combined with Ozanimod.,increase,risk
Olaparib,Quetiapine,The metabolism of Olaparib can be decreased when combined with Quetiapine.,decrease,no risk
Olaparib,Quinidine,The metabolism of Olaparib can be decreased when combined with Quinidine.,decrease,no risk
Olaparib,Quinine,The metabolism of Olaparib can be increased when combined with Quinine.,increase,no risk
Olaparib,Quinupristin,The metabolism of Olaparib can be decreased when combined with Quinupristin.,decrease,no risk
Olaparib,Quizartinib,The metabolism of Olaparib can be decreased when combined with Quizartinib.,decrease,no risk
Olaparib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Olaparib.,increase,risk
Olaparib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Olaparib.,increase,no risk
Olaparib,Udenafil,The metabolism of Olaparib can be decreased when combined with Udenafil.,decrease,no risk
Olaparib,Upadacitinib,The risk or severity of adverse effects can be increased when Olaparib is combined with Upadacitinib.,increase,risk
Olaparib,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Olaparib.,increase,risk
Olaparib,Vadadustat,The serum concentration of Olaparib can be increased when it is combined with Vadadustat.,increase,no risk
Olaparib,Valbenazine,The metabolism of Olaparib can be decreased when combined with Valbenazine.,decrease,no risk
Olaparib,Valproic acid,The serum concentration of Olaparib can be increased when it is combined with Valproic acid.,increase,no risk
Olaparib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Olaparib.,increase,risk
Olaparib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Olaparib.,increase,risk
Olaparib,Vemurafenib,The metabolism of Olaparib can be increased when combined with Vemurafenib.,increase,no risk
Olaparib,Venetoclax,The metabolism of Olaparib can be decreased when combined with Venetoclax.,decrease,no risk
Olaparib,Verapamil,The metabolism of Olaparib can be decreased when combined with Verapamil.,decrease,no risk
Olaparib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Olaparib.,decrease,no risk
Olaparib,Vilanterol,The risk or severity of adverse effects can be increased when Olaparib is combined with Vilanterol.,increase,risk
Olaparib,Viloxazine,The metabolism of Olaparib can be decreased when combined with Viloxazine.,decrease,no risk
Olaparib,Vinblastine,The metabolism of Olaparib can be increased when combined with Vinblastine.,increase,no risk
Olaparib,Vincristine,The metabolism of Vincristine can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vindesine,The metabolism of Vindesine can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Vitamin E,The metabolism of Olaparib can be increased when combined with Vitamin E.,increase,no risk
Olaparib,Voclosporin,The risk or severity of adverse effects can be increased when Olaparib is combined with Voclosporin.,increase,risk
Olaparib,Vonoprazan,The metabolism of Olaparib can be decreased when combined with Vonoprazan.,decrease,no risk
Olaparib,Vorapaxar,The metabolism of Olaparib can be decreased when combined with Vorapaxar.,decrease,no risk
Olaparib,Voriconazole,The metabolism of Olaparib can be decreased when combined with Voriconazole.,decrease,no risk
Olaparib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Olaparib.,increase,risk
Olaparib,Vortioxetine,The metabolism of Olaparib can be decreased when combined with Vortioxetine.,decrease,no risk
Olaparib,Voxelotor,The serum concentration of Olaparib can be increased when it is combined with Voxelotor.,increase,no risk
Olaparib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Olaparib.,increase,no risk
Olaparib,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Olaparib.,increase,risk
Olaparib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Olaparib.,increase,risk
Olaparib,Zafirlukast,The serum concentration of Olaparib can be increased when it is combined with Zafirlukast.,increase,no risk
Olaparib,Zaleplon,The metabolism of Olaparib can be decreased when combined with Zaleplon.,decrease,no risk
Olaparib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Olaparib.,increase,risk
Olaparib,Zimelidine,The metabolism of Olaparib can be decreased when combined with Zimelidine.,decrease,no risk
Olaparib,Ziprasidone,The metabolism of Olaparib can be decreased when combined with Ziprasidone.,decrease,no risk
Olaparib,Zonisamide,The metabolism of Olaparib can be decreased when combined with Zonisamide.,decrease,no risk
Olaparib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Olaparib.,decrease,no risk
Olaparib,Zuclopenthixol,The metabolism of Olaparib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Leronlimab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Leronlimab.,increase,risk
Leronlimab,Obinutuzumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Obinutuzumab.,increase,risk
Leronlimab,Ocrelizumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Ocrelizumab.,increase,risk
Leronlimab,Odesivimab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Odesivimab.,increase,risk
Leronlimab,Ofatumumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Ofatumumab.,increase,risk
Leronlimab,Olaratumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Olaratumab.,increase,risk
Leronlimab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Leronlimab.,increase,risk
Leronlimab,Quinestrol,Quinestrol may increase the thrombogenic activities of Leronlimab.,increase,no risk
Leronlimab,Ublituximab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Ublituximab.,increase,risk
Leronlimab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Leronlimab.,increase,risk
Leronlimab,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Leronlimab.,decrease,no risk
Leronlimab,Vedolizumab,The risk or severity of adverse effects can be increased when Leronlimab is combined with Vedolizumab.,increase,risk
Leronlimab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Leronlimab.,decrease,no risk
Leronlimab,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Leronlimab.,decrease,no risk
GI-5005,Gemtuzumab ozogamicin,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
GI-5005,Glatiramer,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Glatiramer.,decrease,no risk
GI-5005,Golimumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Golimumab.,decrease,no risk
GI-5005,Guselkumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Guselkumab.,decrease,no risk
GI-5005,Hydrocortisone,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydrocortisone.,decrease,no risk
GI-5005,Hydrocortisone acetate,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
GI-5005,Hydrocortisone butyrate,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
GI-5005,Hydrocortisone succinate,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
GI-5005,Hydroxychloroquine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
GI-5005,Hydroxyurea,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Hydroxyurea.,decrease,no risk
GI-5005,Obinutuzumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Obinutuzumab.,decrease,no risk
GI-5005,Ocrelizumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Ocrelizumab.,decrease,no risk
GI-5005,Ofatumumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Ofatumumab.,decrease,no risk
GI-5005,Olaparib,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Olaparib.,decrease,no risk
GI-5005,Oxaliplatin,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Oxaliplatin.,decrease,no risk
GI-5005,Ozanimod,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Ozanimod.,decrease,no risk
GI-5005,Ublituximab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Ublituximab.,decrease,no risk
GI-5005,Upadacitinib,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Upadacitinib.,decrease,no risk
GI-5005,Vedolizumab,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vedolizumab.,decrease,no risk
GI-5005,Vilanterol,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vilanterol.,decrease,no risk
GI-5005,Vinblastine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vinblastine.,decrease,no risk
GI-5005,Vincristine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vincristine.,decrease,no risk
GI-5005,Vindesine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vindesine.,decrease,no risk
GI-5005,Vinorelbine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vinorelbine.,decrease,no risk
GI-5005,Voclosporin,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Voclosporin.,decrease,no risk
GI-5005,Vorinostat,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Vorinostat.,decrease,no risk
GI-5005,Zidovudine,The therapeutic efficacy of GI-5005 can be decreased when used in combination with Zidovudine.,decrease,no risk
Sifalimumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Sifalimumab.,increase,risk
Sifalimumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Odesivimab,The risk or severity of adverse effects can be increased when Sifalimumab is combined with Odesivimab.,increase,risk
Sifalimumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Sifalimumab.,increase,no risk
Sifalimumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Sifalimumab.,increase,risk
Sifalimumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Sifalimumab.,increase,risk
Sifalimumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Sifalimumab.,increase,risk
Urelumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Urelumab.,increase,risk
Urelumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Urelumab.,increase,risk
Urelumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Urelumab.,increase,risk
Urelumab,Odesivimab,The risk or severity of adverse effects can be increased when Urelumab is combined with Odesivimab.,increase,risk
Urelumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Urelumab.,increase,risk
Urelumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Urelumab.,increase,risk
Urelumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Urelumab.,increase,risk
Urelumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Urelumab.,increase,no risk
Urelumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Urelumab.,increase,risk
Urelumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Urelumab.,increase,risk
Urelumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Urelumab.,increase,risk
Lebrikizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Lebrikizumab is combined with Ocrelizumab.,increase,risk
Lebrikizumab,Odesivimab,The risk or severity of adverse effects can be increased when Lebrikizumab is combined with Odesivimab.,increase,risk
Lebrikizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Lebrikizumab.,increase,no risk
Lebrikizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Lebrikizumab.,increase,risk
Lebrikizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Lebrikizumab.,increase,risk
Radezolid,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Radezolid.,decrease,no risk
Radezolid,Benzocaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Benzocaine.,increase,risk
Radezolid,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Benzyl alcohol.,increase,risk
Radezolid,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Bupivacaine.,increase,risk
Radezolid,Butacaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Butacaine.,increase,risk
Radezolid,Butamben,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Butamben.,increase,risk
Radezolid,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Oxetacaine.,increase,risk
Radezolid,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Radezolid is combined with Oxybuprocaine.,increase,risk
Radezolid,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Radezolid.,decrease,no risk
Radezolid,Warfarin,The risk or severity of bleeding can be increased when Radezolid is combined with Warfarin.,increase,risk
Transcrocetinate,Benzocaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Benzocaine.,increase,risk
Transcrocetinate,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Benzyl alcohol.,increase,risk
Transcrocetinate,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Bupivacaine.,increase,risk
Transcrocetinate,Butacaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Butacaine.,increase,risk
Transcrocetinate,Butamben,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Butamben.,increase,risk
Transcrocetinate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Oxetacaine.,increase,risk
Transcrocetinate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Transcrocetinate is combined with Oxybuprocaine.,increase,risk
Iniparib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Benzocaine.,increase,risk
Iniparib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Benzyl alcohol.,increase,risk
Iniparib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Bupivacaine.,increase,risk
Iniparib,Butacaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Butacaine.,increase,risk
Iniparib,Butamben,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Butamben.,increase,risk
Iniparib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Oxetacaine.,increase,risk
Iniparib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Iniparib is combined with Oxybuprocaine.,increase,risk
Binimetinib,Gatifloxacin,The metabolism of Binimetinib can be decreased when combined with Gatifloxacin.,decrease,no risk
Binimetinib,Gefitinib,Gefitinib may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Gemcitabine,The serum concentration of Binimetinib can be increased when it is combined with Gemcitabine.,increase,no risk
Binimetinib,Gemfibrozil,The metabolism of Binimetinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Binimetinib,Gemifloxacin,The metabolism of Binimetinib can be decreased when combined with Gemifloxacin.,decrease,no risk
Binimetinib,Gilteritinib,Gilteritinib may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Givosiran,The serum concentration of Binimetinib can be increased when it is combined with Givosiran.,increase,no risk
Binimetinib,Glasdegib,The serum concentration of Binimetinib can be increased when it is combined with Glasdegib.,increase,no risk
Binimetinib,Glecaprevir,The serum concentration of Binimetinib can be increased when it is combined with Glecaprevir.,increase,no risk
Binimetinib,Glofitamab,The serum concentration of Binimetinib can be increased when it is combined with Glofitamab.,increase,no risk
Binimetinib,Golimumab,The metabolism of Binimetinib can be increased when combined with Golimumab.,increase,no risk
Binimetinib,Grazoprevir,Grazoprevir may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Grepafloxacin,The metabolism of Binimetinib can be decreased when combined with Grepafloxacin.,decrease,no risk
Binimetinib,Guanabenz,The metabolism of Binimetinib can be decreased when combined with Guanabenz.,decrease,no risk
Binimetinib,Haloperidol,The metabolism of Binimetinib can be decreased when combined with Haloperidol.,decrease,no risk
Binimetinib,Hydrocortisone,The metabolism of Binimetinib can be increased when combined with Hydrocortisone.,increase,no risk
Binimetinib,Hydroxyprogesterone caproate,The metabolism of Binimetinib can be increased when combined with Hydroxyprogesterone caproate.,increase,no risk
Binimetinib,Ketoconazole,The serum concentration of Binimetinib can be increased when it is combined with Ketoconazole.,increase,no risk
Binimetinib,Obeticholic acid,The risk or severity of adverse effects can be increased when Obeticholic acid is combined with Binimetinib.,increase,risk
Binimetinib,Olanzapine,The metabolism of Binimetinib can be decreased when combined with Olanzapine.,decrease,no risk
Binimetinib,Omadacycline,The serum concentration of Binimetinib can be increased when it is combined with Omadacycline.,increase,no risk
Binimetinib,Ombitasvir,The metabolism of Binimetinib can be decreased when combined with Ombitasvir.,decrease,no risk
Binimetinib,Omeprazole,The metabolism of Binimetinib can be decreased when combined with Omeprazole.,decrease,no risk
Binimetinib,Ondansetron,The metabolism of Binimetinib can be decreased when combined with Ondansetron.,decrease,no risk
Binimetinib,Oritavancin,The metabolism of Binimetinib can be decreased when combined with Oritavancin.,decrease,no risk
Binimetinib,Orphenadrine,The metabolism of Binimetinib can be decreased when combined with Orphenadrine.,decrease,no risk
Binimetinib,Osilodrostat,The serum concentration of Binimetinib can be increased when it is combined with Osilodrostat.,increase,no risk
Binimetinib,Osimertinib,The serum concentration of Binimetinib can be decreased when it is combined with Osimertinib.,decrease,no risk
Binimetinib,Oteseconazole,The serum concentration of Binimetinib can be increased when it is combined with Oteseconazole.,increase,no risk
Binimetinib,Oxcarbazepine,The metabolism of Binimetinib can be decreased when combined with Oxcarbazepine.,decrease,no risk
Binimetinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Oxetacaine.,increase,risk
Binimetinib,Oxtriphylline,The metabolism of Binimetinib can be decreased when combined with Oxtriphylline.,decrease,no risk
Binimetinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Binimetinib is combined with Oxybuprocaine.,increase,risk
Binimetinib,Quinidine,The serum concentration of Binimetinib can be increased when it is combined with Quinidine.,increase,no risk
Binimetinib,Quinine,The serum concentration of Binimetinib can be increased when it is combined with Quinine.,increase,no risk
Binimetinib,Quizartinib,The serum concentration of Binimetinib can be increased when it is combined with Quizartinib.,increase,no risk
Binimetinib,Ubrogepant,The serum concentration of Binimetinib can be increased when it is combined with Ubrogepant.,increase,no risk
Binimetinib,Umbralisib,The serum concentration of Binimetinib can be increased when it is combined with Umbralisib.,increase,no risk
Binimetinib,Umeclidinium,The serum concentration of Binimetinib can be increased when it is combined with Umeclidinium.,increase,no risk
Binimetinib,Vadadustat,Vadadustat may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Valproic acid,The metabolism of Binimetinib can be decreased when combined with Valproic acid.,decrease,no risk
Binimetinib,Vandetanib,The serum concentration of Binimetinib can be increased when it is combined with Vandetanib.,increase,no risk
Binimetinib,Vardenafil,The serum concentration of Binimetinib can be increased when it is combined with Vardenafil.,increase,no risk
Binimetinib,Velpatasvir,The serum concentration of Binimetinib can be increased when it is combined with Velpatasvir.,increase,no risk
Binimetinib,Vemurafenib,The serum concentration of Binimetinib can be increased when it is combined with Vemurafenib.,increase,no risk
Binimetinib,Venetoclax,The serum concentration of Binimetinib can be increased when it is combined with Venetoclax.,increase,no risk
Binimetinib,Venlafaxine,Venlafaxine may increase the excretion rate of Binimetinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Binimetinib,Verapamil,The serum concentration of Binimetinib can be increased when it is combined with Verapamil.,increase,no risk
Binimetinib,Viloxazine,The metabolism of Binimetinib can be decreased when combined with Viloxazine.,decrease,no risk
Binimetinib,Vinblastine,The serum concentration of Binimetinib can be increased when it is combined with Vinblastine.,increase,no risk
Binimetinib,Vincristine,The serum concentration of Binimetinib can be increased when it is combined with Vincristine.,increase,no risk
Binimetinib,Vinflunine,The serum concentration of Binimetinib can be increased when it is combined with Vinflunine.,increase,no risk
Binimetinib,Vismodegib,Vismodegib may decrease the excretion rate of Binimetinib which could result in a higher serum level.,decrease,no risk
Binimetinib,Voclosporin,The serum concentration of Binimetinib can be increased when it is combined with Voclosporin.,increase,no risk
Binimetinib,Vonoprazan,The metabolism of Binimetinib can be decreased when combined with Vonoprazan.,decrease,no risk
Binimetinib,Vorapaxar,The serum concentration of Binimetinib can be increased when it is combined with Vorapaxar.,increase,no risk
Binimetinib,Voriconazole,The metabolism of Binimetinib can be decreased when combined with Voriconazole.,decrease,no risk
Binimetinib,Voxilaprevir,The serum concentration of Binimetinib can be increased when it is combined with Voxilaprevir.,increase,no risk
Binimetinib,Warfarin,The metabolism of Binimetinib can be decreased when combined with Warfarin.,decrease,no risk
Binimetinib,Zafirlukast,The metabolism of Binimetinib can be decreased when combined with Zafirlukast.,decrease,no risk
Binimetinib,Zidovudine,The metabolism of Binimetinib can be increased when combined with Zidovudine.,increase,no risk
Binimetinib,Zileuton,The metabolism of Binimetinib can be decreased when combined with Zileuton.,decrease,no risk
Binimetinib,Zolmitriptan,The metabolism of Binimetinib can be decreased when combined with Zolmitriptan.,decrease,no risk
Binimetinib,Zolpidem,The metabolism of Binimetinib can be decreased when combined with Zolpidem.,decrease,no risk
Binimetinib,Zonisamide,The serum concentration of Binimetinib can be increased when it is combined with Zonisamide.,increase,no risk
Binimetinib,Zotepine,The metabolism of Binimetinib can be decreased when combined with Zotepine.,decrease,no risk
Ivacaftor,Galantamine,The serum concentration of Galantamine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gemfibrozil,The serum concentration of Gemfibrozil can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gestrinone,The serum concentration of Gestrinone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gliclazide,The serum concentration of Gliclazide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glimepiride,The serum concentration of Glimepiride can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glipizide,The serum concentration of Glipizide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Gliquidone,The serum concentration of Gliquidone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Glofitamab,The serum concentration of Ivacaftor can be increased when it is combined with Glofitamab.,increase,no risk
Ivacaftor,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Golimumab,The metabolism of Ivacaftor can be increased when combined with Golimumab.,increase,no risk
Ivacaftor,Granisetron,The serum concentration of Granisetron can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Guanfacine,The serum concentration of Guanfacine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Halcinonide,The serum concentration of Halcinonide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Halofantrine,The serum concentration of Halofantrine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Haloperidol,The metabolism of Ivacaftor can be decreased when combined with Haloperidol.,decrease,no risk
Ivacaftor,Halothane,The serum concentration of Halothane can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocodone,The serum concentration of Hydrocodone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone phosphate,The serum concentration of Hydrocortisone phosphate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydromorphone,The serum concentration of Hydromorphone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydroxychloroquine,The serum concentration of Hydroxychloroquine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Hydroxyzine,The serum concentration of Hydroxyzine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ketamine,The serum concentration of Ketamine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ketazolam,The serum concentration of Ketazolam can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ketoconazole,The metabolism of Ivacaftor can be decreased when combined with Ketoconazole.,decrease,no risk
Ivacaftor,Ketorolac,The serum concentration of Ketorolac can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Olodaterol,The serum concentration of Olodaterol can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Olutasidenib,The serum concentration of Olutasidenib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Opium,The serum concentration of Opium can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Orphenadrine,The serum concentration of Orphenadrine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ospemifene,The serum concentration of Ospemifene can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Oxcarbazepine,The metabolism of Ivacaftor can be increased when combined with Oxcarbazepine.,increase,no risk
Ivacaftor,Oxybutynin,The serum concentration of Oxybutynin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Oxycodone,The serum concentration of Oxycodone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Oxymorphone,The serum concentration of Oxymorphone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quazepam,The serum concentration of Quazepam can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quinine,The serum concentration of Quinine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Udenafil,The serum concentration of Udenafil can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ulipristal,The serum concentration of Ulipristal can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Upadacitinib,The serum concentration of Upadacitinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vadadustat,The serum concentration of Ivacaftor can be increased when it is combined with Vadadustat.,increase,no risk
Ivacaftor,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Valdecoxib,The serum concentration of Valdecoxib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Valsartan,The serum concentration of Valsartan can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ivacaftor.,decrease,no risk
Ivacaftor,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Venetoclax,The metabolism of Ivacaftor can be decreased when combined with Venetoclax.,decrease,no risk
Ivacaftor,Venlafaxine,The serum concentration of Venlafaxine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Verapamil,The metabolism of Ivacaftor can be decreased when combined with Verapamil.,decrease,no risk
Ivacaftor,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vilazodone,The serum concentration of Vilazodone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Viloxazine,The metabolism of Ivacaftor can be decreased when combined with Viloxazine.,decrease,no risk
Ivacaftor,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vitamin D,The serum concentration of Vitamin D can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vitamin E,The serum concentration of Vitamin E can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vonoprazan,The serum concentration of Vonoprazan can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Vorapaxar,The serum concentration of Vorapaxar can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Voriconazole,The serum concentration of Ivacaftor can be increased when it is combined with Voriconazole.,increase,no risk
Ivacaftor,Vortioxetine,The serum concentration of Vortioxetine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Ximelagatran,The serum concentration of Ximelagatran can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Yohimbine,The serum concentration of Yohimbine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zafirlukast,The serum concentration of Zafirlukast can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zaleplon,The serum concentration of Zaleplon can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zimelidine,The metabolism of Ivacaftor can be decreased when combined with Zimelidine.,decrease,no risk
Ivacaftor,Ziprasidone,The metabolism of Ivacaftor can be decreased when combined with Ziprasidone.,decrease,no risk
Ivacaftor,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zopiclone,The serum concentration of Zopiclone can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zuclopenthixol,The serum concentration of Zuclopenthixol can be increased when it is combined with Ivacaftor.,increase,no risk
Ivacaftor,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Ivacaftor.,increase,no risk
Obeticholic acid,Gemfibrozil,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Gemfibrozil.,decrease,no risk
Obeticholic acid,Gestrinone,The therapeutic efficacy of Obeticholic acid can be decreased when used in combination with Gestrinone.,decrease,no risk
Obeticholic acid,Glyburide,The risk or severity of adverse effects can be increased when Glyburide is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Heparin,The risk or severity of bleeding and bruising can be increased when Heparin is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Obeticholic acid,Kaolin,Kaolin can cause a decrease in the absorption of Obeticholic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Obeticholic acid,Ketoconazole,The risk or severity of adverse effects can be increased when Ketoconazole is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Quinidine,The risk or severity of adverse effects can be increased when Quinidine is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Quinine,The metabolism of Quinine can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Urokinase,The risk or severity of bleeding and bruising can be increased when Urokinase is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Ursodeoxycholic acid is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Verapamil,The metabolism of Verapamil can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Vorapaxar,The risk or severity of adverse effects can be increased when Vorapaxar is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Warfarin,The therapeutic efficacy of Warfarin can be decreased when used in combination with Obeticholic acid.,decrease,no risk
Obeticholic acid,Ximelagatran,The risk or severity of bleeding and bruising can be increased when Ximelagatran is combined with Obeticholic acid.,increase,risk
Obeticholic acid,Zileuton,The metabolism of Zileuton can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Obeticholic acid.,decrease,no risk
Obeticholic acid,Zotepine,The metabolism of Zotepine can be decreased when combined with Obeticholic acid.,decrease,no risk
Ebselen,Gatifloxacin,Ebselen may increase the neuroexcitatory activities of Gatifloxacin.,increase,no risk
Ebselen,Gemifloxacin,Ebselen may increase the neuroexcitatory activities of Gemifloxacin.,increase,no risk
Ebselen,Gentamicin,The risk or severity of nephrotoxicity can be increased when Ebselen is combined with Gentamicin.,increase,risk
Ebselen,Gliclazide,The protein binding of Gliclazide can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Glimepiride,The protein binding of Glimepiride can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Glipizide,The protein binding of Glipizide can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Gliquidone,The protein binding of Gliquidone can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Glyburide,The protein binding of Glyburide can be decreased when combined with Ebselen.,decrease,no risk
Ebselen,Glycol salicylate,The risk or severity of adverse effects can be increased when Glycol salicylate is combined with Ebselen.,increase,risk
Ebselen,Grepafloxacin,Ebselen may increase the neuroexcitatory activities of Grepafloxacin.,increase,no risk
Ebselen,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Guanadrel,The therapeutic efficacy of Guanadrel can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Guanethidine,The therapeutic efficacy of Guanethidine can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Guanoxan,The therapeutic efficacy of Guanoxan can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Haloperidol,The therapeutic efficacy of Haloperidol can be increased when used in combination with Ebselen.,increase,no risk
Ebselen,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Ebselen.,increase,risk
Ebselen,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Ebselen is combined with Heparin.,increase,risk
Ebselen,Hydralazine,Ebselen may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Ebselen,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Hydrocortisone,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Ebselen.,increase,risk
Ebselen,Hydrocortisone acetate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone acetate is combined with Ebselen.,increase,risk
Ebselen,Hydrocortisone butyrate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone butyrate is combined with Ebselen.,increase,risk
Ebselen,Hydrocortisone cypionate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone cypionate is combined with Ebselen.,increase,risk
Ebselen,Hydrocortisone succinate,The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone succinate is combined with Ebselen.,increase,risk
Ebselen,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Ebselen.,decrease,no risk
Ebselen,Kanamycin,The risk or severity of nephrotoxicity can be increased when Ebselen is combined with Kanamycin.,increase,risk
Ebselen,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Ebselen.,increase,risk
Ebselen,Ketorolac,The risk or severity of adverse effects can be increased when Ketorolac is combined with Ebselen.,increase,risk
Sotatercept,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Sotatercept.,increase,risk
Sotatercept,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Sotatercept.,increase,risk
Sotatercept,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Sotatercept.,increase,risk
Sotatercept,Odesivimab,The risk or severity of adverse effects can be increased when Sotatercept is combined with Odesivimab.,increase,risk
Sotatercept,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Sotatercept.,increase,risk
Sotatercept,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Sotatercept.,increase,risk
Sotatercept,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sotatercept.,increase,risk
Sotatercept,Quinestrol,Quinestrol may increase the thrombogenic activities of Sotatercept.,increase,no risk
Sotatercept,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Sotatercept.,increase,risk
Sotatercept,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Sotatercept.,increase,risk
Sotatercept,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Sotatercept.,increase,risk
Glembatumumab vedotin,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Human varicella-zoster immune globulin.,increase,risk
Glembatumumab vedotin,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Glembatumumab vedotin.,increase,risk
Glembatumumab vedotin,Obinutuzumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Obinutuzumab.,increase,risk
Glembatumumab vedotin,Ocrelizumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Ocrelizumab.,increase,risk
Glembatumumab vedotin,Odesivimab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Odesivimab.,increase,risk
Glembatumumab vedotin,Ofatumumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Ofatumumab.,increase,risk
Glembatumumab vedotin,Olaratumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Olaratumab.,increase,risk
Glembatumumab vedotin,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Glembatumumab vedotin.,increase,risk
Glembatumumab vedotin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Glembatumumab vedotin is combined with Oxetacaine.,increase,risk
Glembatumumab vedotin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Glembatumumab vedotin is combined with Oxybuprocaine.,increase,risk
Glembatumumab vedotin,Quinestrol,Quinestrol may increase the thrombogenic activities of Glembatumumab vedotin.,increase,no risk
Glembatumumab vedotin,Ublituximab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Ublituximab.,increase,risk
Glembatumumab vedotin,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Glembatumumab vedotin.,increase,risk
Glembatumumab vedotin,Vedolizumab,The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with Vedolizumab.,increase,risk
Tecovirimat,Gemfibrozil,The metabolism of Tecovirimat can be decreased when combined with Gemfibrozil.,decrease,no risk
Tecovirimat,Gestrinone,The metabolism of Gestrinone can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Glasdegib,The metabolism of Glasdegib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Glyburide,The metabolism of Glyburide can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Halofantrine,The metabolism of Halofantrine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Tecovirimat.,decrease,no risk
Tecovirimat,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ketamine,The metabolism of Ketamine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ketorolac,The metabolism of Ketorolac can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Olaparib,The metabolism of Olaparib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Tecovirimat.,decrease,no risk
Tecovirimat,Olodaterol,The metabolism of Olodaterol can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Osimertinib,The metabolism of Osimertinib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ozanimod,The metabolism of Ozanimod can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Quinidine,The metabolism of Quinidine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Quinine,The metabolism of Quinine can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Tecovirimat.,decrease,no risk
Tecovirimat,Ulipristal,The metabolism of Ulipristal can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Vandetanib,The metabolism of Vandetanib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Tecovirimat.,decrease,no risk
Tecovirimat,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Venetoclax,The metabolism of Venetoclax can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tecovirimat.,decrease,no risk
Tecovirimat,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Vinblastine,The metabolism of Vinblastine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vincristine,The metabolism of Vincristine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vindesine,The metabolism of Vindesine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vinflunine,The metabolism of Vinflunine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Warfarin,The metabolism of Warfarin can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Tecovirimat.,decrease,no risk
Tecovirimat,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Zidovudine,The metabolism of Zidovudine can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Tecovirimat.,decrease,no risk
Tecovirimat,Zopiclone,The metabolism of Zopiclone can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Tecovirimat.,increase,no risk
Tecovirimat,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Tecovirimat.,decrease,no risk
AMG-222,Gatifloxacin,The therapeutic efficacy of AMG-222 can be increased when used in combination with Gatifloxacin.,increase,no risk
AMG-222,Gefapixant,The therapeutic efficacy of AMG-222 can be increased when used in combination with Gefapixant.,increase,no risk
AMG-222,Gemifloxacin,The therapeutic efficacy of AMG-222 can be increased when used in combination with Gemifloxacin.,increase,no risk
AMG-222,Gliclazide,AMG-222 may increase the hypoglycemic activities of Gliclazide.,increase,no risk
AMG-222,Glimepiride,AMG-222 may increase the hypoglycemic activities of Glimepiride.,increase,no risk
AMG-222,Glipizide,AMG-222 may increase the hypoglycemic activities of Glipizide.,increase,no risk
AMG-222,Gliquidone,AMG-222 may increase the hypoglycemic activities of Gliquidone.,increase,no risk
AMG-222,Glyburide,AMG-222 may increase the hypoglycemic activities of Glyburide.,increase,no risk
AMG-222,Glymidine,The therapeutic efficacy of AMG-222 can be increased when used in combination with Glymidine.,increase,no risk
AMG-222,Goserelin,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Goserelin.,decrease,no risk
AMG-222,Grepafloxacin,The therapeutic efficacy of AMG-222 can be increased when used in combination with Grepafloxacin.,increase,no risk
AMG-222,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with AMG-222.,increase,risk
AMG-222,Haloperidol,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Haloperidol.,decrease,no risk
AMG-222,Histrelin,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Histrelin.,decrease,no risk
AMG-222,Hydrochlorothiazide,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
AMG-222,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with AMG-222.,increase,risk
AMG-222,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with AMG-222.,increase,risk
AMG-222,Hydroflumethiazide,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
AMG-222,Hydroxychloroquine,The therapeutic efficacy of AMG-222 can be increased when used in combination with Hydroxychloroquine.,increase,no risk
AMG-222,Hydroxyprogesterone caproate,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
AMG-222,Octreotide,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Octreotide.,decrease,no risk
AMG-222,Ofloxacin,The therapeutic efficacy of AMG-222 can be increased when used in combination with Ofloxacin.,increase,no risk
AMG-222,Olanzapine,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Olanzapine.,decrease,no risk
AMG-222,Olsalazine,Olsalazine may increase the hypoglycemic activities of AMG-222.,increase,no risk
AMG-222,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of AMG-222.,increase,no risk
AMG-222,Oxprenolol,The therapeutic efficacy of AMG-222 can be increased when used in combination with Oxprenolol.,increase,no risk
AMG-222,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of AMG-222.,increase,no risk
AMG-222,Quetiapine,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Quetiapine.,decrease,no risk
AMG-222,Quinapril,The risk or severity of angioedema can be increased when AMG-222 is combined with Quinapril.,increase,risk
AMG-222,Quinethazone,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Quinethazone.,decrease,no risk
AMG-222,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with AMG-222.,increase,risk
AMG-222,Quinupramine,Quinupramine may decrease the hypoglycemic activities of AMG-222.,decrease,no risk
AMG-222,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with AMG-222.,increase,risk
AMG-222,Udenafil,The therapeutic efficacy of AMG-222 can be increased when used in combination with Udenafil.,increase,no risk
AMG-222,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with AMG-222.,increase,risk
AMG-222,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with AMG-222.,increase,risk
AMG-222,Valdecoxib,The therapeutic efficacy of AMG-222 can be increased when used in combination with Valdecoxib.,increase,no risk
AMG-222,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with AMG-222.,increase,risk
AMG-222,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with AMG-222.,increase,risk
AMG-222,Vemurafenib,The therapeutic efficacy of AMG-222 can be increased when used in combination with Vemurafenib.,increase,no risk
AMG-222,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with AMG-222.,increase,risk
AMG-222,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with AMG-222.,increase,risk
AMG-222,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with AMG-222.,increase,risk
AMG-222,Vorinostat,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Vorinostat.,decrease,no risk
AMG-222,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with AMG-222.,increase,risk
AMG-222,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with AMG-222.,increase,risk
AMG-222,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with AMG-222.,increase,risk
AMG-222,Ziprasidone,The therapeutic efficacy of AMG-222 can be decreased when used in combination with Ziprasidone.,decrease,no risk
AMG-222,Zofenopril,The risk or severity of angioedema can be increased when AMG-222 is combined with Zofenopril.,increase,risk
AMG-222,Zonisamide,The therapeutic efficacy of AMG-222 can be increased when used in combination with Zonisamide.,increase,no risk
Aldoxorubicin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Benzocaine.,increase,risk
Aldoxorubicin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Benzyl alcohol.,increase,risk
Aldoxorubicin,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Bleomycin,The risk or severity of cardiotoxicity can be increased when Bleomycin is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Bortezomib,The risk or severity of cardiotoxicity can be increased when Bortezomib is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Bupivacaine.,increase,risk
Aldoxorubicin,Busulfan,The risk or severity of cardiotoxicity can be increased when Busulfan is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Butacaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Butacaine.,increase,risk
Aldoxorubicin,Butamben,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Butamben.,increase,risk
Aldoxorubicin,Ouabain,Ouabain may decrease the cardiotoxic activities of Aldoxorubicin.,decrease,no risk
Aldoxorubicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Oxetacaine.,increase,risk
Aldoxorubicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Aldoxorubicin is combined with Oxybuprocaine.,increase,risk
Aldoxorubicin,Vinblastine,The risk or severity of cardiotoxicity can be increased when Vinblastine is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Vincristine,The risk or severity of cardiotoxicity can be increased when Vincristine is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Vindesine,The risk or severity of cardiotoxicity can be increased when Vindesine is combined with Aldoxorubicin.,increase,risk
Aldoxorubicin,Vinorelbine,The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Aldoxorubicin.,increase,risk
Cariprazine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Cariprazine.,increase,risk
Cariprazine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Cariprazine is combined with Gabapentin enacarbil.,increase,risk
Cariprazine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Cariprazine.,increase,risk
Cariprazine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Cariprazine is combined with Ganaxolone.",increase,risk
Cariprazine,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Cariprazine.,increase,risk
Cariprazine,Gilteritinib,The therapeutic efficacy of Cariprazine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Cariprazine,Glofitamab,The serum concentration of Cariprazine can be increased when it is combined with Glofitamab.,increase,no risk
Cariprazine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Cariprazine.,increase,risk
Cariprazine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Cariprazine.,increase,risk
Cariprazine,Guanabenz,Cariprazine may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Cariprazine,Guanadrel,Cariprazine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Cariprazine,Guanethidine,Cariprazine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Cariprazine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Cariprazine.,increase,risk
Cariprazine,Guanoxan,Cariprazine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Cariprazine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Cariprazine.,increase,risk
Cariprazine,Haloperidol,The metabolism of Cariprazine can be decreased when combined with Haloperidol.,decrease,no risk
Cariprazine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Cariprazine.,increase,risk
Cariprazine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Cariprazine.,increase,risk
Cariprazine,Hydralazine,Cariprazine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Cariprazine,Hydrochlorothiazide,Cariprazine may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Cariprazine,Hydrocodone,Cariprazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Cariprazine,Hydroflumethiazide,Cariprazine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Cariprazine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Cariprazine.,increase,risk
Cariprazine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Cariprazine.,increase,no risk
Cariprazine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Cariprazine.,increase,risk
Cariprazine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Cariprazine.,increase,risk
Cariprazine,Ketoconazole,The metabolism of Cariprazine can be decreased when combined with Ketoconazole.,decrease,no risk
Cariprazine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Cariprazine.,increase,risk
Cariprazine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Cariprazine.,increase,risk
AV-412,Benzocaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Benzocaine.,increase,risk
AV-412,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Benzyl alcohol.,increase,risk
AV-412,Bupivacaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Bupivacaine.,increase,risk
AV-412,Butacaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Butacaine.,increase,risk
AV-412,Butamben,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Butamben.,increase,risk
AV-412,Oxetacaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Oxetacaine.,increase,risk
AV-412,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when AV-412 is combined with Oxybuprocaine.,increase,risk
Benralizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Benralizumab.,increase,risk
Benralizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Benralizumab.,increase,risk
Benralizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Benralizumab.,increase,risk
Benralizumab,Odesivimab,The risk or severity of adverse effects can be increased when Benralizumab is combined with Odesivimab.,increase,risk
Benralizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Benralizumab.,increase,risk
Benralizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Benralizumab.,increase,risk
Benralizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Benralizumab.,increase,risk
Benralizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Benralizumab.,increase,no risk
Benralizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Benralizumab.,increase,risk
Benralizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Benralizumab.,increase,risk
Benralizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Benralizumab.,increase,risk
Brentuximab vedotin,Boceprevir,The metabolism of Brentuximab vedotin can be decreased when combined with Boceprevir.,decrease,no risk
Brentuximab vedotin,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Brentuximab vedotin.",decrease,no risk
Brentuximab vedotin,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Bosentan,The metabolism of Brentuximab vedotin can be increased when combined with Bosentan.,increase,no risk
Brentuximab vedotin,Bosutinib,The metabolism of Brentuximab vedotin can be decreased when combined with Bosutinib.,decrease,no risk
Brentuximab vedotin,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Brodalumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Brodalumab.,increase,risk
Brentuximab vedotin,Brolucizumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Brolucizumab.,increase,risk
Brentuximab vedotin,Budesonide,The metabolism of Brentuximab vedotin can be increased when combined with Budesonide.,increase,no risk
Brentuximab vedotin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Bupivacaine.,increase,risk
Brentuximab vedotin,Buprenorphine,The metabolism of Brentuximab vedotin can be decreased when combined with Buprenorphine.,decrease,no risk
Brentuximab vedotin,Burosumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Burosumab.,increase,risk
Brentuximab vedotin,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Butacaine,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Butacaine.,increase,risk
Brentuximab vedotin,Butalbital,The metabolism of Brentuximab vedotin can be increased when combined with Butalbital.,increase,no risk
Brentuximab vedotin,Butamben,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Butamben.,increase,risk
Brentuximab vedotin,Galcanezumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Galcanezumab.,increase,risk
Brentuximab vedotin,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Gilteritinib,The metabolism of Brentuximab vedotin can be decreased when combined with Gilteritinib.,decrease,no risk
Brentuximab vedotin,Ginkgo biloba,The metabolism of Brentuximab vedotin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Brentuximab vedotin,Glasdegib,The serum concentration of Brentuximab vedotin can be increased when it is combined with Glasdegib.,increase,no risk
Brentuximab vedotin,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Glecaprevir,The serum concentration of Brentuximab vedotin can be increased when it is combined with Glecaprevir.,increase,no risk
Brentuximab vedotin,Glofitamab,The serum concentration of Brentuximab vedotin can be increased when it is combined with Glofitamab.,increase,no risk
Brentuximab vedotin,Glyburide,The metabolism of Brentuximab vedotin can be decreased when combined with Glyburide.,decrease,no risk
Brentuximab vedotin,Glycerol phenylbutyrate,The metabolism of Brentuximab vedotin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Brentuximab vedotin,Golimumab,The metabolism of Brentuximab vedotin can be increased when combined with Golimumab.,increase,no risk
Brentuximab vedotin,Grapefruit,The serum concentration of Brentuximab vedotin can be increased when it is combined with Grapefruit.,increase,no risk
Brentuximab vedotin,Grazoprevir,The serum concentration of Brentuximab vedotin can be increased when it is combined with Grazoprevir.,increase,no risk
Brentuximab vedotin,Griseofulvin,The metabolism of Brentuximab vedotin can be increased when combined with Griseofulvin.,increase,no risk
Brentuximab vedotin,Guselkumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Guselkumab.,increase,risk
Brentuximab vedotin,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Human cytomegalovirus immune globulin.,increase,risk
Brentuximab vedotin,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Human Rho(D) immune globulin.,increase,risk
Brentuximab vedotin,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Human varicella-zoster immune globulin.,increase,risk
Brentuximab vedotin,Hydralazine,The serum concentration of Brentuximab vedotin can be increased when it is combined with Hydralazine.,increase,no risk
Brentuximab vedotin,Hydrocortamate,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortamate.,increase,no risk
Brentuximab vedotin,Hydrocortisone,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone.,increase,no risk
Brentuximab vedotin,Hydrocortisone acetate,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Brentuximab vedotin,Hydrocortisone butyrate,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Brentuximab vedotin,Hydrocortisone succinate,The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Brentuximab vedotin,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Brentuximab vedotin.,decrease,no risk
Brentuximab vedotin,Ketazolam,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ketazolam.,increase,no risk
Brentuximab vedotin,Ketoconazole,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ketoconazole.,increase,no risk
Brentuximab vedotin,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Obinutuzumab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Obinutuzumab.,increase,risk
Brentuximab vedotin,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Octreotide,The serum concentration of Brentuximab vedotin can be increased when it is combined with Octreotide.,increase,no risk
Brentuximab vedotin,Odesivimab,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Odesivimab.,increase,risk
Brentuximab vedotin,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Olaparib,The metabolism of Brentuximab vedotin can be decreased when combined with Olaparib.,decrease,no risk
Brentuximab vedotin,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Olutasidenib,The metabolism of Brentuximab vedotin can be increased when combined with Olutasidenib.,increase,no risk
Brentuximab vedotin,Omadacycline,The serum concentration of Brentuximab vedotin can be increased when it is combined with Omadacycline.,increase,no risk
Brentuximab vedotin,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Omaveloxolone,The serum concentration of Brentuximab vedotin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Brentuximab vedotin,Ombitasvir,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ombitasvir.,increase,no risk
Brentuximab vedotin,Oritavancin,The metabolism of Brentuximab vedotin can be increased when combined with Oritavancin.,increase,no risk
Brentuximab vedotin,Orphenadrine,The metabolism of Brentuximab vedotin can be decreased when combined with Orphenadrine.,decrease,no risk
Brentuximab vedotin,Osilodrostat,The metabolism of Brentuximab vedotin can be decreased when combined with Osilodrostat.,decrease,no risk
Brentuximab vedotin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Brentuximab vedotin.,increase,risk
Brentuximab vedotin,Oxcarbazepine,The metabolism of Brentuximab vedotin can be increased when combined with Oxcarbazepine.,increase,no risk
Brentuximab vedotin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Oxetacaine.,increase,risk
Brentuximab vedotin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Brentuximab vedotin is combined with Oxybuprocaine.,increase,risk
Brentuximab vedotin,Oxybutynin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Oxybutynin.,increase,no risk
Brentuximab vedotin,Ozanimod,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ozanimod.,increase,risk
Brentuximab vedotin,Quinestrol,Quinestrol may increase the thrombogenic activities of Brentuximab vedotin.,increase,no risk
Brentuximab vedotin,Quinidine,The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinidine.,increase,no risk
Brentuximab vedotin,Quinine,The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinine.,increase,no risk
Brentuximab vedotin,Quinupristin,The metabolism of Brentuximab vedotin can be decreased when combined with Quinupristin.,decrease,no risk
Brentuximab vedotin,Quizartinib,The serum concentration of Brentuximab vedotin can be increased when it is combined with Quizartinib.,increase,no risk
Danoprevir,Galantamine,The metabolism of Galantamine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Glyburide,The metabolism of Glyburide can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Granisetron,The metabolism of Granisetron can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ketamine,The metabolism of Ketamine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ketoconazole,The metabolism of Ketoconazole can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Olaparib,The metabolism of Olaparib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Opium,The metabolism of Opium can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Quazepam,The metabolism of Quazepam can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Quinidine,The metabolism of Quinidine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Quinine,The metabolism of Quinine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Udenafil,The metabolism of Udenafil can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Verapamil,The metabolism of Verapamil can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vincristine,The metabolism of Vincristine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vindesine,The metabolism of Vindesine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Danoprevir.,increase,no risk
Danoprevir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Warfarin,The metabolism of Warfarin can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zileuton,The metabolism of Zileuton can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zotepine,The metabolism of Zotepine can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Danoprevir.,decrease,no risk
Danoprevir,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Danoprevir.,increase,no risk
Filanesib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Benzocaine.,increase,risk
Filanesib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Benzyl alcohol.,increase,risk
Filanesib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Bupivacaine.,increase,risk
Filanesib,Butacaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Butacaine.,increase,risk
Filanesib,Butamben,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Butamben.,increase,risk
Filanesib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Oxetacaine.,increase,risk
Filanesib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Filanesib is combined with Oxybuprocaine.,increase,risk
Olaratumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Olaratumab is combined with Human varicella-zoster immune globulin.,increase,risk
Olaratumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Olaratumab.,increase,risk
Olaratumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Obinutuzumab.,increase,risk
Olaratumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ocrelizumab.,increase,risk
Olaratumab,Odesivimab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Odesivimab.,increase,risk
Olaratumab,Ofatumumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ofatumumab.,increase,risk
Olaratumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Olaratumab.,increase,risk
Olaratumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Oxetacaine.,increase,risk
Olaratumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Olaratumab is combined with Oxybuprocaine.,increase,risk
Olaratumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Olaratumab.,increase,no risk
Olaratumab,Ublituximab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ublituximab.,increase,risk
Olaratumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Olaratumab.,increase,risk
Olaratumab,Vedolizumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Vedolizumab.,increase,risk
Trofinetide,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Olaparib,The metabolism of Olaparib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Quinidine,The metabolism of Quinidine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Valsartan,The serum concentration of Valsartan can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vincristine,The metabolism of Vincristine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vindesine,The metabolism of Vindesine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Warfarin,The metabolism of Warfarin can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Trofinetide.,increase,no risk
Trofinetide,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Trofinetide.,decrease,no risk
Trofinetide,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Trofinetide.,decrease,no risk
Favipiravir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Grepafloxacin,The excretion of Grepafloxacin can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Halothane,The metabolism of Halothane can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Favipiravir.,decrease,no risk
Favipiravir,Hydrochlorothiazide,The excretion of Hydrochlorothiazide can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Hydrocortisone,The excretion of Hydrocortisone can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Ketamine,The metabolism of Ketamine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Oseltamivir,The excretion of Oseltamivir can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Oxytetracycline,The excretion of Oxytetracycline can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Quinapril,The excretion of Quinapril can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Quinine,The serum concentration of Quinine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vadadustat,The serum concentration of Vadadustat can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Valaciclovir,The excretion of Valaciclovir can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Valproic acid,The excretion of Valproic acid can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Favipiravir.,decrease,no risk
Favipiravir,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Favipiravir.,decrease,no risk
Favipiravir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vincristine,The excretion of Vincristine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Favipiravir.,increase,no risk
Favipiravir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Favipiravir.,decrease,no risk
Favipiravir,Zalcitabine,The excretion of Zalcitabine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Zidovudine,The excretion of Zidovudine can be decreased when combined with Favipiravir.,decrease,no risk
Favipiravir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Favipiravir.,decrease,no risk
IPH 2101,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with IPH 2101.,increase,risk
IPH 2101,Obinutuzumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Obinutuzumab.,increase,risk
IPH 2101,Ocrelizumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Ocrelizumab.,increase,risk
IPH 2101,Odesivimab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Odesivimab.,increase,risk
IPH 2101,Ofatumumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Ofatumumab.,increase,risk
IPH 2101,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with IPH 2101.,increase,risk
IPH 2101,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with IPH 2101.,increase,risk
IPH 2101,Quinestrol,Quinestrol may increase the thrombogenic activities of IPH 2101.,increase,no risk
IPH 2101,Ublituximab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Ublituximab.,increase,risk
IPH 2101,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with IPH 2101.,increase,risk
IPH 2101,Vedolizumab,The risk or severity of adverse effects can be increased when IPH 2101 is combined with Vedolizumab.,increase,risk
TB-402,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with TB-402.,increase,risk
TB-402,Obinutuzumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Obinutuzumab.,increase,risk
TB-402,Ocrelizumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Ocrelizumab.,increase,risk
TB-402,Odesivimab,The risk or severity of adverse effects can be increased when TB-402 is combined with Odesivimab.,increase,risk
TB-402,Ofatumumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Ofatumumab.,increase,risk
TB-402,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with TB-402.,increase,risk
TB-402,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with TB-402.,increase,risk
TB-402,Quinestrol,Quinestrol may increase the thrombogenic activities of TB-402.,increase,no risk
TB-402,Ublituximab,The risk or severity of adverse effects can be increased when TB-402 is combined with Ublituximab.,increase,risk
TB-402,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with TB-402.,increase,risk
TB-402,Vedolizumab,The risk or severity of adverse effects can be increased when TB-402 is combined with Vedolizumab.,increase,risk
Gevokizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Gevokizumab.,increase,risk
Gevokizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Odesivimab,The risk or severity of adverse effects can be increased when Gevokizumab is combined with Odesivimab.,increase,risk
Gevokizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Gevokizumab.,increase,no risk
Gevokizumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Gevokizumab.,increase,risk
Gevokizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Gevokizumab.,increase,risk
Gevokizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Gevokizumab.,increase,risk
Lumateperone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Lumateperone.,increase,risk
Lumateperone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Lumateperone is combined with Gabapentin enacarbil.,increase,risk
Lumateperone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Lumateperone.,increase,risk
Lumateperone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Lumateperone is combined with Ganaxolone.",increase,risk
Lumateperone,Gemfibrozil,The serum concentration of Lumateperone can be increased when it is combined with Gemfibrozil.,increase,no risk
Lumateperone,Gepirone,The risk or severity of CNS depression can be increased when Lumateperone is combined with Gepirone.,increase,risk
Lumateperone,Glecaprevir,The serum concentration of Lumateperone can be increased when it is combined with Glecaprevir.,increase,no risk
Lumateperone,Glofitamab,The serum concentration of Lumateperone can be increased when it is combined with Glofitamab.,increase,no risk
Lumateperone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Lumateperone.,increase,risk
Lumateperone,Glycerol phenylbutyrate,The serum concentration of Lumateperone can be decreased when it is combined with Glycerol phenylbutyrate.,decrease,no risk
Lumateperone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Lumateperone.,increase,risk
Lumateperone,Griseofulvin,The serum concentration of Lumateperone can be decreased when it is combined with Griseofulvin.,decrease,no risk
Lumateperone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Lumateperone.,increase,risk
Lumateperone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Lumateperone.,increase,risk
Lumateperone,Haloperidol,The serum concentration of Lumateperone can be increased when it is combined with Haloperidol.,increase,no risk
Lumateperone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Lumateperone.,increase,risk
Lumateperone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Lumateperone.,increase,risk
Lumateperone,Hydrocodone,Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Lumateperone,Hydrocortamate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortamate.,decrease,no risk
Lumateperone,Hydrocortisone,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Lumateperone,Hydrocortisone acetate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone acetate.,decrease,no risk
Lumateperone,Hydrocortisone butyrate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone butyrate.,decrease,no risk
Lumateperone,Hydrocortisone probutate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone probutate.,decrease,no risk
Lumateperone,Hydrocortisone succinate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone succinate.,decrease,no risk
Lumateperone,Hydrocortisone valerate,The serum concentration of Lumateperone can be decreased when it is combined with Hydrocortisone valerate.,decrease,no risk
Lumateperone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Lumateperone.,increase,risk
Lumateperone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Lumateperone.,increase,no risk
Lumateperone,Ketamine,The serum concentration of Lumateperone can be decreased when it is combined with Ketamine.,decrease,no risk
Lumateperone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Lumateperone.,increase,risk
Lumateperone,Ketoconazole,The serum concentration of Lumateperone can be increased when it is combined with Ketoconazole.,increase,no risk
Lumateperone,Olanzapine,The risk or severity of adverse effects can be increased when Lumateperone is combined with Olanzapine.,increase,risk
Lumateperone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Lumateperone is combined with Oliceridine.",increase,risk
Lumateperone,Olutasidenib,The serum concentration of Lumateperone can be decreased when it is combined with Olutasidenib.,decrease,no risk
Lumateperone,Omaveloxolone,The serum concentration of Lumateperone can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lumateperone,Ombitasvir,The serum concentration of Lumateperone can be increased when it is combined with Ombitasvir.,increase,no risk
Lumateperone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Lumateperone.,increase,risk
Lumateperone,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Lumateperone.,decrease,no risk
Lumateperone,Opium,The risk or severity of CNS depression can be increased when Lumateperone is combined with Opium.,increase,risk
Lumateperone,Oritavancin,The serum concentration of Lumateperone can be decreased when it is combined with Oritavancin.,decrease,no risk
Lumateperone,Orphenadrine,Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Lumateperone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Lumateperone.,increase,risk
Lumateperone,Oxcarbazepine,The serum concentration of Lumateperone can be decreased when it is combined with Oxcarbazepine.,decrease,no risk
Lumateperone,Oxiconazole,The serum concentration of Lumateperone can be decreased when it is combined with Oxiconazole.,decrease,no risk
Lumateperone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Lumateperone.,increase,risk
Lumateperone,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Lumateperone.,increase,risk
Lumateperone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Lumateperone.,increase,risk
Lumateperone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Lumateperone.,increase,risk
Lumateperone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Lumateperone.,increase,risk
Lumateperone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Lumateperone.,increase,risk
Lumateperone,Quetiapine,The risk or severity of adverse effects can be increased when Lumateperone is combined with Quetiapine.,increase,risk
Lumateperone,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Lumateperone.,decrease,no risk
Lumateperone,Quinine,The serum concentration of Lumateperone can be decreased when it is combined with Quinine.,decrease,no risk
Lumateperone,Quinupramine,The risk or severity of CNS depression can be increased when Lumateperone is combined with Quinupramine.,increase,risk
Lumateperone,Quizartinib,The serum concentration of Lumateperone can be increased when it is combined with Quizartinib.,increase,no risk
Lumateperone,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Lumateperone.,increase,risk
Lumateperone,Vadadustat,The serum concentration of Lumateperone can be increased when it is combined with Vadadustat.,increase,no risk
Lumateperone,Valproic acid,The serum concentration of Lumateperone can be increased when it is combined with Valproic acid.,increase,no risk
Lumateperone,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Lumateperone.,increase,risk
Lumateperone,Vemurafenib,The serum concentration of Lumateperone can be decreased when it is combined with Vemurafenib.,decrease,no risk
Lumateperone,Venetoclax,The serum concentration of Lumateperone can be increased when it is combined with Venetoclax.,increase,no risk
Lumateperone,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Lumateperone.,increase,risk
Lumateperone,Verapamil,The serum concentration of Lumateperone can be increased when it is combined with Verapamil.,increase,no risk
Lumateperone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Lumateperone.,increase,risk
Lumateperone,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Lumateperone.,increase,risk
Lumateperone,Viloxazine,The metabolism of Lumateperone can be decreased when combined with Viloxazine.,decrease,no risk
Lumateperone,Vinblastine,The serum concentration of Lumateperone can be decreased when it is combined with Vinblastine.,decrease,no risk
Lumateperone,Vitamin E,The serum concentration of Lumateperone can be decreased when it is combined with Vitamin E.,decrease,no risk
Lumateperone,Voriconazole,The serum concentration of Lumateperone can be increased when it is combined with Voriconazole.,increase,no risk
Lumateperone,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Lumateperone.,increase,risk
Lumateperone,Warfarin,The serum concentration of Lumateperone can be decreased when it is combined with Warfarin.,decrease,no risk
Lumateperone,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Lumateperone.,increase,risk
Lumateperone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Lumateperone.,increase,risk
Lumateperone,Ziconotide,The risk or severity of CNS depression can be increased when Lumateperone is combined with Ziconotide.,increase,risk
Lumateperone,Zidovudine,The metabolism of Lumateperone can be increased when combined with Zidovudine.,increase,no risk
Lumateperone,Zimelidine,The serum concentration of Lumateperone can be increased when it is combined with Zimelidine.,increase,no risk
Lumateperone,Ziprasidone,The serum concentration of Lumateperone can be increased when it is combined with Ziprasidone.,increase,no risk
Lumateperone,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Lumateperone.,increase,risk
Lumateperone,Zolpidem,Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Lumateperone,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Lumateperone.,increase,risk
Lumateperone,Zopiclone,The risk or severity of adverse effects can be increased when Lumateperone is combined with Zopiclone.,increase,risk
Lumateperone,Zotepine,The risk or severity of adverse effects can be increased when Lumateperone is combined with Zotepine.,increase,risk
Lumateperone,Zuclopenthixol,The risk or severity of adverse effects can be increased when Lumateperone is combined with Zuclopenthixol.,increase,risk
Lumateperone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Lumateperone.,increase,risk
Caplacizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Galcanezumab.,increase,risk
Caplacizumab,Gemcitabine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Gemcitabine.,increase,risk
Caplacizumab,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Caplacizumab is combined with Gemtuzumab ozogamicin.,increase,risk
Caplacizumab,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Caplacizumab.,increase,no risk
Caplacizumab,Glofitamab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Glofitamab.,increase,risk
Caplacizumab,Glucosamine,Glucosamine may increase the antiplatelet activities of Caplacizumab.,increase,no risk
Caplacizumab,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Caplacizumab.,increase,risk
Caplacizumab,Golimumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Golimumab.,increase,risk
Caplacizumab,Guselkumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Guselkumab.,increase,risk
Caplacizumab,Heparin,The risk or severity of bleeding can be increased when Caplacizumab is combined with Heparin.,increase,risk
Caplacizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Caplacizumab.,increase,risk
Caplacizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Caplacizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Caplacizumab.,increase,risk
Caplacizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Human Rho(D) immune globulin.,increase,risk
Caplacizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Caplacizumab,Hydroxyurea,The risk or severity of bleeding can be increased when Caplacizumab is combined with Hydroxyurea.,increase,risk
Caplacizumab,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Caplacizumab.,increase,risk
Caplacizumab,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Caplacizumab.,increase,risk
Caplacizumab,Obeticholic acid,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Obeticholic acid.,increase,risk
Caplacizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Caplacizumab.,increase,risk
Caplacizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Obinutuzumab.,increase,risk
Caplacizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ocrelizumab.,increase,risk
Caplacizumab,Odesivimab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Odesivimab.,increase,risk
Caplacizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ofatumumab.,increase,risk
Caplacizumab,Olaparib,The risk or severity of bleeding can be increased when Caplacizumab is combined with Olaparib.,increase,risk
Caplacizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Caplacizumab.,increase,risk
Caplacizumab,Olsalazine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Olsalazine.,increase,risk
Caplacizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Caplacizumab.,increase,risk
Caplacizumab,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Caplacizumab.,increase,no risk
Caplacizumab,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Caplacizumab.,increase,risk
Caplacizumab,Oxaliplatin,The risk or severity of bleeding can be increased when Caplacizumab is combined with Oxaliplatin.,increase,risk
Caplacizumab,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Caplacizumab.,increase,risk
Caplacizumab,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Caplacizumab.,increase,risk
Caplacizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Caplacizumab.,increase,no risk
Caplacizumab,Ublituximab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ublituximab.,increase,risk
Caplacizumab,Urokinase,Caplacizumab may increase the anticoagulant activities of Urokinase.,increase,no risk
Caplacizumab,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Ursodeoxycholic acid.,increase,risk
Caplacizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Caplacizumab.,increase,risk
Caplacizumab,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Caplacizumab.,increase,risk
Caplacizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Caplacizumab is combined with Vedolizumab.,increase,risk
Caplacizumab,Venlafaxine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Venlafaxine.,increase,risk
Caplacizumab,Vinblastine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vinblastine.,increase,risk
Caplacizumab,Vindesine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vindesine.,increase,risk
Caplacizumab,Vinorelbine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vinorelbine.,increase,risk
Caplacizumab,Vitamin E,Vitamin E may increase the antiplatelet activities of Caplacizumab.,increase,no risk
Caplacizumab,Vorapaxar,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vorapaxar.,increase,risk
Caplacizumab,Vorinostat,The risk or severity of bleeding can be increased when Caplacizumab is combined with Vorinostat.,increase,risk
Caplacizumab,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Caplacizumab.,increase,risk
Caplacizumab,Warfarin,The risk or severity of bleeding can be increased when Caplacizumab is combined with Warfarin.,increase,risk
Caplacizumab,Ximelagatran,The risk or severity of bleeding can be increased when Caplacizumab is combined with Ximelagatran.,increase,risk
Caplacizumab,Zidovudine,The risk or severity of bleeding can be increased when Caplacizumab is combined with Zidovudine.,increase,risk
Caplacizumab,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Caplacizumab.,increase,risk
IMC-1C11,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with IMC-1C11.,increase,risk
IMC-1C11,Obinutuzumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Obinutuzumab.,increase,risk
IMC-1C11,Ocrelizumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Ocrelizumab.,increase,risk
IMC-1C11,Odesivimab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Odesivimab.,increase,risk
IMC-1C11,Ofatumumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Ofatumumab.,increase,risk
IMC-1C11,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with IMC-1C11.,increase,risk
IMC-1C11,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with IMC-1C11.,increase,risk
IMC-1C11,Quinestrol,Quinestrol may increase the thrombogenic activities of IMC-1C11.,increase,no risk
IMC-1C11,Ublituximab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Ublituximab.,increase,risk
IMC-1C11,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with IMC-1C11.,increase,risk
IMC-1C11,Vedolizumab,The risk or severity of adverse effects can be increased when IMC-1C11 is combined with Vedolizumab.,increase,risk
YKP-1358,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with YKP-1358.,increase,risk
YKP-1358,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Gabapentin enacarbil.,increase,risk
YKP-1358,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with YKP-1358.,increase,risk
YKP-1358,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when YKP-1358 is combined with Ganaxolone.",increase,risk
YKP-1358,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with YKP-1358.,increase,risk
YKP-1358,Gilteritinib,The therapeutic efficacy of YKP-1358 can be decreased when used in combination with Gilteritinib.,decrease,no risk
YKP-1358,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with YKP-1358.,increase,risk
YKP-1358,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with YKP-1358.,increase,risk
YKP-1358,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with YKP-1358.,increase,risk
YKP-1358,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with YKP-1358.,increase,risk
YKP-1358,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with YKP-1358.,increase,risk
YKP-1358,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with YKP-1358.,increase,risk
YKP-1358,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with YKP-1358.,increase,risk
YKP-1358,Hydrocodone,YKP-1358 may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
YKP-1358,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with YKP-1358.,increase,risk
YKP-1358,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of YKP-1358.,increase,no risk
YKP-1358,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with YKP-1358.,increase,risk
YKP-1358,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with YKP-1358.,increase,risk
YKP-1358,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with YKP-1358.,increase,risk
YKP-1358,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when YKP-1358 is combined with Oliceridine.",increase,risk
YKP-1358,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with YKP-1358.,increase,risk
YKP-1358,Opium,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Opium.,increase,risk
YKP-1358,Orphenadrine,YKP-1358 may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
YKP-1358,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with YKP-1358.,increase,risk
YKP-1358,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with YKP-1358.,increase,risk
YKP-1358,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with YKP-1358.,increase,risk
YKP-1358,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with YKP-1358.,increase,risk
YKP-1358,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with YKP-1358.,increase,risk
YKP-1358,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with YKP-1358.,increase,risk
YKP-1358,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with YKP-1358.,increase,risk
YKP-1358,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with YKP-1358.,increase,risk
YKP-1358,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with YKP-1358.,increase,risk
YKP-1358,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with YKP-1358.,decrease,no risk
YKP-1358,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with YKP-1358.,increase,risk
YKP-1358,Quinupramine,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Quinupramine.,increase,risk
YKP-1358,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with YKP-1358.,increase,risk
YKP-1358,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when YKP-1358 is combined with Valproate bismuth.,increase,risk
YKP-1358,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with YKP-1358.,increase,risk
YKP-1358,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with YKP-1358.,increase,risk
YKP-1358,Venlafaxine,The risk or severity of serotonin syndrome can be increased when YKP-1358 is combined with Venlafaxine.,increase,risk
YKP-1358,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with YKP-1358.,increase,risk
YKP-1358,Vilazodone,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Vilazodone.,increase,risk
YKP-1358,Viloxazine,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Viloxazine.,increase,risk
YKP-1358,Vortioxetine,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Vortioxetine.,increase,risk
YKP-1358,Warfarin,The risk or severity of adverse effects can be increased when YKP-1358 is combined with Warfarin.,increase,risk
YKP-1358,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with YKP-1358.,increase,risk
YKP-1358,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with YKP-1358.,increase,risk
YKP-1358,Ziconotide,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Ziconotide.,increase,risk
YKP-1358,Zimelidine,The risk or severity of adverse effects can be increased when YKP-1358 is combined with Zimelidine.,increase,risk
YKP-1358,Ziprasidone,The risk or severity of adverse effects can be increased when YKP-1358 is combined with Ziprasidone.,increase,risk
YKP-1358,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with YKP-1358.,increase,risk
YKP-1358,Zolpidem,YKP-1358 may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
YKP-1358,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with YKP-1358.,increase,risk
YKP-1358,Zopiclone,The risk or severity of adverse effects can be increased when YKP-1358 is combined with Zopiclone.,increase,risk
YKP-1358,Zotepine,The risk or severity of CNS depression can be increased when YKP-1358 is combined with Zotepine.,increase,risk
YKP-1358,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with YKP-1358.,increase,risk
YKP-1358,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with YKP-1358.,increase,risk
Eldelumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Eldelumab.,increase,risk
Eldelumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Obinutuzumab.,increase,risk
Eldelumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Ocrelizumab.,increase,risk
Eldelumab,Odesivimab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Odesivimab.,increase,risk
Eldelumab,Ofatumumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Ofatumumab.,increase,risk
Eldelumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Eldelumab.,increase,risk
Eldelumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Eldelumab.,increase,risk
Eldelumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Eldelumab.,increase,no risk
Eldelumab,Ublituximab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Ublituximab.,increase,risk
Eldelumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Eldelumab.,increase,risk
Eldelumab,Vedolizumab,The risk or severity of adverse effects can be increased when Eldelumab is combined with Vedolizumab.,increase,risk
"1alpha,24S-Dihydroxyvitamin D2",Vamorolone,"The therapeutic efficacy of 1alpha,24S-Dihydroxyvitamin D2 can be decreased when used in combination with Vamorolone.",decrease,no risk
"1alpha,24S-Dihydroxyvitamin D2",Vitamin D,"The risk or severity of adverse effects can be increased when 1alpha,24S-Dihydroxyvitamin D2 is combined with Vitamin D.",increase,risk
Cenobamate,Brivaracetam,The serum concentration of Brivaracetam can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Bromazepam,The metabolism of Cenobamate can be decreased when combined with Bromazepam.,decrease,no risk
Cenobamate,Bromocriptine,The serum concentration of Bromocriptine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Bromotheophylline,Cenobamate may increase the excretion rate of Bromotheophylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cenobamate,Brompheniramine,The serum concentration of Brompheniramine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Budesonide,The serum concentration of Budesonide can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Bupivacaine,The serum concentration of Bupivacaine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Buprenorphine,The serum concentration of Buprenorphine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Bupropion,The serum concentration of Bupropion can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Buspirone,The serum concentration of Buspirone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Busulfan,The serum concentration of Busulfan can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Butacaine,The risk or severity of methemoglobinemia can be increased when Cenobamate is combined with Butacaine.,increase,risk
Cenobamate,Butamben,The risk or severity of methemoglobinemia can be increased when Cenobamate is combined with Butamben.,increase,risk
Cenobamate,Butriptyline,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Butriptyline.,decrease,no risk
Cenobamate,Galantamine,The serum concentration of Galantamine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gamolenic acid,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Cenobamate,Ganciclovir,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Ganciclovir.,decrease,no risk
Cenobamate,Gefitinib,The serum concentration of Gefitinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gemfibrozil,The serum concentration of Gemfibrozil can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gepirone,The serum concentration of Gepirone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gilteritinib,The serum concentration of Gilteritinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Glasdegib,The serum concentration of Glasdegib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Gliclazide,The serum concentration of Gliclazide can be increased when it is combined with Cenobamate.,increase,no risk
Cenobamate,Glofitamab,The serum concentration of Cenobamate can be increased when it is combined with Glofitamab.,increase,no risk
Cenobamate,Glyburide,The serum concentration of Glyburide can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Glycerin,The metabolism of Cenobamate can be increased when combined with Glycerin.,increase,no risk
Cenobamate,Golimumab,The metabolism of Cenobamate can be increased when combined with Golimumab.,increase,no risk
Cenobamate,Granisetron,The serum concentration of Granisetron can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Grazoprevir,The serum concentration of Grazoprevir can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Grepafloxacin,The serum concentration of Grepafloxacin can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Guanfacine,The serum concentration of Guanfacine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Halcinonide,The serum concentration of Halcinonide can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Halofantrine,The serum concentration of Halofantrine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Haloperidol,The serum concentration of Haloperidol can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Halothane,The serum concentration of Halothane can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocodone,The serum concentration of Hydrocodone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone,The serum concentration of Hydrocortisone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone phosphate,The serum concentration of Hydrocortisone phosphate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydroxychloroquine,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Cenobamate,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Hydroxyzine,The serum concentration of Hydroxyzine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ketamine,The serum concentration of Ketamine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ketazolam,The serum concentration of Ketazolam can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ketoconazole,The serum concentration of Ketoconazole can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ketorolac,The metabolism of Ketorolac can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Olanzapine,The metabolism of Cenobamate can be decreased when combined with Olanzapine.,decrease,no risk
Cenobamate,Olaparib,The serum concentration of Olaparib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Olodaterol,The metabolism of Olodaterol can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Olutasidenib,The serum concentration of Olutasidenib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Omaveloxolone,The serum concentration of Omaveloxolone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Omeprazole,The serum concentration of Omeprazole can be increased when it is combined with Cenobamate.,increase,no risk
Cenobamate,Ondansetron,The serum concentration of Ondansetron can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Opium,The serum concentration of Opium can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oritavancin,The metabolism of Cenobamate can be decreased when combined with Oritavancin.,decrease,no risk
Cenobamate,Orlistat,Orlistat can cause a decrease in the absorption of Cenobamate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Cenobamate,Orphenadrine,The serum concentration of Orphenadrine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Osilodrostat,The serum concentration of Osilodrostat can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Osimertinib,The serum concentration of Osimertinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ospemifene,The serum concentration of Ospemifene can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oxcarbazepine,The metabolism of Cenobamate can be increased when combined with Oxcarbazepine.,increase,no risk
Cenobamate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cenobamate is combined with Oxetacaine.,increase,risk
Cenobamate,Oxtriphylline,Cenobamate may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Cenobamate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cenobamate is combined with Oxybuprocaine.,increase,risk
Cenobamate,Oxybutynin,The serum concentration of Oxybutynin can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oxycodone,The serum concentration of Oxycodone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Oxymorphone,The serum concentration of Oxymorphone can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Ozanimod,The metabolism of Ozanimod can be increased when combined with Cenobamate.,increase,no risk
Cenobamate,Quazepam,The serum concentration of Quazepam can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Quetiapine,The serum concentration of Quetiapine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Quinidine,The serum concentration of Quinidine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Quinine,The serum concentration of Quinine can be decreased when it is combined with Cenobamate.,decrease,no risk
Cenobamate,Quinupramine,The therapeutic efficacy of Cenobamate can be decreased when used in combination with Quinupramine.,decrease,no risk
Cenobamate,Quizartinib,The serum concentration of Quizartinib can be decreased when it is combined with Cenobamate.,decrease,no risk
Amatuximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Amatuximab.,increase,risk
Amatuximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Amatuximab.,increase,risk
Amatuximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Amatuximab.,increase,risk
Amatuximab,Odesivimab,The risk or severity of adverse effects can be increased when Amatuximab is combined with Odesivimab.,increase,risk
Amatuximab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Amatuximab.,increase,risk
Amatuximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Amatuximab.,increase,risk
Amatuximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Amatuximab.,increase,risk
Amatuximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Amatuximab.,increase,no risk
Amatuximab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Amatuximab.,increase,risk
Amatuximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Amatuximab.,increase,risk
Amatuximab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Amatuximab.,increase,risk
Bisegliptin,Gatifloxacin,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Gatifloxacin.,increase,no risk
Bisegliptin,Gefapixant,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Gefapixant.,increase,no risk
Bisegliptin,Gemifloxacin,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Gemifloxacin.,increase,no risk
Bisegliptin,Gliclazide,Bisegliptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Bisegliptin,Glimepiride,Bisegliptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Bisegliptin,Glipizide,Bisegliptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Bisegliptin,Gliquidone,Bisegliptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Bisegliptin,Glyburide,Bisegliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Bisegliptin,Glymidine,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Glymidine.,increase,no risk
Bisegliptin,Goserelin,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Bisegliptin,Grepafloxacin,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Bisegliptin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Bisegliptin.,increase,risk
Bisegliptin,Haloperidol,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Haloperidol.,decrease,no risk
Bisegliptin,Histrelin,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Bisegliptin,Hydrochlorothiazide,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Bisegliptin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Bisegliptin.,increase,risk
Bisegliptin,Hydroflumethiazide,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Bisegliptin,Hydroxychloroquine,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Bisegliptin,Hydroxyprogesterone caproate,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Bisegliptin,Octreotide,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Octreotide.,decrease,no risk
Bisegliptin,Ofloxacin,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Ofloxacin.,increase,no risk
Bisegliptin,Olanzapine,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Olanzapine.,decrease,no risk
Bisegliptin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Bisegliptin.,increase,no risk
Bisegliptin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Bisegliptin.,increase,no risk
Bisegliptin,Oxprenolol,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Oxprenolol.,increase,no risk
Bisegliptin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Bisegliptin.,increase,no risk
Bisegliptin,Quetiapine,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Quetiapine.,decrease,no risk
Bisegliptin,Quinapril,The risk or severity of angioedema can be increased when Bisegliptin is combined with Quinapril.,increase,risk
Bisegliptin,Quinethazone,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Quinethazone.,decrease,no risk
Bisegliptin,Quinine,The risk or severity of hypoglycemia can be increased when Quinine is combined with Bisegliptin.,increase,risk
Bisegliptin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Bisegliptin.,decrease,no risk
Bisegliptin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Bisegliptin.,increase,risk
Bisegliptin,Udenafil,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Udenafil.,increase,no risk
Bisegliptin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Bisegliptin.,increase,risk
Bisegliptin,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Bisegliptin.,increase,risk
Bisegliptin,Valdecoxib,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Valdecoxib.,increase,no risk
Bisegliptin,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Bisegliptin.,increase,risk
Bisegliptin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Bisegliptin.,increase,risk
Bisegliptin,Vemurafenib,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Vemurafenib.,increase,no risk
Bisegliptin,Venlafaxine,The risk or severity of hypoglycemia can be increased when Venlafaxine is combined with Bisegliptin.,increase,risk
Bisegliptin,Verapamil,The risk or severity of hypoglycemia can be increased when Verapamil is combined with Bisegliptin.,increase,risk
Bisegliptin,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Bisegliptin.,increase,risk
Bisegliptin,Vorinostat,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Vorinostat.,decrease,no risk
Bisegliptin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Bisegliptin.,increase,risk
Bisegliptin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Bisegliptin.,increase,risk
Bisegliptin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Bisegliptin.,increase,risk
Bisegliptin,Ziprasidone,The therapeutic efficacy of Bisegliptin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Bisegliptin,Zofenopril,The risk or severity of angioedema can be increased when Bisegliptin is combined with Zofenopril.,increase,risk
Bisegliptin,Zonisamide,The therapeutic efficacy of Bisegliptin can be increased when used in combination with Zonisamide.,increase,no risk
Nivolumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Nivolumab is combined with Human varicella-zoster immune globulin.,increase,risk
Nivolumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Nivolumab.,increase,risk
Nivolumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Nivolumab.,increase,risk
Nivolumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Ocrelizumab.,increase,risk
Nivolumab,Odesivimab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Odesivimab.,increase,risk
Nivolumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Nivolumab.,increase,risk
Nivolumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Nivolumab.,increase,risk
Nivolumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nivolumab.,increase,risk
Nivolumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nivolumab is combined with Oxetacaine.,increase,risk
Nivolumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nivolumab is combined with Oxybuprocaine.,increase,risk
Nivolumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Nivolumab.,increase,no risk
Nivolumab,Ublituximab,The risk or severity of adverse effects can be increased when Nivolumab is combined with Ublituximab.,increase,risk
Nivolumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Nivolumab.,increase,risk
Nivolumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Nivolumab.,increase,risk
Tirbanibulin,Voriconazole,The serum concentration of Tirbanibulin can be increased when it is combined with Voriconazole.,increase,no risk
Tucatinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Tucatinib is combined with Butacaine.,increase,risk
Tucatinib,Butamben,The risk or severity of methemoglobinemia can be increased when Tucatinib is combined with Butamben.,increase,risk
Tucatinib,Galantamine,The metabolism of Tucatinib can be decreased when combined with Galantamine.,decrease,no risk
Tucatinib,Ganciclovir,The excretion of Ganciclovir can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Gefitinib,The metabolism of Tucatinib can be decreased when combined with Gefitinib.,decrease,no risk
Tucatinib,Gemcitabine,Tucatinib may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Tucatinib,Gemfibrozil,The metabolism of Tucatinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Tucatinib,Gentamicin,The serum concentration of Gentamicin can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Gepirone,The metabolism of Tucatinib can be decreased when combined with Gepirone.,decrease,no risk
Tucatinib,Gestrinone,The metabolism of Tucatinib can be decreased when combined with Gestrinone.,decrease,no risk
Tucatinib,Gilteritinib,Tucatinib may decrease the excretion rate of Gilteritinib which could result in a higher serum level.,decrease,no risk
Tucatinib,Glasdegib,Tucatinib may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Tucatinib,Glecaprevir,Tucatinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Tucatinib,Glyburide,The metabolism of Tucatinib can be decreased when combined with Glyburide.,decrease,no risk
Tucatinib,Golimumab,The metabolism of Tucatinib can be increased when combined with Golimumab.,increase,no risk
Tucatinib,Granisetron,The metabolism of Tucatinib can be decreased when combined with Granisetron.,decrease,no risk
Tucatinib,Grazoprevir,Tucatinib may decrease the excretion rate of Grazoprevir which could result in a higher serum level.,decrease,no risk
Tucatinib,Grepafloxacin,The metabolism of Tucatinib can be decreased when combined with Grepafloxacin.,decrease,no risk
Tucatinib,Guanfacine,The metabolism of Tucatinib can be decreased when combined with Guanfacine.,decrease,no risk
Tucatinib,Guanidine,The excretion of Guanidine can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Halcinonide,The metabolism of Tucatinib can be decreased when combined with Halcinonide.,decrease,no risk
Tucatinib,Halofantrine,The metabolism of Tucatinib can be decreased when combined with Halofantrine.,decrease,no risk
Tucatinib,Haloperidol,The metabolism of Tucatinib can be decreased when combined with Haloperidol.,decrease,no risk
Tucatinib,Halothane,The metabolism of Tucatinib can be decreased when combined with Halothane.,decrease,no risk
Tucatinib,Histamine,The serum concentration of Histamine can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Hydrocodone,The metabolism of Tucatinib can be decreased when combined with Hydrocodone.,decrease,no risk
Tucatinib,Hydrocortisone,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone.,decrease,no risk
Tucatinib,Hydrocortisone acetate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone acetate.,decrease,no risk
Tucatinib,Hydrocortisone butyrate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone butyrate.,decrease,no risk
Tucatinib,Hydrocortisone cypionate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Tucatinib,Hydrocortisone phosphate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Tucatinib,Hydrocortisone probutate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone probutate.,decrease,no risk
Tucatinib,Hydrocortisone succinate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone succinate.,decrease,no risk
Tucatinib,Hydrocortisone valerate,The metabolism of Tucatinib can be decreased when combined with Hydrocortisone valerate.,decrease,no risk
Tucatinib,Hydroxychloroquine,The metabolism of Tucatinib can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Tucatinib,Hydroxyprogesterone caproate,The metabolism of Tucatinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Tucatinib,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Ketamine,The metabolism of Tucatinib can be decreased when combined with Ketamine.,decrease,no risk
Tucatinib,Ketazolam,The metabolism of Tucatinib can be decreased when combined with Ketazolam.,decrease,no risk
Tucatinib,Ketoconazole,The metabolism of Tucatinib can be decreased when combined with Ketoconazole.,decrease,no risk
Tucatinib,Ketoprofen,The metabolism of Tucatinib can be decreased when combined with Ketoprofen.,decrease,no risk
Tucatinib,Ketorolac,The metabolism of Tucatinib can be decreased when combined with Ketorolac.,decrease,no risk
Tucatinib,Olaparib,The metabolism of Tucatinib can be decreased when combined with Olaparib.,decrease,no risk
Tucatinib,Oliceridine,The metabolism of Tucatinib can be decreased when combined with Oliceridine.,decrease,no risk
Tucatinib,Olodaterol,The metabolism of Tucatinib can be decreased when combined with Olodaterol.,decrease,no risk
Tucatinib,Olutasidenib,The metabolism of Tucatinib can be decreased when combined with Olutasidenib.,decrease,no risk
Tucatinib,Omadacycline,Tucatinib may decrease the excretion rate of Omadacycline which could result in a higher serum level.,decrease,no risk
Tucatinib,Omaveloxolone,The metabolism of Tucatinib can be decreased when combined with Omaveloxolone.,decrease,no risk
Tucatinib,Ombitasvir,Tucatinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Tucatinib,Ondansetron,The metabolism of Tucatinib can be decreased when combined with Ondansetron.,decrease,no risk
Tucatinib,Opium,The metabolism of Tucatinib can be decreased when combined with Opium.,decrease,no risk
Tucatinib,Orphenadrine,The metabolism of Tucatinib can be decreased when combined with Orphenadrine.,decrease,no risk
Tucatinib,Osilodrostat,The metabolism of Tucatinib can be decreased when combined with Osilodrostat.,decrease,no risk
Tucatinib,Osimertinib,Tucatinib may decrease the excretion rate of Osimertinib which could result in a higher serum level.,decrease,no risk
Tucatinib,Ospemifene,The metabolism of Tucatinib can be decreased when combined with Ospemifene.,decrease,no risk
Tucatinib,Oteseconazole,The serum concentration of Tucatinib can be increased when it is combined with Oteseconazole.,increase,no risk
Tucatinib,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tucatinib is combined with Oxetacaine.,increase,risk
Tucatinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tucatinib is combined with Oxybuprocaine.,increase,risk
Tucatinib,Oxybutynin,The metabolism of Tucatinib can be decreased when combined with Oxybutynin.,decrease,no risk
Tucatinib,Oxycodone,The metabolism of Tucatinib can be decreased when combined with Oxycodone.,decrease,no risk
Tucatinib,Oxymorphone,The metabolism of Tucatinib can be decreased when combined with Oxymorphone.,decrease,no risk
Tucatinib,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Quazepam,The metabolism of Tucatinib can be decreased when combined with Quazepam.,decrease,no risk
Tucatinib,Quetiapine,The metabolism of Tucatinib can be decreased when combined with Quetiapine.,decrease,no risk
Tucatinib,Quinidine,Tucatinib may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Tucatinib,Quinine,Tucatinib may decrease the excretion rate of Quinine which could result in a higher serum level.,decrease,no risk
Tucatinib,Quizartinib,Tucatinib may decrease the excretion rate of Quizartinib which could result in a higher serum level.,decrease,no risk
Tucatinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Tucatinib.,increase,no risk
Tucatinib,Udenafil,The metabolism of Tucatinib can be decreased when combined with Udenafil.,decrease,no risk
Tucatinib,Ulipristal,The metabolism of Tucatinib can be decreased when combined with Ulipristal.,decrease,no risk
Tucatinib,Umbralisib,The serum concentration of Tucatinib can be increased when it is combined with Umbralisib.,increase,no risk
Tucatinib,Umeclidinium,Tucatinib may decrease the excretion rate of Umeclidinium which could result in a higher serum level.,decrease,no risk
Tucatinib,Upadacitinib,The metabolism of Tucatinib can be decreased when combined with Upadacitinib.,decrease,no risk
Tucatinib,Vadadustat,The serum concentration of Tucatinib can be increased when it is combined with Vadadustat.,increase,no risk
Tucatinib,Valbenazine,The metabolism of Tucatinib can be decreased when combined with Valbenazine.,decrease,no risk
Tucatinib,Valdecoxib,The metabolism of Tucatinib can be decreased when combined with Valdecoxib.,decrease,no risk
Tucatinib,Vamorolone,The metabolism of Tucatinib can be decreased when combined with Vamorolone.,decrease,no risk
Tucatinib,Vandetanib,The metabolism of Tucatinib can be decreased when combined with Vandetanib.,decrease,no risk
Tucatinib,Vardenafil,Tucatinib may decrease the excretion rate of Vardenafil which could result in a higher serum level.,decrease,no risk
Tucatinib,Varenicline,The excretion of Varenicline can be decreased when combined with Tucatinib.,decrease,no risk
Tucatinib,Velpatasvir,Tucatinib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Tucatinib,Vemurafenib,The serum concentration of Tucatinib can be increased when it is combined with Vemurafenib.,increase,no risk
Tucatinib,Venetoclax,Tucatinib may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Tucatinib,Venlafaxine,The metabolism of Tucatinib can be decreased when combined with Venlafaxine.,decrease,no risk
Tucatinib,Verapamil,Tucatinib may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Tucatinib,Vilanterol,The metabolism of Tucatinib can be decreased when combined with Vilanterol.,decrease,no risk
Tucatinib,Vilazodone,The metabolism of Tucatinib can be decreased when combined with Vilazodone.,decrease,no risk
Tucatinib,Vinblastine,Tucatinib may decrease the excretion rate of Vinblastine which could result in a higher serum level.,decrease,no risk
Tucatinib,Vincristine,Tucatinib may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Tucatinib,Vindesine,The metabolism of Tucatinib can be decreased when combined with Vindesine.,decrease,no risk
Tucatinib,Vinflunine,Tucatinib may decrease the excretion rate of Vinflunine which could result in a higher serum level.,decrease,no risk
Tucatinib,Vinorelbine,The metabolism of Tucatinib can be decreased when combined with Vinorelbine.,decrease,no risk
Tucatinib,Vismodegib,Vismodegib may decrease the excretion rate of Tucatinib which could result in a higher serum level.,decrease,no risk
Tucatinib,Vitamin D,The metabolism of Tucatinib can be decreased when combined with Vitamin D.,decrease,no risk
Tucatinib,Vitamin E,The metabolism of Tucatinib can be decreased when combined with Vitamin E.,decrease,no risk
Tucatinib,Voclosporin,Tucatinib may decrease the excretion rate of Voclosporin which could result in a higher serum level.,decrease,no risk
Tucatinib,Vonoprazan,The metabolism of Tucatinib can be decreased when combined with Vonoprazan.,decrease,no risk
Tucatinib,Vorapaxar,The metabolism of Tucatinib can be decreased when combined with Vorapaxar.,decrease,no risk
Tucatinib,Voriconazole,The metabolism of Tucatinib can be decreased when combined with Voriconazole.,decrease,no risk
Tucatinib,Vortioxetine,The metabolism of Tucatinib can be decreased when combined with Vortioxetine.,decrease,no risk
Tucatinib,Voxelotor,The metabolism of Tucatinib can be decreased when combined with Voxelotor.,decrease,no risk
Tucatinib,Voxilaprevir,Tucatinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Tucatinib,Warfarin,The metabolism of Tucatinib can be decreased when combined with Warfarin.,decrease,no risk
Tucatinib,Yohimbine,The metabolism of Tucatinib can be decreased when combined with Yohimbine.,decrease,no risk
Tucatinib,Zaleplon,The metabolism of Tucatinib can be decreased when combined with Zaleplon.,decrease,no risk
Tucatinib,Zanubrutinib,The metabolism of Tucatinib can be decreased when combined with Zanubrutinib.,decrease,no risk
Tucatinib,Zidovudine,The metabolism of Tucatinib can be decreased when combined with Zidovudine.,decrease,no risk
Tucatinib,Zileuton,The metabolism of Tucatinib can be decreased when combined with Zileuton.,decrease,no risk
Tucatinib,Ziprasidone,The metabolism of Tucatinib can be decreased when combined with Ziprasidone.,decrease,no risk
Tucatinib,Zolpidem,The metabolism of Tucatinib can be decreased when combined with Zolpidem.,decrease,no risk
Tucatinib,Zonisamide,The metabolism of Tucatinib can be decreased when combined with Zonisamide.,decrease,no risk
Tucatinib,Zopiclone,The metabolism of Tucatinib can be decreased when combined with Zopiclone.,decrease,no risk
Tucatinib,Zotepine,The metabolism of Tucatinib can be decreased when combined with Zotepine.,decrease,no risk
Tucatinib,Zuclopenthixol,The metabolism of Tucatinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Tucatinib,Zuranolone,The metabolism of Tucatinib can be decreased when combined with Zuranolone.,decrease,no risk
Sertindole,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Sertindole.,increase,risk
Sertindole,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Sertindole is combined with Gabapentin enacarbil.,increase,risk
Sertindole,Galantamine,The metabolism of Sertindole can be decreased when combined with Galantamine.,decrease,no risk
Sertindole,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Sertindole.,increase,risk
Sertindole,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Sertindole is combined with Ganaxolone.",increase,risk
Sertindole,Gefitinib,The metabolism of Sertindole can be decreased when combined with Gefitinib.,decrease,no risk
Sertindole,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Sertindole.,increase,risk
Sertindole,Gilteritinib,The therapeutic efficacy of Sertindole can be decreased when used in combination with Gilteritinib.,decrease,no risk
Sertindole,Givosiran,The serum concentration of Sertindole can be increased when it is combined with Givosiran.,increase,no risk
Sertindole,Glasdegib,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Glasdegib.,increase,risk
Sertindole,Glofitamab,The serum concentration of Sertindole can be increased when it is combined with Glofitamab.,increase,no risk
Sertindole,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Sertindole.,increase,risk
Sertindole,Glycerol phenylbutyrate,The metabolism of Sertindole can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Sertindole,Golimumab,The metabolism of Sertindole can be increased when combined with Golimumab.,increase,no risk
Sertindole,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Sertindole.,increase,risk
Sertindole,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Sertindole.,increase,risk
Sertindole,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Sertindole.,increase,risk
Sertindole,Halofantrine,The metabolism of Sertindole can be decreased when combined with Halofantrine.,decrease,no risk
Sertindole,Haloperidol,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Haloperidol.,increase,risk
Sertindole,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Sertindole.,increase,risk
Sertindole,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Sertindole.,increase,risk
Sertindole,Hydrocodone,Sertindole may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Sertindole,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Sertindole.,increase,risk
Sertindole,Hydroxychloroquine,The metabolism of Sertindole can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Sertindole,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Hydroxyzine.,increase,risk
Sertindole,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Sertindole.,increase,risk
Sertindole,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Sertindole.,increase,risk
Sertindole,Ketoconazole,The metabolism of Sertindole can be decreased when combined with Ketoconazole.,decrease,no risk
Sertindole,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Sertindole.,increase,risk
Sertindole,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Sertindole is combined with Oliceridine.",increase,risk
Sertindole,Omaveloxolone,The serum concentration of Sertindole can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Sertindole,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Sertindole.,increase,risk
Sertindole,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Sertindole.,decrease,no risk
Sertindole,Opium,The risk or severity of CNS depression can be increased when Sertindole is combined with Opium.,increase,risk
Sertindole,Oritavancin,The metabolism of Sertindole can be decreased when combined with Oritavancin.,decrease,no risk
Sertindole,Orphenadrine,Sertindole may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Sertindole,Osilodrostat,The metabolism of Sertindole can be decreased when combined with Osilodrostat.,decrease,no risk
Sertindole,Ospemifene,The metabolism of Sertindole can be decreased when combined with Ospemifene.,decrease,no risk
Sertindole,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Sertindole.,increase,risk
Sertindole,Oxamniquine,The metabolism of Sertindole can be decreased when combined with Oxamniquine.,decrease,no risk
Sertindole,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Sertindole.,increase,risk
Sertindole,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Sertindole.,increase,risk
Sertindole,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Sertindole.,increase,risk
Sertindole,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Sertindole.,increase,risk
Sertindole,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Sertindole.,increase,risk
Sertindole,Oxybutynin,The metabolism of Sertindole can be decreased when combined with Oxybutynin.,decrease,no risk
Sertindole,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Sertindole.,increase,risk
Sertindole,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Sertindole.,increase,risk
Sertindole,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Sertindole.,increase,risk
Sertindole,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Sertindole.,increase,risk
Sertindole,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Sertindole.,decrease,no risk
Sertindole,Quinidine,The metabolism of Sertindole can be decreased when combined with Quinidine.,decrease,no risk
Sertindole,Quinine,The metabolism of Sertindole can be decreased when combined with Quinine.,decrease,no risk
Sertindole,Quinupramine,The risk or severity of CNS depression can be increased when Sertindole is combined with Quinupramine.,increase,risk
Sertindole,Quizartinib,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Quizartinib.,increase,risk
Sertindole,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Sertindole.,decrease,no risk
Sertindole,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Sertindole.,increase,risk
Sertindole,Vadadustat,The serum concentration of Sertindole can be increased when it is combined with Vadadustat.,increase,no risk
Sertindole,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Sertindole.,decrease,no risk
Sertindole,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Sertindole is combined with Valproate bismuth.,increase,risk
Sertindole,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Sertindole.,increase,risk
Sertindole,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Sertindole.,increase,risk
Sertindole,Vemurafenib,The metabolism of Sertindole can be decreased when combined with Vemurafenib.,decrease,no risk
Sertindole,Venetoclax,The metabolism of Sertindole can be decreased when combined with Venetoclax.,decrease,no risk
Sertindole,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Sertindole is combined with Venlafaxine.,increase,risk
Sertindole,Verapamil,The metabolism of Sertindole can be decreased when combined with Verapamil.,decrease,no risk
Sertindole,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Sertindole.,decrease,no risk
Sertindole,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Sertindole.,increase,risk
Sertindole,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Sertindole.,increase,risk
Sertindole,Vilazodone,The metabolism of Sertindole can be decreased when combined with Vilazodone.,decrease,no risk
Sertindole,Viloxazine,The metabolism of Sertindole can be decreased when combined with Viloxazine.,decrease,no risk
Sertindole,Vinblastine,The metabolism of Sertindole can be decreased when combined with Vinblastine.,decrease,no risk
Sertindole,Vincristine,Vincristine may increase the neurotoxic activities of Sertindole.,increase,no risk
Sertindole,Vinorelbine,The metabolism of Sertindole can be decreased when combined with Vinorelbine.,decrease,no risk
Sertindole,Viomycin,Sertindole may increase the neurotoxic activities of Viomycin.,increase,no risk
Sertindole,Voriconazole,The metabolism of Sertindole can be decreased when combined with Voriconazole.,decrease,no risk
Sertindole,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Sertindole.,increase,risk
Sertindole,Warfarin,The risk or severity of adverse effects can be increased when Sertindole is combined with Warfarin.,increase,risk
Sertindole,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Sertindole.,increase,risk
Sertindole,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Sertindole.,increase,risk
Sertindole,Ziconotide,The risk or severity of CNS depression can be increased when Sertindole is combined with Ziconotide.,increase,risk
Sertindole,Zimelidine,The risk or severity of adverse effects can be increased when Sertindole is combined with Zimelidine.,increase,risk
Sertindole,Ziprasidone,The risk or severity of QTc prolongation can be increased when Sertindole is combined with Ziprasidone.,increase,risk
Sertindole,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Sertindole.,increase,risk
Sertindole,Zolpidem,Sertindole may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Sertindole,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Sertindole.,increase,risk
Sertindole,Zopiclone,The risk or severity of adverse effects can be increased when Sertindole is combined with Zopiclone.,increase,risk
Sertindole,Zotepine,The risk or severity of CNS depression can be increased when Sertindole is combined with Zotepine.,increase,risk
Sertindole,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Sertindole.,increase,risk
Sertindole,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Sertindole.,increase,risk
Spiramycin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Spiramycin.,decrease,no risk
Spiramycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Benzocaine.,increase,risk
Spiramycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Benzyl alcohol.,increase,risk
Spiramycin,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Spiramycin.,increase,no risk
Spiramycin,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Spiramycin.,increase,no risk
Spiramycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Bupivacaine.,increase,risk
Spiramycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Butacaine.,increase,risk
Spiramycin,Butamben,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Butamben.,increase,risk
Spiramycin,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Spiramycin.,increase,no risk
Spiramycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Oxetacaine.,increase,risk
Spiramycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Spiramycin is combined with Oxybuprocaine.,increase,risk
Spiramycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Spiramycin.,decrease,no risk
Spiramycin,Warfarin,The risk or severity of bleeding can be increased when Spiramycin is combined with Warfarin.,increase,risk
Methenamine,Vonoprazan,The therapeutic efficacy of Methenamine can be decreased when used in combination with Vonoprazan.,decrease,no risk
Methenamine,Warfarin,The risk or severity of bleeding can be increased when Methenamine is combined with Warfarin.,increase,risk
Methenamine,Zonisamide,The serum concentration of the active metabolites of Methenamine can be reduced when Methenamine is used in combination with Zonisamide resulting in a loss in efficacy., ,no risk
Sulfathiazole,Benzylpenicillin,Sulfathiazole may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Mianserin,Boceprevir,The metabolism of Mianserin can be decreased when combined with Boceprevir.,decrease,no risk
Mianserin,Bortezomib,The metabolism of Mianserin can be decreased when combined with Bortezomib.,decrease,no risk
Mianserin,Bosentan,Mianserin may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Mianserin,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Mianserin.,increase,risk
Mianserin,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Mianserin.,increase,risk
Mianserin,Bretylium,Mianserin may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Mianserin,Brexanolone,The therapeutic efficacy of Brexanolone can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Brexpiprazole,The risk or severity of adverse effects can be increased when Mianserin is combined with Brexpiprazole.,increase,risk
Mianserin,Brimonidine,The therapeutic efficacy of Brimonidine can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Brivaracetam,The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Mianserin.,increase,risk
Mianserin,Bromocriptine,The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Bromperidol,The risk or severity of adverse effects can be increased when Mianserin is combined with Bromperidol.,increase,risk
Mianserin,Brompheniramine,Mianserin may increase the anticholinergic activities of Brompheniramine.,increase,no risk
Mianserin,Buclizine,Mianserin may increase the anticholinergic activities of Buclizine.,increase,no risk
Mianserin,Bumadizone,The risk or severity of hypertension can be increased when Mianserin is combined with Bumadizone.,increase,risk
Mianserin,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Mianserin.,increase,risk
Mianserin,Buprenorphine,Mianserin may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Mianserin,Bupropion,The metabolism of Mianserin can be decreased when combined with Bupropion.,decrease,no risk
Mianserin,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Mianserin.,increase,risk
Mianserin,Butabarbital,Mianserin may increase the central nervous system depressant (CNS depressant) activities of Butabarbital.,increase,no risk
Mianserin,Butalbital,The therapeutic efficacy of Butalbital can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Butaperazine,The risk or severity of adverse effects can be increased when Mianserin is combined with Butaperazine.,increase,risk
Mianserin,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Mianserin.,increase,risk
Mianserin,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Mianserin.,increase,risk
Mianserin,Butriptyline,The risk or severity of CNS depression can be increased when Mianserin is combined with Butriptyline.,increase,risk
Mianserin,Butylscopolamine,Mianserin may increase the anticholinergic activities of Butylscopolamine.,increase,no risk
Mianserin,Gabapentin,The therapeutic efficacy of Gabapentin can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Mianserin is combined with Gabapentin enacarbil.,increase,risk
Mianserin,Galantamine,The metabolism of Mianserin can be decreased when combined with Galantamine.,decrease,no risk
Mianserin,Gallamine triethiodide,Mianserin may increase the anticholinergic activities of Gallamine triethiodide.,increase,no risk
Mianserin,Ganaxolone,The therapeutic efficacy of Ganaxolone can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Gatifloxacin,The metabolism of Mianserin can be decreased when combined with Gatifloxacin.,decrease,no risk
Mianserin,Gefitinib,The metabolism of Mianserin can be decreased when combined with Gefitinib.,decrease,no risk
Mianserin,Gemfibrozil,The metabolism of Mianserin can be decreased when combined with Gemfibrozil.,decrease,no risk
Mianserin,Gemifloxacin,The metabolism of Mianserin can be decreased when combined with Gemifloxacin.,decrease,no risk
Mianserin,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Mianserin.,increase,risk
Mianserin,Gilteritinib,The therapeutic efficacy of Mianserin can be decreased when used in combination with Gilteritinib.,decrease,no risk
Mianserin,Givosiran,The serum concentration of Mianserin can be increased when it is combined with Givosiran.,increase,no risk
Mianserin,Glofitamab,The serum concentration of Mianserin can be increased when it is combined with Glofitamab.,increase,no risk
Mianserin,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Mianserin.,increase,risk
Mianserin,Glycerol phenylbutyrate,The metabolism of Mianserin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Mianserin,Glycopyrronium,Mianserin may increase the anticholinergic activities of Glycopyrronium.,increase,no risk
Mianserin,Golimumab,The metabolism of Mianserin can be increased when combined with Golimumab.,increase,no risk
Mianserin,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Mianserin.,increase,risk
Mianserin,Grepafloxacin,The metabolism of Mianserin can be decreased when combined with Grepafloxacin.,decrease,no risk
Mianserin,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Guanadrel,Mianserin may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Mianserin,Guanethidine,Mianserin may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Mianserin,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Guanoxan,Mianserin may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Mianserin,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Mianserin.,increase,risk
Mianserin,Halofantrine,The metabolism of Mianserin can be decreased when combined with Halofantrine.,decrease,no risk
Mianserin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Mianserin.,increase,risk
Mianserin,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Mianserin.,increase,risk
Mianserin,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Mianserin.,increase,risk
Mianserin,Hexocyclium,Mianserin may increase the anticholinergic activities of Hexocyclium.,increase,no risk
Mianserin,Homatropine methylbromide,Mianserin may increase the anticholinergic activities of Homatropine methylbromide.,increase,no risk
Mianserin,Hydralazine,Mianserin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Mianserin,Hydrochlorothiazide,Mianserin may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Mianserin,Hydrocodone,Mianserin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Mianserin,Hydrocortisone,The metabolism of Mianserin can be increased when combined with Hydrocortisone.,increase,no risk
Mianserin,Hydroflumethiazide,Mianserin may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Mianserin,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Mianserin.,increase,risk
Mianserin,Hydroxychloroquine,The metabolism of Mianserin can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Mianserin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Mianserin.,increase,no risk
Mianserin,Hyoscyamine,Mianserin may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Mianserin,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Mianserin.,increase,risk
Mianserin,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Mianserin.,increase,risk
Mianserin,Ketoconazole,The metabolism of Mianserin can be decreased when combined with Ketoconazole.,decrease,no risk
Mianserin,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Mianserin.,increase,risk
Mianserin,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Mianserin.,increase,risk
Mianserin,Obeticholic acid,The metabolism of Mianserin can be decreased when combined with Obeticholic acid.,decrease,no risk
Mianserin,Olanzapine,Mianserin may increase the anticholinergic activities of Olanzapine.,increase,no risk
Mianserin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Mianserin is combined with Oliceridine.",increase,risk
Mianserin,Olmesartan,Mianserin may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Mianserin,Olodaterol,The risk or severity of hypertension can be increased when Mianserin is combined with Olodaterol.,increase,risk
Mianserin,Omaveloxolone,The serum concentration of Mianserin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Mianserin,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Mianserin.,increase,risk
Mianserin,Opium,The risk or severity of CNS depression can be increased when Mianserin is combined with Opium.,increase,risk
Mianserin,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Mianserin.,increase,risk
Mianserin,Oritavancin,The metabolism of Mianserin can be decreased when combined with Oritavancin.,decrease,no risk
Mianserin,Orphenadrine,Mianserin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Mianserin,Osilodrostat,The metabolism of Mianserin can be decreased when combined with Osilodrostat.,decrease,no risk
Mianserin,Osimertinib,The serum concentration of Mianserin can be decreased when it is combined with Osimertinib.,decrease,no risk
Mianserin,Ospemifene,The metabolism of Mianserin can be decreased when combined with Ospemifene.,decrease,no risk
Mianserin,Oxamniquine,The metabolism of Mianserin can be decreased when combined with Oxamniquine.,decrease,no risk
Mianserin,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Mianserin.,increase,risk
Mianserin,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Mianserin.,increase,risk
Mianserin,Oxcarbazepine,The therapeutic efficacy of Oxcarbazepine can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Mianserin.,increase,risk
Mianserin,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Mianserin.,increase,risk
Mianserin,Oxtriphylline,The metabolism of Mianserin can be decreased when combined with Oxtriphylline.,decrease,no risk
Mianserin,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Mianserin.,increase,risk
Mianserin,Oxybutynin,Mianserin may increase the anticholinergic activities of Oxybutynin.,increase,no risk
Mianserin,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Mianserin.,increase,risk
Mianserin,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Mianserin.,increase,risk
Mianserin,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Mianserin.,increase,risk
Mianserin,Oxyphencyclimine,Mianserin may increase the anticholinergic activities of Oxyphencyclimine.,increase,no risk
Mianserin,Oxyphenonium,Mianserin may increase the anticholinergic activities of Oxyphenonium.,increase,no risk
Mianserin,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Mianserin.,increase,risk
Mianserin,Quetiapine,Mianserin may increase the anticholinergic activities of Quetiapine.,increase,no risk
Mianserin,Quinapril,Mianserin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Mianserin,Quinidine,Mianserin may increase the anticholinergic activities of Quinidine.,increase,no risk
Mianserin,Quinine,The metabolism of Mianserin can be decreased when combined with Quinine.,decrease,no risk
Mianserin,Quinupramine,The risk or severity of CNS depression can be increased when Mianserin is combined with Quinupramine.,increase,risk
Mianserin,Umeclidinium,Mianserin may increase the anticholinergic activities of Umeclidinium.,increase,no risk
Mianserin,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Mianserin.,increase,risk
Mianserin,Vadadustat,The serum concentration of Mianserin can be decreased when it is combined with Vadadustat.,decrease,no risk
Mianserin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Mianserin.,increase,risk
Mianserin,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Mianserin is combined with Valproate bismuth.,increase,risk
Mianserin,Valproic acid,The therapeutic efficacy of Valproic acid can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Valsartan,Mianserin may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Mianserin,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Mianserin.,increase,risk
Mianserin,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Vemurafenib,The serum concentration of Mianserin can be increased when it is combined with Vemurafenib.,increase,no risk
Mianserin,Venetoclax,The metabolism of Mianserin can be decreased when combined with Venetoclax.,decrease,no risk
Mianserin,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Mianserin is combined with Venlafaxine.,increase,risk
Mianserin,Verapamil,The metabolism of Mianserin can be decreased when combined with Verapamil.,decrease,no risk
Mianserin,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Vigabatrin,The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Mianserin.,decrease,no risk
Mianserin,Vilanterol,The risk or severity of hypertension can be increased when Mianserin is combined with Vilanterol.,increase,risk
Mianserin,Vilazodone,The metabolism of Mianserin can be decreased when combined with Vilazodone.,decrease,no risk
Mianserin,Viloxazine,The metabolism of Mianserin can be decreased when combined with Viloxazine.,decrease,no risk
Mianserin,Vinblastine,The metabolism of Mianserin can be decreased when combined with Vinblastine.,decrease,no risk
Mianserin,Vinorelbine,The metabolism of Mianserin can be decreased when combined with Vinorelbine.,decrease,no risk
Mianserin,Voriconazole,The metabolism of Mianserin can be decreased when combined with Voriconazole.,decrease,no risk
Mianserin,Vortioxetine,The risk or severity of adverse effects can be increased when Mianserin is combined with Vortioxetine.,increase,risk
Mianserin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Mianserin.,decrease,no risk
Mianserin,Warfarin,The metabolism of Mianserin can be decreased when combined with Warfarin.,decrease,no risk
Teicoplanin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Teicoplanin.,decrease,no risk
Teicoplanin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Benzocaine.,increase,risk
Teicoplanin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Benzyl alcohol.,increase,risk
Teicoplanin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Bupivacaine.,increase,risk
Teicoplanin,Butacaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Butacaine.,increase,risk
Teicoplanin,Butamben,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Butamben.,increase,risk
Teicoplanin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Oxetacaine.,increase,risk
Teicoplanin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Teicoplanin is combined with Oxybuprocaine.,increase,risk
Teicoplanin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Teicoplanin.,decrease,no risk
Teicoplanin,Warfarin,The risk or severity of bleeding can be increased when Teicoplanin is combined with Warfarin.,increase,risk
Sulfadimethoxine,Benzylpenicillin,Sulfadimethoxine may decrease the excretion rate of Benzylpenicillin which could result in a higher serum level.,decrease,no risk
Sulfadimethoxine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Sulfadimethoxine.,increase,risk
Sulfadimethoxine,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Sulfadimethoxine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Sulfadimethoxine.,increase,no risk
Nylidrin,Galantamine,Galantamine may increase the bradycardic activities of Nylidrin.,increase,no risk
Nylidrin,Gallamine triethiodide,Nylidrin may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Nylidrin,Gliclazide,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Gliclazide.,increase,risk
Nylidrin,Glimepiride,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Glimepiride.,increase,risk
Nylidrin,Glipizide,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Glipizide.,increase,risk
Nylidrin,Gliquidone,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Gliquidone.,increase,risk
Nylidrin,Glofitamab,The serum concentration of Nylidrin can be increased when it is combined with Glofitamab.,increase,no risk
Nylidrin,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Nylidrin.,decrease,no risk
Nylidrin,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Nylidrin.,decrease,no risk
Nylidrin,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Nylidrin.,decrease,no risk
Nylidrin,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Nylidrin.,increase,risk
Nylidrin,Glymidine,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Glymidine.,increase,risk
Nylidrin,Guanabenz,Nylidrin may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Nylidrin,Guanadrel,Nylidrin may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Nylidrin,Guanethidine,Nylidrin may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Nylidrin,Guanfacine,Nylidrin may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Nylidrin,Guanoxan,Nylidrin may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Nylidrin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Nylidrin.,increase,no risk
Nylidrin,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Nylidrin.,increase,risk
Nylidrin,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Nylidrin.,increase,risk
Nylidrin,Hexocyclium,The risk or severity of Tachycardia can be increased when Nylidrin is combined with Hexocyclium.,increase,risk
Nylidrin,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Nylidrin.,increase,risk
Nylidrin,Hydralazine,Nylidrin may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Nylidrin,Hydrochlorothiazide,Nylidrin may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Nylidrin,Hydroflumethiazide,Nylidrin may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Nylidrin,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Nylidrin.,increase,risk
Nylidrin,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Nylidrin.,increase,risk
Nylidrin,Ketoconazole,The metabolism of Nylidrin can be decreased when combined with Ketoconazole.,decrease,no risk
Nylidrin,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Nylidrin.,increase,risk
Nylidrin,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Nylidrin.,increase,risk
Nylidrin,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Nylidrin.,increase,no risk
Nylidrin,Olanzapine,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Olanzapine.,decrease,no risk
Nylidrin,Olmesartan,Nylidrin may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Nylidrin,Olodaterol,The risk or severity of hypertension can be increased when Nylidrin is combined with Olodaterol.,increase,risk
Nylidrin,Omaveloxolone,The serum concentration of Nylidrin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Nylidrin,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Nylidrin.,increase,risk
Nylidrin,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Nylidrin.,increase,risk
Nylidrin,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Nylidrin.,increase,no risk
Nylidrin,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Nylidrin.,increase,no risk
Nylidrin,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Nylidrin.,increase,risk
Nylidrin,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Oxtriphylline,The risk or severity of adverse effects can be increased when Nylidrin is combined with Oxtriphylline.,increase,risk
Nylidrin,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Nylidrin.,increase,risk
Nylidrin,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Nylidrin.,increase,risk
Nylidrin,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Nylidrin.,increase,risk
Nylidrin,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Nylidrin.,increase,risk
Nylidrin,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Nylidrin.,decrease,no risk
Nylidrin,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Nylidrin.,increase,risk
Nylidrin,Quetiapine,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Quetiapine.,decrease,no risk
Nylidrin,Quinapril,Nylidrin may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Nylidrin,Quinidine,Quinidine may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Quinine,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Quinine.,increase,risk
Nylidrin,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Nylidrin.,increase,risk
Nylidrin,Umeclidinium,The risk or severity of Tachycardia can be increased when Nylidrin is combined with Umeclidinium.,increase,risk
Nylidrin,Vadadustat,The serum concentration of Nylidrin can be increased when it is combined with Vadadustat.,increase,no risk
Nylidrin,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Nylidrin.,increase,risk
Nylidrin,Valsartan,Nylidrin may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Nylidrin,Vecuronium,Nylidrin may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Nylidrin,Venetoclax,The metabolism of Nylidrin can be decreased when combined with Venetoclax.,decrease,no risk
Nylidrin,Venlafaxine,Venlafaxine may increase the tachycardic activities of Nylidrin.,increase,no risk
Nylidrin,Verapamil,Verapamil may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Vernakalant,Nylidrin may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Nylidrin,Vilanterol,The risk or severity of hypertension can be increased when Nylidrin is combined with Vilanterol.,increase,risk
Nylidrin,Vilazodone,The risk or severity of hypertension can be increased when Nylidrin is combined with Vilazodone.,increase,risk
Nylidrin,Vildagliptin,The risk or severity of hypoglycemia can be increased when Nylidrin is combined with Vildagliptin.,increase,risk
Nylidrin,Viloxazine,The metabolism of Nylidrin can be decreased when combined with Viloxazine.,decrease,no risk
Nylidrin,Voriconazole,The metabolism of Nylidrin can be decreased when combined with Voriconazole.,decrease,no risk
Nylidrin,Vortioxetine,The risk or severity of hypertension can be increased when Nylidrin is combined with Vortioxetine.,increase,risk
Nylidrin,Xamoterol,The risk or severity of hypertension can be increased when Nylidrin is combined with Xamoterol.,increase,risk
Nylidrin,Xylometazoline,Nylidrin may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Nylidrin,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Nylidrin.,increase,risk
Nylidrin,Ziconotide,Nylidrin may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Nylidrin,Zimelidine,The metabolism of Nylidrin can be decreased when combined with Zimelidine.,decrease,no risk
Nylidrin,Ziprasidone,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Nylidrin,Zofenopril,Nylidrin may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Nylidrin,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Nylidrin.,increase,risk
Nylidrin,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Nylidrin.,increase,no risk
Nylidrin,Zuclopenthixol,The therapeutic efficacy of Nylidrin can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Pizotifen,Butaperazine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Butaperazine.,increase,risk
Pizotifen,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Pizotifen.,increase,risk
Pizotifen,Butorphanol,The risk or severity of adverse effects can be increased when Pizotifen is combined with Butorphanol.,increase,risk
Pizotifen,Butriptyline,The risk or severity of CNS depression can be increased when Pizotifen is combined with Butriptyline.,increase,risk
Pizotifen,Butylscopolamine,The risk or severity of adverse effects can be increased when Pizotifen is combined with Butylscopolamine.,increase,risk
Pizotifen,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Pizotifen.,increase,risk
Pizotifen,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Pizotifen is combined with Gabapentin enacarbil.,increase,risk
Pizotifen,Galantamine,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Galantamine.,decrease,no risk
Pizotifen,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Pizotifen.,increase,risk
Pizotifen,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Pizotifen is combined with Ganaxolone.",increase,risk
Pizotifen,Gepirone,The risk or severity of serotonin syndrome can be increased when Gepirone is combined with Pizotifen.,increase,risk
Pizotifen,Gilteritinib,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Gilteritinib.,decrease,no risk
Pizotifen,Ginkgo biloba,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Ginkgo biloba.,decrease,no risk
Pizotifen,Glucagon,Pizotifen may increase the gastrointestinal motility reducing activities of Glucagon.,increase,no risk
Pizotifen,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Pizotifen.,increase,risk
Pizotifen,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Glycopyrronium,The risk or severity of adverse effects can be increased when Pizotifen is combined with Glycopyrronium.,increase,risk
Pizotifen,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Pizotifen.,increase,risk
Pizotifen,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Guanadrel,Pizotifen may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Pizotifen,Guanethidine,Pizotifen may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Pizotifen,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Guanoxan,Pizotifen may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Pizotifen,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Pizotifen.,increase,risk
Pizotifen,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Pizotifen.,increase,risk
Pizotifen,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Pizotifen.,increase,risk
Pizotifen,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Pizotifen.,increase,risk
Pizotifen,Hexocyclium,The risk or severity of adverse effects can be increased when Pizotifen is combined with Hexocyclium.,increase,risk
Pizotifen,Homatropine,The risk or severity of adverse effects can be increased when Pizotifen is combined with Homatropine.,increase,risk
Pizotifen,Homatropine methylbromide,The risk or severity of adverse effects can be increased when Homatropine methylbromide is combined with Pizotifen.,increase,risk
Pizotifen,Huperzine A,The therapeutic efficacy of Pizotifen can be decreased when used in combination with Huperzine A.,decrease,no risk
Pizotifen,Hydralazine,Pizotifen may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Pizotifen,Hydrochlorothiazide,Pizotifen may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Pizotifen,Hydrocodone,Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Pizotifen,Hydroflumethiazide,Pizotifen may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Pizotifen,Hydromorphone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Hydromorphone.,increase,risk
Pizotifen,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Pizotifen.,increase,no risk
Pizotifen,Hyoscyamine,Pizotifen may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Pizotifen,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Pizotifen.,increase,risk
Pizotifen,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Pizotifen.,increase,risk
Pizotifen,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Pizotifen.,increase,risk
Pizotifen,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Pizotifen.,increase,risk
Pizotifen,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Pizotifen is combined with Oliceridine.",increase,risk
Pizotifen,Olmesartan,Pizotifen may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Pizotifen,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Pizotifen.,increase,risk
Pizotifen,Opium,The risk or severity of adverse effects can be increased when Pizotifen is combined with Opium.,increase,risk
Pizotifen,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Orphenadrine,Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Pizotifen,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Pizotifen.,increase,risk
Pizotifen,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Pizotifen.,increase,risk
Pizotifen,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Pizotifen.,increase,risk
Pizotifen,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Pizotifen.,increase,risk
Pizotifen,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Pizotifen.,increase,no risk
Pizotifen,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Pizotifen.,increase,risk
Pizotifen,Oxybutynin,The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pizotifen.,increase,risk
Pizotifen,Oxycodone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Oxycodone.,increase,risk
Pizotifen,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Oxymorphone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Oxymorphone.,increase,risk
Pizotifen,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Pizotifen.,increase,risk
Pizotifen,Oxyphencyclimine,The risk or severity of adverse effects can be increased when Oxyphencyclimine is combined with Pizotifen.,increase,risk
Pizotifen,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Oxyphenonium,The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Pizotifen.,increase,risk
Pizotifen,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Pizotifen.,increase,risk
Pizotifen,Quetiapine,"Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Quinapril,Pizotifen may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Pizotifen,Quinethazone,The serum concentration of Quinethazone can be increased when it is combined with Pizotifen.,increase,no risk
Pizotifen,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Pizotifen.,increase,risk
Pizotifen,Quinupramine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Quinupramine.,increase,risk
Pizotifen,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Pizotifen.,increase,risk
Pizotifen,Umeclidinium,The risk or severity of adverse effects can be increased when Pizotifen is combined with Umeclidinium.,increase,risk
Pizotifen,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Pizotifen.,increase,risk
Pizotifen,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Pizotifen.,increase,risk
Pizotifen,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Pizotifen is combined with Valproate bismuth.,increase,risk
Pizotifen,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Pizotifen.,increase,risk
Pizotifen,Valsartan,Pizotifen may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Pizotifen,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Pizotifen.,increase,risk
Pizotifen,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Pizotifen.,increase,risk
Pizotifen,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Pizotifen is combined with Venlafaxine.,increase,risk
Pizotifen,Verapamil,The risk or severity of hypotension can be increased when Pizotifen is combined with Verapamil.,increase,risk
Pizotifen,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Pizotifen.,increase,risk
Pizotifen,Vilanterol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Vilazodone,The risk or severity of CNS depression can be increased when Pizotifen is combined with Vilazodone.,increase,risk
Pizotifen,Viloxazine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Viloxazine.,increase,risk
Pizotifen,Vortioxetine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Vortioxetine.,increase,risk
Pizotifen,Warfarin,The risk or severity of adverse effects can be increased when Pizotifen is combined with Warfarin.,increase,risk
Pizotifen,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Pizotifen.,decrease,no risk
Pizotifen,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Pizotifen.,increase,risk
Pizotifen,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Pizotifen.,increase,risk
Pizotifen,Ziconotide,The risk or severity of CNS depression can be increased when Pizotifen is combined with Ziconotide.,increase,risk
Pizotifen,Zimelidine,The risk or severity of adverse effects can be increased when Pizotifen is combined with Zimelidine.,increase,risk
Pizotifen,Ziprasidone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Ziprasidone.,increase,risk
Pizotifen,Zofenopril,Pizotifen may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Pizotifen,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Pizotifen.,increase,risk
Pizotifen,Zolpidem,Pizotifen may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Pizotifen,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Pizotifen.,increase,risk
Pizotifen,Zopiclone,The risk or severity of adverse effects can be increased when Pizotifen is combined with Zopiclone.,increase,risk
Pizotifen,Zotepine,The risk or severity of CNS depression can be increased when Pizotifen is combined with Zotepine.,increase,risk
Pizotifen,Zuclopenthixol,"Zuclopenthixol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Pizotifen.",increase,no risk
Pizotifen,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Pizotifen.,increase,risk
Pentaerythritol tetranitrate,Gabapentin enacarbil,Pentaerythritol tetranitrate may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadodiamide,Gadodiamide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadofosveset trisodium,Pentaerythritol tetranitrate may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadoteric acid,Pentaerythritol tetranitrate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gadoteridol,Gadoteridol may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ganciclovir,Ganciclovir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gemcitabine,Gemcitabine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gentamicin,Pentaerythritol tetranitrate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Gimeracil,Pentaerythritol tetranitrate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Givosiran,Givosiran may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Glipizide,Glipizide may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Glycerol phenylbutyrate,Pentaerythritol tetranitrate may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Golodirsen,Pentaerythritol tetranitrate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Goserelin,Goserelin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Guanethidine,Guanethidine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Guanfacine,Guanfacine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Haloperidol,Haloperidol may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Hydralazine,Hydralazine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pentaerythritol tetranitrate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pentaerythritol tetranitrate,Hydromorphone,Hydromorphone may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Hydroxyethyl Starch,Pentaerythritol tetranitrate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Kanamycin,Pentaerythritol tetranitrate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ketamine,Ketamine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ketazolam,Ketazolam may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ketoprofen,Ketoprofen may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Ketorolac,Ketorolac may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Octinoxate,Pentaerythritol tetranitrate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Olsalazine,Olsalazine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Opium,Pentaerythritol tetranitrate may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oseltamivir,Oseltamivir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxacillin,Oxacillin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxaprozin,Oxaprozin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxazepam,Oxazepam may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxybenzone,Oxybenzone may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Oxyquinoline,Pentaerythritol tetranitrate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Quetiapine,Quetiapine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Quinethazone,Quinethazone may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pentaerythritol tetranitrate,Quinidine,Pentaerythritol tetranitrate may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Udenafil,The risk or severity of hypotension can be increased when Udenafil is combined with Pentaerythritol tetranitrate.,increase,risk
Pentaerythritol tetranitrate,Vaborbactam,Pentaerythritol tetranitrate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Valaciclovir,Valaciclovir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Valbenazine,Pentaerythritol tetranitrate may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Valdecoxib,Valdecoxib may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Valganciclovir,Valganciclovir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Vancomycin,Pentaerythritol tetranitrate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Vardenafil,The risk or severity of hypotension can be increased when Vardenafil is combined with Pentaerythritol tetranitrate.,increase,risk
Pentaerythritol tetranitrate,Varenicline,Varenicline may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Venlafaxine,Venlafaxine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Verapamil,Verapamil may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Pentaerythritol tetranitrate,Vilanterol,Pentaerythritol tetranitrate may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Viloxazine,Pentaerythritol tetranitrate may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Vortioxetine,Pentaerythritol tetranitrate may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Warfarin,Pentaerythritol tetranitrate may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Zaleplon,Zaleplon may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Zanamivir,Zanamivir may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.,decrease,no risk
Pentaerythritol tetranitrate,Zonisamide,Zonisamide may increase the vasodilatory activities of Pentaerythritol tetranitrate.,increase,no risk
Rimonabant,Gabapentin,The risk or severity of adverse effects can be increased when Rimonabant is combined with Gabapentin.,increase,risk
Rimonabant,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Rimonabant is combined with Gabapentin enacarbil.,increase,risk
Rimonabant,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Gallamine triethiodide.,increase,risk
Rimonabant,Ganaxolone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ganaxolone.,increase,risk
Rimonabant,Gepirone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Gepirone.,increase,risk
Rimonabant,Glofitamab,The serum concentration of Rimonabant can be increased when it is combined with Glofitamab.,increase,no risk
Rimonabant,Glutethimide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Glutethimide.,increase,risk
Rimonabant,Glycopyrronium,The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Rimonabant.,increase,risk
Rimonabant,Granisetron,The risk or severity of adverse effects can be increased when Rimonabant is combined with Granisetron.,increase,risk
Rimonabant,Guanabenz,The risk or severity of Tachycardia can be increased when Guanabenz is combined with Rimonabant.,increase,risk
Rimonabant,Guanfacine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Guanfacine.,increase,risk
Rimonabant,Halazepam,The risk or severity of adverse effects can be increased when Rimonabant is combined with Halazepam.,increase,risk
Rimonabant,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Rimonabant.,increase,no risk
Rimonabant,Halothane,The risk or severity of adverse effects can be increased when Rimonabant is combined with Halothane.,increase,risk
Rimonabant,Hexafluronium,The risk or severity of adverse effects can be increased when Rimonabant is combined with Hexafluronium.,increase,risk
Rimonabant,Hexocyclium,The risk or severity of Tachycardia and drowsiness can be increased when Hexocyclium is combined with Rimonabant.,increase,risk
Rimonabant,Homatropine methylbromide,The risk or severity of Tachycardia and drowsiness can be increased when Homatropine methylbromide is combined with Rimonabant.,increase,risk
Rimonabant,Hydrocodone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Hydrocodone.,increase,risk
Rimonabant,Hydromorphone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Hydromorphone.,increase,risk
Rimonabant,Hydroxyzine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Hydroxyzine.,increase,risk
Rimonabant,Hyoscyamine,The risk or severity of Tachycardia and drowsiness can be increased when Hyoscyamine is combined with Rimonabant.,increase,risk
Rimonabant,Ketamine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ketamine.,increase,risk
Rimonabant,Ketazolam,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ketazolam.,increase,risk
Rimonabant,Ketoconazole,The metabolism of Rimonabant can be decreased when combined with Ketoconazole.,decrease,no risk
Rimonabant,Olanzapine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Olanzapine.,increase,risk
Rimonabant,Oliceridine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oliceridine.,increase,risk
Rimonabant,Olodaterol,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Olodaterol.,increase,risk
Rimonabant,Omaveloxolone,The serum concentration of Rimonabant can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Rimonabant,Ondansetron,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ondansetron.,increase,risk
Rimonabant,Opium,The risk or severity of adverse effects can be increased when Rimonabant is combined with Opium.,increase,risk
Rimonabant,Orciprenaline,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Orciprenaline.,increase,risk
Rimonabant,Orphenadrine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Orphenadrine.,increase,risk
Rimonabant,Oxazepam,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxazepam.,increase,risk
Rimonabant,Oxcarbazepine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxcarbazepine.,increase,risk
Rimonabant,Oxitriptan,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxitriptan.,increase,risk
Rimonabant,Oxprenolol,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxprenolol.,increase,risk
Rimonabant,Oxybuprocaine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxybuprocaine.,increase,risk
Rimonabant,Oxybutynin,The risk or severity of Tachycardia and drowsiness can be increased when Oxybutynin is combined with Rimonabant.,increase,risk
Rimonabant,Oxycodone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxycodone.,increase,risk
Rimonabant,Oxymetazoline,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Oxymetazoline.,increase,risk
Rimonabant,Oxymorphone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Oxymorphone.,increase,risk
Rimonabant,Oxyphencyclimine,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphencyclimine is combined with Rimonabant.,increase,risk
Rimonabant,Oxyphenonium,The risk or severity of Tachycardia and drowsiness can be increased when Oxyphenonium is combined with Rimonabant.,increase,risk
Rimonabant,Quazepam,The risk or severity of adverse effects can be increased when Rimonabant is combined with Quazepam.,increase,risk
Rimonabant,Quetiapine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Quetiapine.,increase,risk
Rimonabant,Quinidine,The risk or severity of Tachycardia and drowsiness can be increased when Quinidine is combined with Rimonabant.,increase,risk
Rimonabant,Quinine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Quinine.,increase,risk
Rimonabant,Quinupramine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Quinupramine.,increase,risk
Rimonabant,Umeclidinium,The risk or severity of Tachycardia and drowsiness can be increased when Umeclidinium is combined with Rimonabant.,increase,risk
Rimonabant,Urethane,The risk or severity of adverse effects can be increased when Rimonabant is combined with Urethane.,increase,risk
Rimonabant,Vadadustat,The serum concentration of Rimonabant can be increased when it is combined with Vadadustat.,increase,no risk
Rimonabant,Valproic acid,The risk or severity of adverse effects can be increased when Rimonabant is combined with Valproic acid.,increase,risk
Rimonabant,Vecuronium,The risk or severity of adverse effects can be increased when Rimonabant is combined with Vecuronium.,increase,risk
Rimonabant,Venetoclax,The metabolism of Rimonabant can be decreased when combined with Venetoclax.,decrease,no risk
Rimonabant,Venlafaxine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Venlafaxine.,increase,risk
Rimonabant,Verapamil,The metabolism of Rimonabant can be decreased when combined with Verapamil.,decrease,no risk
Rimonabant,Vigabatrin,The risk or severity of adverse effects can be increased when Rimonabant is combined with Vigabatrin.,increase,risk
Rimonabant,Vilanterol,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Vilanterol.,increase,risk
Rimonabant,Vilazodone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Vilazodone.,increase,risk
Rimonabant,Viloxazine,The metabolism of Rimonabant can be decreased when combined with Viloxazine.,decrease,no risk
Rimonabant,Voriconazole,The metabolism of Rimonabant can be decreased when combined with Voriconazole.,decrease,no risk
Rimonabant,Vortioxetine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Vortioxetine.,increase,risk
Rimonabant,Xamoterol,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Xamoterol.,increase,risk
Rimonabant,Xylometazoline,The risk or severity of Tachycardia can be increased when Rimonabant is combined with Xylometazoline.,increase,risk
Rimonabant,Yohimbine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Yohimbine.,increase,risk
Rimonabant,Zaleplon,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zaleplon.,increase,risk
Rimonabant,Ziconotide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ziconotide.,increase,risk
Rimonabant,Zimelidine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zimelidine.,increase,risk
Rimonabant,Ziprasidone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Ziprasidone.,increase,risk
Rimonabant,Zolmitriptan,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zolmitriptan.,increase,risk
Rimonabant,Zolpidem,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zolpidem.,increase,risk
Rimonabant,Zonisamide,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zonisamide.,increase,risk
Rimonabant,Zopiclone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zopiclone.,increase,risk
Rimonabant,Zotepine,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zotepine.,increase,risk
Rimonabant,Zuclopenthixol,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zuclopenthixol.,increase,risk
Rimonabant,Zuranolone,The risk or severity of adverse effects can be increased when Rimonabant is combined with Zuranolone.,increase,risk
Rubitecan,Benzocaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Benzocaine.,increase,risk
Rubitecan,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Benzyl alcohol.,increase,risk
Rubitecan,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Bupivacaine.,increase,risk
Rubitecan,Butacaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Butacaine.,increase,risk
Rubitecan,Butamben,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Butamben.,increase,risk
Rubitecan,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Oxetacaine.,increase,risk
Rubitecan,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Rubitecan is combined with Oxybuprocaine.,increase,risk
Garenoxacin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Garenoxacin.,increase,risk
Garenoxacin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Garenoxacin.,increase,risk
Garenoxacin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Garenoxacin.,increase,risk
Garenoxacin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Garenoxacin.,increase,risk
Garenoxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Garenoxacin.,increase,risk
Garenoxacin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Gilteritinib.,increase,risk
Garenoxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Garenoxacin is combined with Glasdegib.,increase,risk
Garenoxacin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Garenoxacin.,increase,no risk
Garenoxacin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Garenoxacin.,increase,no risk
Garenoxacin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Garenoxacin.,increase,no risk
Garenoxacin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Garenoxacin.,increase,no risk
Garenoxacin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Garenoxacin.,increase,no risk
Lumiliximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Lumiliximab.,increase,risk
Lumiliximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Obinutuzumab.,increase,risk
Lumiliximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Ocrelizumab.,increase,risk
Lumiliximab,Odesivimab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Odesivimab.,increase,risk
Lumiliximab,Ofatumumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Ofatumumab.,increase,risk
Lumiliximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Lumiliximab.,increase,risk
Lumiliximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lumiliximab.,increase,risk
Lumiliximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Lumiliximab.,increase,no risk
Lumiliximab,Ublituximab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Ublituximab.,increase,risk
Lumiliximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Lumiliximab.,increase,risk
Lumiliximab,Vedolizumab,The risk or severity of adverse effects can be increased when Lumiliximab is combined with Vedolizumab.,increase,risk
Plevitrexed,Benzocaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Benzocaine.,increase,risk
Plevitrexed,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Benzyl alcohol.,increase,risk
Plevitrexed,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Bupivacaine.,increase,risk
Plevitrexed,Butacaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Butacaine.,increase,risk
Plevitrexed,Butamben,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Butamben.,increase,risk
Plevitrexed,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Oxetacaine.,increase,risk
Plevitrexed,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Plevitrexed is combined with Oxybuprocaine.,increase,risk
Ruxolitinib,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bacitracin,Bacitracin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Baclofen,Baclofen may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Balsalazide,Balsalazide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Baricitinib,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Baricitinib.,increase,risk
Ruxolitinib,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Ruxolitinib.,increase,risk
Ruxolitinib,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Beclomethasone dipropionate,The metabolism of Ruxolitinib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Ruxolitinib,Belatacept,The risk or severity of adverse effects can be increased when Belatacept is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Belimumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Belimumab.,increase,risk
Ruxolitinib,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Belumosudil,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Belumosudil.,increase,risk
Ruxolitinib,Belzutifan,The serum concentration of Ruxolitinib can be decreased when it is combined with Belzutifan.,decrease,no risk
Ruxolitinib,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bendamustine,The risk or severity of adverse effects can be increased when Bendamustine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bendroflumethiazide,Ruxolitinib may increase the bradycardic activities of Bendroflumethiazide.,increase,no risk
Ruxolitinib,Benorilate,Benorilate may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benoxaprofen,Benoxaprofen may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benserazide,Ruxolitinib may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benzatropine,Benzatropine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benznidazole,Ruxolitinib may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Benzocaine.,increase,risk
Ruxolitinib,Benzthiazide,Benzthiazide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Benzydamine,Benzydamine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Benzyl alcohol.,increase,risk
Ruxolitinib,Bepotastine,Bepotastine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bepridil,Ruxolitinib may increase the bradycardic activities of Bepridil.,increase,no risk
Ruxolitinib,Beractant,Ruxolitinib may increase the bradycardic activities of Beractant.,increase,no risk
Ruxolitinib,Berotralstat,The serum concentration of Ruxolitinib can be increased when it is combined with Berotralstat.,increase,no risk
Ruxolitinib,Betamethasone,The metabolism of Ruxolitinib can be increased when combined with Betamethasone.,increase,no risk
Ruxolitinib,Betamethasone phosphate,The metabolism of Ruxolitinib can be increased when combined with Betamethasone phosphate.,increase,no risk
Ruxolitinib,Betaxolol,Ruxolitinib may increase the bradycardic activities of Betaxolol.,increase,no risk
Ruxolitinib,Betrixaban,The risk or severity of bleeding can be increased when Betrixaban is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bexarotene,The metabolism of Ruxolitinib can be increased when combined with Bexarotene.,increase,no risk
Ruxolitinib,Bicalutamide,The metabolism of Ruxolitinib can be decreased when combined with Bicalutamide.,decrease,no risk
Ruxolitinib,Bicisate,Ruxolitinib may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bifonazole,The metabolism of Ruxolitinib can be decreased when combined with Bifonazole.,decrease,no risk
Ruxolitinib,Bimekizumab,The metabolism of Ruxolitinib can be increased when combined with Bimekizumab.,increase,no risk
Ruxolitinib,Bismuth subgallate,Ruxolitinib may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bisoprolol,Ruxolitinib may increase the bradycardic activities of Bisoprolol.,increase,no risk
Ruxolitinib,Bisoxatin,Ruxolitinib may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Blinatumomab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Blinatumomab.,increase,risk
Ruxolitinib,Boceprevir,The metabolism of Ruxolitinib can be decreased when combined with Boceprevir.,decrease,no risk
Ruxolitinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Ruxolitinib.",decrease,no risk
Ruxolitinib,Bortezomib,The risk or severity of adverse effects can be increased when Bortezomib is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Bosentan,The metabolism of Ruxolitinib can be increased when combined with Bosentan.,increase,no risk
Ruxolitinib,Bosutinib,The metabolism of Ruxolitinib can be decreased when combined with Bosutinib.,decrease,no risk
Ruxolitinib,Brentuximab vedotin,The serum concentration of Ruxolitinib can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Ruxolitinib,Bretylium,Ruxolitinib may increase the bradycardic activities of Bretylium.,increase,no risk
Ruxolitinib,Brivaracetam,Brivaracetam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Brodalumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Brodalumab.,increase,risk
Ruxolitinib,Bromazepam,Bromazepam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bromotheophylline,Bromotheophylline may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Budesonide,The metabolism of Ruxolitinib can be increased when combined with Budesonide.,increase,no risk
Ruxolitinib,Bumadizone,Bumadizone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Bumetanide,Bumetanide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Bupivacaine.,increase,risk
Ruxolitinib,Buprenorphine,The metabolism of Ruxolitinib can be decreased when combined with Buprenorphine.,decrease,no risk
Ruxolitinib,Bupropion,Bupropion may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Buspirone,Buspirone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Butabarbital,Butabarbital may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Butacaine.,increase,risk
Ruxolitinib,Butalbital,The metabolism of Ruxolitinib can be increased when combined with Butalbital.,increase,no risk
Ruxolitinib,Butamben,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Butamben.,increase,risk
Ruxolitinib,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadodiamide,Gadodiamide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadoteric acid,Ruxolitinib may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gadoteridol,Gadoteridol may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Galantamine,Ruxolitinib may increase the bradycardic activities of Galantamine.,increase,no risk
Ruxolitinib,Ganciclovir,Ganciclovir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Gemfibrozil,The metabolism of Ruxolitinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Ruxolitinib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Gentamicin,Ruxolitinib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gilteritinib,The metabolism of Ruxolitinib can be decreased when combined with Gilteritinib.,decrease,no risk
Ruxolitinib,Gimeracil,Ruxolitinib may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ginkgo biloba,The metabolism of Ruxolitinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ruxolitinib,Givosiran,Givosiran may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Glecaprevir,The metabolism of Ruxolitinib can be decreased when combined with Glecaprevir.,decrease,no risk
Ruxolitinib,Gliclazide,The metabolism of Ruxolitinib can be decreased when combined with Gliclazide.,decrease,no risk
Ruxolitinib,Glimepiride,The metabolism of Ruxolitinib can be decreased when combined with Glimepiride.,decrease,no risk
Ruxolitinib,Glipizide,Glipizide may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Gliquidone,The metabolism of Ruxolitinib can be decreased when combined with Gliquidone.,decrease,no risk
Ruxolitinib,Glofitamab,The serum concentration of Ruxolitinib can be increased when it is combined with Glofitamab.,increase,no risk
Ruxolitinib,Glyburide,The metabolism of Ruxolitinib can be decreased when combined with Glyburide.,decrease,no risk
Ruxolitinib,Glycerol phenylbutyrate,The metabolism of Ruxolitinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Ruxolitinib,Golimumab,The metabolism of Ruxolitinib can be increased when combined with Golimumab.,increase,no risk
Ruxolitinib,Golodirsen,Ruxolitinib may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Goserelin,Goserelin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Grapefruit,The serum concentration of Ruxolitinib can be increased when it is combined with Grapefruit.,increase,no risk
Ruxolitinib,Griseofulvin,The metabolism of Ruxolitinib can be increased when combined with Griseofulvin.,increase,no risk
Ruxolitinib,Guanethidine,Guanethidine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Guanfacine,Ruxolitinib may increase the bradycardic activities of Guanfacine.,increase,no risk
Ruxolitinib,Guselkumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Guselkumab.,increase,risk
Ruxolitinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ruxolitinib.,increase,no risk
Ruxolitinib,Halothane,The metabolism of Ruxolitinib can be decreased when combined with Halothane.,decrease,no risk
Ruxolitinib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Hydralazine,The serum concentration of Ruxolitinib can be increased when it is combined with Hydralazine.,increase,no risk
Ruxolitinib,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Hydrocortamate,The metabolism of Ruxolitinib can be increased when combined with Hydrocortamate.,increase,no risk
Ruxolitinib,Hydrocortisone,The metabolism of Ruxolitinib can be increased when combined with Hydrocortisone.,increase,no risk
Ruxolitinib,Hydrocortisone acetate,The metabolism of Ruxolitinib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Ruxolitinib,Hydrocortisone butyrate,The metabolism of Ruxolitinib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Ruxolitinib,Hydrocortisone succinate,The metabolism of Ruxolitinib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Ruxolitinib,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Hydromorphone,Hydromorphone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Hydroxyethyl Starch,Ruxolitinib may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Kanamycin,Ruxolitinib may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ketamine,Ketamine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ketazolam,The serum concentration of Ruxolitinib can be increased when it is combined with Ketazolam.,increase,no risk
Ruxolitinib,Ketoconazole,The metabolism of Ruxolitinib can be decreased when combined with Ketoconazole.,decrease,no risk
Ruxolitinib,Ketoprofen,Ketoprofen may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ketorolac,Ketorolac may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Obinutuzumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Obinutuzumab.,increase,risk
Ruxolitinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Ocrelizumab.,increase,risk
Ruxolitinib,Octinoxate,Ruxolitinib may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Octreotide,The serum concentration of Ruxolitinib can be increased when it is combined with Octreotide.,increase,no risk
Ruxolitinib,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Olanzapine,The metabolism of Ruxolitinib can be decreased when combined with Olanzapine.,decrease,no risk
Ruxolitinib,Olaparib,The metabolism of Ruxolitinib can be decreased when combined with Olaparib.,decrease,no risk
Ruxolitinib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Ruxolitinib.,decrease,no risk
Ruxolitinib,Olsalazine,Olsalazine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Olutasidenib,The metabolism of Ruxolitinib can be increased when combined with Olutasidenib.,increase,no risk
Ruxolitinib,Omaveloxolone,The serum concentration of Ruxolitinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ruxolitinib,Ondansetron,The metabolism of Ruxolitinib can be decreased when combined with Ondansetron.,decrease,no risk
Ruxolitinib,Opium,Ruxolitinib may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oritavancin,The metabolism of Ruxolitinib can be increased when combined with Oritavancin.,increase,no risk
Ruxolitinib,Orphenadrine,The metabolism of Ruxolitinib can be decreased when combined with Orphenadrine.,decrease,no risk
Ruxolitinib,Oseltamivir,Oseltamivir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Osilodrostat,The metabolism of Ruxolitinib can be decreased when combined with Osilodrostat.,decrease,no risk
Ruxolitinib,Osimertinib,The metabolism of Ruxolitinib can be decreased when combined with Osimertinib.,decrease,no risk
Ruxolitinib,Ospemifene,The metabolism of Ruxolitinib can be decreased when combined with Ospemifene.,decrease,no risk
Ruxolitinib,Oxacillin,Oxacillin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Oxandrolone,The metabolism of Ruxolitinib can be decreased when combined with Oxandrolone.,decrease,no risk
Ruxolitinib,Oxaprozin,Oxaprozin may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxazepam,Oxazepam may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxcarbazepine,The metabolism of Ruxolitinib can be increased when combined with Oxcarbazepine.,increase,no risk
Ruxolitinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Oxetacaine.,increase,risk
Ruxolitinib,Oxprenolol,Ruxolitinib may increase the bradycardic activities of Oxprenolol.,increase,no risk
Ruxolitinib,Oxybenzone,Oxybenzone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ruxolitinib is combined with Oxybuprocaine.,increase,risk
Ruxolitinib,Oxybutynin,The serum concentration of Ruxolitinib can be increased when it is combined with Oxybutynin.,increase,no risk
Ruxolitinib,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Oxyquinoline,Ruxolitinib may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Ozanimod,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Ozanimod.,increase,risk
Ruxolitinib,Quetiapine,Quetiapine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Quinethazone,Quinethazone may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ruxolitinib,Quinidine,The metabolism of Ruxolitinib can be decreased when combined with Quinidine.,decrease,no risk
Ruxolitinib,Quinine,The metabolism of Ruxolitinib can be increased when combined with Quinine.,increase,no risk
Ruxolitinib,Quinupristin,The metabolism of Ruxolitinib can be decreased when combined with Quinupristin.,decrease,no risk
Ruxolitinib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Upadacitinib,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Upadacitinib.,increase,risk
Ruxolitinib,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vaborbactam,Ruxolitinib may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Vadadustat,The serum concentration of Ruxolitinib can be increased when it is combined with Vadadustat.,increase,no risk
Ruxolitinib,Valaciclovir,Valaciclovir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Valbenazine,Ruxolitinib may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Valdecoxib,The metabolism of Ruxolitinib can be decreased when combined with Valdecoxib.,decrease,no risk
Ruxolitinib,Valganciclovir,Valganciclovir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Valproic acid,The serum concentration of Ruxolitinib can be increased when it is combined with Valproic acid.,increase,no risk
Ruxolitinib,Valsartan,The metabolism of Ruxolitinib can be decreased when combined with Valsartan.,decrease,no risk
Ruxolitinib,Vancomycin,Ruxolitinib may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Vardenafil,The metabolism of Ruxolitinib can be decreased when combined with Vardenafil.,decrease,no risk
Ruxolitinib,Varenicline,Varenicline may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Vedolizumab,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Vedolizumab.,increase,risk
Ruxolitinib,Vemurafenib,The metabolism of Ruxolitinib can be increased when combined with Vemurafenib.,increase,no risk
Ruxolitinib,Venetoclax,The metabolism of Ruxolitinib can be decreased when combined with Venetoclax.,decrease,no risk
Ruxolitinib,Venlafaxine,Venlafaxine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Verapamil,Ruxolitinib may increase the bradycardic activities of Verapamil.,increase,no risk
Ruxolitinib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ruxolitinib.,decrease,no risk
Ruxolitinib,Vilanterol,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Vilanterol.,increase,risk
Ruxolitinib,Viloxazine,The metabolism of Ruxolitinib can be decreased when combined with Viloxazine.,decrease,no risk
Ruxolitinib,Vinblastine,The metabolism of Ruxolitinib can be increased when combined with Vinblastine.,increase,no risk
Ruxolitinib,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vitamin E,The metabolism of Ruxolitinib can be increased when combined with Vitamin E.,increase,no risk
Ruxolitinib,Voclosporin,The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Voclosporin.,increase,risk
Ruxolitinib,Vorapaxar,The metabolism of Ruxolitinib can be decreased when combined with Vorapaxar.,decrease,no risk
Ruxolitinib,Voriconazole,The metabolism of Ruxolitinib can be decreased when combined with Voriconazole.,decrease,no risk
Ruxolitinib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Vortioxetine,Ruxolitinib may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Voxelotor,The serum concentration of Ruxolitinib can be increased when it is combined with Voxelotor.,increase,no risk
Ruxolitinib,Warfarin,The metabolism of Ruxolitinib can be increased when combined with Warfarin.,increase,no risk
Ruxolitinib,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Zafirlukast,The serum concentration of Ruxolitinib can be increased when it is combined with Zafirlukast.,increase,no risk
Ruxolitinib,Zaleplon,Zaleplon may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Zanamivir,Zanamivir may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.,decrease,no risk
Ruxolitinib,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Ruxolitinib.,increase,risk
Ruxolitinib,Zileuton,The metabolism of Ruxolitinib can be decreased when combined with Zileuton.,decrease,no risk
Ruxolitinib,Zimelidine,The metabolism of Ruxolitinib can be decreased when combined with Zimelidine.,decrease,no risk
Ruxolitinib,Ziprasidone,The metabolism of Ruxolitinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ruxolitinib,Zolpidem,The metabolism of Ruxolitinib can be decreased when combined with Zolpidem.,decrease,no risk
Ruxolitinib,Zonisamide,Ruxolitinib may increase the bradycardic activities of Zonisamide.,increase,no risk
Ruxolitinib,Zopiclone,The metabolism of Ruxolitinib can be decreased when combined with Zopiclone.,decrease,no risk
Ruxolitinib,Zuclopenthixol,The metabolism of Ruxolitinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Fedratinib,Boceprevir,The serum concentration of Fedratinib can be increased when it is combined with Boceprevir.,increase,no risk
Fedratinib,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Bosentan,The serum concentration of Fedratinib can be decreased when it is combined with Bosentan.,decrease,no risk
Fedratinib,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brexpiprazole,The serum concentration of Brexpiprazole can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brinzolamide,The serum concentration of Brinzolamide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Brivaracetam,The serum concentration of Brivaracetam can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Bupivacaine,The serum concentration of Bupivacaine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Buprenorphine,The serum concentration of Buprenorphine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Buspirone,The serum concentration of Buspirone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Butacaine.,increase,risk
Fedratinib,Butamben,The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Butamben.,increase,risk
Fedratinib,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Fedratinib.,decrease,no risk
Fedratinib,Galantamine,The serum concentration of Galantamine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ganciclovir,Fedratinib may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Fedratinib,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gemfibrozil,The serum concentration of Gemfibrozil can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gentamicin,Fedratinib may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Fedratinib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gestrinone,The serum concentration of Gestrinone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Glecaprevir,Fedratinib may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Fedratinib,Gliclazide,The serum concentration of Gliclazide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Glofitamab,The serum concentration of Fedratinib can be increased when it is combined with Glofitamab.,increase,no risk
Fedratinib,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Golimumab,The metabolism of Fedratinib can be increased when combined with Golimumab.,increase,no risk
Fedratinib,Granisetron,The serum concentration of Granisetron can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Grepafloxacin,The serum concentration of Grepafloxacin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Guanfacine,The serum concentration of Guanfacine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Guanidine,Fedratinib may decrease the excretion rate of Guanidine which could result in a higher serum level.,decrease,no risk
Fedratinib,Halcinonide,The serum concentration of Halcinonide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Halofantrine,The serum concentration of Halofantrine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Halothane,The serum concentration of Halothane can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Histamine,Fedratinib may decrease the excretion rate of Histamine which could result in a higher serum level.,decrease,no risk
Fedratinib,Hydrocodone,The serum concentration of Hydrocodone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone acetate,The serum concentration of Hydrocortisone acetate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone butyrate,The serum concentration of Hydrocortisone butyrate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone cypionate,The serum concentration of Hydrocortisone cypionate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone phosphate,The serum concentration of Hydrocortisone phosphate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone probutate,The serum concentration of Hydrocortisone probutate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone succinate,The serum concentration of Hydrocortisone succinate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydrocortisone valerate,The serum concentration of Hydrocortisone valerate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydroxychloroquine,The serum concentration of Hydroxychloroquine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Hydroxyzine,The serum concentration of Hydroxyzine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ketamine,The serum concentration of Ketamine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ketazolam,The serum concentration of Ketazolam can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ketoconazole,The serum concentration of Fedratinib can be increased when it is combined with Ketoconazole.,increase,no risk
Fedratinib,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Fedratinib.,increase,risk
Fedratinib,Olanzapine,The serum concentration of Olanzapine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Olutasidenib,The serum concentration of Olutasidenib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ombitasvir,Fedratinib may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Fedratinib,Omeprazole,The serum concentration of Omeprazole can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ondansetron,The serum concentration of Ondansetron can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Opium,The serum concentration of Opium can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oritavancin,The metabolism of Fedratinib can be decreased when combined with Oritavancin.,decrease,no risk
Fedratinib,Orphenadrine,The serum concentration of Orphenadrine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ospemifene,The serum concentration of Ospemifene can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ouabain,The excretion of Ouabain can be decreased when combined with Fedratinib.,decrease,no risk
Fedratinib,Oxaliplatin,Fedratinib may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Fedratinib,Oxcarbazepine,The metabolism of Fedratinib can be decreased when combined with Oxcarbazepine.,decrease,no risk
Fedratinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Oxetacaine.,increase,risk
Fedratinib,Oxprenolol,The serum concentration of Oxprenolol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Fedratinib is combined with Oxybuprocaine.,increase,risk
Fedratinib,Oxybutynin,The serum concentration of Oxybutynin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oxycodone,The serum concentration of Oxycodone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Oxymorphone,The serum concentration of Oxymorphone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ozanimod,Fedratinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Fedratinib,Quazepam,The serum concentration of Quazepam can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Quinine,The serum concentration of Quinine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Udenafil,The serum concentration of Udenafil can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Ulipristal,The serum concentration of Ulipristal can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Umbralisib,The serum concentration of Fedratinib can be increased when it is combined with Umbralisib.,increase,no risk
Fedratinib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Upadacitinib,The serum concentration of Upadacitinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vadadustat,The serum concentration of Fedratinib can be increased when it is combined with Vadadustat.,increase,no risk
Fedratinib,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Valdecoxib,The serum concentration of Valdecoxib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Valsartan,The excretion of Valsartan can be decreased when combined with Fedratinib.,decrease,no risk
Fedratinib,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Varenicline,Fedratinib may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Fedratinib,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vemurafenib,The serum concentration of Fedratinib can be increased when it is combined with Vemurafenib.,increase,no risk
Fedratinib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Venlafaxine,The serum concentration of Venlafaxine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vernakalant,The serum concentration of Vernakalant can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vilazodone,The serum concentration of Vilazodone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Fedratinib.,increase,no risk
Fedratinib,Viloxazine,The metabolism of Fedratinib can be decreased when combined with Viloxazine.,decrease,no risk
Fedratinib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vitamin D,The serum concentration of Vitamin D can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vitamin E,The serum concentration of Vitamin E can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vonoprazan,The serum concentration of Vonoprazan can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Vorapaxar,The serum concentration of Vorapaxar can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Voriconazole,The serum concentration of Fedratinib can be increased when it is combined with Voriconazole.,increase,no risk
Fedratinib,Vortioxetine,The serum concentration of Vortioxetine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Yohimbine,The serum concentration of Yohimbine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zafirlukast,The metabolism of Fedratinib can be decreased when combined with Zafirlukast.,decrease,no risk
Fedratinib,Zaleplon,The serum concentration of Zaleplon can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zileuton,The serum concentration of Zileuton can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zimelidine,The metabolism of Fedratinib can be decreased when combined with Zimelidine.,decrease,no risk
Fedratinib,Ziprasidone,The serum concentration of Ziprasidone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zolpidem,The serum concentration of Zolpidem can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zonisamide,The serum concentration of Zonisamide can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zopiclone,The serum concentration of Zopiclone can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zotepine,The serum concentration of Zotepine can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zuclopenthixol,The serum concentration of Zuclopenthixol can be increased when it is combined with Fedratinib.,increase,no risk
Fedratinib,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Fedratinib.,increase,no risk
Canakinumab,Bepridil,The metabolism of Bepridil can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Besilesomab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Besilesomab.,increase,risk
Canakinumab,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Canakinumab.,increase,risk
Canakinumab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Canakinumab.,increase,risk
Canakinumab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Bezlotoxumab.,increase,risk
Canakinumab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bimekizumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Bimekizumab.,increase,risk
Canakinumab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Canakinumab.,increase,risk
Canakinumab,Blinatumomab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Blinatumomab.,increase,risk
Canakinumab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Canakinumab.",decrease,no risk
Canakinumab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bosentan,The metabolism of Bosentan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brodalumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Brodalumab.,increase,risk
Canakinumab,Brolucizumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Brolucizumab.,increase,risk
Canakinumab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Canakinumab.,increase,risk
Canakinumab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Bupropion,The metabolism of Bupropion can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Burosumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Burosumab.,increase,risk
Canakinumab,Buspirone,The metabolism of Buspirone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Busulfan,The metabolism of Busulfan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Galantamine,The metabolism of Galantamine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Galcanezumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Galcanezumab.,increase,risk
Canakinumab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Canakinumab.,increase,risk
Canakinumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Canakinumab.,increase,risk
Canakinumab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Canakinumab.,increase,risk
Canakinumab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glipizide,The metabolism of Glipizide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Glofitamab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Glofitamab.,increase,risk
Canakinumab,Glyburide,The metabolism of Glyburide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Golimumab,The risk or severity of infection and neutropenia can be increased when Golimumab is combined with Canakinumab.,increase,risk
Canakinumab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Guselkumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Guselkumab.,increase,risk
Canakinumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Haloperidol,The metabolism of Haloperidol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Halothane,The metabolism of Halothane can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Canakinumab.,increase,risk
Canakinumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Canakinumab is combined with Human adenovirus e serotype 4 strain cl-68578 antigen.,increase,risk
Canakinumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Canakinumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Canakinumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Canakinumab.,increase,risk
Canakinumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Canakinumab is combined with Human Rho(D) immune globulin.,increase,risk
Canakinumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Canakinumab is combined with Human varicella-zoster immune globulin.,increase,risk
Canakinumab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Canakinumab is combined with Hydrocortisone succinate.,increase,risk
Canakinumab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Canakinumab.,increase,risk
Canakinumab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Ketamine,The metabolism of Ketamine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Canakinumab.,increase,risk
Canakinumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Obinutuzumab.,increase,risk
Canakinumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Ocrelizumab.,increase,risk
Canakinumab,Odesivimab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Odesivimab.,increase,risk
Canakinumab,Ofatumumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Ofatumumab.,increase,risk
Canakinumab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Olaparib,The metabolism of Olaparib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Canakinumab.,increase,risk
Canakinumab,Oliceridine,The metabolism of Oliceridine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Canakinumab.,increase,risk
Canakinumab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Opium,The metabolism of Opium can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Canakinumab.,increase,risk
Canakinumab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ozanimod,The risk or severity of adverse effects can be increased when Canakinumab is combined with Ozanimod.,increase,risk
Canakinumab,Quetiapine,The metabolism of Quetiapine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Canakinumab.,increase,no risk
Canakinumab,Quinidine,The metabolism of Quinidine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Quinine,The metabolism of Quinine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Quizartinib,The metabolism of Quizartinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Canakinumab.,increase,risk
Canakinumab,Udenafil,The metabolism of Udenafil can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Upadacitinib,The risk or severity of adverse effects can be increased when Canakinumab is combined with Upadacitinib.,increase,risk
Canakinumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Canakinumab.,increase,risk
Canakinumab,Valbenazine,The metabolism of Valbenazine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Valproic acid,The metabolism of Valproic acid can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Valsartan,The metabolism of Valsartan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vandetanib,The metabolism of Vandetanib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vardenafil,The metabolism of Vardenafil can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Canakinumab is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Canakinumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Vedolizumab,The risk or severity of adverse effects can be increased when Canakinumab is combined with Vedolizumab.,increase,risk
Canakinumab,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Venetoclax,The metabolism of Venetoclax can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Verapamil,The metabolism of Verapamil can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vernakalant,The metabolism of Vernakalant can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Canakinumab.,decrease,no risk
Canakinumab,Vilanterol,The risk or severity of adverse effects can be increased when Canakinumab is combined with Vilanterol.,increase,risk
Canakinumab,Vilazodone,The metabolism of Vilazodone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vinblastine,The metabolism of Vinblastine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vincristine,The metabolism of Vincristine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vindesine,The metabolism of Vindesine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vinflunine,The metabolism of Vinflunine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Voclosporin,The risk or severity of adverse effects can be increased when Canakinumab is combined with Voclosporin.,increase,risk
Canakinumab,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Voriconazole,The metabolism of Voriconazole can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Canakinumab.,increase,risk
Canakinumab,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Voxelotor,The metabolism of Voxelotor can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Warfarin,The metabolism of Warfarin can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Yellow fever vaccine,The risk or severity of infection can be increased when Canakinumab is combined with Yellow fever vaccine.,increase,risk
Canakinumab,Yohimbine,The metabolism of Yohimbine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zaleplon,The metabolism of Zaleplon can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zidovudine,The metabolism of Zidovudine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zileuton,The metabolism of Zileuton can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zolpidem,The metabolism of Zolpidem can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zonisamide,The metabolism of Zonisamide can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zopiclone,The metabolism of Zopiclone can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zotepine,The metabolism of Zotepine can be increased when combined with Canakinumab.,increase,no risk
Canakinumab,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Canakinumab.,increase,no risk
Glycerol phenylbutyrate,Bumadizone,Bumadizone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Bumetanide,Bumetanide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Bupropion,Bupropion may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Buspirone,The metabolism of Buspirone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Busulfan,The metabolism of Busulfan can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Butabarbital,Butabarbital may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadodiamide,Gadodiamide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadoteric acid,Glycerol phenylbutyrate may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gadoteridol,Gadoteridol may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Galantamine,The metabolism of Galantamine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Ganciclovir,Ganciclovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Gemcitabine,Gemcitabine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gentamicin,Glycerol phenylbutyrate may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Gestrinone,The metabolism of Gestrinone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Gimeracil,Glycerol phenylbutyrate may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Givosiran,Givosiran may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Glipizide,Glipizide may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Golodirsen,Glycerol phenylbutyrate may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Goserelin,Goserelin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Guanethidine,Guanethidine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Guanfacine,Guanfacine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Hydralazine,Hydralazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Hydrocortisone,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Glycerol phenylbutyrate,Hydrocortisone acetate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Glycerol phenylbutyrate,Hydrocortisone butyrate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Glycerol phenylbutyrate,Hydrocortisone cypionate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone cypionate.,decrease,no risk
Glycerol phenylbutyrate,Hydrocortisone succinate,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Glycerol phenylbutyrate,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Hydromorphone,Hydromorphone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Hydroxyethyl Starch,Glycerol phenylbutyrate may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Kanamycin,Glycerol phenylbutyrate may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ketamine,Ketamine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ketazolam,Ketazolam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ketoprofen,Ketoprofen may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ketorolac,Ketorolac may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Octinoxate,Glycerol phenylbutyrate may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Olaparib,The metabolism of Olaparib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Olsalazine,Olsalazine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Opium,The metabolism of Opium can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Oseltamivir,Oseltamivir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Osimertinib,The metabolism of Osimertinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Oxacillin,Oxacillin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxaprozin,Oxaprozin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxazepam,Oxazepam may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Oxybenzone,Oxybenzone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Oxyquinoline,Glycerol phenylbutyrate may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Quinethazone,Quinethazone may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Quinidine,The metabolism of Quinidine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Quinine,The metabolism of Quinine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Ulipristal,The metabolism of Ulipristal can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Vaborbactam,Glycerol phenylbutyrate may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Valaciclovir,Valaciclovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Valdecoxib,Valdecoxib may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Valganciclovir,Valganciclovir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Valproic acid,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Valproic acid.,decrease,no risk
Glycerol phenylbutyrate,Vamorolone,The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Vamorolone.,decrease,no risk
Glycerol phenylbutyrate,Vancomycin,Glycerol phenylbutyrate may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Vandetanib,The metabolism of Vandetanib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Varenicline,Varenicline may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Venetoclax,The metabolism of Venetoclax can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Verapamil,Verapamil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Vilanterol,Glycerol phenylbutyrate may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Viloxazine,Glycerol phenylbutyrate may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Vinblastine,The metabolism of Vinblastine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vincristine,The metabolism of Vincristine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vindesine,The metabolism of Vindesine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vinflunine,The metabolism of Vinflunine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Warfarin,The metabolism of Warfarin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Zaleplon,Zaleplon may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Zanamivir,Zanamivir may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Glycerol phenylbutyrate,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Glycerol phenylbutyrate,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Glycerol phenylbutyrate,Zonisamide,Zonisamide may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Glycerol phenylbutyrate,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Paclitaxel trevatide,Benzocaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Benzocaine.,increase,risk
Paclitaxel trevatide,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Benzyl alcohol.,increase,risk
Paclitaxel trevatide,Bevacizumab,The risk or severity of cardiotoxicity can be increased when Bevacizumab is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Bleomycin,The risk or severity of cardiotoxicity can be increased when Bleomycin is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Bortezomib,The risk or severity of cardiotoxicity can be increased when Bortezomib is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Bupivacaine.,increase,risk
Paclitaxel trevatide,Busulfan,The risk or severity of cardiotoxicity can be increased when Busulfan is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Butacaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Butacaine.,increase,risk
Paclitaxel trevatide,Butamben,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Butamben.,increase,risk
Paclitaxel trevatide,Ouabain,Ouabain may decrease the cardiotoxic activities of Paclitaxel trevatide.,decrease,no risk
Paclitaxel trevatide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Oxetacaine.,increase,risk
Paclitaxel trevatide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Paclitaxel trevatide is combined with Oxybuprocaine.,increase,risk
Paclitaxel trevatide,Vinblastine,The risk or severity of cardiotoxicity can be increased when Vinblastine is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Vincristine,The risk or severity of cardiotoxicity can be increased when Vincristine is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Vindesine,The risk or severity of cardiotoxicity can be increased when Vindesine is combined with Paclitaxel trevatide.,increase,risk
Paclitaxel trevatide,Vinorelbine,The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Paclitaxel trevatide.,increase,risk
Noscapine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Glipizide,The metabolism of Glipizide can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Glyburide,The metabolism of Glyburide can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Halothane,The metabolism of Halothane can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Ketamine,The metabolism of Ketamine can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Quinine,The metabolism of Quinine can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Valsartan,The metabolism of Valsartan can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Noscapine.,increase,no risk
Noscapine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zileuton,The metabolism of Zileuton can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Noscapine.,decrease,no risk
Noscapine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Noscapine.,decrease,no risk
Romidepsin,Buprenorphine,The metabolism of Romidepsin can be decreased when combined with Buprenorphine.,decrease,no risk
Romidepsin,Bupropion,The metabolism of Romidepsin can be decreased when combined with Bupropion.,decrease,no risk
Romidepsin,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Romidepsin.,increase,risk
Romidepsin,Buspirone,The metabolism of Romidepsin can be decreased when combined with Buspirone.,decrease,no risk
Romidepsin,Butacaine,The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Butacaine.,increase,risk
Romidepsin,Butalbital,The metabolism of Romidepsin can be increased when combined with Butalbital.,increase,no risk
Romidepsin,Butamben,The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Butamben.,increase,risk
Romidepsin,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Romidepsin.,increase,risk
Romidepsin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Romidepsin.,increase,risk
Romidepsin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Romidepsin.,increase,risk
Romidepsin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Romidepsin.,increase,risk
Romidepsin,Gefitinib,The metabolism of Romidepsin can be decreased when combined with Gefitinib.,decrease,no risk
Romidepsin,Gemcitabine,The serum concentration of Romidepsin can be increased when it is combined with Gemcitabine.,increase,no risk
Romidepsin,Gemfibrozil,The excretion of Romidepsin can be decreased when combined with Gemfibrozil.,decrease,no risk
Romidepsin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Romidepsin.,increase,risk
Romidepsin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Romidepsin.,increase,risk
Romidepsin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Romidepsin.,increase,risk
Romidepsin,Ginkgo biloba,The metabolism of Romidepsin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Romidepsin,Glasdegib,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Glasdegib.,increase,risk
Romidepsin,Glecaprevir,The serum concentration of Romidepsin can be increased when it is combined with Glecaprevir.,increase,no risk
Romidepsin,Glofitamab,The serum concentration of Romidepsin can be increased when it is combined with Glofitamab.,increase,no risk
Romidepsin,Glyburide,The metabolism of Romidepsin can be decreased when combined with Glyburide.,decrease,no risk
Romidepsin,Glycerol phenylbutyrate,The metabolism of Romidepsin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Romidepsin,Golimumab,The metabolism of Romidepsin can be increased when combined with Golimumab.,increase,no risk
Romidepsin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Romidepsin.,increase,risk
Romidepsin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Romidepsin.,increase,risk
Romidepsin,Grapefruit,The serum concentration of Romidepsin can be increased when it is combined with Grapefruit.,increase,no risk
Romidepsin,Grazoprevir,The serum concentration of Romidepsin can be increased when it is combined with Grazoprevir.,increase,no risk
Romidepsin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Romidepsin.,increase,risk
Romidepsin,Griseofulvin,The metabolism of Romidepsin can be increased when combined with Griseofulvin.,increase,no risk
Romidepsin,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Romidepsin.,increase,risk
Romidepsin,Haloperidol,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Haloperidol.,increase,risk
Romidepsin,Halothane,The metabolism of Romidepsin can be decreased when combined with Halothane.,decrease,no risk
Romidepsin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Romidepsin.,increase,risk
Romidepsin,Hydralazine,The serum concentration of Romidepsin can be increased when it is combined with Hydralazine.,increase,no risk
Romidepsin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Romidepsin.,increase,risk
Romidepsin,Hydrocodone,The metabolism of Romidepsin can be decreased when combined with Hydrocodone.,decrease,no risk
Romidepsin,Hydrocortamate,The metabolism of Romidepsin can be increased when combined with Hydrocortamate.,increase,no risk
Romidepsin,Hydrocortisone,The metabolism of Romidepsin can be increased when combined with Hydrocortisone.,increase,no risk
Romidepsin,Hydrocortisone acetate,The metabolism of Romidepsin can be increased when combined with Hydrocortisone acetate.,increase,no risk
Romidepsin,Hydrocortisone butyrate,The metabolism of Romidepsin can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Romidepsin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Hydrocortisone succinate,The metabolism of Romidepsin can be increased when combined with Hydrocortisone succinate.,increase,no risk
Romidepsin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Romidepsin.,increase,risk
Romidepsin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Hydroxyzine.,increase,risk
Romidepsin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Romidepsin.,increase,risk
Romidepsin,Ketamine,The metabolism of Romidepsin can be decreased when combined with Ketamine.,decrease,no risk
Romidepsin,Ketazolam,The serum concentration of Romidepsin can be increased when it is combined with Ketazolam.,increase,no risk
Romidepsin,Ketoconazole,The metabolism of Romidepsin can be decreased when combined with Ketoconazole.,decrease,no risk
Romidepsin,Octreotide,The serum concentration of Romidepsin can be increased when it is combined with Octreotide.,increase,no risk
Romidepsin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Romidepsin.,increase,risk
Romidepsin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Romidepsin.,increase,risk
Romidepsin,Olaparib,The metabolism of Romidepsin can be decreased when combined with Olaparib.,decrease,no risk
Romidepsin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Romidepsin.,increase,risk
Romidepsin,Olutasidenib,The metabolism of Romidepsin can be increased when combined with Olutasidenib.,increase,no risk
Romidepsin,Omadacycline,The serum concentration of Romidepsin can be increased when it is combined with Omadacycline.,increase,no risk
Romidepsin,Omaveloxolone,The serum concentration of Romidepsin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Romidepsin,Ombitasvir,The serum concentration of Romidepsin can be increased when it is combined with Ombitasvir.,increase,no risk
Romidepsin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Romidepsin.,increase,risk
Romidepsin,Oritavancin,The metabolism of Romidepsin can be increased when combined with Oritavancin.,increase,no risk
Romidepsin,Orphenadrine,The metabolism of Romidepsin can be decreased when combined with Orphenadrine.,decrease,no risk
Romidepsin,Osilodrostat,The metabolism of Romidepsin can be decreased when combined with Osilodrostat.,decrease,no risk
Romidepsin,Osimertinib,The metabolism of Romidepsin can be decreased when combined with Osimertinib.,decrease,no risk
Romidepsin,Ospemifene,The metabolism of Romidepsin can be decreased when combined with Ospemifene.,decrease,no risk
Romidepsin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Romidepsin.,increase,risk
Romidepsin,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Romidepsin.,increase,risk
Romidepsin,Oxcarbazepine,The metabolism of Romidepsin can be increased when combined with Oxcarbazepine.,increase,no risk
Romidepsin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Oxetacaine.,increase,risk
Romidepsin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Romidepsin is combined with Oxybuprocaine.,increase,risk
Romidepsin,Oxybutynin,The serum concentration of Romidepsin can be increased when it is combined with Oxybutynin.,increase,no risk
Romidepsin,Oxycodone,The metabolism of Romidepsin can be decreased when combined with Oxycodone.,decrease,no risk
Romidepsin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Romidepsin.,increase,risk
Romidepsin,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Romidepsin.,increase,risk
Romidepsin,Quinidine,The serum concentration of Romidepsin can be increased when it is combined with Quinidine.,increase,no risk
Romidepsin,Quinine,The serum concentration of Romidepsin can be increased when it is combined with Quinine.,increase,no risk
Romidepsin,Quinupristin,The metabolism of Romidepsin can be decreased when combined with Quinupristin.,decrease,no risk
Romidepsin,Quizartinib,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Quizartinib.,increase,risk
Romidepsin,Ubrogepant,The serum concentration of Romidepsin can be increased when it is combined with Ubrogepant.,increase,no risk
Romidepsin,Udenafil,The metabolism of Udenafil can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Umbralisib,The serum concentration of Romidepsin can be increased when it is combined with Umbralisib.,increase,no risk
Romidepsin,Umeclidinium,The serum concentration of Romidepsin can be increased when it is combined with Umeclidinium.,increase,no risk
Romidepsin,Vadadustat,The serum concentration of Romidepsin can be decreased when it is combined with Vadadustat.,decrease,no risk
Romidepsin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Valproic acid,The serum concentration of Romidepsin can be increased when it is combined with Valproic acid.,increase,no risk
Romidepsin,Vandetanib,The serum concentration of Romidepsin can be increased when it is combined with Vandetanib.,increase,no risk
Romidepsin,Vardenafil,The serum concentration of Romidepsin can be increased when it is combined with Vardenafil.,increase,no risk
Romidepsin,Velpatasvir,The serum concentration of Romidepsin can be increased when it is combined with Velpatasvir.,increase,no risk
Romidepsin,Vemurafenib,The serum concentration of Romidepsin can be increased when it is combined with Vemurafenib.,increase,no risk
Romidepsin,Venetoclax,The serum concentration of Romidepsin can be increased when it is combined with Venetoclax.,increase,no risk
Romidepsin,Verapamil,The serum concentration of Romidepsin can be increased when it is combined with Verapamil.,increase,no risk
Romidepsin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Romidepsin.,increase,risk
Romidepsin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Romidepsin.,increase,risk
Romidepsin,Viloxazine,The metabolism of Romidepsin can be decreased when combined with Viloxazine.,decrease,no risk
Romidepsin,Vinblastine,The metabolism of Romidepsin can be increased when combined with Vinblastine.,increase,no risk
Romidepsin,Vincristine,The metabolism of Vincristine can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Romidepsin.,increase,no risk
Romidepsin,Vitamin E,The metabolism of Romidepsin can be increased when combined with Vitamin E.,increase,no risk
Romidepsin,Voclosporin,The serum concentration of Romidepsin can be increased when it is combined with Voclosporin.,increase,no risk
Romidepsin,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Vorapaxar,The serum concentration of Romidepsin can be increased when it is combined with Vorapaxar.,increase,no risk
Romidepsin,Voriconazole,The metabolism of Romidepsin can be decreased when combined with Voriconazole.,decrease,no risk
Romidepsin,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Romidepsin is combined with Vorinostat.,increase,risk
Romidepsin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Voxelotor,The serum concentration of Romidepsin can be increased when it is combined with Voxelotor.,increase,no risk
Romidepsin,Voxilaprevir,The serum concentration of Romidepsin can be increased when it is combined with Voxilaprevir.,increase,no risk
Romidepsin,Warfarin,Romidepsin may increase the anticoagulant activities of Warfarin.,increase,no risk
Romidepsin,Zafirlukast,The serum concentration of Romidepsin can be increased when it is combined with Zafirlukast.,increase,no risk
Romidepsin,Zaleplon,The metabolism of Romidepsin can be decreased when combined with Zaleplon.,decrease,no risk
Romidepsin,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Romidepsin.,decrease,no risk
Romidepsin,Zimelidine,The metabolism of Romidepsin can be decreased when combined with Zimelidine.,decrease,no risk
Romidepsin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Romidepsin is combined with Ziprasidone.,increase,risk
Romidepsin,Zonisamide,The serum concentration of Romidepsin can be increased when it is combined with Zonisamide.,increase,no risk
Romidepsin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Zuclopenthixol is combined with Romidepsin.,increase,risk
IMO-2055,Benzocaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Benzocaine.,increase,risk
IMO-2055,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Benzyl alcohol.,increase,risk
IMO-2055,Bupivacaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Bupivacaine.,increase,risk
IMO-2055,Butacaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Butacaine.,increase,risk
IMO-2055,Butamben,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Butamben.,increase,risk
IMO-2055,Oxetacaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Oxetacaine.,increase,risk
IMO-2055,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when IMO-2055 is combined with Oxybuprocaine.,increase,risk
Ipilimumab,Bumadizone,Bumadizone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Bumetanide,Bumetanide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ipilimumab,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Bupivacaine.,increase,risk
Ipilimumab,Bupropion,Bupropion may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Burosumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Burosumab.,increase,risk
Ipilimumab,Buspirone,Buspirone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Butabarbital,Butabarbital may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Butacaine,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Butacaine.,increase,risk
Ipilimumab,Butamben,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Butamben.,increase,risk
Ipilimumab,Gabapentin enacarbil,Ipilimumab may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadodiamide,Gadodiamide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadofosveset trisodium,Ipilimumab may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadoteric acid,Ipilimumab may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gadoteridol,Gadoteridol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Galcanezumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Galcanezumab.,increase,risk
Ipilimumab,Ganciclovir,Ganciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gemcitabine,Gemcitabine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ipilimumab.,increase,risk
Ipilimumab,Gentamicin,Ipilimumab may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Gimeracil,Ipilimumab may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ipilimumab,Givosiran,Givosiran may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Glipizide,Glipizide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Glofitamab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Glofitamab.,increase,risk
Ipilimumab,Glycerol phenylbutyrate,Ipilimumab may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ipilimumab,Golimumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Golimumab.,increase,risk
Ipilimumab,Golodirsen,Ipilimumab may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ipilimumab,Goserelin,Goserelin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Guanethidine,Guanethidine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Guanfacine,Guanfacine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Guselkumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Guselkumab.,increase,risk
Ipilimumab,Haloperidol,Haloperidol may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Ipilimumab.,increase,risk
Ipilimumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Ipilimumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Ipilimumab.,increase,risk
Ipilimumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Human Rho(D) immune globulin.,increase,risk
Ipilimumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Human varicella-zoster immune globulin.,increase,risk
Ipilimumab,Hydralazine,Hydralazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ipilimumab,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ipilimumab,Hydromorphone,Hydromorphone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Hydroxyethyl Starch,Ipilimumab may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ipilimumab,Kanamycin,Ipilimumab may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ketamine,Ketamine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ketazolam,Ketazolam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ketoprofen,Ketoprofen may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ketorolac,Ketorolac may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Ipilimumab.,increase,risk
Ipilimumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Obinutuzumab.,increase,risk
Ipilimumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ocrelizumab.,increase,risk
Ipilimumab,Octinoxate,Ipilimumab may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ipilimumab,Odesivimab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Odesivimab.,increase,risk
Ipilimumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ofatumumab.,increase,risk
Ipilimumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Ipilimumab.,increase,risk
Ipilimumab,Olsalazine,Olsalazine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Ipilimumab.,increase,risk
Ipilimumab,Opium,Ipilimumab may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oseltamivir,Oseltamivir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxacillin,Oxacillin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxaprozin,Oxaprozin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxazepam,Oxazepam may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Oxetacaine.,increase,risk
Ipilimumab,Oxybenzone,Oxybenzone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ipilimumab is combined with Oxybuprocaine.,increase,risk
Ipilimumab,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Oxyquinoline,Ipilimumab may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ipilimumab,Quetiapine,Quetiapine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Ipilimumab.,increase,no risk
Ipilimumab,Quinethazone,Quinethazone may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ipilimumab,Quinidine,Ipilimumab may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Ublituximab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Ublituximab.,increase,risk
Ipilimumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Ipilimumab.,increase,risk
Ipilimumab,Vaborbactam,Ipilimumab may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ipilimumab,Valaciclovir,Valaciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Valbenazine,Ipilimumab may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Valdecoxib,Valdecoxib may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Valganciclovir,Valganciclovir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Vancomycin,Ipilimumab may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Varenicline,Varenicline may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Vedolizumab,The risk or severity of adverse effects can be increased when Ipilimumab is combined with Vedolizumab.,increase,risk
Ipilimumab,Vemurafenib,Ipilimumab may increase the hepatotoxic activities of Vemurafenib.,increase,no risk
Ipilimumab,Venlafaxine,Venlafaxine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Verapamil,Verapamil may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Vilanterol,Ipilimumab may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ipilimumab,Viloxazine,Ipilimumab may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Vortioxetine,Ipilimumab may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ipilimumab,Warfarin,Ipilimumab may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ipilimumab,Zaleplon,Zaleplon may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Zanamivir,Zanamivir may decrease the excretion rate of Ipilimumab which could result in a higher serum level.,decrease,no risk
Ipilimumab,Zonisamide,Zonisamide may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Solabegron,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Solabegron.,increase,risk
Solabegron,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Solabegron.,increase,risk
Solabegron,Guanabenz,Solabegron may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Solabegron,Guanadrel,Solabegron may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Solabegron,Guanethidine,Solabegron may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Solabegron,Guanfacine,Solabegron may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Solabegron,Guanoxan,Solabegron may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Solabegron,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Solabegron.,increase,risk
Solabegron,Hexocyclium,The risk or severity of Tachycardia can be increased when Solabegron is combined with Hexocyclium.,increase,risk
Solabegron,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Solabegron.,increase,risk
Solabegron,Hydralazine,Solabegron may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Solabegron,Hydrochlorothiazide,Solabegron may decrease the antihypertensive activities of Hydrochlorothiazide.,decrease,no risk
Solabegron,Hydroflumethiazide,Solabegron may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Solabegron,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Solabegron.,increase,risk
Solabegron,Ketamine,The risk or severity of Tachycardia can be increased when Ketamine is combined with Solabegron.,increase,risk
Solabegron,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Solabegron.,increase,risk
Solabegron,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Solabegron.,increase,risk
Solabegron,Olanzapine,The therapeutic efficacy of Solabegron can be decreased when used in combination with Olanzapine.,decrease,no risk
Solabegron,Olmesartan,Solabegron may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Solabegron,Olodaterol,The risk or severity of hypertension can be increased when Solabegron is combined with Olodaterol.,increase,risk
Solabegron,Orciprenaline,The risk or severity of hypertension can be increased when Orciprenaline is combined with Solabegron.,increase,risk
Solabegron,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Solabegron.,increase,risk
Solabegron,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Solabegron.,increase,risk
Solabegron,Oxprenolol,The therapeutic efficacy of Solabegron can be decreased when used in combination with Oxprenolol.,decrease,no risk
Solabegron,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Solabegron.,increase,risk
Solabegron,Oxymetazoline,The risk or severity of hypertension can be increased when Oxymetazoline is combined with Solabegron.,increase,risk
Solabegron,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Solabegron.,increase,risk
Solabegron,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Solabegron.,increase,risk
Solabegron,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Solabegron.,increase,risk
Solabegron,Quetiapine,The therapeutic efficacy of Solabegron can be decreased when used in combination with Quetiapine.,decrease,no risk
Solabegron,Quinapril,Solabegron may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Solabegron,Quinidine,The therapeutic efficacy of Solabegron can be decreased when used in combination with Quinidine.,decrease,no risk
Solabegron,Quinupramine,The risk or severity of hypertension can be increased when Quinupramine is combined with Solabegron.,increase,risk
Solabegron,Umeclidinium,The risk or severity of Tachycardia can be increased when Solabegron is combined with Umeclidinium.,increase,risk
Solabegron,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Solabegron.,increase,risk
Solabegron,Valsartan,Solabegron may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Solabegron,Venlafaxine,Venlafaxine may increase the tachycardic activities of Solabegron.,increase,no risk
Solabegron,Verapamil,The therapeutic efficacy of Solabegron can be decreased when used in combination with Verapamil.,decrease,no risk
Solabegron,Vibegron,Solabegron may increase the smooth muscle relaxing activities of Vibegron.,increase,no risk
Solabegron,Vilanterol,The risk or severity of hypertension can be increased when Solabegron is combined with Vilanterol.,increase,risk
Solabegron,Vilazodone,The risk or severity of hypertension can be increased when Solabegron is combined with Vilazodone.,increase,risk
Solabegron,Vortioxetine,The risk or severity of hypertension can be increased when Solabegron is combined with Vortioxetine.,increase,risk
Solabegron,Xamoterol,The risk or severity of hypertension can be increased when Solabegron is combined with Xamoterol.,increase,risk
Solabegron,Xylometazoline,The risk or severity of hypertension can be increased when Solabegron is combined with Xylometazoline.,increase,risk
Solabegron,Yohimbine,The risk or severity of hypertension can be increased when Yohimbine is combined with Solabegron.,increase,risk
Solabegron,Ziprasidone,The therapeutic efficacy of Solabegron can be decreased when used in combination with Ziprasidone.,decrease,no risk
Solabegron,Zofenopril,Solabegron may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Solabegron,Zolmitriptan,The risk or severity of hypertension can be increased when Zolmitriptan is combined with Solabegron.,increase,risk
Solabegron,Zuclopenthixol,The therapeutic efficacy of Solabegron can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Zosuquidar,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Vincristine,The excretion of Vincristine can be decreased when combined with Zosuquidar.,decrease,no risk
Zosuquidar,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Zosuquidar.,increase,no risk
Zosuquidar,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Zosuquidar.,increase,no risk
Nimotuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Nimotuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Nimotuzumab.,increase,risk
Nimotuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Obinutuzumab.,increase,risk
Nimotuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Ocrelizumab.,increase,risk
Nimotuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Odesivimab.,increase,risk
Nimotuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Ofatumumab.,increase,risk
Nimotuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Nimotuzumab.,increase,risk
Nimotuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Nimotuzumab.,increase,risk
Nimotuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nimotuzumab is combined with Oxetacaine.,increase,risk
Nimotuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nimotuzumab is combined with Oxybuprocaine.,increase,risk
Nimotuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Nimotuzumab.,increase,no risk
Nimotuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Ublituximab.,increase,risk
Nimotuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Nimotuzumab.,increase,risk
Nimotuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Nimotuzumab is combined with Vedolizumab.,increase,risk
Pixantrone,Benzocaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Benzocaine.,increase,risk
Pixantrone,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Benzyl alcohol.,increase,risk
Pixantrone,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Bupivacaine.,increase,risk
Pixantrone,Butacaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Butacaine.,increase,risk
Pixantrone,Butamben,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Butamben.,increase,risk
Pixantrone,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Oxetacaine.,increase,risk
Pixantrone,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pixantrone is combined with Oxybuprocaine.,increase,risk
Elocalcitol,Vamorolone,The therapeutic efficacy of Elocalcitol can be decreased when used in combination with Vamorolone.,decrease,no risk
Elocalcitol,Vitamin D,The risk or severity of adverse effects can be increased when Elocalcitol is combined with Vitamin D.,increase,risk
Seliciclib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Benzocaine.,increase,risk
Seliciclib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Benzyl alcohol.,increase,risk
Seliciclib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Bupivacaine.,increase,risk
Seliciclib,Butacaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Butacaine.,increase,risk
Seliciclib,Butamben,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Butamben.,increase,risk
Seliciclib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Oxetacaine.,increase,risk
Seliciclib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Seliciclib is combined with Oxybuprocaine.,increase,risk
Icatibant,Gabapentin enacarbil,Icatibant may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Icatibant,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gadodiamide,Gadodiamide may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gadofosveset trisodium,Icatibant may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Icatibant,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gadoteric acid,Icatibant may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Icatibant,Gadoteridol,Gadoteridol may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Ganciclovir,Ganciclovir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gemcitabine,Gemcitabine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Gentamicin,Icatibant may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Icatibant,Gimeracil,Icatibant may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Icatibant,Givosiran,Givosiran may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Glipizide,Glipizide may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Glycerol phenylbutyrate,Icatibant may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Icatibant,Golodirsen,Icatibant may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Icatibant,Goserelin,Goserelin may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Guanethidine,Guanethidine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Guanfacine,Guanfacine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Haloperidol,Haloperidol may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Hydralazine,Hydralazine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Icatibant,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Icatibant,Hydromorphone,Hydromorphone may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Hydroxyethyl Starch,Icatibant may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Icatibant,Kanamycin,Icatibant may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Icatibant,Ketamine,Ketamine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Ketazolam,Ketazolam may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Ketoprofen,Ketoprofen may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Ketorolac,Ketorolac may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Octinoxate,Icatibant may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Icatibant,Olsalazine,Olsalazine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Opium,Icatibant may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Icatibant,Oseltamivir,Oseltamivir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxacillin,Oxacillin may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxaprozin,Oxaprozin may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxazepam,Oxazepam may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxybenzone,Oxybenzone may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Oxyquinoline,Icatibant may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Icatibant,Quetiapine,Quetiapine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Quinapril,Icatibant may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Icatibant,Quinethazone,Quinethazone may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Icatibant,Quinidine,Icatibant may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Icatibant,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Icatibant.,increase,risk
Icatibant,Vaborbactam,Icatibant may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Icatibant,Valaciclovir,Valaciclovir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Valbenazine,Icatibant may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Icatibant,Valdecoxib,Valdecoxib may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Valganciclovir,Valganciclovir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Icatibant.,increase,risk
Icatibant,Vancomycin,Icatibant may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Icatibant,Varenicline,Varenicline may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Venlafaxine,Venlafaxine may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Verapamil,Verapamil may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Vilanterol,Icatibant may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Icatibant,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Icatibant.,increase,risk
Icatibant,Viloxazine,Icatibant may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Icatibant,Vortioxetine,Icatibant may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Icatibant,Warfarin,Icatibant may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Icatibant,Zaleplon,Zaleplon may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Zanamivir,Zanamivir may decrease the excretion rate of Icatibant which could result in a higher serum level.,decrease,no risk
Icatibant,Zofenopril,Icatibant may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Icatibant,Zonisamide,Zonisamide may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alovudine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Alovudine.,decrease,no risk
Alovudine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Alovudine.,decrease,no risk
Atrasentan,Quinidine,The excretion of Atrasentan can be decreased when combined with Quinidine.,decrease,no risk
Atrasentan,Quinine,The excretion of Atrasentan can be decreased when combined with Quinine.,decrease,no risk
Atrasentan,Valsartan,The excretion of Atrasentan can be decreased when combined with Valsartan.,decrease,no risk
Atrasentan,Velpatasvir,The excretion of Atrasentan can be decreased when combined with Velpatasvir.,decrease,no risk
Atrasentan,Venetoclax,The excretion of Atrasentan can be decreased when combined with Venetoclax.,decrease,no risk
Atrasentan,Vinblastine,The excretion of Atrasentan can be decreased when combined with Vinblastine.,decrease,no risk
Atrasentan,Vincristine,The excretion of Atrasentan can be decreased when combined with Vincristine.,decrease,no risk
Atrasentan,Voxilaprevir,The excretion of Atrasentan can be decreased when combined with Voxilaprevir.,decrease,no risk
Tedisamil,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Tedisamil.,increase,risk
Tedisamil,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Tedisamil.,increase,risk
Tedisamil,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Tedisamil.,increase,risk
Tedisamil,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Tedisamil.,increase,risk
Tedisamil,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Tedisamil.,increase,risk
Tedisamil,Gilteritinib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Gilteritinib.,increase,risk
Tedisamil,Glasdegib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Glasdegib.,increase,risk
Tedisamil,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tedisamil.,increase,risk
Tedisamil,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Tedisamil.,increase,risk
Tedisamil,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Grepafloxacin.,increase,risk
Tedisamil,Halofantrine,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Halofantrine.,increase,risk
Tedisamil,Haloperidol,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Haloperidol.,increase,risk
Tedisamil,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Tedisamil.,increase,risk
Tedisamil,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Tedisamil.,increase,risk
Tedisamil,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Tedisamil.,increase,risk
Tedisamil,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Hydroxyzine.,increase,risk
Tedisamil,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Tedisamil.,increase,risk
Tedisamil,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Tedisamil.,increase,risk
Tedisamil,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Tedisamil.,increase,risk
Tedisamil,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Tedisamil.,increase,risk
Tedisamil,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Tedisamil.,increase,risk
Tedisamil,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Tedisamil.,increase,risk
Tedisamil,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Tedisamil.,increase,risk
Tedisamil,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Tedisamil.,increase,risk
Tedisamil,Oxatomide,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Oxatomide.,increase,risk
Tedisamil,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Tedisamil.,increase,risk
Tedisamil,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Tedisamil.,increase,risk
Tedisamil,Quinidine,Quinidine may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Quinine,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Quinine.,increase,risk
Tedisamil,Quizartinib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Quizartinib.,increase,risk
Tedisamil,Valproic acid,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Valproic acid.,increase,risk
Tedisamil,Vandetanib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Vandetanib.,increase,risk
Tedisamil,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Tedisamil.,increase,risk
Tedisamil,Vemurafenib,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Vemurafenib.,increase,risk
Tedisamil,Verapamil,Verapamil may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Vernakalant,Tedisamil may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Tedisamil,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Tedisamil.,increase,risk
Tedisamil,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Tedisamil.,increase,risk
Tedisamil,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Tedisamil.,increase,risk
Tedisamil,Xylometazoline,Tedisamil may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Tedisamil,Ziconotide,Tedisamil may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Tedisamil,Ziprasidone,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Ziprasidone.,increase,risk
Tedisamil,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Tedisamil.,increase,no risk
Tedisamil,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Tedisamil is combined with Zuclopenthixol.,increase,risk
Rufinamide,Gabapentin,The risk or severity of adverse effects can be increased when Rufinamide is combined with Gabapentin.,increase,risk
Rufinamide,Gabapentin enacarbil,The risk or severity of adverse effects can be increased when Rufinamide is combined with Gabapentin enacarbil.,increase,risk
Rufinamide,Gallamine triethiodide,The risk or severity of adverse effects can be increased when Rufinamide is combined with Gallamine triethiodide.,increase,risk
Rufinamide,Gamolenic acid,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Rufinamide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Rufinamide is combined with Ganaxolone.",increase,risk
Rufinamide,Ganciclovir,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Ganciclovir.,decrease,no risk
Rufinamide,Gepirone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Gepirone.,increase,risk
Rufinamide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Glutethimide,The risk or severity of adverse effects can be increased when Rufinamide is combined with Glutethimide.,increase,risk
Rufinamide,Granisetron,The risk or severity of adverse effects can be increased when Rufinamide is combined with Granisetron.,increase,risk
Rufinamide,Guanfacine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Guanfacine.,increase,risk
Rufinamide,Halazepam,The risk or severity of adverse effects can be increased when Rufinamide is combined with Halazepam.,increase,risk
Rufinamide,Halofantrine,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Halofantrine.,decrease,no risk
Rufinamide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Rufinamide.,increase,risk
Rufinamide,Halothane,The risk or severity of adverse effects can be increased when Rufinamide is combined with Halothane.,increase,risk
Rufinamide,Hexafluronium,The risk or severity of adverse effects can be increased when Rufinamide is combined with Hexafluronium.,increase,risk
Rufinamide,Hydrocodone,Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Rufinamide,Hydromorphone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Hydromorphone.,increase,risk
Rufinamide,Hydroxychloroquine,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Rufinamide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Rufinamide.,increase,no risk
Rufinamide,Ketamine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Ketamine.,increase,risk
Rufinamide,Ketazolam,The risk or severity of adverse effects can be increased when Rufinamide is combined with Ketazolam.,increase,risk
Rufinamide,Olanzapine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Olanzapine.,increase,risk
Rufinamide,Olaparib,The metabolism of Olaparib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Rufinamide is combined with Oliceridine.",increase,risk
Rufinamide,Ondansetron,The risk or severity of adverse effects can be increased when Rufinamide is combined with Ondansetron.,increase,risk
Rufinamide,Opium,The risk or severity of adverse effects can be increased when Rufinamide is combined with Opium.,increase,risk
Rufinamide,Orlistat,Orlistat can cause a decrease in the absorption of Rufinamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Rufinamide,Orphenadrine,Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Rufinamide,Osimertinib,The metabolism of Osimertinib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Oxazepam,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxazepam.,increase,risk
Rufinamide,Oxcarbazepine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxcarbazepine.,increase,risk
Rufinamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Rufinamide is combined with Oxetacaine.,increase,risk
Rufinamide,Oxitriptan,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxitriptan.,increase,risk
Rufinamide,Oxprenolol,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxprenolol.,increase,risk
Rufinamide,Oxtriphylline,Rufinamide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rufinamide,Oxybuprocaine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxybuprocaine.,increase,risk
Rufinamide,Oxycodone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxycodone.,increase,risk
Rufinamide,Oxymorphone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Oxymorphone.,increase,risk
Rufinamide,Quazepam,The risk or severity of adverse effects can be increased when Rufinamide is combined with Quazepam.,increase,risk
Rufinamide,Quetiapine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Quetiapine.,increase,risk
Rufinamide,Quinidine,The metabolism of Quinidine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Quinine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Quinine.,increase,risk
Rufinamide,Quinupramine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Quinupramine.,increase,risk
Rufinamide,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Rufinamide.,decrease,no risk
Rufinamide,Ulipristal,The metabolism of Ulipristal can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Urethane,The risk or severity of adverse effects can be increased when Rufinamide is combined with Urethane.,increase,risk
Rufinamide,Valganciclovir,The therapeutic efficacy of Rufinamide can be decreased when used in combination with Valganciclovir.,decrease,no risk
Rufinamide,Valproic acid,The serum concentration of Rufinamide can be increased when it is combined with Valproic acid.,increase,no risk
Rufinamide,Vandetanib,The metabolism of Vandetanib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vecuronium,The risk or severity of adverse effects can be increased when Rufinamide is combined with Vecuronium.,increase,risk
Rufinamide,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Venetoclax,The metabolism of Venetoclax can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Venlafaxine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Venlafaxine.,increase,risk
Rufinamide,Vigabatrin,The risk or severity of adverse effects can be increased when Rufinamide is combined with Vigabatrin.,increase,risk
Rufinamide,Vilazodone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Vilazodone.,increase,risk
Rufinamide,Viloxazine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Viloxazine.,increase,risk
Rufinamide,Vinblastine,The metabolism of Vinblastine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vincristine,The metabolism of Vincristine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vindesine,The metabolism of Vindesine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vinflunine,The metabolism of Vinflunine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Vortioxetine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Vortioxetine.,increase,risk
Rufinamide,Warfarin,The metabolism of Warfarin can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Yohimbine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Yohimbine.,increase,risk
Rufinamide,Zaleplon,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zaleplon.,increase,risk
Rufinamide,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Rufinamide.,increase,no risk
Rufinamide,Ziconotide,The risk or severity of CNS depression can be increased when Rufinamide is combined with Ziconotide.,increase,risk
Rufinamide,Zimelidine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zimelidine.,increase,risk
Rufinamide,Ziprasidone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Ziprasidone.,increase,risk
Rufinamide,Zolmitriptan,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zolmitriptan.,increase,risk
Rufinamide,Zolpidem,Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Rufinamide,Zonisamide,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zonisamide.,increase,risk
Rufinamide,Zopiclone,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zopiclone.,increase,risk
Rufinamide,Zotepine,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zotepine.,increase,risk
Rufinamide,Zuclopenthixol,The risk or severity of adverse effects can be increased when Rufinamide is combined with Zuclopenthixol.,increase,risk
Rufinamide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Rufinamide.,increase,risk
Lasofoxifene,Ospemifene,The risk or severity of adverse effects can be increased when Lasofoxifene is combined with Ospemifene.,increase,risk
Alogliptin,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Bicisate,Alogliptin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Alogliptin,Bimekizumab,The metabolism of Alogliptin can be increased when combined with Bimekizumab.,increase,no risk
Alogliptin,Biperiden,The metabolism of Alogliptin can be decreased when combined with Biperiden.,decrease,no risk
Alogliptin,Bismuth subgallate,Alogliptin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Alogliptin,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Bisoprolol,The therapeutic efficacy of Alogliptin can be increased when used in combination with Bisoprolol.,increase,no risk
Alogliptin,Bisoxatin,Alogliptin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Alogliptin,Bleomycin,Bleomycin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Boceprevir,The metabolism of Alogliptin can be decreased when combined with Boceprevir.,decrease,no risk
Alogliptin,Bortezomib,The metabolism of Alogliptin can be decreased when combined with Bortezomib.,decrease,no risk
Alogliptin,Bosentan,The therapeutic efficacy of Alogliptin can be increased when used in combination with Bosentan.,increase,no risk
Alogliptin,Brexpiprazole,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Alogliptin,Brivaracetam,Brivaracetam may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Bromazepam,Bromazepam may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Bromocriptine,The risk or severity of hypoglycemia can be increased when Bromocriptine is combined with Alogliptin.,increase,risk
Alogliptin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Alogliptin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Alogliptin,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Alogliptin.,increase,risk
Alogliptin,Bumadizone,Bumadizone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Bumetanide,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Bumetanide.,decrease,no risk
Alogliptin,Bupivacaine,The metabolism of Alogliptin can be decreased when combined with Bupivacaine.,decrease,no risk
Alogliptin,Buprenorphine,The metabolism of Alogliptin can be decreased when combined with Buprenorphine.,decrease,no risk
Alogliptin,Bupropion,The metabolism of Alogliptin can be decreased when combined with Bupropion.,decrease,no risk
Alogliptin,Buserelin,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Buserelin.,decrease,no risk
Alogliptin,Buspirone,Buspirone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Butabarbital,Butabarbital may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Alogliptin.,decrease,no risk
Alogliptin,Gabapentin enacarbil,Alogliptin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadodiamide,Gadodiamide may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadofosveset trisodium,Alogliptin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadoteric acid,Alogliptin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Alogliptin,Gadoteridol,Gadoteridol may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Galantamine,The metabolism of Alogliptin can be decreased when combined with Galantamine.,decrease,no risk
Alogliptin,Ganciclovir,Ganciclovir may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gatifloxacin,The therapeutic efficacy of Alogliptin can be increased when used in combination with Gatifloxacin.,increase,no risk
Alogliptin,Gefapixant,The therapeutic efficacy of Alogliptin can be increased when used in combination with Gefapixant.,increase,no risk
Alogliptin,Gefitinib,The metabolism of Alogliptin can be decreased when combined with Gefitinib.,decrease,no risk
Alogliptin,Gemcitabine,Gemcitabine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gemifloxacin,The therapeutic efficacy of Alogliptin can be increased when used in combination with Gemifloxacin.,increase,no risk
Alogliptin,Gentamicin,Alogliptin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Alogliptin,Gimeracil,Alogliptin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Alogliptin,Givosiran,The serum concentration of Alogliptin can be increased when it is combined with Givosiran.,increase,no risk
Alogliptin,Gliclazide,Alogliptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Alogliptin,Glimepiride,Alogliptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Alogliptin,Glipizide,Alogliptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Alogliptin,Gliquidone,Alogliptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Alogliptin,Glofitamab,The serum concentration of Alogliptin can be increased when it is combined with Glofitamab.,increase,no risk
Alogliptin,Glyburide,Alogliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Alogliptin,Glycerol phenylbutyrate,The metabolism of Alogliptin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Alogliptin,Glymidine,The therapeutic efficacy of Alogliptin can be increased when used in combination with Glymidine.,increase,no risk
Alogliptin,Golimumab,The metabolism of Alogliptin can be increased when combined with Golimumab.,increase,no risk
Alogliptin,Golodirsen,Alogliptin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Alogliptin,Goserelin,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Alogliptin,Grepafloxacin,The therapeutic efficacy of Alogliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Alogliptin,Guanethidine,Guanethidine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Guanfacine,Guanfacine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Alogliptin.,increase,risk
Alogliptin,Halofantrine,The metabolism of Alogliptin can be decreased when combined with Halofantrine.,decrease,no risk
Alogliptin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Alogliptin.,increase,no risk
Alogliptin,Histrelin,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Alogliptin,Hydralazine,Hydralazine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Hydrochlorothiazide,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Alogliptin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Alogliptin.,increase,risk
Alogliptin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Alogliptin.,increase,risk
Alogliptin,Hydroflumethiazide,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Alogliptin,Hydromorphone,Hydromorphone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Hydroxychloroquine,The therapeutic efficacy of Alogliptin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Alogliptin,Hydroxyethyl Starch,Alogliptin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Alogliptin,Hydroxyprogesterone caproate,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Alogliptin,Hydroxyzine,The metabolism of Alogliptin can be decreased when combined with Hydroxyzine.,decrease,no risk
Alogliptin,Kanamycin,Alogliptin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketamine,Ketamine may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketazolam,Ketazolam may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketoconazole,The metabolism of Alogliptin can be decreased when combined with Ketoconazole.,decrease,no risk
Alogliptin,Ketoprofen,Ketoprofen may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketorolac,Ketorolac may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Alogliptin is combined with Ketotifen.,increase,risk
Alogliptin,Octinoxate,Alogliptin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Alogliptin,Octreotide,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Octreotide.,decrease,no risk
Alogliptin,Ofloxacin,The therapeutic efficacy of Alogliptin can be increased when used in combination with Ofloxacin.,increase,no risk
Alogliptin,Olanzapine,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Olanzapine.,decrease,no risk
Alogliptin,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Alogliptin.,decrease,no risk
Alogliptin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Omaveloxolone,The serum concentration of Alogliptin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Alogliptin,Ondansetron,The metabolism of Alogliptin can be decreased when combined with Ondansetron.,decrease,no risk
Alogliptin,Opium,Alogliptin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Alogliptin,Oritavancin,The metabolism of Alogliptin can be decreased when combined with Oritavancin.,decrease,no risk
Alogliptin,Orphenadrine,The metabolism of Alogliptin can be decreased when combined with Orphenadrine.,decrease,no risk
Alogliptin,Oseltamivir,Oseltamivir may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Osilodrostat,The metabolism of Alogliptin can be decreased when combined with Osilodrostat.,decrease,no risk
Alogliptin,Ospemifene,The metabolism of Alogliptin can be decreased when combined with Ospemifene.,decrease,no risk
Alogliptin,Oxacillin,Oxacillin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Oxamniquine,The metabolism of Alogliptin can be decreased when combined with Oxamniquine.,decrease,no risk
Alogliptin,Oxandrolone,Oxandrolone may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Oxaprozin,Oxaprozin may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Oxazepam,Oxazepam may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Oxprenolol,The therapeutic efficacy of Alogliptin can be increased when used in combination with Oxprenolol.,increase,no risk
Alogliptin,Oxybenzone,Oxybenzone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Oxybutynin,The metabolism of Alogliptin can be decreased when combined with Oxybutynin.,decrease,no risk
Alogliptin,Oxycodone,The metabolism of Alogliptin can be decreased when combined with Oxycodone.,decrease,no risk
Alogliptin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Alogliptin.,increase,no risk
Alogliptin,Oxymorphone,The metabolism of Alogliptin can be decreased when combined with Oxymorphone.,decrease,no risk
Alogliptin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Alogliptin which could result in a higher serum level.,decrease,no risk
Alogliptin,Oxyquinoline,Alogliptin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Alogliptin,Quetiapine,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Quetiapine.,decrease,no risk
Alogliptin,Quinapril,The risk or severity of angioedema can be increased when Alogliptin is combined with Quinapril.,increase,risk
Alogliptin,Quinethazone,The therapeutic efficacy of Alogliptin can be decreased when used in combination with Quinethazone.,decrease,no risk
Alogliptin,Quinidine,The metabolism of Alogliptin can be decreased when combined with Quinidine.,decrease,no risk
Alogliptin,Quinine,The metabolism of Alogliptin can be decreased when combined with Quinine.,decrease,no risk
Alogliptin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Alogliptin.,decrease,no risk
Tapentadol,Gabapentin,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin.,increase,no risk
Tapentadol,Gabapentin enacarbil,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gabapentin enacarbil.,increase,no risk
Tapentadol,Gallamine triethiodide,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gallamine triethiodide.,increase,no risk
Tapentadol,Ganaxolone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ganaxolone.,increase,no risk
Tapentadol,Gepirone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Gepirone.,increase,no risk
Tapentadol,Gilteritinib,The therapeutic efficacy of Tapentadol can be decreased when used in combination with Gilteritinib.,decrease,no risk
Tapentadol,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Glutethimide,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Glutethimide.,increase,no risk
Tapentadol,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Glycopyrronium,The risk or severity of urinary retention and constipation can be increased when Glycopyrronium is combined with Tapentadol.,increase,risk
Tapentadol,Granisetron,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Granisetron.,increase,no risk
Tapentadol,Guanfacine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Guanfacine.,increase,no risk
Tapentadol,Halazepam,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Halazepam.,increase,no risk
Tapentadol,Haloperidol,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Haloperidol.,increase,no risk
Tapentadol,Halothane,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Halothane.,increase,no risk
Tapentadol,Hexafluronium,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Hexafluronium.,increase,no risk
Tapentadol,Hexocyclium,The risk or severity of urinary retention and constipation can be increased when Hexocyclium is combined with Tapentadol.,increase,risk
Tapentadol,Homatropine,The risk or severity of urinary retention and constipation can be increased when Homatropine is combined with Tapentadol.,increase,risk
Tapentadol,Homatropine methylbromide,The risk or severity of urinary retention and constipation can be increased when Homatropine methylbromide is combined with Tapentadol.,increase,risk
Tapentadol,Hydrochlorothiazide,The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Hydrocodone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tapentadol,Hydroflumethiazide,The therapeutic efficacy of Hydroflumethiazide can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Hydromorphone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Hydromorphone.,increase,no risk
Tapentadol,Hydroxyamphetamine,The risk or severity of serotonin syndrome can be increased when Hydroxyamphetamine is combined with Tapentadol.,increase,risk
Tapentadol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tapentadol.,increase,no risk
Tapentadol,Hyoscyamine,The risk or severity of urinary retention and constipation can be increased when Hyoscyamine is combined with Tapentadol.,increase,risk
Tapentadol,Ketamine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ketamine.,increase,no risk
Tapentadol,Ketazolam,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ketazolam.,increase,no risk
Tapentadol,Olanzapine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Olanzapine.,increase,no risk
Tapentadol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tapentadol is combined with Oliceridine.",increase,risk
Tapentadol,Ondansetron,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ondansetron.,increase,no risk
Tapentadol,Opium,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Opium.,increase,no risk
Tapentadol,Orphenadrine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tapentadol,Oxazepam,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxazepam.,increase,no risk
Tapentadol,Oxcarbazepine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxcarbazepine.,increase,no risk
Tapentadol,Oxitriptan,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxitriptan.,increase,no risk
Tapentadol,Oxprenolol,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxprenolol.,increase,no risk
Tapentadol,Oxybuprocaine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxybuprocaine.,increase,no risk
Tapentadol,Oxybutynin,The risk or severity of urinary retention and constipation can be increased when Oxybutynin is combined with Tapentadol.,increase,risk
Tapentadol,Oxycodone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxycodone.,increase,no risk
Tapentadol,Oxymorphone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Oxymorphone.,increase,no risk
Tapentadol,Oxyphencyclimine,The risk or severity of urinary retention and constipation can be increased when Oxyphencyclimine is combined with Tapentadol.,increase,risk
Tapentadol,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Oxyphenonium,The risk or severity of urinary retention and constipation can be increased when Oxyphenonium is combined with Tapentadol.,increase,risk
Tapentadol,Quazepam,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quazepam.,increase,no risk
Tapentadol,Quetiapine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quetiapine.,increase,no risk
Tapentadol,Quinethazone,The therapeutic efficacy of Quinethazone can be decreased when used in combination with Tapentadol.,decrease,no risk
Tapentadol,Quinidine,The risk or severity of urinary retention and constipation can be increased when Quinidine is combined with Tapentadol.,increase,risk
Tapentadol,Quinine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quinine.,increase,no risk
Tapentadol,Quinupramine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Quinupramine.,increase,no risk
Tapentadol,Umeclidinium,The risk or severity of urinary retention and constipation can be increased when Umeclidinium is combined with Tapentadol.,increase,risk
Tapentadol,Urethane,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Urethane.,increase,no risk
Tapentadol,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Valproate bismuth is combined with Tapentadol.,increase,risk
Tapentadol,Valproic acid,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Valproic acid.,increase,no risk
Tapentadol,Vecuronium,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vecuronium.,increase,no risk
Tapentadol,Venlafaxine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Venlafaxine.,increase,no risk
Tapentadol,Vigabatrin,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vigabatrin.,increase,no risk
Tapentadol,Vilazodone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vilazodone.,increase,no risk
Tapentadol,Viloxazine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.,increase,no risk
Tapentadol,Vortioxetine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.,increase,no risk
Tapentadol,Warfarin,The risk or severity of adverse effects can be increased when Tapentadol is combined with Warfarin.,increase,risk
Tapentadol,Yohimbine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Yohimbine.,increase,no risk
Tapentadol,Zaleplon,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zaleplon.,increase,no risk
Tapentadol,Ziconotide,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.,increase,no risk
Tapentadol,Zimelidine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zimelidine.,increase,no risk
Tapentadol,Ziprasidone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Ziprasidone.,increase,no risk
Tapentadol,Zolmitriptan,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zolmitriptan.,increase,no risk
Tapentadol,Zolpidem,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tapentadol,Zonisamide,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zonisamide.,increase,no risk
Tapentadol,Zopiclone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zopiclone.,increase,no risk
Tapentadol,Zotepine,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zotepine.,increase,no risk
Tapentadol,Zuclopenthixol,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zuclopenthixol.,increase,no risk
Tapentadol,Zuranolone,Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Zuranolone.,increase,no risk
Hyaluronidase (human recombinant),Quinestrol,The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Quinestrol.,decrease,no risk
Hyaluronidase (human recombinant),Ziprasidone,The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Ziprasidone.,decrease,no risk
Hyaluronidase (human recombinant),Zuclopenthixol,The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Sugammadex,Bemiparin,The risk or severity of bleeding and hemorrhage can be increased when Bemiparin is combined with Sugammadex.,increase,risk
Sugammadex,Betrixaban,The risk or severity of bleeding and hemorrhage can be increased when Betrixaban is combined with Sugammadex.,increase,risk
Sugammadex,Bivalirudin,The risk or severity of bleeding and hemorrhage can be increased when Bivalirudin is combined with Sugammadex.,increase,risk
Sugammadex,Gestrinone,The serum concentration of Gestrinone can be decreased when it is combined with Sugammadex.,decrease,no risk
Sugammadex,Heparin,The risk or severity of bleeding and hemorrhage can be increased when Heparin is combined with Sugammadex.,increase,risk
Sugammadex,Hydroxyprogesterone caproate,The serum concentration of Hydroxyprogesterone caproate can be decreased when it is combined with Sugammadex.,decrease,no risk
Sugammadex,Urokinase,The risk or severity of bleeding and hemorrhage can be increased when Urokinase is combined with Sugammadex.,increase,risk
Sugammadex,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Sugammadex.,increase,risk
Sugammadex,Warfarin,The risk or severity of bleeding and hemorrhage can be increased when Warfarin is combined with Sugammadex.,increase,risk
Sugammadex,Ximelagatran,The risk or severity of bleeding and hemorrhage can be increased when Ximelagatran is combined with Sugammadex.,increase,risk
Silodosin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Silodosin.,increase,no risk
Silodosin,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Silodosin.,increase,no risk
Silodosin,Glasdegib,The excretion of Silodosin can be decreased when combined with Glasdegib.,decrease,no risk
Silodosin,Glecaprevir,The excretion of Silodosin can be decreased when combined with Glecaprevir.,decrease,no risk
Silodosin,Glofitamab,The serum concentration of Silodosin can be increased when it is combined with Glofitamab.,increase,no risk
Silodosin,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Silodosin.,increase,no risk
Silodosin,Guanabenz,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanabenz is combined with Silodosin.,increase,risk
Silodosin,Guanadrel,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanadrel is combined with Silodosin.,increase,risk
Silodosin,Guanethidine,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanethidine is combined with Silodosin.,increase,risk
Silodosin,Guanfacine,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanfacine is combined with Silodosin.,increase,risk
Silodosin,Guanoxan,The risk or severity of orthostatic hypotension and dizziness can be increased when Guanoxan is combined with Silodosin.,increase,risk
Silodosin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Silodosin.,increase,no risk
Silodosin,Hydralazine,The risk or severity of orthostatic hypotension and dizziness can be increased when Hydralazine is combined with Silodosin.,increase,risk
Silodosin,Hydrochlorothiazide,The risk or severity of orthostatic hypotension and dizziness can be increased when Hydrochlorothiazide is combined with Silodosin.,increase,risk
Silodosin,Hydroflumethiazide,The risk or severity of orthostatic hypotension and dizziness can be increased when Hydroflumethiazide is combined with Silodosin.,increase,risk
Silodosin,Ketoconazole,The excretion of Silodosin can be decreased when combined with Ketoconazole.,decrease,no risk
Prasugrel,Benoxaprofen,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Prasugrel.,increase,risk
Prasugrel,Benserazide,Prasugrel may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Prasugrel,Benzatropine,Benzatropine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Benznidazole,Prasugrel may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Prasugrel,Benzocaine,The metabolism of Prasugrel can be decreased when combined with Benzocaine.,decrease,no risk
Prasugrel,Benzphetamine,The metabolism of Prasugrel can be decreased when combined with Benzphetamine.,decrease,no risk
Prasugrel,Benzthiazide,Benzthiazide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Benzydamine,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Prasugrel.,increase,risk
Prasugrel,Bepotastine,Bepotastine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Prasugrel.,decrease,no risk
Prasugrel,Betamethasone,The metabolism of Prasugrel can be increased when combined with Betamethasone.,increase,no risk
Prasugrel,Betrixaban,The risk or severity of bleeding can be increased when Prasugrel is combined with Betrixaban.,increase,risk
Prasugrel,Bexarotene,The risk or severity of bleeding can be increased when Prasugrel is combined with Bexarotene.,increase,risk
Prasugrel,Bicisate,Prasugrel may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Prasugrel,Bimekizumab,The metabolism of Prasugrel can be increased when combined with Bimekizumab.,increase,no risk
Prasugrel,Bismuth subgallate,Prasugrel may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Prasugrel,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Prasugrel.,increase,risk
Prasugrel,Bisoprolol,Bisoprolol may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Bisoxatin,Prasugrel may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Prasugrel,Bivalirudin,The risk or severity of bleeding can be increased when Prasugrel is combined with Bivalirudin.,increase,risk
Prasugrel,Bleomycin,Bleomycin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Blinatumomab,The risk or severity of bleeding can be increased when Prasugrel is combined with Blinatumomab.,increase,risk
Prasugrel,Bortezomib,The risk or severity of bleeding can be increased when Prasugrel is combined with Bortezomib.,increase,risk
Prasugrel,Bosentan,The metabolism of Prasugrel can be increased when combined with Bosentan.,increase,no risk
Prasugrel,Bosutinib,The risk or severity of bleeding can be increased when Prasugrel is combined with Bosutinib.,increase,risk
Prasugrel,Brivaracetam,The metabolism of Prasugrel can be decreased when combined with Brivaracetam.,decrease,no risk
Prasugrel,Bromazepam,Bromazepam may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Bromotheophylline,Bromotheophylline may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Brompheniramine,The metabolism of Prasugrel can be decreased when combined with Brompheniramine.,decrease,no risk
Prasugrel,Budesonide,Budesonide may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Prasugrel.,increase,risk
Prasugrel,Bumetanide,Bumetanide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Buprenorphine,The metabolism of Prasugrel can be decreased when combined with Buprenorphine.,decrease,no risk
Prasugrel,Bupropion,The metabolism of Prasugrel can be decreased when combined with Bupropion.,decrease,no risk
Prasugrel,Buspirone,Buspirone may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Busulfan,The risk or severity of bleeding can be increased when Prasugrel is combined with Busulfan.,increase,risk
Prasugrel,Butabarbital,Butabarbital may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gabapentin enacarbil,Prasugrel may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadodiamide,Gadodiamide may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadofosveset trisodium,Prasugrel may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadoteric acid,Prasugrel may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Prasugrel,Gadoteridol,Gadoteridol may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Ganciclovir,Ganciclovir may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gemcitabine,The risk or severity of bleeding can be increased when Prasugrel is combined with Gemcitabine.,increase,risk
Prasugrel,Gemfibrozil,The metabolism of Prasugrel can be decreased when combined with Gemfibrozil.,decrease,no risk
Prasugrel,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Prasugrel is combined with Gemtuzumab ozogamicin.,increase,risk
Prasugrel,Gentamicin,Prasugrel may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Prasugrel,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Prasugrel.,increase,risk
Prasugrel,Gimeracil,Prasugrel may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Prasugrel,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Prasugrel.,increase,no risk
Prasugrel,Givosiran,Givosiran may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gliclazide,The metabolism of Prasugrel can be decreased when combined with Gliclazide.,decrease,no risk
Prasugrel,Glimepiride,The metabolism of Prasugrel can be decreased when combined with Glimepiride.,decrease,no risk
Prasugrel,Glipizide,Glipizide may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Gliquidone,The metabolism of Prasugrel can be decreased when combined with Gliquidone.,decrease,no risk
Prasugrel,Glofitamab,The serum concentration of Prasugrel can be increased when it is combined with Glofitamab.,increase,no risk
Prasugrel,Glucosamine,Glucosamine may increase the antiplatelet activities of Prasugrel.,increase,no risk
Prasugrel,Glyburide,The metabolism of Prasugrel can be decreased when combined with Glyburide.,decrease,no risk
Prasugrel,Glycerol phenylbutyrate,Prasugrel may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Prasugrel,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Prasugrel.,increase,risk
Prasugrel,Golimumab,The metabolism of Prasugrel can be increased when combined with Golimumab.,increase,no risk
Prasugrel,Golodirsen,Prasugrel may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Prasugrel,Goserelin,Goserelin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Guanethidine,Guanethidine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Guanfacine,Guanfacine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Prasugrel.,increase,no risk
Prasugrel,Halothane,The metabolism of Prasugrel can be decreased when combined with Halothane.,decrease,no risk
Prasugrel,Hemin,Hemin may increase the anticoagulant activities of Prasugrel.,increase,no risk
Prasugrel,Heparin,The risk or severity of bleeding can be increased when Prasugrel is combined with Heparin.,increase,risk
Prasugrel,Hydralazine,Hydralazine may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Hydrocodone,The metabolism of Prasugrel can be decreased when combined with Hydrocodone.,decrease,no risk
Prasugrel,Hydrocortisone,The metabolism of Prasugrel can be increased when combined with Hydrocortisone.,increase,no risk
Prasugrel,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Prasugrel,Hydromorphone,Hydromorphone may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Hydroxyethyl Starch,Prasugrel may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Prasugrel,Hydroxyprogesterone caproate,The therapeutic efficacy of Prasugrel can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Prasugrel,Hydroxyurea,The risk or severity of bleeding can be increased when Prasugrel is combined with Hydroxyurea.,increase,risk
Prasugrel,Kanamycin,Prasugrel may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Prasugrel,Ketamine,The metabolism of Prasugrel can be decreased when combined with Ketamine.,decrease,no risk
Prasugrel,Ketazolam,Ketazolam may decrease the excretion rate of Prasugrel which could result in a higher serum level.,decrease,no risk
Prasugrel,Ketoconazole,The metabolism of Prasugrel can be decreased when combined with Ketoconazole.,decrease,no risk
Prasugrel,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Prasugrel.,increase,risk
Prasugrel,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Prasugrel.,increase,risk
Eltrombopag,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Gatifloxacin,The metabolism of Eltrombopag can be decreased when combined with Gatifloxacin.,decrease,no risk
Eltrombopag,Gefitinib,Eltrombopag may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Eltrombopag,Gemfibrozil,The metabolism of Eltrombopag can be decreased when combined with Gemfibrozil.,decrease,no risk
Eltrombopag,Gemifloxacin,The metabolism of Eltrombopag can be decreased when combined with Gemifloxacin.,decrease,no risk
Eltrombopag,Givosiran,The serum concentration of Eltrombopag can be increased when it is combined with Givosiran.,increase,no risk
Eltrombopag,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Glecaprevir,Eltrombopag may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Eltrombopag,Glipizide,The metabolism of Glipizide can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Glofitamab,The serum concentration of Eltrombopag can be increased when it is combined with Glofitamab.,increase,no risk
Eltrombopag,Glyburide,Eltrombopag may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Eltrombopag,Golimumab,The metabolism of Eltrombopag can be increased when combined with Golimumab.,increase,no risk
Eltrombopag,Grazoprevir,The excretion of Grazoprevir can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Grepafloxacin,The metabolism of Eltrombopag can be decreased when combined with Grepafloxacin.,decrease,no risk
Eltrombopag,Guanabenz,The metabolism of Eltrombopag can be decreased when combined with Guanabenz.,decrease,no risk
Eltrombopag,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Haloperidol,The metabolism of Eltrombopag can be decreased when combined with Haloperidol.,decrease,no risk
Eltrombopag,Hydrocortisone,The metabolism of Eltrombopag can be increased when combined with Hydrocortisone.,increase,no risk
Eltrombopag,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Kaolin,Kaolin can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Ketamine,The metabolism of Ketamine can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Ketoconazole,The metabolism of Eltrombopag can be decreased when combined with Ketoconazole.,decrease,no risk
Eltrombopag,Ketoprofen,The metabolism of Ketoprofen can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Obeticholic acid,The metabolism of Eltrombopag can be decreased when combined with Obeticholic acid.,decrease,no risk
Eltrombopag,Olanzapine,The metabolism of Eltrombopag can be decreased when combined with Olanzapine.,decrease,no risk
Eltrombopag,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Omaveloxolone,The serum concentration of Eltrombopag can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Eltrombopag,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Ondansetron,The metabolism of Eltrombopag can be decreased when combined with Ondansetron.,decrease,no risk
Eltrombopag,Orphenadrine,The metabolism of Eltrombopag can be decreased when combined with Orphenadrine.,decrease,no risk
Eltrombopag,Osilodrostat,The metabolism of Eltrombopag can be decreased when combined with Osilodrostat.,decrease,no risk
Eltrombopag,Osimertinib,The serum concentration of Eltrombopag can be decreased when it is combined with Osimertinib.,decrease,no risk
Eltrombopag,Ouabain,The excretion of Ouabain can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Oxaliplatin,Eltrombopag may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Eltrombopag,Oxazepam,The metabolism of Oxazepam can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Oxtriphylline,The metabolism of Eltrombopag can be decreased when combined with Oxtriphylline.,decrease,no risk
Eltrombopag,Oxybutynin,The metabolism of Eltrombopag can be decreased when combined with Oxybutynin.,decrease,no risk
Eltrombopag,Ozanimod,Eltrombopag may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Eltrombopag,Quinidine,The metabolism of Eltrombopag can be decreased when combined with Quinidine.,decrease,no risk
Eltrombopag,Quinine,The metabolism of Eltrombopag can be decreased when combined with Quinine.,decrease,no risk
Eltrombopag,Quizartinib,The metabolism of Eltrombopag can be decreased when combined with Quizartinib.,decrease,no risk
Eltrombopag,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Eltrombopag.,increase,no risk
Eltrombopag,Vadadustat,The serum concentration of Eltrombopag can be increased when it is combined with Vadadustat.,increase,no risk
Eltrombopag,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Valsartan,The excretion of Valsartan can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Vemurafenib,The serum concentration of Eltrombopag can be increased when it is combined with Vemurafenib.,increase,no risk
Eltrombopag,Venetoclax,Eltrombopag may decrease the excretion rate of Venetoclax which could result in a higher serum level.,decrease,no risk
Eltrombopag,Verapamil,The metabolism of Eltrombopag can be decreased when combined with Verapamil.,decrease,no risk
Eltrombopag,Vericiguat,The metabolism of Vericiguat can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Viloxazine,The metabolism of Eltrombopag can be decreased when combined with Viloxazine.,decrease,no risk
Eltrombopag,Vincristine,Eltrombopag may decrease the excretion rate of Vincristine which could result in a higher serum level.,decrease,no risk
Eltrombopag,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Warfarin,The metabolism of Eltrombopag can be decreased when combined with Warfarin.,decrease,no risk
Eltrombopag,Zidovudine,The metabolism of Eltrombopag can be increased when combined with Zidovudine.,increase,no risk
Eltrombopag,Zileuton,The metabolism of Eltrombopag can be decreased when combined with Zileuton.,decrease,no risk
Eltrombopag,Zinc,Zinc can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Eltrombopag,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Eltrombopag resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Eltrombopag,Zolmitriptan,The metabolism of Eltrombopag can be decreased when combined with Zolmitriptan.,decrease,no risk
Eltrombopag,Zolpidem,The metabolism of Eltrombopag can be decreased when combined with Zolpidem.,decrease,no risk
Eltrombopag,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Eltrombopag.,decrease,no risk
Eltrombopag,Zotepine,The metabolism of Zotepine can be decreased when combined with Eltrombopag.,decrease,no risk
Doripenem,Gabapentin enacarbil,Doripenem may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Doripenem,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Gadodiamide,Gadodiamide may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Gadofosveset trisodium,Doripenem may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Doripenem,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Gadoteric acid,Doripenem may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Doripenem,Gadoteridol,Gadoteridol may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Ganciclovir,The excretion of Doripenem can be decreased when combined with Ganciclovir.,decrease,no risk
Doripenem,Gemcitabine,Gemcitabine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Gemfibrozil,The excretion of Doripenem can be decreased when combined with Gemfibrozil.,decrease,no risk
Doripenem,Gentamicin,Doripenem may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Doripenem,Gimeracil,Doripenem may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Doripenem,Givosiran,Givosiran may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Glipizide,Glipizide may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Glycerol phenylbutyrate,Doripenem may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Doripenem,Golodirsen,Doripenem may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Doripenem,Goserelin,Goserelin may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Guanethidine,Guanethidine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Guanfacine,Guanfacine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Guanidine,The excretion of Doripenem can be decreased when combined with Guanidine.,decrease,no risk
Doripenem,Haloperidol,Haloperidol may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Hydralazine,Hydralazine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doripenem,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doripenem,Hydromorphone,Hydromorphone may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Hydroxyethyl Starch,Doripenem may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Doripenem,Kanamycin,Doripenem may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Doripenem,Ketamine,Ketamine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Ketazolam,Ketazolam may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Ketoprofen,The excretion of Doripenem can be decreased when combined with Ketoprofen.,decrease,no risk
Doripenem,Ketorolac,Ketorolac may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Octinoxate,Doripenem may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Doripenem,Olsalazine,Olsalazine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Opium,Doripenem may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Doripenem,Oseltamivir,Oseltamivir may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Ouabain,The excretion of Doripenem can be decreased when combined with Ouabain.,decrease,no risk
Doripenem,Oxacillin,Oxacillin may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxaprozin,Oxaprozin may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxazepam,Oxazepam may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Doripenem is combined with Oxetacaine.,increase,risk
Doripenem,Oxybenzone,Oxybenzone may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Doripenem is combined with Oxybuprocaine.,increase,risk
Doripenem,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Oxyquinoline,Doripenem may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Doripenem,Oxytetracycline,The excretion of Doripenem can be decreased when combined with Oxytetracycline.,decrease,no risk
Doripenem,Quetiapine,Quetiapine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Quinethazone,Quinethazone may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Doripenem,Quinidine,Doripenem may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Doripenem,Vaborbactam,Doripenem may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Doripenem,Vadadustat,The serum concentration of Doripenem can be increased when it is combined with Vadadustat.,increase,no risk
Doripenem,Valaciclovir,Valaciclovir may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Valbenazine,Doripenem may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Doripenem,Valdecoxib,Valdecoxib may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Valganciclovir,Valganciclovir may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Valproic acid,The serum concentration of Valproic acid can be decreased when it is combined with Doripenem.,decrease,no risk
Doripenem,Vancomycin,Doripenem may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Doripenem,Varenicline,Varenicline may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Venlafaxine,Venlafaxine may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Verapamil,Verapamil may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Doripenem.,decrease,no risk
Doripenem,Vilanterol,Doripenem may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Doripenem,Viloxazine,Doripenem may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Doripenem,Vortioxetine,Doripenem may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Doripenem,Warfarin,Doripenem may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Doripenem,Zaleplon,Zaleplon may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Zanamivir,Zanamivir may decrease the excretion rate of Doripenem which could result in a higher serum level.,decrease,no risk
Doripenem,Zidovudine,The excretion of Doripenem can be decreased when combined with Zidovudine.,decrease,no risk
Doripenem,Zonisamide,Zonisamide may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Betamethasone phosphate,The metabolism of Tolvaptan can be increased when combined with Betamethasone phosphate.,increase,no risk
Tolvaptan,Betaxolol,The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Tolvaptan.,increase,risk
Tolvaptan,Betrixaban,The serum concentration of Tolvaptan can be increased when it is combined with Betrixaban.,increase,no risk
Tolvaptan,Bexarotene,The metabolism of Tolvaptan can be increased when combined with Bexarotene.,increase,no risk
Tolvaptan,Bicalutamide,The metabolism of Tolvaptan can be decreased when combined with Bicalutamide.,decrease,no risk
Tolvaptan,Bicisate,Tolvaptan may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Bifonazole,The metabolism of Tolvaptan can be decreased when combined with Bifonazole.,decrease,no risk
Tolvaptan,Bimekizumab,The metabolism of Tolvaptan can be increased when combined with Bimekizumab.,increase,no risk
Tolvaptan,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Tolvaptan.,increase,no risk
Tolvaptan,Bisacodyl,The risk or severity of dehydration can be increased when Tolvaptan is combined with Bisacodyl.,increase,risk
Tolvaptan,Bismuth subgallate,Tolvaptan may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Bisoprolol,Tolvaptan may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Bisoxatin,The risk or severity of dehydration can be increased when Tolvaptan is combined with Bisoxatin.,increase,risk
Tolvaptan,Bleomycin,Tolvaptan may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Boceprevir,The metabolism of Tolvaptan can be decreased when combined with Boceprevir.,decrease,no risk
Tolvaptan,Bortezomib,The serum concentration of Tolvaptan can be increased when it is combined with Bortezomib.,increase,no risk
Tolvaptan,Bosentan,The metabolism of Tolvaptan can be increased when combined with Bosentan.,increase,no risk
Tolvaptan,Bosutinib,The metabolism of Tolvaptan can be decreased when combined with Bosutinib.,decrease,no risk
Tolvaptan,Brentuximab vedotin,The serum concentration of Tolvaptan can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Tolvaptan,Brivaracetam,Tolvaptan may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Bromazepam,Tolvaptan may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Budesonide,The metabolism of Tolvaptan can be increased when combined with Budesonide.,increase,no risk
Tolvaptan,Bumadizone,The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Bumadizone.,increase,risk
Tolvaptan,Bumetanide,Tolvaptan may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Buprenorphine,The metabolism of Tolvaptan can be decreased when combined with Buprenorphine.,decrease,no risk
Tolvaptan,Bupropion,Tolvaptan may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Buspirone,Tolvaptan may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Butabarbital,Tolvaptan may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Butalbital,The metabolism of Tolvaptan can be increased when combined with Butalbital.,increase,no risk
Tolvaptan,Butorphanol,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Butorphanol.,decrease,no risk
Tolvaptan,Gabapentin enacarbil,Tolvaptan may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadobenic acid,Tolvaptan may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadodiamide,Tolvaptan may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadofosveset trisodium,Tolvaptan may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadopentetic acid,Tolvaptan may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadoteric acid,Tolvaptan may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gadoteridol,Tolvaptan may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ganciclovir,Tolvaptan may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gemcitabine,Tolvaptan may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gemfibrozil,Tolvaptan may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Gilteritinib,The metabolism of Tolvaptan can be decreased when combined with Gilteritinib.,decrease,no risk
Tolvaptan,Gimeracil,Tolvaptan may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ginkgo biloba,The metabolism of Tolvaptan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Tolvaptan,Glasdegib,The serum concentration of Tolvaptan can be increased when it is combined with Glasdegib.,increase,no risk
Tolvaptan,Glecaprevir,The serum concentration of Tolvaptan can be increased when it is combined with Glecaprevir.,increase,no risk
Tolvaptan,Glipizide,Tolvaptan may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Glofitamab,The serum concentration of Tolvaptan can be increased when it is combined with Glofitamab.,increase,no risk
Tolvaptan,Gluconic Acid,The risk or severity of dehydration can be increased when Tolvaptan is combined with Gluconic Acid.,increase,risk
Tolvaptan,Glyburide,The metabolism of Tolvaptan can be decreased when combined with Glyburide.,decrease,no risk
Tolvaptan,Glycerin,The risk or severity of dehydration can be increased when Tolvaptan is combined with Glycerin.,increase,risk
Tolvaptan,Glycerol phenylbutyrate,The metabolism of Tolvaptan can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Tolvaptan,Golimumab,The metabolism of Tolvaptan can be increased when combined with Golimumab.,increase,no risk
Tolvaptan,Golodirsen,Tolvaptan may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Goserelin,Tolvaptan may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Grapefruit,The serum concentration of Tolvaptan can be increased when it is combined with Grapefruit.,increase,no risk
Tolvaptan,Grazoprevir,The serum concentration of Tolvaptan can be increased when it is combined with Grazoprevir.,increase,no risk
Tolvaptan,Griseofulvin,The metabolism of Tolvaptan can be increased when combined with Griseofulvin.,increase,no risk
Tolvaptan,Guanethidine,Tolvaptan may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Guanfacine,Tolvaptan may increase the excretion rate of Guanfacine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Tolvaptan.,increase,no risk
Tolvaptan,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Tolvaptan.,increase,risk
Tolvaptan,Hydralazine,The serum concentration of Tolvaptan can be increased when it is combined with Hydralazine.,increase,no risk
Tolvaptan,Hydrocodone,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Hydrocodone.,decrease,no risk
Tolvaptan,Hydrocortamate,The metabolism of Tolvaptan can be increased when combined with Hydrocortamate.,increase,no risk
Tolvaptan,Hydrocortisone,The metabolism of Tolvaptan can be increased when combined with Hydrocortisone.,increase,no risk
Tolvaptan,Hydrocortisone acetate,The metabolism of Tolvaptan can be increased when combined with Hydrocortisone acetate.,increase,no risk
Tolvaptan,Hydrocortisone butyrate,The metabolism of Tolvaptan can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Tolvaptan,Hydrocortisone succinate,The metabolism of Tolvaptan can be increased when combined with Hydrocortisone succinate.,increase,no risk
Tolvaptan,Hydromorphone,Tolvaptan may increase the excretion rate of Hydromorphone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Hydroxocobalamin,Tolvaptan may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Hydroxyethyl Starch,Tolvaptan may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ketamine,Tolvaptan may increase the excretion rate of Ketamine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ketazolam,The serum concentration of Tolvaptan can be increased when it is combined with Ketazolam.,increase,no risk
Tolvaptan,Ketoconazole,The metabolism of Tolvaptan can be decreased when combined with Ketoconazole.,decrease,no risk
Tolvaptan,Ketoprofen,Tolvaptan may increase the excretion rate of Ketoprofen which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Tolvaptan.,increase,risk
Tolvaptan,Octinoxate,Tolvaptan may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Octreotide,The serum concentration of Tolvaptan can be increased when it is combined with Octreotide.,increase,no risk
Tolvaptan,Olaparib,The metabolism of Tolvaptan can be decreased when combined with Olaparib.,decrease,no risk
Tolvaptan,Oliceridine,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Oliceridine.,decrease,no risk
Tolvaptan,Olmesartan,The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Olmesartan.,increase,risk
Tolvaptan,Olutasidenib,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Olutasidenib.,decrease,no risk
Tolvaptan,Omadacycline,The serum concentration of Tolvaptan can be increased when it is combined with Omadacycline.,increase,no risk
Tolvaptan,Omaveloxolone,The serum concentration of Tolvaptan can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Tolvaptan,Ombitasvir,The serum concentration of Tolvaptan can be increased when it is combined with Ombitasvir.,increase,no risk
Tolvaptan,Opium,Tolvaptan may increase the excretion rate of Opium which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oritavancin,The metabolism of Tolvaptan can be increased when combined with Oritavancin.,increase,no risk
Tolvaptan,Orphenadrine,The metabolism of Tolvaptan can be decreased when combined with Orphenadrine.,decrease,no risk
Tolvaptan,Oseltamivir,Tolvaptan may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Osilodrostat,The metabolism of Tolvaptan can be decreased when combined with Osilodrostat.,decrease,no risk
Tolvaptan,Osimertinib,The metabolism of Tolvaptan can be decreased when combined with Osimertinib.,decrease,no risk
Tolvaptan,Oxacillin,Tolvaptan may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oxaprozin,Tolvaptan may increase the excretion rate of Oxaprozin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oxazepam,Tolvaptan may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oxcarbazepine,The metabolism of Tolvaptan can be increased when combined with Oxcarbazepine.,increase,no risk
Tolvaptan,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Tolvaptan.,increase,risk
Tolvaptan,Oxybenzone,Tolvaptan may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Oxybutynin,The serum concentration of Tolvaptan can be increased when it is combined with Oxybutynin.,increase,no risk
Tolvaptan,Oxycodone,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Oxycodone.,decrease,no risk
Tolvaptan,Oxymorphone,The therapeutic efficacy of Tolvaptan can be decreased when used in combination with Oxymorphone.,decrease,no risk
Tolvaptan,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Tolvaptan.,increase,risk
Tolvaptan,Oxyphenisatin acetate,The risk or severity of dehydration can be increased when Tolvaptan is combined with Oxyphenisatin acetate.,increase,risk
Tolvaptan,Oxyquinoline,Tolvaptan may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Quetiapine,Tolvaptan may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Quinapril,Tolvaptan may increase the hyperkalemic activities of Quinapril.,increase,no risk
Tolvaptan,Quinidine,The serum concentration of Tolvaptan can be increased when it is combined with Quinidine.,increase,no risk
Tolvaptan,Quinine,The serum concentration of Tolvaptan can be increased when it is combined with Quinine.,increase,no risk
Tolvaptan,Quinupristin,The metabolism of Tolvaptan can be decreased when combined with Quinupristin.,decrease,no risk
Tolvaptan,Quizartinib,The serum concentration of Tolvaptan can be increased when it is combined with Quizartinib.,increase,no risk
Tolvaptan,Ubrogepant,The serum concentration of Tolvaptan can be increased when it is combined with Ubrogepant.,increase,no risk
Tolvaptan,Umbralisib,The serum concentration of Tolvaptan can be increased when it is combined with Umbralisib.,increase,no risk
Tolvaptan,Umeclidinium,The serum concentration of Tolvaptan can be increased when it is combined with Umeclidinium.,increase,no risk
Tolvaptan,Vaborbactam,Tolvaptan may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Vadadustat,The serum concentration of Tolvaptan can be increased when it is combined with Vadadustat.,increase,no risk
Tolvaptan,Valaciclovir,Tolvaptan may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Valbenazine,Tolvaptan may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Valdecoxib,The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Tolvaptan.,increase,risk
Tolvaptan,Valganciclovir,Tolvaptan may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Valproic acid,The serum concentration of Tolvaptan can be increased when it is combined with Valproic acid.,increase,no risk
Tolvaptan,Valsartan,The risk or severity of hyperkalemia can be increased when Tolvaptan is combined with Valsartan.,increase,risk
Tolvaptan,Vancomycin,Tolvaptan may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Vandetanib,The serum concentration of Tolvaptan can be increased when it is combined with Vandetanib.,increase,no risk
Tolvaptan,Vardenafil,The serum concentration of Tolvaptan can be increased when it is combined with Vardenafil.,increase,no risk
Tolvaptan,Varenicline,Tolvaptan may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Velpatasvir,The serum concentration of Tolvaptan can be increased when it is combined with Velpatasvir.,increase,no risk
Tolvaptan,Vemurafenib,The serum concentration of Tolvaptan can be increased when it is combined with Vemurafenib.,increase,no risk
Tolvaptan,Venetoclax,The serum concentration of Tolvaptan can be increased when it is combined with Venetoclax.,increase,no risk
Tolvaptan,Venlafaxine,Tolvaptan may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Verapamil,The serum concentration of Tolvaptan can be increased when it is combined with Verapamil.,increase,no risk
Tolvaptan,Vilanterol,Tolvaptan may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Viloxazine,The metabolism of Tolvaptan can be decreased when combined with Viloxazine.,decrease,no risk
Tolvaptan,Vinblastine,The metabolism of Tolvaptan can be increased when combined with Vinblastine.,increase,no risk
Tolvaptan,Vincristine,The serum concentration of Tolvaptan can be increased when it is combined with Vincristine.,increase,no risk
Tolvaptan,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Tolvaptan.,increase,no risk
Tolvaptan,Vitamin E,The metabolism of Tolvaptan can be increased when combined with Vitamin E.,increase,no risk
Tolvaptan,Voclosporin,The serum concentration of Tolvaptan can be increased when it is combined with Voclosporin.,increase,no risk
Tolvaptan,Vorapaxar,The serum concentration of Tolvaptan can be increased when it is combined with Vorapaxar.,increase,no risk
Tolvaptan,Voriconazole,The serum concentration of Tolvaptan can be increased when it is combined with Voriconazole.,increase,no risk
Tolvaptan,Vortioxetine,Tolvaptan may increase the excretion rate of Vortioxetine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Voxelotor,The serum concentration of Tolvaptan can be increased when it is combined with Voxelotor.,increase,no risk
Tolvaptan,Voxilaprevir,The serum concentration of Tolvaptan can be increased when it is combined with Voxilaprevir.,increase,no risk
Tolvaptan,Warfarin,The metabolism of Tolvaptan can be increased when combined with Warfarin.,increase,no risk
Tolvaptan,Zafirlukast,The serum concentration of Tolvaptan can be increased when it is combined with Zafirlukast.,increase,no risk
Tolvaptan,Zaleplon,Tolvaptan may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Zanamivir,Tolvaptan may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tolvaptan,Ziconotide,The risk or severity of CNS depression can be increased when Tolvaptan is combined with Ziconotide.,increase,risk
Tolvaptan,Zimelidine,The metabolism of Tolvaptan can be decreased when combined with Zimelidine.,decrease,no risk
Tolvaptan,Ziprasidone,The metabolism of Tolvaptan can be decreased when combined with Ziprasidone.,decrease,no risk
Tolvaptan,Zofenopril,Tolvaptan may increase the hyperkalemic activities of Zofenopril.,increase,no risk
Tolvaptan,Zonisamide,The serum concentration of Tolvaptan can be increased when it is combined with Zonisamide.,increase,no risk
Tolvaptan,Zuclopenthixol,The metabolism of Tolvaptan can be decreased when combined with Zuclopenthixol.,decrease,no risk
Regadenoson,Bromotheophylline,Bromotheophylline may decrease effectiveness of Regadenoson as a diagnostic agent.,decrease,no risk
Regadenoson,Oxtriphylline,Oxtriphylline may decrease effectiveness of Regadenoson as a diagnostic agent.,decrease,no risk
Ferumoxytol,Gatifloxacin,Ferumoxytol can cause a decrease in the absorption of Gatifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Gemifloxacin,Ferumoxytol can cause a decrease in the absorption of Gemifloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Grepafloxacin,Ferumoxytol can cause a decrease in the absorption of Grepafloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Ofloxacin,Ferumoxytol can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ferumoxytol,Omeprazole,The absorption of Ferumoxytol can be decreased when combined with Omeprazole.,decrease,no risk
Asenapine,Bethanidine,The therapeutic efficacy of Bethanidine can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Bifonazole,Asenapine can cause a decrease in the absorption of Bifonazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Asenapine.,increase,risk
Asenapine,Bimekizumab,The metabolism of Asenapine can be increased when combined with Bimekizumab.,increase,no risk
Asenapine,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Asenapine.,decrease,no risk
Asenapine,Biperiden,The therapeutic efficacy of Biperiden can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Bismuth subcitrate potassium,Asenapine may increase the neurotoxic activities of Bismuth subcitrate potassium.,increase,no risk
Asenapine,Bismuth subgallate,Asenapine may increase the neurotoxic activities of Bismuth subgallate.,increase,no risk
Asenapine,Bismuth subnitrate,Asenapine may increase the neurotoxic activities of Bismuth subnitrate.,increase,no risk
Asenapine,Bisoprolol,Bisoprolol may increase the orthostatic hypotensive activities of Asenapine.,increase,no risk
Asenapine,Boceprevir,The metabolism of Asenapine can be decreased when combined with Boceprevir.,decrease,no risk
Asenapine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Asenapine.,increase,risk
Asenapine,Bosentan,Asenapine may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Asenapine,Bosutinib,Asenapine can cause a decrease in the absorption of Bosutinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Asenapine.,increase,risk
Asenapine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Asenapine.,increase,risk
Asenapine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Asenapine.,increase,risk
Asenapine,Brexanolone,The risk or severity of CNS depression can be increased when Asenapine is combined with Brexanolone.,increase,risk
Asenapine,Brexpiprazole,"Asenapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Brexpiprazole.",increase,no risk
Asenapine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Asenapine.,increase,no risk
Asenapine,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Asenapine.,increase,risk
Asenapine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Asenapine.,increase,risk
Asenapine,Bromocriptine,"Bromocriptine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Asenapine.,decrease,no risk
Asenapine,Bromperidol,The risk or severity of CNS depression can be increased when Asenapine is combined with Bromperidol.,increase,risk
Asenapine,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Asenapine.,increase,risk
Asenapine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Asenapine.,increase,risk
Asenapine,Budesonide,Asenapine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Bumadizone,The risk or severity of hypertension can be increased when Asenapine is combined with Bumadizone.,increase,risk
Asenapine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Asenapine.,increase,risk
Asenapine,Buprenorphine,Asenapine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Asenapine,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Asenapine.,increase,risk
Asenapine,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Asenapine.,increase,risk
Asenapine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Asenapine.,increase,risk
Asenapine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Asenapine.,increase,risk
Asenapine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Asenapine.,increase,risk
Asenapine,Butaperazine,The risk or severity of CNS depression can be increased when Asenapine is combined with Butaperazine.,increase,risk
Asenapine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Asenapine.,increase,risk
Asenapine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Asenapine.,increase,risk
Asenapine,Butriptyline,The risk or severity of QTc prolongation can be increased when Butriptyline is combined with Asenapine.,increase,risk
Asenapine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Asenapine.,increase,risk
Asenapine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Asenapine is combined with Gabapentin enacarbil.,increase,risk
Asenapine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Asenapine.,increase,risk
Asenapine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Asenapine.,increase,risk
Asenapine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Asenapine.,increase,risk
Asenapine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Asenapine is combined with Ganaxolone.",increase,risk
Asenapine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Asenapine.,increase,risk
Asenapine,Gefitinib,Asenapine can cause a decrease in the absorption of Gefitinib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Gemfibrozil,The metabolism of Asenapine can be decreased when combined with Gemfibrozil.,decrease,no risk
Asenapine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Asenapine.,increase,risk
Asenapine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Asenapine.,increase,risk
Asenapine,Gilteritinib,The therapeutic efficacy of Asenapine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Asenapine,Givosiran,The serum concentration of Asenapine can be increased when it is combined with Givosiran.,increase,no risk
Asenapine,Glasdegib,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Glasdegib.,increase,risk
Asenapine,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Glofitamab,The serum concentration of Asenapine can be increased when it is combined with Glofitamab.,increase,no risk
Asenapine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Asenapine.,increase,risk
Asenapine,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Golimumab,The metabolism of Asenapine can be increased when combined with Golimumab.,increase,no risk
Asenapine,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Asenapine.,increase,risk
Asenapine,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Asenapine.,increase,risk
Asenapine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Grepafloxacin is combined with Asenapine.,increase,risk
Asenapine,Guanabenz,The therapeutic efficacy of Guanabenz can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Guanadrel,Asenapine may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Asenapine,Guanethidine,Asenapine may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Asenapine,Guanfacine,The therapeutic efficacy of Guanfacine can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Guanoxan,Asenapine may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Asenapine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Asenapine.,increase,risk
Asenapine,Halofantrine,The risk or severity of QTc prolongation can be increased when Halofantrine is combined with Asenapine.,increase,risk
Asenapine,Haloperidol,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Haloperidol.,increase,risk
Asenapine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Asenapine.,increase,risk
Asenapine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Asenapine.,increase,risk
Asenapine,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Asenapine.,increase,risk
Asenapine,Hydralazine,Asenapine may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Asenapine,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Asenapine.,increase,risk
Asenapine,Hydrocodone,Asenapine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Asenapine,Hydroflumethiazide,Asenapine may decrease the antihypertensive activities of Hydroflumethiazide.,decrease,no risk
Asenapine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Asenapine.,increase,risk
Asenapine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Asenapine.,increase,risk
Asenapine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Hydroxyzine.,increase,risk
Asenapine,Hyoscyamine,Asenapine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Asenapine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Asenapine.,increase,risk
Asenapine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Asenapine.,increase,risk
Asenapine,Ketoconazole,Asenapine can cause a decrease in the absorption of Ketoconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Asenapine.,increase,risk
Asenapine,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Asenapine.,increase,risk
Asenapine,Obeticholic acid,The metabolism of Asenapine can be decreased when combined with Obeticholic acid.,decrease,no risk
Asenapine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Asenapine.,increase,risk
Asenapine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Asenapine.,increase,risk
Asenapine,Olanzapine,"Olanzapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Asenapine is combined with Oliceridine.",increase,risk
Asenapine,Olmesartan,Asenapine may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Asenapine,Olodaterol,The therapeutic efficacy of Olodaterol can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Omaveloxolone,The serum concentration of Asenapine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Asenapine,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Asenapine.,increase,risk
Asenapine,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Opium,The risk or severity of CNS depression can be increased when Asenapine is combined with Opium.,increase,risk
Asenapine,Orciprenaline,The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Orphenadrine,Asenapine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Asenapine,Osilodrostat,The metabolism of Asenapine can be decreased when combined with Osilodrostat.,decrease,no risk
Asenapine,Osimertinib,The serum concentration of Asenapine can be decreased when it is combined with Osimertinib.,decrease,no risk
Asenapine,Oteseconazole,Asenapine can cause a decrease in the absorption of Oteseconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Asenapine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Asenapine.,increase,risk
Asenapine,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Asenapine.,increase,risk
Asenapine,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Asenapine.,increase,risk
Asenapine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Asenapine.,increase,risk
Asenapine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Asenapine.,increase,risk
Asenapine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Asenapine.,increase,risk
Asenapine,Oxprenolol,Oxprenolol may increase the orthostatic hypotensive activities of Asenapine.,increase,no risk
Asenapine,Oxtriphylline,The metabolism of Asenapine can be decreased when combined with Oxtriphylline.,decrease,no risk
Asenapine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Asenapine.,increase,risk
Asenapine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Asenapine.,increase,risk
Asenapine,Oxymetazoline,The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Asenapine.,increase,risk
Asenapine,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Asenapine.,increase,risk
Asenapine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Asenapine.,increase,risk
Asenapine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Asenapine.,increase,risk
Asenapine,Quetiapine,"Quetiapine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Quinapril,Asenapine may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Asenapine,Quinidine,"Quinidine may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Quinine,The risk or severity of QTc prolongation can be increased when Quinine is combined with Asenapine.,increase,risk
Asenapine,Quinupramine,The risk or severity of CNS depression can be increased when Asenapine is combined with Quinupramine.,increase,risk
Asenapine,Quizartinib,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Quizartinib.,increase,risk
Asenapine,Udenafil,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Asenapine.,increase,risk
Asenapine,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Asenapine.,increase,risk
Asenapine,Vadadustat,The serum concentration of Asenapine can be increased when it is combined with Vadadustat.,increase,no risk
Asenapine,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Asenapine.,increase,risk
Asenapine,Valproate bismuth,The risk or severity of serotonin syndrome can be increased when Asenapine is combined with Valproate bismuth.,increase,risk
Asenapine,Valproic acid,The risk or severity of QTc prolongation can be increased when Valproic acid is combined with Asenapine.,increase,risk
Asenapine,Valsartan,Asenapine may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Asenapine,Vandetanib,The risk or severity of QTc prolongation can be increased when Vandetanib is combined with Asenapine.,increase,risk
Asenapine,Vardenafil,The risk or severity of hypotension and syncope can be increased when Vardenafil is combined with Asenapine.,increase,risk
Asenapine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Asenapine.,increase,risk
Asenapine,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Asenapine.,increase,risk
Asenapine,Venetoclax,The metabolism of Asenapine can be decreased when combined with Venetoclax.,decrease,no risk
Asenapine,Venlafaxine,The risk or severity of serotonin syndrome can be increased when Asenapine is combined with Venlafaxine.,increase,risk
Asenapine,Verapamil,The metabolism of Asenapine can be decreased when combined with Verapamil.,decrease,no risk
Asenapine,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Asenapine.,increase,risk
Asenapine,Vibegron,The therapeutic efficacy of Vibegron can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Asenapine.,increase,risk
Asenapine,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Asenapine.,increase,risk
Asenapine,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Asenapine.,increase,risk
Asenapine,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Viloxazine,The metabolism of Asenapine can be decreased when combined with Viloxazine.,decrease,no risk
Asenapine,Vincristine,Vincristine may increase the neurotoxic activities of Asenapine.,increase,no risk
Asenapine,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Asenapine.,increase,no risk
Asenapine,Viomycin,Asenapine may increase the neurotoxic activities of Viomycin.,increase,no risk
Asenapine,Voriconazole,The metabolism of Asenapine can be decreased when combined with Voriconazole.,decrease,no risk
Asenapine,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Asenapine.,increase,risk
Asenapine,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Asenapine.,increase,risk
Asenapine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Asenapine.,decrease,no risk
Asenapine,Warfarin,The metabolism of Asenapine can be decreased when combined with Warfarin.,decrease,no risk
Asenapine,Xamoterol,The therapeutic efficacy of Xamoterol can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Xylometazoline,The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Asenapine.,decrease,no risk
Asenapine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Asenapine.,increase,risk
Asenapine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Asenapine.,increase,risk
Asenapine,Ziconotide,The risk or severity of CNS depression can be increased when Asenapine is combined with Ziconotide.,increase,risk
Asenapine,Zileuton,The metabolism of Asenapine can be decreased when combined with Zileuton.,decrease,no risk
Asenapine,Zimelidine,The risk or severity of adverse effects can be increased when Asenapine is combined with Zimelidine.,increase,risk
Asenapine,Ziprasidone,The risk or severity of QTc prolongation can be increased when Asenapine is combined with Ziprasidone.,increase,risk
Asenapine,Zofenopril,Asenapine may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Asenapine,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Asenapine.,increase,risk
Asenapine,Zolpidem,Asenapine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Asenapine,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Asenapine.,increase,risk
Asenapine,Zopiclone,The risk or severity of adverse effects can be increased when Asenapine is combined with Zopiclone.,increase,risk
Asenapine,Zotepine,The risk or severity of CNS depression can be increased when Asenapine is combined with Zotepine.,increase,risk
Asenapine,Zuclopenthixol,"Zuclopenthixol may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Asenapine.",increase,no risk
Asenapine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Asenapine.,increase,risk
Vernakalant,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gadobenic acid.,increase,risk
Vernakalant,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Vernakalant.,increase,risk
Vernakalant,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Vernakalant.,increase,risk
Vernakalant,Gefitinib,The metabolism of Vernakalant can be decreased when combined with Gefitinib.,decrease,no risk
Vernakalant,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gemifloxacin.,increase,risk
Vernakalant,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Vernakalant.,increase,risk
Vernakalant,Gilteritinib,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Gilteritinib.,increase,risk
Vernakalant,Givosiran,The serum concentration of Vernakalant can be increased when it is combined with Givosiran.,increase,no risk
Vernakalant,Glasdegib,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Glasdegib.,increase,risk
Vernakalant,Glycerol phenylbutyrate,The metabolism of Vernakalant can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Vernakalant,Golimumab,The metabolism of Vernakalant can be increased when combined with Golimumab.,increase,no risk
Vernakalant,Goserelin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Goserelin.,increase,risk
Vernakalant,Granisetron,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Granisetron.,increase,risk
Vernakalant,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Grepafloxacin.,increase,risk
Vernakalant,Halofantrine,The metabolism of Vernakalant can be decreased when combined with Halofantrine.,decrease,no risk
Vernakalant,Haloperidol,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Haloperidol.,increase,risk
Vernakalant,Histrelin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Histrelin.,increase,risk
Vernakalant,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Vernakalant.,increase,risk
Vernakalant,Hydroxychloroquine,The metabolism of Vernakalant can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Vernakalant,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Hydroxyzine.,increase,risk
Vernakalant,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Ketoconazole,The metabolism of Vernakalant can be decreased when combined with Ketoconazole.,decrease,no risk
Vernakalant,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Vernakalant.,increase,risk
Vernakalant,Ofloxacin,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ofloxacin.,increase,risk
Vernakalant,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Vernakalant.,increase,risk
Vernakalant,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Olodaterol,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Olodaterol.,increase,risk
Vernakalant,Ondansetron,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ondansetron.,increase,risk
Vernakalant,Opium,The metabolism of Opium can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Oritavancin,The metabolism of Vernakalant can be decreased when combined with Oritavancin.,decrease,no risk
Vernakalant,Orphenadrine,The metabolism of Vernakalant can be decreased when combined with Orphenadrine.,decrease,no risk
Vernakalant,Osilodrostat,The metabolism of Vernakalant can be decreased when combined with Osilodrostat.,decrease,no risk
Vernakalant,Ospemifene,The metabolism of Vernakalant can be decreased when combined with Ospemifene.,decrease,no risk
Vernakalant,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Vernakalant.,increase,risk
Vernakalant,Oxamniquine,The metabolism of Vernakalant can be decreased when combined with Oxamniquine.,decrease,no risk
Vernakalant,Oxatomide,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Oxatomide.,increase,risk
Vernakalant,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Oxybutynin,The metabolism of Vernakalant can be decreased when combined with Oxybutynin.,decrease,no risk
Vernakalant,Oxycodone,The metabolism of Vernakalant can be decreased when combined with Oxycodone.,decrease,no risk
Vernakalant,Oxymorphone,The metabolism of Vernakalant can be decreased when combined with Oxymorphone.,decrease,no risk
Vernakalant,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Vernakalant.,increase,risk
Vernakalant,Quetiapine,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Quetiapine.,increase,risk
Vernakalant,Quinidine,Quinidine may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Quinine,The metabolism of Vernakalant can be decreased when combined with Quinine.,decrease,no risk
Vernakalant,Quizartinib,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Quizartinib.,increase,risk
Vernakalant,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Valproic acid,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Valproic acid.,increase,risk
Vernakalant,Vandetanib,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Vandetanib.,increase,risk
Vernakalant,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Vernakalant.,increase,risk
Vernakalant,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Vernakalant.,increase,risk
Vernakalant,Venlafaxine,The metabolism of Vernakalant can be decreased when combined with Venlafaxine.,decrease,no risk
Vernakalant,Verapamil,Verapamil may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Vernakalant.,increase,risk
Vernakalant,Vilazodone,The metabolism of Vernakalant can be decreased when combined with Vilazodone.,decrease,no risk
Vernakalant,Viloxazine,The metabolism of Vernakalant can be decreased when combined with Viloxazine.,decrease,no risk
Vernakalant,Vinblastine,The metabolism of Vernakalant can be decreased when combined with Vinblastine.,decrease,no risk
Vernakalant,Vinorelbine,The metabolism of Vernakalant can be decreased when combined with Vinorelbine.,decrease,no risk
Vernakalant,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Vernakalant.,increase,risk
Vernakalant,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Vernakalant.,increase,risk
Vernakalant,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Vernakalant.,decrease,no risk
Vernakalant,Xylometazoline,Vernakalant may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Vernakalant,Yohimbine,The metabolism of Vernakalant can be decreased when combined with Yohimbine.,decrease,no risk
Vernakalant,Ziconotide,Vernakalant may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Vernakalant,Ziprasidone,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Ziprasidone.,increase,risk
Vernakalant,Zolpidem,The metabolism of Vernakalant can be decreased when combined with Zolpidem.,decrease,no risk
Vernakalant,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Vernakalant.,increase,no risk
Vernakalant,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Zuclopenthixol.,increase,risk
Lacosamide,Galantamine,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Galantamine is combined with Lacosamide.",increase,risk
Lacosamide,Gamolenic acid,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Lacosamide,Ganciclovir,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Ganciclovir.,decrease,no risk
Lacosamide,Gemfibrozil,The metabolism of Lacosamide can be decreased when combined with Gemfibrozil.,decrease,no risk
Lacosamide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Ginkgo biloba,The metabolism of Lacosamide can be decreased when combined with Ginkgo biloba.,decrease,no risk
Lacosamide,Glecaprevir,The metabolism of Lacosamide can be decreased when combined with Glecaprevir.,decrease,no risk
Lacosamide,Gliclazide,The metabolism of Lacosamide can be decreased when combined with Gliclazide.,decrease,no risk
Lacosamide,Glimepiride,The metabolism of Lacosamide can be decreased when combined with Glimepiride.,decrease,no risk
Lacosamide,Glipizide,The metabolism of Lacosamide can be decreased when combined with Glipizide.,decrease,no risk
Lacosamide,Gliquidone,The metabolism of Lacosamide can be decreased when combined with Gliquidone.,decrease,no risk
Lacosamide,Glofitamab,The serum concentration of Lacosamide can be increased when it is combined with Glofitamab.,increase,no risk
Lacosamide,Glyburide,The metabolism of Lacosamide can be decreased when combined with Glyburide.,decrease,no risk
Lacosamide,Glycerol phenylbutyrate,The metabolism of Lacosamide can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Lacosamide,Golimumab,The metabolism of Lacosamide can be increased when combined with Golimumab.,increase,no risk
Lacosamide,Grapefruit,The metabolism of Lacosamide can be decreased when combined with Grapefruit.,decrease,no risk
Lacosamide,Griseofulvin,The metabolism of Lacosamide can be increased when combined with Griseofulvin.,increase,no risk
Lacosamide,Guanfacine,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Guanfacine is combined with Lacosamide.",increase,risk
Lacosamide,Halofantrine,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Halofantrine.,decrease,no risk
Lacosamide,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Lacosamide.,increase,no risk
Lacosamide,Halothane,The metabolism of Lacosamide can be decreased when combined with Halothane.,decrease,no risk
Lacosamide,Hydralazine,The metabolism of Lacosamide can be decreased when combined with Hydralazine.,decrease,no risk
Lacosamide,Hydrocortamate,The metabolism of Lacosamide can be increased when combined with Hydrocortamate.,increase,no risk
Lacosamide,Hydrocortisone,The metabolism of Lacosamide can be increased when combined with Hydrocortisone.,increase,no risk
Lacosamide,Hydrocortisone acetate,The metabolism of Lacosamide can be increased when combined with Hydrocortisone acetate.,increase,no risk
Lacosamide,Hydrocortisone butyrate,The metabolism of Lacosamide can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Lacosamide,Hydrocortisone succinate,The metabolism of Lacosamide can be increased when combined with Hydrocortisone succinate.,increase,no risk
Lacosamide,Hydromorphone,The metabolism of Lacosamide can be decreased when combined with Hydromorphone.,decrease,no risk
Lacosamide,Hydroxychloroquine,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Lacosamide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Ketamine,The metabolism of Lacosamide can be decreased when combined with Ketamine.,decrease,no risk
Lacosamide,Ketazolam,The metabolism of Lacosamide can be decreased when combined with Ketazolam.,decrease,no risk
Lacosamide,Ketoconazole,The metabolism of Lacosamide can be decreased when combined with Ketoconazole.,decrease,no risk
Lacosamide,Ketorolac,The metabolism of Lacosamide can be decreased when combined with Ketorolac.,decrease,no risk
Lacosamide,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Lacosamide.,increase,no risk
Lacosamide,Olanzapine,The metabolism of Lacosamide can be decreased when combined with Olanzapine.,decrease,no risk
Lacosamide,Olaparib,The metabolism of Olaparib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Olutasidenib,The metabolism of Lacosamide can be increased when combined with Olutasidenib.,increase,no risk
Lacosamide,Omaveloxolone,The serum concentration of Lacosamide can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Lacosamide,Omeprazole,The metabolism of Lacosamide can be decreased when combined with Omeprazole.,decrease,no risk
Lacosamide,Ondansetron,The metabolism of Lacosamide can be decreased when combined with Ondansetron.,decrease,no risk
Lacosamide,Oritavancin,The metabolism of Lacosamide can be increased when combined with Oritavancin.,increase,no risk
Lacosamide,Orlistat,Orlistat can cause a decrease in the absorption of Lacosamide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Lacosamide,Orphenadrine,The metabolism of Lacosamide can be decreased when combined with Orphenadrine.,decrease,no risk
Lacosamide,Osilodrostat,The metabolism of Lacosamide can be decreased when combined with Osilodrostat.,decrease,no risk
Lacosamide,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Ospemifene,The metabolism of Lacosamide can be decreased when combined with Ospemifene.,decrease,no risk
Lacosamide,Oxandrolone,The metabolism of Lacosamide can be decreased when combined with Oxandrolone.,decrease,no risk
Lacosamide,Oxcarbazepine,The metabolism of Lacosamide can be increased when combined with Oxcarbazepine.,increase,no risk
Lacosamide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Lacosamide is combined with Oxetacaine.,increase,risk
Lacosamide,Oxprenolol,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Oxprenolol is combined with Lacosamide.",increase,risk
Lacosamide,Oxtriphylline,Lacosamide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Lacosamide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Lacosamide is combined with Oxybuprocaine.,increase,risk
Lacosamide,Oxybutynin,The metabolism of Lacosamide can be decreased when combined with Oxybutynin.,decrease,no risk
Lacosamide,Quinidine,The metabolism of Quinidine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Quinine,The metabolism of Lacosamide can be increased when combined with Quinine.,increase,no risk
Lacosamide,Quinupramine,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Quinupramine.,decrease,no risk
Lacosamide,Quinupristin,The metabolism of Lacosamide can be decreased when combined with Quinupristin.,decrease,no risk
Lacosamide,Ulipristal,The metabolism of Ulipristal can be increased when combined with Lacosamide.,increase,no risk
Lacosamide,Vadadustat,The serum concentration of Lacosamide can be increased when it is combined with Vadadustat.,increase,no risk
Lacosamide,Valdecoxib,The metabolism of Lacosamide can be decreased when combined with Valdecoxib.,decrease,no risk
Lacosamide,Valganciclovir,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Valganciclovir.,decrease,no risk
Lacosamide,Valproic acid,The metabolism of Lacosamide can be decreased when combined with Valproic acid.,decrease,no risk
Lacosamide,Valsartan,The metabolism of Lacosamide can be decreased when combined with Valsartan.,decrease,no risk
Lacosamide,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vardenafil,The metabolism of Lacosamide can be decreased when combined with Vardenafil.,decrease,no risk
Lacosamide,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Venlafaxine,The therapeutic efficacy of Lacosamide can be decreased when used in combination with Venlafaxine.,decrease,no risk
Lacosamide,Verapamil,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Verapamil is combined with Lacosamide.",increase,risk
Lacosamide,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Viloxazine,The metabolism of Lacosamide can be decreased when combined with Viloxazine.,decrease,no risk
Lacosamide,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vincristine,The metabolism of Vincristine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vindesine,The metabolism of Vindesine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Vitamin E,The metabolism of Lacosamide can be increased when combined with Vitamin E.,increase,no risk
Lacosamide,Vonoprazan,The metabolism of Lacosamide can be decreased when combined with Vonoprazan.,decrease,no risk
Lacosamide,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Voriconazole,The metabolism of Lacosamide can be decreased when combined with Voriconazole.,decrease,no risk
Lacosamide,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Warfarin,The metabolism of Warfarin can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Ximelagatran,The metabolism of Lacosamide can be decreased when combined with Ximelagatran.,decrease,no risk
Lacosamide,Zafirlukast,The metabolism of Lacosamide can be decreased when combined with Zafirlukast.,decrease,no risk
Lacosamide,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Lacosamide.,decrease,no risk
Lacosamide,Ziconotide,The risk or severity of CNS depression can be increased when Lacosamide is combined with Ziconotide.,increase,risk
Lacosamide,Zidovudine,The metabolism of Lacosamide can be decreased when combined with Zidovudine.,decrease,no risk
Lacosamide,Zileuton,The metabolism of Lacosamide can be decreased when combined with Zileuton.,decrease,no risk
Lacosamide,Zimelidine,The metabolism of Lacosamide can be decreased when combined with Zimelidine.,decrease,no risk
Lacosamide,Ziprasidone,The metabolism of Lacosamide can be decreased when combined with Ziprasidone.,decrease,no risk
Lacosamide,Zolpidem,The metabolism of Lacosamide can be decreased when combined with Zolpidem.,decrease,no risk
Lacosamide,Zonisamide,"The risk or severity of ventricular arrhythmias, bradycardia, and heart block can be increased when Zonisamide is combined with Lacosamide.",increase,risk
Lacosamide,Zopiclone,The metabolism of Lacosamide can be decreased when combined with Zopiclone.,decrease,no risk
Lacosamide,Zuclopenthixol,The metabolism of Lacosamide can be decreased when combined with Zuclopenthixol.,decrease,no risk
Dalbavancin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Dalbavancin.,decrease,no risk
Dalbavancin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Benzocaine.,increase,risk
Dalbavancin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Benzyl alcohol.,increase,risk
Dalbavancin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Bupivacaine.,increase,risk
Dalbavancin,Butacaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Butacaine.,increase,risk
Dalbavancin,Butamben,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Butamben.,increase,risk
Dalbavancin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Oxetacaine.,increase,risk
Dalbavancin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Dalbavancin is combined with Oxybuprocaine.,increase,risk
Dalbavancin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Dalbavancin.,decrease,no risk
Dalbavancin,Warfarin,The risk or severity of bleeding can be increased when Dalbavancin is combined with Warfarin.,increase,risk
Rivaroxaban,Belinostat,The serum concentration of Rivaroxaban can be increased when it is combined with Belinostat.,increase,no risk
Rivaroxaban,Belumosudil,Belumosudil may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bemiparin,Bemiparin may increase the anticoagulant activities of Rivaroxaban.,increase,no risk
Rivaroxaban,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Bendroflumethiazide,Bendroflumethiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rivaroxaban,Benorilate,The risk or severity of bleeding and hemorrhage can be increased when Benorilate is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Benoxaprofen,The risk or severity of bleeding and hemorrhage can be increased when Benoxaprofen is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Benserazide,Rivaroxaban may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Benzatropine,Benzatropine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Benznidazole,Rivaroxaban may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Benzthiazide,Benzthiazide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rivaroxaban,Benzydamine,The risk or severity of bleeding and hemorrhage can be increased when Benzydamine is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Bepotastine,Bepotastine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Beroctocog alfa,The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Rivaroxaban.,decrease,no risk
Rivaroxaban,Berotralstat,The metabolism of Rivaroxaban can be decreased when combined with Berotralstat.,decrease,no risk
Rivaroxaban,Betamethasone,The metabolism of Rivaroxaban can be increased when combined with Betamethasone.,increase,no risk
Rivaroxaban,Betamethasone phosphate,The metabolism of Rivaroxaban can be increased when combined with Betamethasone phosphate.,increase,no risk
Rivaroxaban,Betrixaban,Betrixaban may increase the anticoagulant activities of Rivaroxaban.,increase,no risk
Rivaroxaban,Bexarotene,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Bexarotene.,increase,risk
Rivaroxaban,Bicisate,Rivaroxaban may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bimekizumab,The metabolism of Rivaroxaban can be increased when combined with Bimekizumab.,increase,no risk
Rivaroxaban,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Bismuth subgallate,Rivaroxaban may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Bisoprolol,The serum concentration of Rivaroxaban can be increased when it is combined with Bisoprolol.,increase,no risk
Rivaroxaban,Bisoxatin,Rivaroxaban may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bivalirudin,Bivalirudin may increase the anticoagulant activities of Rivaroxaban.,increase,no risk
Rivaroxaban,Bleomycin,Bleomycin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Blinatumomab,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Blinatumomab.,increase,risk
Rivaroxaban,Boceprevir,The metabolism of Rivaroxaban can be decreased when combined with Boceprevir.,decrease,no risk
Rivaroxaban,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Rivaroxaban.,increase,no risk
Rivaroxaban,Brigatinib,Brigatinib may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Brivaracetam,Brivaracetam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bromazepam,Bromazepam may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bromotheophylline,Bromotheophylline may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rivaroxaban,Budesonide,The metabolism of Rivaroxaban can be increased when combined with Budesonide.,increase,no risk
Rivaroxaban,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Rivaroxaban.,increase,risk
Rivaroxaban,Bumetanide,Bumetanide may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Rivaroxaban,Buprenorphine,Buprenorphine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Bupropion,Bupropion may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Buspirone,Buspirone may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Rivaroxaban,Busulfan,The risk or severity of bleeding can be increased when Rivaroxaban is combined with Busulfan.,increase,risk
Rivaroxaban,Butabarbital,Butabarbital may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.,decrease,no risk
Nalmefene,Gabapentin enacarbil,Nalmefene may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadodiamide,Gadodiamide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadofosveset trisodium,Nalmefene may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadoteric acid,Nalmefene may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Nalmefene,Gadoteridol,Gadoteridol may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Ganciclovir,Ganciclovir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gemcitabine,Gemcitabine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Gentamicin,Nalmefene may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Nalmefene,Gimeracil,Nalmefene may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Nalmefene,Givosiran,Givosiran may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Glipizide,Glipizide may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Glycerol phenylbutyrate,Nalmefene may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Nalmefene,Golodirsen,Nalmefene may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Nalmefene,Goserelin,Goserelin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Guanethidine,Guanethidine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Guanfacine,Guanfacine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Haloperidol,Haloperidol may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Hydralazine,Hydralazine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nalmefene,Hydrocodone,The therapeutic efficacy of Hydrocodone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nalmefene,Hydromorphone,The therapeutic efficacy of Hydromorphone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Hydroxyethyl Starch,Nalmefene may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Nalmefene,Kanamycin,Nalmefene may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Nalmefene,Ketamine,Ketamine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Ketazolam,Ketazolam may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Ketoconazole,The metabolism of Nalmefene can be decreased when combined with Ketoconazole.,decrease,no risk
Nalmefene,Ketoprofen,Ketoprofen may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Ketorolac,Ketorolac may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Octinoxate,Nalmefene may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Nalmefene,Oliceridine,The therapeutic efficacy of Oliceridine can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Olsalazine,Olsalazine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Opium,The therapeutic efficacy of Opium can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Oseltamivir,Oseltamivir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxacillin,Oxacillin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxaprozin,Oxaprozin may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxazepam,Oxazepam may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxybenzone,Oxybenzone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxycodone,The therapeutic efficacy of Oxycodone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Oxymorphone,The therapeutic efficacy of Oxymorphone can be decreased when used in combination with Nalmefene.,decrease,no risk
Nalmefene,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Oxyquinoline,Nalmefene may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Nalmefene,Quetiapine,Quetiapine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Quinethazone,Quinethazone may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Nalmefene,Quinidine,Nalmefene may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Nalmefene,Vaborbactam,Nalmefene may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Nalmefene,Valaciclovir,Valaciclovir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Valbenazine,Nalmefene may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Nalmefene,Valdecoxib,Valdecoxib may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Valganciclovir,Valganciclovir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Vancomycin,Nalmefene may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Nalmefene,Varenicline,Varenicline may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Venlafaxine,Venlafaxine may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Verapamil,Verapamil may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Vilanterol,Nalmefene may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Nalmefene,Viloxazine,Nalmefene may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Nalmefene,Vortioxetine,Nalmefene may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Nalmefene,Warfarin,Nalmefene may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Nalmefene,Zaleplon,Zaleplon may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Zanamivir,Zanamivir may decrease the excretion rate of Nalmefene which could result in a higher serum level.,decrease,no risk
Nalmefene,Zonisamide,Zonisamide may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Ridaforolimus,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ridaforolimus is combined with Oxetacaine.,increase,risk
Ridaforolimus,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ridaforolimus is combined with Oxybuprocaine.,increase,risk
Ridaforolimus,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Quinine,The serum concentration of Quinine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ridaforolimus.,decrease,no risk
Ridaforolimus,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Ridaforolimus.,increase,no risk
Ridaforolimus,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Ridaforolimus.,decrease,no risk
Ridaforolimus,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Ridaforolimus.,decrease,no risk
Maribavir,Ganciclovir,The therapeutic efficacy of Ganciclovir can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Gefitinib,Maribavir may decrease the excretion rate of Gefitinib which could result in a higher serum level.,decrease,no risk
Maribavir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Glasdegib,Maribavir may decrease the excretion rate of Glasdegib which could result in a higher serum level.,decrease,no risk
Maribavir,Glecaprevir,Maribavir may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Maribavir,Glofitamab,The serum concentration of Maribavir can be increased when it is combined with Glofitamab.,increase,no risk
Maribavir,Glyburide,Maribavir may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Maribavir,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Ketoconazole,The metabolism of Maribavir can be decreased when combined with Ketoconazole.,decrease,no risk
Maribavir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Omaveloxolone,The serum concentration of Maribavir can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Maribavir,Ombitasvir,Maribavir may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Maribavir,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Oxaliplatin,Maribavir may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Maribavir,Ozanimod,Maribavir may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Maribavir,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Quinine,The serum concentration of Quinine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Vadadustat,The serum concentration of Maribavir can be increased when it is combined with Vadadustat.,increase,no risk
Maribavir,Valganciclovir,The therapeutic efficacy of Valganciclovir can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Velpatasvir,Maribavir may decrease the excretion rate of Velpatasvir which could result in a higher serum level.,decrease,no risk
Maribavir,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Verapamil,The metabolism of Maribavir can be decreased when combined with Verapamil.,decrease,no risk
Maribavir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Maribavir.,decrease,no risk
Maribavir,Viloxazine,The metabolism of Maribavir can be decreased when combined with Viloxazine.,decrease,no risk
Maribavir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Vincristine,The excretion of Vincristine can be decreased when combined with Maribavir.,decrease,no risk
Maribavir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Maribavir.,increase,no risk
Maribavir,Voriconazole,The metabolism of Maribavir can be decreased when combined with Voriconazole.,decrease,no risk
Maribavir,Voxilaprevir,Maribavir may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.,decrease,no risk
Vadimezan,Gatifloxacin,The metabolism of Vadimezan can be decreased when combined with Gatifloxacin.,decrease,no risk
Vadimezan,Gemfibrozil,The metabolism of Vadimezan can be decreased when combined with Gemfibrozil.,decrease,no risk
Vadimezan,Gemifloxacin,The metabolism of Vadimezan can be decreased when combined with Gemifloxacin.,decrease,no risk
Vadimezan,Givosiran,The serum concentration of Vadimezan can be increased when it is combined with Givosiran.,increase,no risk
Vadimezan,Glofitamab,The serum concentration of Vadimezan can be increased when it is combined with Glofitamab.,increase,no risk
Vadimezan,Golimumab,The metabolism of Vadimezan can be increased when combined with Golimumab.,increase,no risk
Vadimezan,Grepafloxacin,The metabolism of Vadimezan can be decreased when combined with Grepafloxacin.,decrease,no risk
Vadimezan,Guanabenz,The metabolism of Vadimezan can be decreased when combined with Guanabenz.,decrease,no risk
Vadimezan,Haloperidol,The metabolism of Vadimezan can be decreased when combined with Haloperidol.,decrease,no risk
Vadimezan,Ketoconazole,The metabolism of Vadimezan can be decreased when combined with Ketoconazole.,decrease,no risk
Vadimezan,Obeticholic acid,The metabolism of Vadimezan can be decreased when combined with Obeticholic acid.,decrease,no risk
Vadimezan,Olanzapine,The metabolism of Vadimezan can be decreased when combined with Olanzapine.,decrease,no risk
Vadimezan,Ondansetron,The metabolism of Vadimezan can be decreased when combined with Ondansetron.,decrease,no risk
Vadimezan,Orphenadrine,The metabolism of Vadimezan can be decreased when combined with Orphenadrine.,decrease,no risk
Vadimezan,Osilodrostat,The metabolism of Vadimezan can be decreased when combined with Osilodrostat.,decrease,no risk
Vadimezan,Osimertinib,The serum concentration of Vadimezan can be decreased when it is combined with Osimertinib.,decrease,no risk
Vadimezan,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Vadimezan is combined with Oxetacaine.,increase,risk
Vadimezan,Oxtriphylline,The metabolism of Vadimezan can be decreased when combined with Oxtriphylline.,decrease,no risk
Vadimezan,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Vadimezan is combined with Oxybuprocaine.,increase,risk
Vadimezan,Quinidine,The metabolism of Vadimezan can be decreased when combined with Quinidine.,decrease,no risk
Vadimezan,Quinine,The metabolism of Vadimezan can be decreased when combined with Quinine.,decrease,no risk
Vadimezan,Valproic acid,The metabolism of Vadimezan can be decreased when combined with Valproic acid.,decrease,no risk
Vadimezan,Vemurafenib,The serum concentration of Vadimezan can be increased when it is combined with Vemurafenib.,increase,no risk
Vadimezan,Verapamil,The metabolism of Vadimezan can be decreased when combined with Verapamil.,decrease,no risk
Vadimezan,Viloxazine,The metabolism of Vadimezan can be decreased when combined with Viloxazine.,decrease,no risk
Vadimezan,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Vadimezan.,decrease,no risk
Vadimezan,Warfarin,The metabolism of Vadimezan can be decreased when combined with Warfarin.,decrease,no risk
Vadimezan,Zileuton,The metabolism of Vadimezan can be decreased when combined with Zileuton.,decrease,no risk
Vadimezan,Zolmitriptan,The metabolism of Vadimezan can be decreased when combined with Zolmitriptan.,decrease,no risk
Vadimezan,Zolpidem,The metabolism of Vadimezan can be decreased when combined with Zolpidem.,decrease,no risk
Vadimezan,Zotepine,The metabolism of Zotepine can be decreased when combined with Vadimezan.,decrease,no risk
Elvucitabine,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Elvucitabine.,decrease,no risk
Elvucitabine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Elvucitabine.,decrease,no risk
Avanafil,Bioallethrin,The serum concentration of Avanafil can be increased when it is combined with Bioallethrin.,increase,no risk
Avanafil,Bisoprolol,The serum concentration of Avanafil can be increased when it is combined with Bisoprolol.,increase,no risk
Avanafil,Boceprevir,The metabolism of Avanafil can be decreased when combined with Boceprevir.,decrease,no risk
Avanafil,Bortezomib,The serum concentration of Avanafil can be increased when it is combined with Bortezomib.,increase,no risk
Avanafil,Bosentan,The serum concentration of Avanafil can be increased when it is combined with Bosentan.,increase,no risk
Avanafil,Bosutinib,The serum concentration of Avanafil can be increased when it is combined with Bosutinib.,increase,no risk
Avanafil,Brentuximab vedotin,The serum concentration of Avanafil can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Avanafil,Bretylium,Bretylium may increase the hypotensive activities of Avanafil.,increase,no risk
Avanafil,Brexpiprazole,Brexpiprazole may increase the hypotensive activities of Avanafil.,increase,no risk
Avanafil,Brigatinib,The serum concentration of Avanafil can be increased when it is combined with Brigatinib.,increase,no risk
Avanafil,Brimonidine,The risk or severity of hypotension can be increased when Avanafil is combined with Brimonidine.,increase,risk
Avanafil,Brinzolamide,The serum concentration of Avanafil can be increased when it is combined with Brinzolamide.,increase,no risk
Avanafil,Brivaracetam,The serum concentration of Avanafil can be increased when it is combined with Brivaracetam.,increase,no risk
Avanafil,Bromocriptine,Bromocriptine may increase the hypotensive activities of Avanafil.,increase,no risk
Avanafil,Budesonide,The serum concentration of Avanafil can be increased when it is combined with Budesonide.,increase,no risk
Avanafil,Bumetanide,The risk or severity of hypotension can be increased when Avanafil is combined with Bumetanide.,increase,risk
Avanafil,Bupivacaine,The serum concentration of Avanafil can be increased when it is combined with Bupivacaine.,increase,no risk
Avanafil,Buprenorphine,The serum concentration of Avanafil can be increased when it is combined with Buprenorphine.,increase,no risk
Avanafil,Bupropion,The metabolism of Avanafil can be decreased when combined with Bupropion.,decrease,no risk
Avanafil,Buspirone,The serum concentration of Avanafil can be increased when it is combined with Buspirone.,increase,no risk
Avanafil,Busulfan,The serum concentration of Avanafil can be increased when it is combined with Busulfan.,increase,no risk
Tariquidar,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Verapamil,The serum concentration of Verapamil can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Vincristine,The excretion of Vincristine can be decreased when combined with Tariquidar.,decrease,no risk
Tariquidar,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Tariquidar.,increase,no risk
Tariquidar,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Tariquidar.,increase,no risk
Clenoliximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Clenoliximab.,increase,risk
Clenoliximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Obinutuzumab.,increase,risk
Clenoliximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Ocrelizumab.,increase,risk
Clenoliximab,Odesivimab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Odesivimab.,increase,risk
Clenoliximab,Ofatumumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Ofatumumab.,increase,risk
Clenoliximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Clenoliximab.,increase,risk
Clenoliximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Clenoliximab.,increase,risk
Clenoliximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Clenoliximab.,increase,no risk
Clenoliximab,Ublituximab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Ublituximab.,increase,risk
Clenoliximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Clenoliximab.,increase,risk
Clenoliximab,Vedolizumab,The risk or severity of adverse effects can be increased when Clenoliximab is combined with Vedolizumab.,increase,risk
Eflornithine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Benzocaine.,increase,risk
Eflornithine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Benzyl alcohol.,increase,risk
Eflornithine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Bupivacaine.,increase,risk
Eflornithine,Butacaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Butacaine.,increase,risk
Eflornithine,Butamben,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Butamben.,increase,risk
Eflornithine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Oxetacaine.,increase,risk
Eflornithine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Eflornithine is combined with Oxybuprocaine.,increase,risk
Lanoteplase,Benazepril,The risk or severity of angioedema can be increased when Benazepril is combined with Lanoteplase.,increase,risk
Lanoteplase,Hydrogen peroxide,The therapeutic efficacy of Hydrogen peroxide can be decreased when used in combination with Lanoteplase.,decrease,no risk
Lanoteplase,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Lanoteplase.,increase,risk
Lanoteplase,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Lanoteplase.,increase,risk
Lanoteplase,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Lanoteplase.,increase,risk
Lanoteplase,Vildagliptin,The risk or severity of angioedema can be increased when Vildagliptin is combined with Lanoteplase.,increase,risk
Lanoteplase,Zofenopril,The risk or severity of angioedema can be increased when Lanoteplase is combined with Zofenopril.,increase,risk
Exisulind,Benzocaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Benzocaine.,increase,risk
Exisulind,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Benzyl alcohol.,increase,risk
Exisulind,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Bupivacaine.,increase,risk
Exisulind,Butacaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Butacaine.,increase,risk
Exisulind,Butamben,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Butamben.,increase,risk
Exisulind,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Oxetacaine.,increase,risk
Exisulind,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Exisulind is combined with Oxybuprocaine.,increase,risk
Fluasterone,Beclomethasone dipropionate,The risk or severity of edema formation can be increased when Fluasterone is combined with Beclomethasone dipropionate.,increase,risk
Fluasterone,Betamethasone,The risk or severity of edema formation can be increased when Fluasterone is combined with Betamethasone.,increase,risk
Fluasterone,Betamethasone phosphate,The risk or severity of edema formation can be increased when Fluasterone is combined with Betamethasone phosphate.,increase,risk
Fluasterone,Budesonide,The risk or severity of edema formation can be increased when Fluasterone is combined with Budesonide.,increase,risk
Fluasterone,Hydrocortisone,The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone.,increase,risk
Fluasterone,Hydrocortisone acetate,The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone acetate.,increase,risk
Fluasterone,Hydrocortisone butyrate,The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone butyrate.,increase,risk
Fluasterone,Hydrocortisone cypionate,The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone cypionate.,increase,risk
Fluasterone,Hydrocortisone succinate,The risk or severity of edema formation can be increased when Fluasterone is combined with Hydrocortisone succinate.,increase,risk
Dersalazine,Gliclazide,Dersalazine may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Dersalazine,Glimepiride,Dersalazine may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Dersalazine,Glipizide,Dersalazine may increase the hypoglycemic activities of Glipizide.,increase,no risk
Dersalazine,Gliquidone,Dersalazine may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Dersalazine,Glyburide,Dersalazine may increase the hypoglycemic activities of Glyburide.,increase,no risk
Dersalazine,Glymidine,Dersalazine may increase the hypoglycemic activities of Glymidine.,increase,no risk
Dersalazine,Heparin,The risk or severity of bleeding can be increased when Dersalazine is combined with Heparin.,increase,risk
Dersalazine,Hyaluronidase,The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Dersalazine.,decrease,no risk
Dersalazine,Hyaluronidase (human recombinant),The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Dersalazine.,decrease,no risk
Dersalazine,Hyaluronidase (ovine),The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Dersalazine.,decrease,no risk
Dersalazine,Hydrocortisone,The serum concentration of Dersalazine can be decreased when it is combined with Hydrocortisone.,decrease,no risk
Dersalazine,Ketoprofen,The risk or severity of bleeding and gastrointestinal bleeding can be increased when Dersalazine is combined with Ketoprofen.,increase,risk
Dersalazine,Ketorolac,The therapeutic efficacy of Dersalazine can be decreased when used in combination with Ketorolac.,decrease,no risk
Dersalazine,Olsalazine,"The risk or severity of bleeding, nephrotoxicity, and gastrointestinal bleeding can be increased when Olsalazine is combined with Dersalazine.",increase,risk
Dersalazine,Ouabain,The serum concentration of Ouabain can be decreased when it is combined with Dersalazine.,decrease,no risk
Dersalazine,Oxaprozin,The therapeutic efficacy of Dersalazine can be decreased when used in combination with Oxaprozin.,decrease,no risk
Dersalazine,Quinapril,The risk or severity of renal failure can be increased when Dersalazine is combined with Quinapril.,increase,risk
Dersalazine,Quinine,Dersalazine may increase the hypoglycemic activities of Quinine.,increase,no risk
Dersalazine,Urokinase,The risk or severity of bleeding can be increased when Dersalazine is combined with Urokinase.,increase,risk
Dersalazine,Valproic acid,The serum concentration of Valproic acid can be increased when it is combined with Dersalazine.,increase,no risk
Dersalazine,Varicella zoster vaccine (live/attenuated),The risk or severity of adverse effects can be increased when Dersalazine is combined with Varicella zoster vaccine (live/attenuated).,increase,risk
Dersalazine,Verapamil,The risk or severity of bleeding can be increased when Verapamil is combined with Dersalazine.,increase,risk
Dersalazine,Vildagliptin,Dersalazine may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Dersalazine,Vorapaxar,The risk or severity of bleeding can be increased when Dersalazine is combined with Vorapaxar.,increase,risk
Dersalazine,Warfarin,Dersalazine may increase the anticoagulant activities of Warfarin.,increase,no risk
Dersalazine,Ximelagatran,The risk or severity of bleeding can be increased when Dersalazine is combined with Ximelagatran.,increase,risk
Dersalazine,Zofenopril,The risk or severity of renal failure can be increased when Dersalazine is combined with Zofenopril.,increase,risk
Dersalazine,Zonisamide,The risk or severity of adverse effects can be increased when Dersalazine is combined with Zonisamide.,increase,risk
Incadronic acid,Gentamicin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Gentamicin is combined with Incadronic acid.,increase,risk
Incadronic acid,Givosiran,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Givosiran is combined with Incadronic acid.,increase,risk
Incadronic acid,Glycol salicylate,The risk or severity of gastrointestinal bleeding can be increased when Glycol salicylate is combined with Incadronic acid.,increase,risk
Incadronic acid,Human calcitonin,The risk or severity of hypocalcemia can be increased when Human calcitonin is combined with Incadronic acid.,increase,risk
Incadronic acid,Hydrochlorothiazide,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Hydrochlorothiazide is combined with Incadronic acid.,increase,risk
Incadronic acid,Hydrotalcite,The serum concentration of Incadronic acid can be decreased when it is combined with Hydrotalcite.,decrease,no risk
Incadronic acid,Kanamycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Kanamycin is combined with Incadronic acid.,increase,risk
Incadronic acid,Ketoprofen,The risk or severity of gastrointestinal bleeding can be increased when Ketoprofen is combined with Incadronic acid.,increase,risk
Incadronic acid,Ketorolac,The risk or severity of gastrointestinal bleeding can be increased when Ketorolac is combined with Incadronic acid.,increase,risk
Incadronic acid,Olsalazine,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Olsalazine is combined with Incadronic acid.,increase,risk
Incadronic acid,Omeprazole,The therapeutic efficacy of Incadronic acid can be decreased when used in combination with Omeprazole.,decrease,no risk
Incadronic acid,Oxaprozin,The risk or severity of gastrointestinal bleeding can be increased when Oxaprozin is combined with Incadronic acid.,increase,risk
Incadronic acid,Oxyphenbutazone,The risk or severity of gastrointestinal bleeding can be increased when Oxyphenbutazone is combined with Incadronic acid.,increase,risk
Incadronic acid,Valaciclovir,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Valaciclovir is combined with Incadronic acid.,increase,risk
Incadronic acid,Valdecoxib,The risk or severity of gastrointestinal bleeding can be increased when Valdecoxib is combined with Incadronic acid.,increase,risk
Incadronic acid,Vancomycin,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Vancomycin is combined with Incadronic acid.,increase,risk
Incadronic acid,Zoledronic acid,The risk or severity of adverse effects can be increased when Zoledronic acid is combined with Incadronic acid.,increase,risk
Hexaminolevulinate,BCG vaccine,BCG vaccine may decrease effectiveness of Hexaminolevulinate as a diagnostic agent.,decrease,no risk
Hexaminolevulinate,Verteporfin,Hexaminolevulinate may increase the photosensitizing activities of Verteporfin.,increase,no risk
Droxidopa,Bisoxatin,Droxidopa may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Droxidopa,Bleomycin,Bleomycin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Bosentan,Droxidopa may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Droxidopa,Bretylium,Droxidopa may decrease the antihypertensive activities of Bretylium.,decrease,no risk
Droxidopa,Brexpiprazole,Brexpiprazole may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Brivaracetam,Brivaracetam may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Bromazepam,Bromazepam may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Droxidopa.,increase,no risk
Droxidopa,Bromotheophylline,Bromotheophylline may increase the excretion rate of Droxidopa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Droxidopa,Brompheniramine,The therapeutic efficacy of Droxidopa can be increased when used in combination with Brompheniramine.,increase,no risk
Droxidopa,Buclizine,The therapeutic efficacy of Droxidopa can be increased when used in combination with Buclizine.,increase,no risk
Droxidopa,Budesonide,The risk or severity of hypokalemia can be increased when Budesonide is combined with Droxidopa.,increase,risk
Droxidopa,Bumadizone,The risk or severity of hypertension can be increased when Droxidopa is combined with Bumadizone.,increase,risk
Droxidopa,Bumetanide,The risk or severity of hypokalemia can be increased when Droxidopa is combined with Bumetanide.,increase,risk
Droxidopa,Bupropion,Bupropion may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Droxidopa.,increase,risk
Droxidopa,Butabarbital,Butabarbital may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Butriptyline,Butriptyline may increase the vasopressor activities of Droxidopa.,increase,no risk
Droxidopa,Butylscopolamine,The risk or severity of Tachycardia can be increased when Droxidopa is combined with Butylscopolamine.,increase,risk
Droxidopa,Gabapentin enacarbil,Droxidopa may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadodiamide,Gadodiamide may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadofosveset trisodium,Droxidopa may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadoteric acid,Droxidopa may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Droxidopa,Gadoteridol,Gadoteridol may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Droxidopa.,increase,risk
Droxidopa,Ganciclovir,Ganciclovir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gemcitabine,Gemcitabine may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Gentamicin,Droxidopa may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Droxidopa,Gimeracil,Droxidopa may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Droxidopa,Givosiran,Givosiran may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Glipizide,Glipizide may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Glycerol phenylbutyrate,Droxidopa may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Droxidopa,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Droxidopa.,increase,risk
Droxidopa,Golodirsen,Droxidopa may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Droxidopa,Goserelin,Goserelin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Guanabenz,Droxidopa may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Droxidopa,Guanadrel,Droxidopa may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Droxidopa,Guanethidine,Droxidopa may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Droxidopa,Guanfacine,Droxidopa may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Droxidopa,Guanoxan,Droxidopa may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Droxidopa,Haloperidol,Haloperidol may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Droxidopa.,increase,risk
Droxidopa,Hexocyclium,The risk or severity of Tachycardia can be increased when Droxidopa is combined with Hexocyclium.,increase,risk
Droxidopa,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Droxidopa.,increase,risk
Droxidopa,Hydralazine,Droxidopa may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Droxidopa,Hydrochlorothiazide,The risk or severity of hypokalemia can be increased when Droxidopa is combined with Hydrochlorothiazide.,increase,risk
Droxidopa,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Droxidopa.,increase,risk
Droxidopa,Hydrocortisone acetate,The risk or severity of hypokalemia can be increased when Hydrocortisone acetate is combined with Droxidopa.,increase,risk
Droxidopa,Hydrocortisone butyrate,The risk or severity of hypokalemia can be increased when Hydrocortisone butyrate is combined with Droxidopa.,increase,risk
Droxidopa,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Droxidopa.,increase,risk
Droxidopa,Hydrocortisone succinate,The risk or severity of hypokalemia can be increased when Hydrocortisone succinate is combined with Droxidopa.,increase,risk
Droxidopa,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Droxidopa is combined with Hydroflumethiazide.,increase,risk
Droxidopa,Hydromorphone,Hydromorphone may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Hydroxyethyl Starch,Droxidopa may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Droxidopa,Hyoscyamine,The risk or severity of Tachycardia can be increased when Hyoscyamine is combined with Droxidopa.,increase,risk
Droxidopa,Kanamycin,Droxidopa may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Droxidopa,Ketamine,Ketamine may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Ketazolam,Ketazolam may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Droxidopa.,increase,risk
Droxidopa,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Droxidopa.,increase,risk
Droxidopa,Ketotifen,The therapeutic efficacy of Droxidopa can be increased when used in combination with Ketotifen.,increase,no risk
Droxidopa,Octinoxate,Droxidopa may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Droxidopa,Olanzapine,The therapeutic efficacy of Droxidopa can be decreased when used in combination with Olanzapine.,decrease,no risk
Droxidopa,Olmesartan,Droxidopa may decrease the antihypertensive activities of Olmesartan.,decrease,no risk
Droxidopa,Olodaterol,The risk or severity of adverse effects can be increased when Droxidopa is combined with Olodaterol.,increase,risk
Droxidopa,Olsalazine,Olsalazine may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Opium,Droxidopa may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Droxidopa,Orciprenaline,The therapeutic efficacy of Orciprenaline can be increased when used in combination with Droxidopa.,increase,no risk
Droxidopa,Orphenadrine,The risk or severity of Tachycardia can be increased when Orphenadrine is combined with Droxidopa.,increase,risk
Droxidopa,Oseltamivir,Oseltamivir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Ouabain,The risk or severity of Cardiac Arrhythmia can be increased when Droxidopa is combined with Ouabain.,increase,risk
Droxidopa,Oxacillin,Oxacillin may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Oxaprozin,The risk or severity of hypertension can be increased when Oxaprozin is combined with Droxidopa.,increase,risk
Droxidopa,Oxatomide,The therapeutic efficacy of Droxidopa can be increased when used in combination with Oxatomide.,increase,no risk
Droxidopa,Oxazepam,Oxazepam may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Oxprenolol,Oxprenolol may decrease the bronchodilatory activities of Droxidopa.,decrease,no risk
Droxidopa,Oxtriphylline,The risk or severity of hypokalemia can be increased when Oxtriphylline is combined with Droxidopa.,increase,risk
Droxidopa,Oxybenzone,Oxybenzone may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Oxybutynin,The risk or severity of Tachycardia can be increased when Oxybutynin is combined with Droxidopa.,increase,risk
Droxidopa,Oxymetazoline,Droxidopa may increase the hypertensive and vasoconstricting activities of Oxymetazoline.,increase,no risk
Droxidopa,Oxyphenbutazone,The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Droxidopa.,increase,risk
Droxidopa,Oxyphencyclimine,The risk or severity of Tachycardia can be increased when Oxyphencyclimine is combined with Droxidopa.,increase,risk
Droxidopa,Oxyphenonium,The risk or severity of Tachycardia can be increased when Oxyphenonium is combined with Droxidopa.,increase,risk
Droxidopa,Oxyquinoline,Droxidopa may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Droxidopa,Quetiapine,The therapeutic efficacy of Droxidopa can be decreased when used in combination with Quetiapine.,decrease,no risk
Droxidopa,Quinapril,Droxidopa may decrease the antihypertensive activities of Quinapril.,decrease,no risk
Droxidopa,Quinethazone,Quinethazone may increase the excretion rate of Droxidopa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Droxidopa,Quinidine,Droxidopa may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Droxidopa,Quinupramine,Quinupramine may increase the vasopressor activities of Droxidopa.,increase,no risk
Droxidopa,Umeclidinium,The risk or severity of Tachycardia can be increased when Droxidopa is combined with Umeclidinium.,increase,risk
Droxidopa,Vaborbactam,Droxidopa may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Droxidopa,Valaciclovir,Valaciclovir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Valbenazine,Droxidopa may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Droxidopa,Valdecoxib,The risk or severity of hypertension can be increased when Valdecoxib is combined with Droxidopa.,increase,risk
Droxidopa,Valganciclovir,Valganciclovir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Valsartan,Droxidopa may decrease the antihypertensive activities of Valsartan.,decrease,no risk
Droxidopa,Vamorolone,The risk or severity of hypokalemia can be increased when Vamorolone is combined with Droxidopa.,increase,risk
Droxidopa,Vancomycin,Droxidopa may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Droxidopa,Varenicline,Varenicline may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Vasopressin,Vasopressin may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Venlafaxine,Venlafaxine may increase the tachycardic activities of Droxidopa.,increase,no risk
Droxidopa,Verapamil,Verapamil may decrease the hypertensive activities of Droxidopa.,decrease,no risk
Droxidopa,Vilanterol,The risk or severity of adverse effects can be increased when Droxidopa is combined with Vilanterol.,increase,risk
Droxidopa,Vilazodone,Vilazodone may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Viloxazine,Droxidopa may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Droxidopa,Vortioxetine,Vortioxetine may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Warfarin,Droxidopa may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Droxidopa,Xamoterol,The risk or severity of hypertension can be increased when Droxidopa is combined with Xamoterol.,increase,risk
Droxidopa,Xylometazoline,The risk or severity of hypertension can be increased when Droxidopa is combined with Xylometazoline.,increase,risk
Droxidopa,Yohimbine,Yohimbine may decrease the hypertensive activities of Droxidopa.,decrease,no risk
Droxidopa,Zaleplon,Zaleplon may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Zanamivir,Zanamivir may decrease the excretion rate of Droxidopa which could result in a higher serum level.,decrease,no risk
Droxidopa,Ziprasidone,Ziprasidone may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Zofenopril,Droxidopa may decrease the antihypertensive activities of Zofenopril.,decrease,no risk
Droxidopa,Zolmitriptan,Zolmitriptan may increase the hypertensive activities of Droxidopa.,increase,no risk
Droxidopa,Zonisamide,Zonisamide may increase the excretion rate of Droxidopa which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Amrubicin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Benzocaine.,increase,risk
Amrubicin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Benzyl alcohol.,increase,risk
Amrubicin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Bupivacaine.,increase,risk
Amrubicin,Butacaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Butacaine.,increase,risk
Amrubicin,Butamben,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Butamben.,increase,risk
Amrubicin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Oxetacaine.,increase,risk
Amrubicin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Amrubicin is combined with Oxybuprocaine.,increase,risk
Tolperisone,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Tolperisone.,increase,risk
Tolperisone,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Tolperisone is combined with Gabapentin enacarbil.,increase,risk
Tolperisone,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tolperisone.,increase,risk
Tolperisone,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tolperisone is combined with Ganaxolone.",increase,risk
Tolperisone,Gepirone,The risk or severity of CNS depression can be increased when Tolperisone is combined with Gepirone.,increase,risk
Tolperisone,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Tolperisone.,increase,risk
Tolperisone,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Tolperisone.,increase,risk
Tolperisone,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Tolperisone.,increase,risk
Tolperisone,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tolperisone.,increase,risk
Tolperisone,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tolperisone.,increase,risk
Tolperisone,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Tolperisone.,increase,risk
Tolperisone,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Tolperisone.,increase,risk
Tolperisone,Hydrocodone,Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tolperisone,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tolperisone.,increase,risk
Tolperisone,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tolperisone.,increase,no risk
Tolperisone,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Tolperisone.,increase,risk
Tolperisone,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Tolperisone.,increase,risk
Tolperisone,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Tolperisone.,increase,risk
Tolperisone,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tolperisone is combined with Oliceridine.",increase,risk
Tolperisone,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Tolperisone.,increase,risk
Tolperisone,Opium,The risk or severity of CNS depression can be increased when Tolperisone is combined with Opium.,increase,risk
Tolperisone,Orphenadrine,Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tolperisone,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Tolperisone.,increase,risk
Tolperisone,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Tolperisone.,increase,risk
Tolperisone,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Tolperisone.,increase,risk
Tolperisone,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Tolperisone.,increase,risk
Tolperisone,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Tolperisone.,increase,risk
Tolperisone,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Tolperisone.,increase,risk
Tolperisone,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Tolperisone.,increase,risk
Tolperisone,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Tolperisone.,increase,risk
Tolperisone,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Tolperisone.,increase,risk
Tolperisone,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Tolperisone.,increase,risk
Tolperisone,Quinupramine,The risk or severity of CNS depression can be increased when Tolperisone is combined with Quinupramine.,increase,risk
Tolperisone,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Tolperisone.,increase,risk
Tolperisone,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Tolperisone.,increase,risk
Tolperisone,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Tolperisone.,increase,risk
Tolperisone,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tolperisone.,increase,risk
Tolperisone,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Tolperisone.,increase,risk
Tolperisone,Vilazodone,The risk or severity of CNS depression can be increased when Tolperisone is combined with Vilazodone.,increase,risk
Tolperisone,Viloxazine,The risk or severity of CNS depression can be increased when Tolperisone is combined with Viloxazine.,increase,risk
Tolperisone,Vortioxetine,The risk or severity of CNS depression can be increased when Tolperisone is combined with Vortioxetine.,increase,risk
Tolperisone,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Tolperisone.,increase,risk
Tolperisone,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Tolperisone.,increase,risk
Tolperisone,Ziconotide,The risk or severity of CNS depression can be increased when Tolperisone is combined with Ziconotide.,increase,risk
Tolperisone,Zimelidine,The risk or severity of adverse effects can be increased when Tolperisone is combined with Zimelidine.,increase,risk
Tolperisone,Ziprasidone,The risk or severity of adverse effects can be increased when Tolperisone is combined with Ziprasidone.,increase,risk
Tolperisone,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tolperisone.,increase,risk
Tolperisone,Zolpidem,Tolperisone may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tolperisone,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Tolperisone.,increase,risk
Tolperisone,Zopiclone,The risk or severity of adverse effects can be increased when Tolperisone is combined with Zopiclone.,increase,risk
Tolperisone,Zotepine,The risk or severity of CNS depression can be increased when Tolperisone is combined with Zotepine.,increase,risk
Tolperisone,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Tolperisone.,increase,risk
Tolperisone,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tolperisone.,increase,risk
Udenafil,Gefitinib,The metabolism of Udenafil can be decreased when combined with Gefitinib.,decrease,no risk
Udenafil,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Glofitamab,The serum concentration of Udenafil can be increased when it is combined with Glofitamab.,increase,no risk
Udenafil,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Golimumab,The metabolism of Udenafil can be increased when combined with Golimumab.,increase,no risk
Udenafil,Guanabenz,Udenafil may increase the antihypertensive activities of Guanabenz.,increase,no risk
Udenafil,Guanadrel,Udenafil may increase the antihypertensive activities of Guanadrel.,increase,no risk
Udenafil,Guanethidine,Udenafil may increase the antihypertensive activities of Guanethidine.,increase,no risk
Udenafil,Guanfacine,Udenafil may increase the antihypertensive activities of Guanfacine.,increase,no risk
Udenafil,Guanoxan,Udenafil may increase the antihypertensive activities of Guanoxan.,increase,no risk
Udenafil,Halofantrine,The metabolism of Udenafil can be decreased when combined with Halofantrine.,decrease,no risk
Udenafil,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Udenafil.,increase,no risk
Udenafil,Halothane,The risk or severity of hypotension can be increased when Udenafil is combined with Halothane.,increase,risk
Udenafil,Hydralazine,Udenafil may increase the antihypertensive activities of Hydralazine.,increase,no risk
Udenafil,Hydrochlorothiazide,Udenafil may increase the antihypertensive activities of Hydrochlorothiazide.,increase,no risk
Udenafil,Hydrocortisone,The metabolism of Udenafil can be decreased when combined with Hydrocortisone.,decrease,no risk
Udenafil,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydroflumethiazide,Udenafil may increase the antihypertensive activities of Hydroflumethiazide.,increase,no risk
Udenafil,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Hydroxyzine,The metabolism of Udenafil can be decreased when combined with Hydroxyzine.,decrease,no risk
Udenafil,Ketoconazole,The metabolism of Udenafil can be decreased when combined with Ketoconazole.,decrease,no risk
Udenafil,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Udenafil.,increase,risk
Udenafil,Obinutuzumab,The risk or severity of hypotension can be increased when Udenafil is combined with Obinutuzumab.,increase,risk
Udenafil,Olanzapine,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Olanzapine.,increase,risk
Udenafil,Olaparib,The metabolism of Olaparib can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Olmesartan,Udenafil may increase the antihypertensive activities of Olmesartan.,increase,no risk
Udenafil,Omaveloxolone,The serum concentration of Udenafil can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Udenafil,Ondansetron,The metabolism of Udenafil can be decreased when combined with Ondansetron.,decrease,no risk
Udenafil,Opicapone,The risk or severity of hypotension can be increased when Udenafil is combined with Opicapone.,increase,risk
Udenafil,Osilodrostat,The metabolism of Udenafil can be decreased when combined with Osilodrostat.,decrease,no risk
Udenafil,Oxcarbazepine,The metabolism of Udenafil can be increased when combined with Oxcarbazepine.,increase,no risk
Udenafil,Oxprenolol,Udenafil may increase the antihypertensive activities of Oxprenolol.,increase,no risk
Udenafil,Oxybutynin,The metabolism of Udenafil can be decreased when combined with Oxybutynin.,decrease,no risk
Udenafil,Oxycodone,The metabolism of Udenafil can be decreased when combined with Oxycodone.,decrease,no risk
Udenafil,Quetiapine,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Quetiapine.,increase,risk
Udenafil,Quinapril,Udenafil may increase the antihypertensive activities of Quinapril.,increase,no risk
Udenafil,Quinidine,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Quinidine.,increase,risk
Udenafil,Quinine,The therapeutic efficacy of Quinine can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Vadadustat,The serum concentration of Udenafil can be increased when it is combined with Vadadustat.,increase,no risk
Udenafil,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Valsartan,Udenafil may increase the antihypertensive activities of Valsartan.,increase,no risk
Udenafil,Vardenafil,The risk or severity of adverse effects can be increased when Vardenafil is combined with Udenafil.,increase,risk
Udenafil,Venetoclax,The metabolism of Udenafil can be decreased when combined with Venetoclax.,decrease,no risk
Udenafil,Verapamil,The metabolism of Udenafil can be decreased when combined with Verapamil.,decrease,no risk
Udenafil,Vericiguat,The risk or severity of hypotension can be increased when Udenafil is combined with Vericiguat.,increase,risk
Udenafil,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Udenafil.,increase,no risk
Udenafil,Viloxazine,The metabolism of Udenafil can be decreased when combined with Viloxazine.,decrease,no risk
Udenafil,Vincristine,The metabolism of Vincristine can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Voriconazole,The metabolism of Udenafil can be decreased when combined with Voriconazole.,decrease,no risk
Udenafil,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Udenafil.,decrease,no risk
Udenafil,Zaleplon,The metabolism of Udenafil can be decreased when combined with Zaleplon.,decrease,no risk
Udenafil,Zimelidine,The metabolism of Udenafil can be decreased when combined with Zimelidine.,decrease,no risk
Udenafil,Ziprasidone,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Ziprasidone.,increase,risk
Udenafil,Zofenopril,Udenafil may increase the antihypertensive activities of Zofenopril.,increase,no risk
Udenafil,Zonisamide,The metabolism of Udenafil can be decreased when combined with Zonisamide.,decrease,no risk
Udenafil,Zuclopenthixol,The risk or severity of hypotension and syncope can be increased when Udenafil is combined with Zuclopenthixol.,increase,risk
Sitaxentan,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Bromocriptine,Bromocriptine may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Bumadizone,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Bumadizone.,decrease,no risk
Sitaxentan,Bumetanide,Bumetanide may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Bupivacaine,Bupivacaine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Bupropion,The metabolism of Bupropion can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Buspirone,Buspirone may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Butriptyline,Butriptyline may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Gemfibrozil,The metabolism of Sitaxentan can be decreased when combined with Gemfibrozil.,decrease,no risk
Sitaxentan,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ginkgo biloba,The metabolism of Sitaxentan can be decreased when combined with Ginkgo biloba.,decrease,no risk
Sitaxentan,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Glipizide,The metabolism of Glipizide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Glofitamab,The serum concentration of Sitaxentan can be increased when it is combined with Glofitamab.,increase,no risk
Sitaxentan,Glyburide,The metabolism of Glyburide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Glycol salicylate,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Sitaxentan,Golimumab,The metabolism of Sitaxentan can be increased when combined with Golimumab.,increase,no risk
Sitaxentan,Guanabenz,Guanabenz may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Guanadrel,Guanadrel may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Guanethidine,Guanethidine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Guanfacine,Guanfacine may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Guanoxan,Sitaxentan may increase the hypotensive activities of Guanoxan.,increase,no risk
Sitaxentan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Halothane,The metabolism of Halothane can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Hydralazine,Hydralazine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Hydrochlorothiazide,The therapeutic efficacy of Sitaxentan can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Sitaxentan,Hydroflumethiazide,The therapeutic efficacy of Sitaxentan can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Sitaxentan,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ketamine,The metabolism of Ketamine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ketoprofen,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Ketoprofen.,decrease,no risk
Sitaxentan,Ketorolac,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Ketorolac.,decrease,no risk
Sitaxentan,Obinutuzumab,Sitaxentan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Sitaxentan,Olanzapine,The metabolism of Sitaxentan can be decreased when combined with Olanzapine.,decrease,no risk
Sitaxentan,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Olmesartan,Olmesartan may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Opicapone,Opicapone may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Oritavancin,The metabolism of Sitaxentan can be decreased when combined with Oritavancin.,decrease,no risk
Sitaxentan,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Oxandrolone,The metabolism of Sitaxentan can be decreased when combined with Oxandrolone.,decrease,no risk
Sitaxentan,Oxaprozin,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Oxaprozin.,decrease,no risk
Sitaxentan,Oxprenolol,Oxprenolol may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Oxymetazoline,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Sitaxentan,Oxyphenbutazone,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Sitaxentan,Quetiapine,Quetiapine may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Quinapril,Quinapril may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Quinine,The metabolism of Quinine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Quinupramine,Quinupramine may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Udenafil,Udenafil may increase the antihypertensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Unoprostone,Sitaxentan may increase the hypotensive activities of Unoprostone.,increase,no risk
Sitaxentan,Vadadustat,The metabolism of Sitaxentan can be decreased when combined with Vadadustat.,decrease,no risk
Sitaxentan,Valdecoxib,The therapeutic efficacy of Sitaxentan can be decreased when used in combination with Valdecoxib.,decrease,no risk
Sitaxentan,Valproic acid,The metabolism of Sitaxentan can be decreased when combined with Valproic acid.,decrease,no risk
Sitaxentan,Valsartan,The metabolism of Sitaxentan can be decreased when combined with Valsartan.,decrease,no risk
Sitaxentan,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Verapamil,Verapamil may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Vericiguat,Vericiguat may increase the hypotensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Vilanterol,Vilanterol may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Xamoterol,Xamoterol may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Xylometazoline,Xylometazoline may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Yohimbine,Yohimbine may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Zafirlukast,The metabolism of Sitaxentan can be decreased when combined with Zafirlukast.,decrease,no risk
Sitaxentan,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Sitaxentan.,increase,no risk
Sitaxentan,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Zileuton,The metabolism of Zileuton can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Ziprasidone,Ziprasidone may increase the antihypertensive activities of Sitaxentan.,increase,no risk
Sitaxentan,Zofenopril,Sitaxentan may increase the hypotensive activities of Zofenopril.,increase,no risk
Sitaxentan,Zolmitriptan,Zolmitriptan may decrease the antihypertensive activities of Sitaxentan.,decrease,no risk
Sitaxentan,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Sitaxentan.,decrease,no risk
Sitaxentan,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Sitaxentan.,decrease,no risk
Sulodexide,Gemcitabine,The risk or severity of bleeding can be increased when Sulodexide is combined with Gemcitabine.,increase,risk
Sulodexide,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Sulodexide is combined with Gemtuzumab ozogamicin.,increase,risk
Sulodexide,Gentamicin,The therapeutic efficacy of Gentamicin can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Sulodexide.,increase,risk
Sulodexide,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Sulodexide.,increase,risk
Sulodexide,Hemin,Hemin may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Sulodexide.,increase,risk
Sulodexide,Hydrochlorothiazide,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Sulodexide,Hydroflumethiazide,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Sulodexide,Hydroxyprogesterone caproate,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Sulodexide,Hydroxyurea,The risk or severity of bleeding can be increased when Sulodexide is combined with Hydroxyurea.,increase,risk
Sulodexide,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Ketoconazole,The risk or severity of hyperkalemia can be increased when Ketoconazole is combined with Sulodexide.,increase,risk
Sulodexide,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Sulodexide.,increase,risk
Sulodexide,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Sulodexide.,increase,risk
Sulodexide,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Sulodexide is combined with Obeticholic acid.,increase,risk
Sulodexide,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Sulodexide is combined with Obinutuzumab.,increase,risk
Sulodexide,Olaparib,The risk or severity of bleeding can be increased when Sulodexide is combined with Olaparib.,increase,risk
Sulodexide,Olive oil,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Olive oil.,decrease,no risk
Sulodexide,Olmesartan,The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Olmesartan.,increase,risk
Sulodexide,Olsalazine,The risk or severity of bleeding can be increased when Sulodexide is combined with Olsalazine.,increase,risk
Sulodexide,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Sulodexide is combined with Omacetaxine mepesuccinate.,increase,risk
Sulodexide,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Sulodexide.,increase,risk
Sulodexide,Omega-3-carboxylic acids,The therapeutic efficacy of Sulodexide can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Sulodexide,Oritavancin,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Oritavancin.,decrease,no risk
Sulodexide,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Sulodexide.,increase,risk
Sulodexide,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Sulodexide.,increase,risk
Sulodexide,Oxprenolol,The risk or severity of hyperkalemia can be increased when Oxprenolol is combined with Sulodexide.,increase,risk
Sulodexide,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Sulodexide.,increase,risk
Sulodexide,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Sulodexide.,increase,risk
Sulodexide,Quinestrol,Quinestrol may decrease the anticoagulant activities of Sulodexide.,decrease,no risk
Sulodexide,Quinidine,The therapeutic efficacy of Sulodexide can be increased when used in combination with Quinidine.,increase,no risk
Sulodexide,Quinine,The therapeutic efficacy of Sulodexide can be increased when used in combination with Quinine.,increase,no risk
Sulodexide,Ulipristal,The therapeutic efficacy of Sulodexide can be decreased when used in combination with Ulipristal.,decrease,no risk
Sulodexide,Urokinase,Urokinase may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Sulodexide is combined with Ursodeoxycholic acid.,increase,risk
Sulodexide,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Sulodexide.,increase,risk
Sulodexide,Valsartan,The risk or severity of hyperkalemia can be increased when Sulodexide is combined with Valsartan.,increase,risk
Sulodexide,Vasopressin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Venlafaxine,The risk or severity of bleeding can be increased when Sulodexide is combined with Venlafaxine.,increase,risk
Sulodexide,Vinblastine,The risk or severity of bleeding can be increased when Sulodexide is combined with Vinblastine.,increase,risk
Sulodexide,Vindesine,The risk or severity of bleeding can be increased when Sulodexide is combined with Vindesine.,increase,risk
Sulodexide,Vinorelbine,The risk or severity of bleeding can be increased when Sulodexide is combined with Vinorelbine.,increase,risk
Sulodexide,Vitamin E,Vitamin E may increase the anticoagulant activities of Sulodexide.,increase,no risk
Sulodexide,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Sulodexide.,decrease,no risk
Sulodexide,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Sulodexide.,increase,risk
Sulodexide,Vorinostat,The risk or severity of bleeding can be increased when Sulodexide is combined with Vorinostat.,increase,risk
Sulodexide,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Sulodexide.,increase,risk
Sulodexide,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Sulodexide.,increase,risk
Sulodexide,Zidovudine,The risk or severity of bleeding can be increased when Sulodexide is combined with Zidovudine.,increase,risk
Sulodexide,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Sulodexide.,increase,risk
Sulodexide,Zofenopril,The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Sulodexide.,increase,risk
Sulodexide,Zonisamide,The risk or severity of hyperkalemia can be increased when Zonisamide is combined with Sulodexide.,increase,risk
Maxacalcitol,Orlistat,Orlistat can cause a decrease in the absorption of Maxacalcitol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Maxacalcitol,Ouabain,The risk or severity of ventricular arrhythmias and Cardiac Arrhythmia can be increased when Maxacalcitol is combined with Ouabain.,increase,risk
Maxacalcitol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Maxacalcitol is combined with Oxetacaine.,increase,risk
Maxacalcitol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Maxacalcitol is combined with Oxybuprocaine.,increase,risk
Maxacalcitol,Quinethazone,The risk or severity of hypokalemia can be increased when Maxacalcitol is combined with Quinethazone.,increase,risk
Maxacalcitol,Vamorolone,The therapeutic efficacy of Maxacalcitol can be decreased when used in combination with Vamorolone.,decrease,no risk
Maxacalcitol,Vitamin D,The risk or severity of adverse effects can be increased when Maxacalcitol is combined with Vitamin D.,increase,risk
Tocilizumab,Benzyl alcohol,The metabolism of Benzyl alcohol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bepridil,The metabolism of Bepridil can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Besilesomab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Besilesomab.,increase,risk
Tocilizumab,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Tocilizumab.,increase,risk
Tocilizumab,Betaxolol,The metabolism of Betaxolol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bevacizumab,The risk or severity of adverse effects can be increased when Bevacizumab is combined with Tocilizumab.,increase,risk
Tocilizumab,Bexarotene,The metabolism of Bexarotene can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bezlotoxumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Bezlotoxumab.,increase,risk
Tocilizumab,Bicalutamide,The metabolism of Bicalutamide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bimekizumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Bimekizumab.,increase,risk
Tocilizumab,Binimetinib,The metabolism of Binimetinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Tocilizumab.,increase,risk
Tocilizumab,Blinatumomab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Blinatumomab.,increase,risk
Tocilizumab,Boceprevir,The metabolism of Boceprevir can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Tocilizumab.",decrease,no risk
Tocilizumab,Bortezomib,The metabolism of Bortezomib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bosentan,The metabolism of Bosentan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bosutinib,The metabolism of Bosutinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brigatinib,The metabolism of Brigatinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brodalumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Brodalumab.,increase,risk
Tocilizumab,Brolucizumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Brolucizumab.,increase,risk
Tocilizumab,Bromazepam,The metabolism of Bromazepam can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Tocilizumab.,increase,risk
Tocilizumab,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Bupropion,The metabolism of Bupropion can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Burosumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Burosumab.,increase,risk
Tocilizumab,Buspirone,The metabolism of Buspirone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Busulfan,The metabolism of Busulfan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Galantamine,The metabolism of Galantamine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Galcanezumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Galcanezumab.,increase,risk
Tocilizumab,Gefitinib,The metabolism of Gefitinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Tocilizumab.,increase,risk
Tocilizumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Tocilizumab.,increase,risk
Tocilizumab,Gestrinone,The metabolism of Gestrinone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glasdegib,The metabolism of Glasdegib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Tocilizumab.,increase,risk
Tocilizumab,Gliclazide,The metabolism of Gliclazide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glimepiride,The metabolism of Glimepiride can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glipizide,The metabolism of Glipizide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Gliquidone,The metabolism of Gliquidone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Glofitamab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Glofitamab.,increase,risk
Tocilizumab,Glyburide,The metabolism of Glyburide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Golimumab,Tocilizumab may increase the immunosuppressive activities of Golimumab.,increase,no risk
Tocilizumab,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Guanabenz,The metabolism of Guanabenz can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Guselkumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Guselkumab.,increase,risk
Tocilizumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Halofantrine,The metabolism of Halofantrine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Haloperidol,The metabolism of Haloperidol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Halothane,The metabolism of Halothane can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Tocilizumab.,increase,risk
Tocilizumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Tocilizumab.,increase,risk
Tocilizumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Tocilizumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Tocilizumab.,increase,risk
Tocilizumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Human Rho(D) immune globulin.,increase,risk
Tocilizumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Human varicella-zoster immune globulin.,increase,risk
Tocilizumab,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Hydrocortisone succinate.,increase,risk
Tocilizumab,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Tocilizumab.,increase,risk
Tocilizumab,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Ketamine,The metabolism of Ketamine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ketorolac,The metabolism of Ketorolac can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Tocilizumab.,increase,risk
Tocilizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Obinutuzumab.,increase,risk
Tocilizumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Tocilizumab.,increase,no risk
Tocilizumab,Odesivimab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Odesivimab.,increase,risk
Tocilizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ofatumumab.,increase,risk
Tocilizumab,Olanzapine,The metabolism of Olanzapine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Olaparib,The metabolism of Olaparib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Tocilizumab.,increase,risk
Tocilizumab,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Tocilizumab.,decrease,no risk
Tocilizumab,Olodaterol,The metabolism of Olodaterol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Tocilizumab.,increase,risk
Tocilizumab,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Omeprazole,The metabolism of Omeprazole can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ondansetron,The metabolism of Ondansetron can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Opium,The metabolism of Opium can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Osimertinib,The metabolism of Osimertinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ospemifene,The metabolism of Ospemifene can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Tocilizumab.,increase,risk
Tocilizumab,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxycodone,The metabolism of Oxycodone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ozanimod,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ozanimod.,increase,risk
Tocilizumab,Quetiapine,The metabolism of Quetiapine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Tocilizumab.,increase,no risk
Tocilizumab,Quinidine,The metabolism of Quinidine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Quinine,The metabolism of Quinine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Quizartinib,The metabolism of Quizartinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Tocilizumab.,increase,risk
Tocilizumab,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Tocilizumab.,decrease,no risk
Tocilizumab,Udenafil,The metabolism of Udenafil can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ulipristal,The metabolism of Ulipristal can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Upadacitinib,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Upadacitinib.,increase,risk
Tocilizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Tocilizumab.,increase,risk
Tocilizumab,Valbenazine,The metabolism of Valbenazine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Valproic acid,The metabolism of Valproic acid can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Valsartan,The metabolism of Valsartan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vandetanib,The metabolism of Vandetanib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vardenafil,The metabolism of Vardenafil can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Tocilizumab.,increase,risk
Tocilizumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Vedolizumab.,increase,risk
Tocilizumab,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Venetoclax,The metabolism of Venetoclax can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Verapamil,The metabolism of Verapamil can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vernakalant,The metabolism of Vernakalant can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Tocilizumab.,decrease,no risk
Tocilizumab,Vilanterol,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Vilanterol.,increase,risk
Tocilizumab,Vilazodone,The metabolism of Vilazodone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vinblastine,The metabolism of Vinblastine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vincristine,The metabolism of Vincristine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vindesine,The metabolism of Vindesine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vinflunine,The metabolism of Vinflunine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Voclosporin,The risk or severity of adverse effects can be increased when Tocilizumab is combined with Voclosporin.,increase,risk
Tocilizumab,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Voriconazole,The metabolism of Voriconazole can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Tocilizumab.,increase,risk
Tocilizumab,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Voxelotor,The metabolism of Voxelotor can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Warfarin,The metabolism of Warfarin can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Tocilizumab.,increase,risk
Tocilizumab,Yohimbine,The metabolism of Yohimbine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zaleplon,The metabolism of Zaleplon can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zidovudine,The metabolism of Zidovudine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zileuton,The metabolism of Zileuton can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zolpidem,The metabolism of Zolpidem can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zonisamide,The metabolism of Zonisamide can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zopiclone,The metabolism of Zopiclone can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zotepine,The metabolism of Zotepine can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Tocilizumab.,increase,no risk
Tocilizumab,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Tocilizumab.,decrease,no risk
Alvimopan,Benzhydrocodone,The risk or severity of adverse effects can be increased when Benzhydrocodone is combined with Alvimopan.,increase,risk
Alvimopan,Buprenorphine,The risk or severity of adverse effects can be increased when Buprenorphine is combined with Alvimopan.,increase,risk
Alvimopan,Butorphanol,The risk or severity of adverse effects can be increased when Butorphanol is combined with Alvimopan.,increase,risk
Alvimopan,Hydrocodone,The risk or severity of adverse effects can be increased when Hydrocodone is combined with Alvimopan.,increase,risk
Alvimopan,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Alvimopan.,increase,risk
Alvimopan,Oliceridine,The risk or severity of adverse effects can be increased when Oliceridine is combined with Alvimopan.,increase,risk
Alvimopan,Opium,The risk or severity of adverse effects can be increased when Opium is combined with Alvimopan.,increase,risk
Alvimopan,Oxycodone,The risk or severity of adverse effects can be increased when Oxycodone is combined with Alvimopan.,increase,risk
Alvimopan,Oxymorphone,The risk or severity of adverse effects can be increased when Oxymorphone is combined with Alvimopan.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Gefitinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gefitinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Gemcitabine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gemcitabine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Gemtuzumab ozogamicin,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gemtuzumab ozogamicin.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Gilteritinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Gilteritinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Glasdegib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Glasdegib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Goserelin,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Goserelin.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Hydroxyprogesterone caproate,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Hydroxyprogesterone caproate.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Hydroxyurea,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Hydroxyurea.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Obinutuzumab,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Obinutuzumab.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Octreotide,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Octreotide.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Ofatumumab,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Ofatumumab.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Olaparib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Olaparib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Olaratumab,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Olaratumab.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Olutasidenib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Olutasidenib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Omacetaxine mepesuccinate,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Omacetaxine mepesuccinate.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Osimertinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Osimertinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Oxaliplatin,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Oxaliplatin.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Quizartinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Quizartinib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Umbralisib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Umbralisib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Uracil mustard,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Uracil mustard.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Urethane,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Urethane.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Valproic acid,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Valproic acid.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Valrubicin,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Valrubicin.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vandetanib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vandetanib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vemurafenib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vemurafenib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Venetoclax,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Venetoclax.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vinblastine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vinblastine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vincristine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vincristine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vindesine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vindesine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vinflunine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vinflunine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vinorelbine,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vinorelbine.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vismodegib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vismodegib.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Vorinostat,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Vorinostat.,increase,risk
Methoxy polyethylene glycol-epoetin beta,Zanubrutinib,The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Zanubrutinib.,increase,risk
Levocetirizine,Benzyl alcohol,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Benzyl alcohol.,increase,risk
Levocetirizine,Benzylpenicilloyl polylysine,Levocetirizine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Levocetirizine,Bepotastine,Bepotastine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bepridil,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Bepridil.,increase,risk
Levocetirizine,Berotralstat,The metabolism of Levocetirizine can be decreased when combined with Berotralstat.,decrease,no risk
Levocetirizine,Betahistine,The therapeutic efficacy of Betahistine can be decreased when used in combination with Levocetirizine.,decrease,no risk
Levocetirizine,Bicisate,Levocetirizine may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bilastine,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Bilastine.,increase,risk
Levocetirizine,Biperiden,Biperiden may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Bismuth subgallate,Levocetirizine may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bisoprolol,Bisoprolol may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bisoxatin,Levocetirizine may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bleomycin,Bleomycin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Boceprevir,The metabolism of Levocetirizine can be decreased when combined with Boceprevir.,decrease,no risk
Levocetirizine,Bortezomib,The risk or severity of QTc prolongation can be increased when Bortezomib is combined with Levocetirizine.,increase,risk
Levocetirizine,Botulinum toxin type A,The risk or severity of CNS depression can be increased when Botulinum toxin type A is combined with Levocetirizine.,increase,risk
Levocetirizine,Botulinum toxin type B,The risk or severity of CNS depression can be increased when Botulinum toxin type B is combined with Levocetirizine.,increase,risk
Levocetirizine,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Levocetirizine.,increase,risk
Levocetirizine,Brexanolone,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Brexanolone.,increase,risk
Levocetirizine,Brexpiprazole,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Brexpiprazole.,increase,risk
Levocetirizine,Brimonidine,Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Levocetirizine.,increase,no risk
Levocetirizine,Brivaracetam,The risk or severity of CNS depression can be increased when Brivaracetam is combined with Levocetirizine.,increase,risk
Levocetirizine,Bromazepam,The risk or severity of CNS depression can be increased when Bromazepam is combined with Levocetirizine.,increase,risk
Levocetirizine,Bromocriptine,The risk or severity of CNS depression can be increased when Bromocriptine is combined with Levocetirizine.,increase,risk
Levocetirizine,Bromotheophylline,Bromotheophylline may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levocetirizine,Bromperidol,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Bromperidol.,increase,risk
Levocetirizine,Brompheniramine,The risk or severity of CNS depression can be increased when Brompheniramine is combined with Levocetirizine.,increase,risk
Levocetirizine,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Levocetirizine.,increase,risk
Levocetirizine,Budesonide,Budesonide may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bumadizone,Bumadizone may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Bumetanide,Bumetanide may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levocetirizine,Bupivacaine,The risk or severity of CNS depression can be increased when Bupivacaine is combined with Levocetirizine.,increase,risk
Levocetirizine,Buprenorphine,Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.,increase,no risk
Levocetirizine,Bupropion,The risk or severity of CNS depression can be increased when Bupropion is combined with Levocetirizine.,increase,risk
Levocetirizine,Buserelin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Buserelin.,increase,risk
Levocetirizine,Buspirone,The risk or severity of CNS depression can be increased when Buspirone is combined with Levocetirizine.,increase,risk
Levocetirizine,Butabarbital,The risk or severity of CNS depression can be increased when Butabarbital is combined with Levocetirizine.,increase,risk
Levocetirizine,Butalbital,The risk or severity of CNS depression can be increased when Butalbital is combined with Levocetirizine.,increase,risk
Levocetirizine,Butaperazine,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Butaperazine.,increase,risk
Levocetirizine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Levocetirizine.,increase,risk
Levocetirizine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Levocetirizine.,increase,risk
Levocetirizine,Butriptyline,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Butriptyline.,increase,risk
Levocetirizine,Butylscopolamine,Butylscopolamine may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Levocetirizine.,increase,risk
Levocetirizine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Gabapentin enacarbil.,increase,risk
Levocetirizine,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Gadobenic acid.,increase,risk
Levocetirizine,Gadodiamide,Gadodiamide may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gadofosveset trisodium,Levocetirizine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gadoteric acid,Levocetirizine may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gadoteridol,Gadoteridol may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Levocetirizine.,increase,risk
Levocetirizine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Levocetirizine.,increase,risk
Levocetirizine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Levocetirizine is combined with Ganaxolone.",increase,risk
Levocetirizine,Ganciclovir,Ganciclovir may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Levocetirizine.,increase,risk
Levocetirizine,Gemcitabine,Gemcitabine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Gemifloxacin.,increase,risk
Levocetirizine,Gentamicin,Levocetirizine may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Levocetirizine,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Levocetirizine.,increase,risk
Levocetirizine,Gilteritinib,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Gilteritinib.,increase,risk
Levocetirizine,Gimeracil,Levocetirizine may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Levocetirizine,Givosiran,Givosiran may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Glasdegib,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Glasdegib.,increase,risk
Levocetirizine,Glipizide,Glipizide may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Glofitamab,The serum concentration of Levocetirizine can be increased when it is combined with Glofitamab.,increase,no risk
Levocetirizine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Levocetirizine.,increase,risk
Levocetirizine,Glycerol phenylbutyrate,Levocetirizine may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Levocetirizine,Glycopyrronium,Glycopyrronium may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Golodirsen,Levocetirizine may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Levocetirizine,Goserelin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Goserelin.,increase,risk
Levocetirizine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Levocetirizine.,increase,risk
Levocetirizine,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Grepafloxacin.,increase,risk
Levocetirizine,Guanethidine,Guanethidine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Levocetirizine.,increase,risk
Levocetirizine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Levocetirizine.,increase,risk
Levocetirizine,Halofantrine,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Halofantrine.,increase,risk
Levocetirizine,Haloperidol,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Haloperidol.,increase,risk
Levocetirizine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Levocetirizine.,increase,risk
Levocetirizine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Levocetirizine.,increase,risk
Levocetirizine,Hexocyclium,Hexocyclium may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Histrelin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Histrelin.,increase,risk
Levocetirizine,Homatropine methylbromide,Homatropine methylbromide may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Hydralazine,Hydralazine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levocetirizine,Hydrocodone,Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Levocetirizine,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Levocetirizine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Levocetirizine.,increase,risk
Levocetirizine,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Levocetirizine.,increase,risk
Levocetirizine,Hydroxyethyl Starch,Levocetirizine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Levocetirizine,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Hydroxyzine.,increase,risk
Levocetirizine,Hyoscyamine,Levocetirizine may increase the anticholinergic activities of Hyoscyamine.,increase,no risk
Levocetirizine,Kanamycin,Levocetirizine may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Levocetirizine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Levocetirizine.,increase,risk
Levocetirizine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Levocetirizine.,increase,risk
Levocetirizine,Ketoconazole,The metabolism of Levocetirizine can be decreased when combined with Ketoconazole.,decrease,no risk
Levocetirizine,Ketoprofen,Ketoprofen may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Ketorolac,Ketorolac may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Octinoxate,Levocetirizine may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Levocetirizine,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Levocetirizine.,increase,risk
Levocetirizine,Ofloxacin,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Ofloxacin.,increase,risk
Levocetirizine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Levocetirizine.,increase,risk
Levocetirizine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Levocetirizine is combined with Oliceridine.",increase,risk
Levocetirizine,Olodaterol,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Olodaterol.,increase,risk
Levocetirizine,Olsalazine,Olsalazine may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Omaveloxolone,The serum concentration of Levocetirizine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Levocetirizine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Levocetirizine.,increase,risk
Levocetirizine,Opium,The risk or severity of CNS depression can be increased when Levocetirizine is combined with Opium.,increase,risk
Levocetirizine,Orphenadrine,Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Levocetirizine,Oseltamivir,Oseltamivir may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Oxacillin,Oxacillin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Levocetirizine.,increase,risk
Levocetirizine,Oxaprozin,Oxaprozin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Oxatomide,The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Oxatomide.,increase,risk
Levocetirizine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Levocetirizine.,increase,risk
Levocetirizine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Levocetirizine.,increase,risk
Levocetirizine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Levocetirizine.,increase,risk
Levocetirizine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Levocetirizine.,increase,risk
Levocetirizine,Oxybenzone,Oxybenzone may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Levocetirizine.,increase,risk
Levocetirizine,Oxybutynin,Oxybutynin may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Levocetirizine.,increase,risk
Levocetirizine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Levocetirizine.,increase,risk
Levocetirizine,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Levocetirizine which could result in a higher serum level.,decrease,no risk
Levocetirizine,Oxyphencyclimine,Oxyphencyclimine may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Oxyphenonium,Oxyphenonium may increase the anticholinergic activities of Levocetirizine.,increase,no risk
Levocetirizine,Oxyquinoline,Levocetirizine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Levocetirizine,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Levocetirizine.,increase,risk
Ziconotide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ziconotide.,increase,risk
Ziconotide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ziconotide is combined with Gabapentin enacarbil.,increase,risk
Ziconotide,Gallamine triethiodide,Ziconotide may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Ziconotide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ziconotide is combined with Ganaxolone.",increase,risk
Ziconotide,Gepirone,The risk or severity of CNS depression can be increased when Ziconotide is combined with Gepirone.,increase,risk
Ziconotide,Gliclazide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Gliclazide.,increase,risk
Ziconotide,Glimepiride,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Glimepiride.,increase,risk
Ziconotide,Glipizide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Glipizide.,increase,risk
Ziconotide,Gliquidone,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Gliquidone.,increase,risk
Ziconotide,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Ziconotide.,decrease,no risk
Ziconotide,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Ziconotide.,increase,risk
Ziconotide,Glyburide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Glyburide.,increase,risk
Ziconotide,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Ziconotide.,decrease,no risk
Ziconotide,Glymidine,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Glymidine.,increase,risk
Ziconotide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Ziconotide.,increase,risk
Ziconotide,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Ziconotide.,increase,risk
Ziconotide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Ziconotide.,increase,risk
Ziconotide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Ziconotide.,increase,risk
Ziconotide,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Ziconotide.,increase,risk
Ziconotide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ziconotide.,increase,risk
Ziconotide,Hydrochlorothiazide,The risk or severity of CNS depression can be increased when Hydrochlorothiazide is combined with Ziconotide.,increase,risk
Ziconotide,Hydrocodone,Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ziconotide,Hydroflumethiazide,The risk or severity of CNS depression can be increased when Hydroflumethiazide is combined with Ziconotide.,increase,risk
Ziconotide,Hydromorphone,The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ziconotide.,increase,risk
Ziconotide,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Ziconotide.,increase,risk
Ziconotide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ziconotide.,increase,no risk
Ziconotide,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Ziconotide,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Ziconotide.,increase,risk
Ziconotide,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Ziconotide.,increase,risk
Ziconotide,Ketoconazole,The therapeutic efficacy of Ketoconazole can be increased when used in combination with Ziconotide.,increase,no risk
Ziconotide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Ziconotide.,increase,risk
Ziconotide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ziconotide is combined with Oliceridine.",increase,risk
Ziconotide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ziconotide.,increase,risk
Ziconotide,Opium,The risk or severity of CNS depression can be increased when Ziconotide is combined with Opium.,increase,risk
Ziconotide,Orphenadrine,Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ziconotide,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Ziconotide.,increase,no risk
Ziconotide,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Ziconotide.,increase,no risk
Ziconotide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ziconotide.,increase,risk
Ziconotide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Ziconotide.,increase,risk
Ziconotide,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Ziconotide.,increase,risk
Ziconotide,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Ziconotide,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Ziconotide.,increase,risk
Ziconotide,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Ziconotide.,increase,risk
Ziconotide,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Ziconotide.,increase,risk
Ziconotide,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Ziconotide.,decrease,no risk
Ziconotide,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Ziconotide.,increase,risk
Ziconotide,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Ziconotide.,increase,risk
Ziconotide,Quinethazone,The risk or severity of CNS depression can be increased when Quinethazone is combined with Ziconotide.,increase,risk
Ziconotide,Quinidine,Quinidine may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Ziconotide,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Ziconotide.,increase,risk
Ziconotide,Quinupramine,The risk or severity of CNS depression can be increased when Ziconotide is combined with Quinupramine.,increase,risk
Ziconotide,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Ziconotide.,increase,risk
Ziconotide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Ziconotide.,increase,risk
Ziconotide,Vecuronium,Ziconotide may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Ziconotide,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Ziconotide.,increase,risk
Ziconotide,Verapamil,Verapamil may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Ziconotide,Vernakalant,Vernakalant may increase the arrhythmogenic activities of Ziconotide.,increase,no risk
Ziconotide,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Ziconotide.,increase,risk
Ziconotide,Vilazodone,The risk or severity of CNS depression can be increased when Ziconotide is combined with Vilazodone.,increase,risk
Ziconotide,Vildagliptin,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Vildagliptin.,increase,risk
Ziconotide,Viloxazine,The risk or severity of CNS depression can be increased when Ziconotide is combined with Viloxazine.,increase,risk
Ziconotide,Voriconazole,The therapeutic efficacy of Voriconazole can be increased when used in combination with Ziconotide.,increase,no risk
Ziconotide,Vortioxetine,The risk or severity of CNS depression can be increased when Ziconotide is combined with Vortioxetine.,increase,risk
Ziconotide,Xylometazoline,Ziconotide may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Ziconotide,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Ziconotide.,increase,risk
Ziconotide,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Ziconotide.,increase,risk
Ziconotide,Zimelidine,The risk or severity of adverse effects can be increased when Ziconotide is combined with Zimelidine.,increase,risk
Ziconotide,Ziprasidone,The risk or severity of adverse effects can be increased when Ziconotide is combined with Ziprasidone.,increase,risk
Ziconotide,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Ziconotide.,increase,risk
Ziconotide,Zolpidem,Ziconotide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ziconotide,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Ziconotide.,increase,risk
Ziconotide,Zopiclone,The risk or severity of CNS depression can be increased when Zopiclone is combined with Ziconotide.,increase,risk
Ziconotide,Zotepine,The risk or severity of CNS depression can be increased when Zotepine is combined with Ziconotide.,increase,risk
Ziconotide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Ziconotide.,increase,risk
Ziconotide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Ziconotide.,increase,risk
Temsirolimus,Bemiparin,The risk or severity of bleeding can be increased when Bemiparin is combined with Temsirolimus.,increase,risk
Temsirolimus,Benazepril,The risk or severity of angioedema can be increased when Benazepril is combined with Temsirolimus.,increase,risk
Temsirolimus,Bendamustine,The serum concentration of Bendamustine can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Temsirolimus.,increase,risk
Temsirolimus,Benzatropine,The metabolism of Benzatropine can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Benzocaine,The risk or severity of methemoglobinemia can be increased when Temsirolimus is combined with Benzocaine.,increase,risk
Temsirolimus,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Temsirolimus.,increase,risk
Temsirolimus,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Temsirolimus is combined with Benzyl alcohol.,increase,risk
Temsirolimus,Bepridil,The metabolism of Bepridil can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Betamethasone,The serum concentration of Betamethasone can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Betamethasone phosphate,The metabolism of Temsirolimus can be increased when combined with Betamethasone phosphate.,increase,no risk
Temsirolimus,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Bexagliflozin,The therapeutic efficacy of Bexagliflozin can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Bexarotene,The metabolism of Temsirolimus can be increased when combined with Bexarotene.,increase,no risk
Temsirolimus,Bicalutamide,The metabolism of Temsirolimus can be decreased when combined with Bicalutamide.,decrease,no risk
Temsirolimus,Bifonazole,The metabolism of Temsirolimus can be decreased when combined with Bifonazole.,decrease,no risk
Temsirolimus,Bimekizumab,The metabolism of Temsirolimus can be increased when combined with Bimekizumab.,increase,no risk
Temsirolimus,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Temsirolimus.,increase,risk
Temsirolimus,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Temsirolimus.,increase,risk
Temsirolimus,Blinatumomab,The risk or severity of adverse effects can be increased when Temsirolimus is combined with Blinatumomab.,increase,risk
Temsirolimus,Boceprevir,The metabolism of Temsirolimus can be decreased when combined with Boceprevir.,decrease,no risk
Temsirolimus,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Temsirolimus.",decrease,no risk
Temsirolimus,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Bosentan,The metabolism of Temsirolimus can be increased when combined with Bosentan.,increase,no risk
Temsirolimus,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Brodalumab,The risk or severity of adverse effects can be increased when Temsirolimus is combined with Brodalumab.,increase,risk
Temsirolimus,Bromocriptine,The serum concentration of Bromocriptine can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Budesonide,The serum concentration of Budesonide can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Temsirolimus is combined with Bupivacaine.,increase,risk
Temsirolimus,Buprenorphine,The metabolism of Temsirolimus can be decreased when combined with Buprenorphine.,decrease,no risk
Temsirolimus,Buspirone,The metabolism of Buspirone can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Temsirolimus.,increase,risk
Temsirolimus,Butacaine,The risk or severity of methemoglobinemia can be increased when Temsirolimus is combined with Butacaine.,increase,risk
Temsirolimus,Butalbital,The metabolism of Temsirolimus can be increased when combined with Butalbital.,increase,no risk
Temsirolimus,Butamben,The risk or severity of methemoglobinemia can be increased when Temsirolimus is combined with Butamben.,increase,risk
Temsirolimus,Galantamine,The metabolism of Galantamine can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Gefitinib,The metabolism of Temsirolimus can be decreased when combined with Gefitinib.,decrease,no risk
Temsirolimus,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Temsirolimus.,increase,risk
Temsirolimus,Gilteritinib,The metabolism of Temsirolimus can be decreased when combined with Gilteritinib.,decrease,no risk
Temsirolimus,Ginkgo biloba,The metabolism of Temsirolimus can be decreased when combined with Ginkgo biloba.,decrease,no risk
Temsirolimus,Glasdegib,The serum concentration of Temsirolimus can be increased when it is combined with Glasdegib.,increase,no risk
Temsirolimus,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Temsirolimus.,increase,risk
Temsirolimus,Glecaprevir,The serum concentration of Temsirolimus can be increased when it is combined with Glecaprevir.,increase,no risk
Temsirolimus,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Glofitamab,The serum concentration of Temsirolimus can be increased when it is combined with Glofitamab.,increase,no risk
Temsirolimus,Glyburide,The metabolism of Temsirolimus can be decreased when combined with Glyburide.,decrease,no risk
Temsirolimus,Glycerol phenylbutyrate,The metabolism of Temsirolimus can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Temsirolimus,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Golimumab,The metabolism of Temsirolimus can be increased when combined with Golimumab.,increase,no risk
Temsirolimus,Grapefruit,The serum concentration of Temsirolimus can be increased when it is combined with Grapefruit.,increase,no risk
Temsirolimus,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Griseofulvin,The metabolism of Temsirolimus can be increased when combined with Griseofulvin.,increase,no risk
Temsirolimus,Guselkumab,The risk or severity of adverse effects can be increased when Temsirolimus is combined with Guselkumab.,increase,risk
Temsirolimus,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Halofantrine,The metabolism of Temsirolimus can be decreased when combined with Halofantrine.,decrease,no risk
Temsirolimus,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Temsirolimus.,increase,risk
Temsirolimus,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Temsirolimus.,increase,risk
Temsirolimus,Hydralazine,The serum concentration of Temsirolimus can be increased when it is combined with Hydralazine.,increase,no risk
Temsirolimus,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Temsirolimus.,increase,risk
Temsirolimus,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Hydrocortamate,The metabolism of Temsirolimus can be increased when combined with Hydrocortamate.,increase,no risk
Temsirolimus,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Hydrocortisone acetate,The metabolism of Temsirolimus can be increased when combined with Hydrocortisone acetate.,increase,no risk
Temsirolimus,Hydrocortisone butyrate,The metabolism of Temsirolimus can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Temsirolimus,Hydrocortisone cypionate,The metabolism of Temsirolimus can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Temsirolimus,Hydrocortisone phosphate,The metabolism of Temsirolimus can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Temsirolimus,Hydrocortisone succinate,The metabolism of Temsirolimus can be increased when combined with Hydrocortisone succinate.,increase,no risk
Temsirolimus,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Temsirolimus.,increase,risk
Temsirolimus,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Temsirolimus.,increase,risk
Temsirolimus,Hydroxyprogesterone caproate,The metabolism of Temsirolimus can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Temsirolimus,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Temsirolimus.,increase,risk
Temsirolimus,Hydroxyzine,The metabolism of Temsirolimus can be decreased when combined with Hydroxyzine.,decrease,no risk
Temsirolimus,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Ketazolam,The serum concentration of Temsirolimus can be increased when it is combined with Ketazolam.,increase,no risk
Temsirolimus,Ketoconazole,The serum concentration of the active metabolites of Temsirolimus can be increased when Temsirolimus is used in combination with Ketoconazole.,increase,no risk
Temsirolimus,Obinutuzumab,The risk or severity of adverse effects can be increased when Temsirolimus is combined with Obinutuzumab.,increase,risk
Temsirolimus,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Temsirolimus.,increase,no risk
Temsirolimus,Octreotide,The serum concentration of Temsirolimus can be increased when it is combined with Octreotide.,increase,no risk
Temsirolimus,Ofatumumab,The risk or severity of adverse effects can be increased when Temsirolimus is combined with Ofatumumab.,increase,risk
Temsirolimus,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Olaparib,The metabolism of Temsirolimus can be decreased when combined with Olaparib.,decrease,no risk
Temsirolimus,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Olutasidenib,The metabolism of Temsirolimus can be increased when combined with Olutasidenib.,increase,no risk
Temsirolimus,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Omaveloxolone,The serum concentration of Temsirolimus can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Temsirolimus,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Ondansetron,The metabolism of Temsirolimus can be decreased when combined with Ondansetron.,decrease,no risk
Temsirolimus,Opium,The metabolism of Opium can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Oritavancin,The metabolism of Temsirolimus can be increased when combined with Oritavancin.,increase,no risk
Temsirolimus,Orphenadrine,The metabolism of Temsirolimus can be decreased when combined with Orphenadrine.,decrease,no risk
Temsirolimus,Osilodrostat,The metabolism of Temsirolimus can be decreased when combined with Osilodrostat.,decrease,no risk
Temsirolimus,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Temsirolimus.,increase,risk
Temsirolimus,Oxcarbazepine,The metabolism of Temsirolimus can be increased when combined with Oxcarbazepine.,increase,no risk
Temsirolimus,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Temsirolimus is combined with Oxetacaine.,increase,risk
Temsirolimus,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Temsirolimus is combined with Oxybuprocaine.,increase,risk
Temsirolimus,Oxybutynin,The serum concentration of Temsirolimus can be increased when it is combined with Oxybutynin.,increase,no risk
Temsirolimus,Oxycodone,The metabolism of Temsirolimus can be decreased when combined with Oxycodone.,decrease,no risk
Temsirolimus,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Ozanimod,The risk or severity of adverse effects can be increased when Temsirolimus is combined with Ozanimod.,increase,risk
Temsirolimus,Quetiapine,The metabolism of Temsirolimus can be decreased when combined with Quetiapine.,decrease,no risk
Temsirolimus,Quinapril,The risk or severity of angioedema can be increased when Quinapril is combined with Temsirolimus.,increase,risk
Temsirolimus,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Quinine,The serum concentration of Quinine can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Quinupristin,The metabolism of Temsirolimus can be decreased when combined with Quinupristin.,decrease,no risk
Temsirolimus,Quizartinib,The serum concentration of Temsirolimus can be increased when it is combined with Quizartinib.,increase,no risk
Temsirolimus,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Temsirolimus.,increase,risk
Temsirolimus,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Udenafil,The metabolism of Temsirolimus can be decreased when combined with Udenafil.,decrease,no risk
Temsirolimus,Umbralisib,The serum concentration of Temsirolimus can be increased when it is combined with Umbralisib.,increase,no risk
Temsirolimus,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Upadacitinib,The risk or severity of adverse effects can be increased when Temsirolimus is combined with Upadacitinib.,increase,risk
Temsirolimus,Urokinase,The risk or severity of angioedema can be increased when Urokinase is combined with Temsirolimus.,increase,risk
Temsirolimus,Vadadustat,The serum concentration of Temsirolimus can be increased when it is combined with Vadadustat.,increase,no risk
Temsirolimus,Valbenazine,The metabolism of Temsirolimus can be decreased when combined with Valbenazine.,decrease,no risk
Temsirolimus,Valproic acid,The serum concentration of Temsirolimus can be increased when it is combined with Valproic acid.,increase,no risk
Temsirolimus,Valsartan,The risk or severity of angioedema can be increased when Valsartan is combined with Temsirolimus.,increase,risk
Temsirolimus,Vandetanib,The serum concentration of Temsirolimus can be increased when it is combined with Vandetanib.,increase,no risk
Temsirolimus,Vardenafil,The serum concentration of Temsirolimus can be increased when it is combined with Vardenafil.,increase,no risk
Temsirolimus,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Temsirolimus.,increase,risk
Temsirolimus,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Vedolizumab,The risk or severity of adverse effects can be increased when Temsirolimus is combined with Vedolizumab.,increase,risk
Temsirolimus,Velpatasvir,The serum concentration of Temsirolimus can be increased when it is combined with Velpatasvir.,increase,no risk
Temsirolimus,Vemurafenib,The serum concentration of Temsirolimus can be increased when it is combined with Vemurafenib.,increase,no risk
Temsirolimus,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Verapamil,The serum concentration of Temsirolimus can be increased when it is combined with Verapamil.,increase,no risk
Temsirolimus,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Vilanterol,The risk or severity of adverse effects can be increased when Temsirolimus is combined with Vilanterol.,increase,risk
Temsirolimus,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Temsirolimus.,decrease,no risk
Temsirolimus,Viloxazine,The metabolism of Temsirolimus can be decreased when combined with Viloxazine.,decrease,no risk
Temsirolimus,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Vincristine,The excretion of Vincristine can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Temsirolimus.,increase,risk
Temsirolimus,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Temsirolimus.,increase,no risk
Temsirolimus,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Temsirolimus.,increase,risk
Temsirolimus,Vitamin E,The metabolism of Temsirolimus can be increased when combined with Vitamin E.,increase,no risk
Temsirolimus,Voclosporin,The serum concentration of Temsirolimus can be increased when it is combined with Voclosporin.,increase,no risk
Temsirolimus,Vonoprazan,The metabolism of Temsirolimus can be decreased when combined with Vonoprazan.,decrease,no risk
Temsirolimus,Vorapaxar,The serum concentration of Temsirolimus can be increased when it is combined with Vorapaxar.,increase,no risk
Temsirolimus,Voriconazole,The serum concentration of Temsirolimus can be increased when it is combined with Voriconazole.,increase,no risk
Temsirolimus,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Temsirolimus.,increase,risk
Temsirolimus,Vortioxetine,The metabolism of Temsirolimus can be decreased when combined with Vortioxetine.,decrease,no risk
Temsirolimus,Voxelotor,The serum concentration of Temsirolimus can be increased when it is combined with Voxelotor.,increase,no risk
Temsirolimus,Voxilaprevir,The serum concentration of Temsirolimus can be increased when it is combined with Voxilaprevir.,increase,no risk
Temsirolimus,Warfarin,The metabolism of Temsirolimus can be increased when combined with Warfarin.,increase,no risk
Temsirolimus,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Temsirolimus.,increase,risk
Temsirolimus,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Temsirolimus.,increase,risk
Temsirolimus,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Zafirlukast,The serum concentration of Temsirolimus can be increased when it is combined with Zafirlukast.,increase,no risk
Temsirolimus,Zaleplon,The metabolism of Temsirolimus can be decreased when combined with Zaleplon.,decrease,no risk
Temsirolimus,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Temsirolimus.,increase,risk
Temsirolimus,Zimelidine,The metabolism of Temsirolimus can be decreased when combined with Zimelidine.,decrease,no risk
Temsirolimus,Ziprasidone,The metabolism of Temsirolimus can be decreased when combined with Ziprasidone.,decrease,no risk
Temsirolimus,Zofenopril,The risk or severity of angioedema can be increased when Temsirolimus is combined with Zofenopril.,increase,risk
Temsirolimus,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Temsirolimus.,decrease,no risk
Temsirolimus,Zonisamide,The serum concentration of Temsirolimus can be increased when it is combined with Zonisamide.,increase,no risk
Temsirolimus,Zuclopenthixol,The metabolism of Temsirolimus can be decreased when combined with Zuclopenthixol.,decrease,no risk
Amisulpride,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Amisulpride.,increase,risk
Amisulpride,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Amisulpride is combined with Gabapentin enacarbil.,increase,risk
Amisulpride,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Amisulpride.,increase,risk
Amisulpride,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Amisulpride.,increase,risk
Amisulpride,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Amisulpride.,increase,risk
Amisulpride,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Amisulpride is combined with Ganaxolone.",increase,risk
Amisulpride,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Amisulpride.,increase,risk
Amisulpride,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Amisulpride.,increase,risk
Amisulpride,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Amisulpride.,increase,risk
Amisulpride,Gilteritinib,The risk or severity of QTc prolongation can be increased when Gilteritinib is combined with Amisulpride.,increase,risk
Amisulpride,Glasdegib,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Glasdegib.,increase,risk
Amisulpride,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Amisulpride.,increase,risk
Amisulpride,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Amisulpride.,increase,risk
Amisulpride,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Amisulpride.,increase,risk
Amisulpride,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Grepafloxacin.,increase,risk
Amisulpride,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Amisulpride.,increase,risk
Amisulpride,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Amisulpride.,increase,risk
Amisulpride,Halofantrine,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Halofantrine.,increase,risk
Amisulpride,Haloperidol,Haloperidol may increase the antipsychotic activities of Amisulpride.,increase,no risk
Amisulpride,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Amisulpride.,increase,risk
Amisulpride,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Amisulpride.,increase,risk
Amisulpride,Histrelin,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Histrelin.,increase,risk
Amisulpride,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Amisulpride.,increase,risk
Amisulpride,Hydrocodone,Amisulpride may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Amisulpride,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Amisulpride.,increase,risk
Amisulpride,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Amisulpride.,increase,risk
Amisulpride,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Hydroxyzine.,increase,risk
Amisulpride,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Amisulpride.,increase,risk
Amisulpride,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Amisulpride.,increase,risk
Amisulpride,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Amisulpride.,increase,risk
Amisulpride,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Amisulpride.,increase,risk
Amisulpride,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Amisulpride.,increase,risk
Amisulpride,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Amisulpride.,increase,risk
Amisulpride,Olanzapine,Olanzapine may increase the antipsychotic activities of Amisulpride.,increase,no risk
Amisulpride,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Amisulpride is combined with Oliceridine.",increase,risk
Amisulpride,Olodaterol,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Olodaterol.,increase,risk
Amisulpride,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Amisulpride.,increase,risk
Amisulpride,Opicapone,The therapeutic efficacy of Opicapone can be decreased when used in combination with Amisulpride.,decrease,no risk
Amisulpride,Opium,The risk or severity of CNS depression can be increased when Amisulpride is combined with Opium.,increase,risk
Amisulpride,Orphenadrine,Amisulpride may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Amisulpride,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Amisulpride.,increase,risk
Amisulpride,Oxatomide,The risk or severity of QTc prolongation can be increased when Oxatomide is combined with Amisulpride.,increase,risk
Amisulpride,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Amisulpride.,increase,risk
Amisulpride,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Amisulpride.,increase,risk
Amisulpride,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Amisulpride.,increase,risk
Amisulpride,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Amisulpride.,increase,risk
Amisulpride,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Amisulpride.,increase,risk
Amisulpride,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Amisulpride.,increase,risk
Amisulpride,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Amisulpride.,increase,risk
Amisulpride,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Amisulpride.,increase,risk
Amisulpride,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Amisulpride.,increase,risk
Amisulpride,Quetiapine,Quetiapine may increase the antipsychotic activities of Amisulpride.,increase,no risk
Amisulpride,Quinagolide,The therapeutic efficacy of Quinagolide can be decreased when used in combination with Amisulpride.,decrease,no risk
Amisulpride,Quinidine,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Quinidine.,increase,risk
Amisulpride,Quinine,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Quinine.,increase,risk
Amisulpride,Quinupramine,The risk or severity of CNS depression can be increased when Amisulpride is combined with Quinupramine.,increase,risk
Amisulpride,Quizartinib,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Quizartinib.,increase,risk
Amisulpride,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Amisulpride.,increase,risk
Amisulpride,Valproate bismuth,Amisulpride may increase the neurotoxic activities of Valproate bismuth.,increase,no risk
Amisulpride,Valproic acid,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Valproic acid.,increase,risk
Amisulpride,Vandetanib,The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Vandetanib.,increase,risk
Amisulpride,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Amisulpride.,increase,risk
Amisulpride,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Amisulpride.,increase,risk
Amisulpride,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Amisulpride.,increase,risk
Amisulpride,Venlafaxine,The risk or severity of adverse effects can be increased when Venlafaxine is combined with Amisulpride.,increase,risk
Amisulpride,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Amisulpride.,increase,risk
Amisulpride,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Amisulpride.,increase,risk
Amisulpride,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Amisulpride.,increase,risk
Amisulpride,Vilazodone,The risk or severity of adverse effects can be increased when Vilazodone is combined with Amisulpride.,increase,risk
Amisulpride,Viloxazine,The risk or severity of CNS depression can be increased when Amisulpride is combined with Viloxazine.,increase,risk
Amisulpride,Vincristine,Vincristine may increase the neurotoxic activities of Amisulpride.,increase,no risk
Amisulpride,Vinorelbine,Vinorelbine may increase the neurotoxic activities of Amisulpride.,increase,no risk
Amisulpride,Viomycin,Amisulpride may increase the neurotoxic activities of Viomycin.,increase,no risk
Amisulpride,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Amisulpride.,increase,risk
Amisulpride,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Amisulpride.,increase,risk
Amisulpride,Vortioxetine,The risk or severity of adverse effects can be increased when Vortioxetine is combined with Amisulpride.,increase,risk
Amisulpride,Warfarin,The risk or severity of adverse effects can be increased when Amisulpride is combined with Warfarin.,increase,risk
Amisulpride,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Amisulpride.,increase,risk
Amisulpride,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Amisulpride.,increase,risk
Amisulpride,Ziconotide,The risk or severity of CNS depression can be increased when Amisulpride is combined with Ziconotide.,increase,risk
Amisulpride,Zimelidine,The risk or severity of adverse effects can be increased when Amisulpride is combined with Zimelidine.,increase,risk
Amisulpride,Ziprasidone,Ziprasidone may increase the antipsychotic activities of Amisulpride.,increase,no risk
Amisulpride,Zolmitriptan,The risk or severity of adverse effects can be increased when Zolmitriptan is combined with Amisulpride.,increase,risk
Amisulpride,Zolpidem,Amisulpride may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Amisulpride,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Amisulpride.,increase,risk
Amisulpride,Zopiclone,The risk or severity of adverse effects can be increased when Amisulpride is combined with Zopiclone.,increase,risk
Amisulpride,Zotepine,Zotepine may increase the antipsychotic activities of Amisulpride.,increase,no risk
Amisulpride,Zuclopenthixol,Zuclopenthixol may increase the antipsychotic activities of Amisulpride.,increase,no risk
Amisulpride,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Amisulpride.,increase,risk
Simeprevir,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Brivaracetam,The metabolism of Brivaracetam can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Bromocriptine,The metabolism of Bromocriptine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Budesonide,Simeprevir may decrease the excretion rate of Budesonide which could result in a higher serum level.,decrease,no risk
Simeprevir,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Buspirone,The metabolism of Buspirone can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Busulfan,The metabolism of Busulfan can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Galantamine,The metabolism of Galantamine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Glasdegib,The metabolism of Glasdegib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Glecaprevir,Simeprevir may decrease the excretion rate of Glecaprevir which could result in a higher serum level.,decrease,no risk
Simeprevir,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Simeprevir.,increase,no risk
Simeprevir,Glimepiride,Simeprevir may decrease the excretion rate of Glimepiride which could result in a higher serum level.,decrease,no risk
Simeprevir,Glipizide,Simeprevir may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Simeprevir,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Simeprevir.,increase,no risk
Simeprevir,Glofitamab,The serum concentration of Simeprevir can be increased when it is combined with Glofitamab.,increase,no risk
Simeprevir,Glyburide,Simeprevir may decrease the excretion rate of Glyburide which could result in a higher serum level.,decrease,no risk
Simeprevir,Glycyrrhizic acid,Simeprevir may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Simeprevir,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Simeprevir.,increase,no risk
Simeprevir,Granisetron,The metabolism of Granisetron can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Simeprevir.,decrease,no risk
Simeprevir,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Ketamine,The metabolism of Ketamine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Ketoconazole,The metabolism of Simeprevir can be decreased when combined with Ketoconazole.,decrease,no risk
Simeprevir,Ketoprofen,The risk or severity of adverse effects can be increased when Ketoprofen is combined with Simeprevir.,increase,risk
Simeprevir,Obeticholic acid,The risk or severity of adverse effects can be increased when Simeprevir is combined with Obeticholic acid.,increase,risk
Simeprevir,Ofloxacin,Simeprevir may decrease the excretion rate of Ofloxacin which could result in a higher serum level.,decrease,no risk
Simeprevir,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Olaparib,The metabolism of Olaparib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Olmesartan,The risk or severity of liver damage can be increased when Olmesartan is combined with Simeprevir.,increase,risk
Simeprevir,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Ombitasvir,Simeprevir may decrease the excretion rate of Ombitasvir which could result in a higher serum level.,decrease,no risk
Simeprevir,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Opium,The metabolism of Opium can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Oteseconazole,The serum concentration of Simeprevir can be increased when it is combined with Oteseconazole.,increase,no risk
Simeprevir,Ouabain,The excretion of Simeprevir can be decreased when combined with Ouabain.,decrease,no risk
Simeprevir,Oxaliplatin,Simeprevir may decrease the excretion rate of Oxaliplatin which could result in a higher serum level.,decrease,no risk
Simeprevir,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Ozanimod,Simeprevir may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Simeprevir,Quazepam,The metabolism of Quazepam can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Quinine,The metabolism of Quinine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Quizartinib,The metabolism of Quizartinib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Udenafil,The metabolism of Udenafil can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Umbralisib,The serum concentration of Simeprevir can be increased when it is combined with Umbralisib.,increase,no risk
Simeprevir,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Ursodeoxycholic acid,Simeprevir may decrease the excretion rate of Ursodeoxycholic acid which could result in a higher serum level.,decrease,no risk
Simeprevir,Vadadustat,The serum concentration of Simeprevir can be increased when it is combined with Vadadustat.,increase,no risk
Simeprevir,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Valsartan,The excretion of Simeprevir can be decreased when combined with Valsartan.,decrease,no risk
Simeprevir,Vamorolone,The metabolism of Vamorolone can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Simeprevir.,decrease,no risk
Simeprevir,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vemurafenib,The serum concentration of Simeprevir can be increased when it is combined with Vemurafenib.,increase,no risk
Simeprevir,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Verapamil,The metabolism of Simeprevir can be decreased when combined with Verapamil.,decrease,no risk
Simeprevir,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Simeprevir.,decrease,no risk
Simeprevir,Vilanterol,The metabolism of Vilanterol can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Simeprevir.,increase,no risk
Simeprevir,Viloxazine,The metabolism of Simeprevir can be decreased when combined with Viloxazine.,decrease,no risk
Simeprevir,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Vincristine,The excretion of Vincristine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vindesine,The metabolism of Vindesine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vismodegib,Vismodegib may decrease the excretion rate of Simeprevir which could result in a higher serum level.,decrease,no risk
Simeprevir,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Voriconazole,The metabolism of Simeprevir can be decreased when combined with Voriconazole.,decrease,no risk
Simeprevir,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Simeprevir.,decrease,no risk
Simeprevir,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zavegepant,The serum concentration of Zavegepant can be increased when it is combined with Simeprevir.,increase,no risk
Simeprevir,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zileuton,The metabolism of Zileuton can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zimelidine,The metabolism of Simeprevir can be decreased when combined with Zimelidine.,decrease,no risk
Simeprevir,Ziprasidone,The metabolism of Simeprevir can be decreased when combined with Ziprasidone.,decrease,no risk
Simeprevir,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zotepine,The metabolism of Zotepine can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Simeprevir.,decrease,no risk
Simeprevir,Zuranolone,The metabolism of Zuranolone can be decreased when combined with Simeprevir.,decrease,no risk
Icosapent ethyl,Gemcitabine,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Gemcitabine.,increase,risk
Icosapent ethyl,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Gemtuzumab ozogamicin.,increase,risk
Icosapent ethyl,Ginkgo biloba,Ginkgo biloba may increase the antiplatelet activities of Icosapent ethyl.,increase,no risk
Icosapent ethyl,Glucosamine,Glucosamine may increase the antiplatelet activities of Icosapent ethyl.,increase,no risk
Icosapent ethyl,Glycol salicylate,The risk or severity of bleeding can be increased when Glycol salicylate is combined with Icosapent ethyl.,increase,risk
Icosapent ethyl,Heparin,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Heparin.,increase,risk
Icosapent ethyl,Hydroxyurea,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Hydroxyurea.,increase,risk
Icosapent ethyl,Ketoprofen,The risk or severity of bleeding can be increased when Ketoprofen is combined with Icosapent ethyl.,increase,risk
Icosapent ethyl,Ketorolac,The risk or severity of bleeding can be increased when Ketorolac is combined with Icosapent ethyl.,increase,risk
Icosapent ethyl,Obeticholic acid,The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Obeticholic acid.,increase,risk
Icosapent ethyl,Obinutuzumab,The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Obinutuzumab.,increase,risk
Icosapent ethyl,Olaparib,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Olaparib.,increase,risk
Icosapent ethyl,Olsalazine,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Olsalazine.,increase,risk
Icosapent ethyl,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Icosapent ethyl.,increase,no risk
Icosapent ethyl,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Icosapent ethyl.,increase,risk
Icosapent ethyl,Oxaliplatin,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Oxaliplatin.,increase,risk
Icosapent ethyl,Oxaprozin,The risk or severity of bleeding can be increased when Oxaprozin is combined with Icosapent ethyl.,increase,risk
Icosapent ethyl,Oxyphenbutazone,The risk or severity of bleeding can be increased when Oxyphenbutazone is combined with Icosapent ethyl.,increase,risk
Icosapent ethyl,Urokinase,Icosapent ethyl may increase the anticoagulant activities of Urokinase.,increase,no risk
Icosapent ethyl,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Icosapent ethyl is combined with Ursodeoxycholic acid.,increase,risk
Icosapent ethyl,Valdecoxib,The risk or severity of bleeding can be increased when Valdecoxib is combined with Icosapent ethyl.,increase,risk
Icosapent ethyl,Venlafaxine,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Venlafaxine.,increase,risk
Icosapent ethyl,Vinblastine,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Vinblastine.,increase,risk
Icosapent ethyl,Vindesine,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Vindesine.,increase,risk
Icosapent ethyl,Vinorelbine,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Vinorelbine.,increase,risk
Icosapent ethyl,Vorapaxar,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Vorapaxar.,increase,risk
Icosapent ethyl,Vorinostat,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Vorinostat.,increase,risk
Icosapent ethyl,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Icosapent ethyl.,increase,risk
Icosapent ethyl,Warfarin,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Warfarin.,increase,risk
Icosapent ethyl,Ximelagatran,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Ximelagatran.,increase,risk
Icosapent ethyl,Zidovudine,The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Zidovudine.,increase,risk
Icosapent ethyl,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Icosapent ethyl.,increase,risk
Dapagliflozin,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Bosentan,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Bosentan.,increase,no risk
Dapagliflozin,Bretylium,The risk or severity of adverse effects can be increased when Bretylium is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Brexpiprazole,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Dapagliflozin,Brivaracetam,The metabolism of Dapagliflozin can be decreased when combined with Brivaracetam.,decrease,no risk
Dapagliflozin,Bromazepam,The metabolism of Bromazepam can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Bromocriptine,Dapagliflozin may increase the hypoglycemic activities of Bromocriptine.,increase,no risk
Dapagliflozin,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Bumetanide,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Bumetanide.,decrease,no risk
Dapagliflozin,Bupivacaine,The risk or severity of adverse effects can be increased when Bupivacaine is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Buprenorphine,The metabolism of Dapagliflozin can be decreased when combined with Buprenorphine.,decrease,no risk
Dapagliflozin,Bupropion,The metabolism of Dapagliflozin can be decreased when combined with Bupropion.,decrease,no risk
Dapagliflozin,Buserelin,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Buserelin.,decrease,no risk
Dapagliflozin,Buspirone,The metabolism of Dapagliflozin can be decreased when combined with Buspirone.,decrease,no risk
Dapagliflozin,Butabarbital,Butabarbital may increase the hypotensive activities of Dapagliflozin.,increase,no risk
Dapagliflozin,Butalbital,Butalbital may increase the hypotensive activities of Dapagliflozin.,increase,no risk
Dapagliflozin,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Dapagliflozin.,decrease,no risk
Dapagliflozin,Galantamine,The metabolism of Dapagliflozin can be decreased when combined with Galantamine.,decrease,no risk
Dapagliflozin,Gatifloxacin,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Gatifloxacin.,increase,no risk
Dapagliflozin,Gefapixant,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Gefapixant.,increase,no risk
Dapagliflozin,Gefitinib,The metabolism of Dapagliflozin can be decreased when combined with Gefitinib.,decrease,no risk
Dapagliflozin,Gemfibrozil,The metabolism of Dapagliflozin can be decreased when combined with Gemfibrozil.,decrease,no risk
Dapagliflozin,Gemifloxacin,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Gemifloxacin.,increase,no risk
Dapagliflozin,Ginkgo biloba,The metabolism of Dapagliflozin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Dapagliflozin,Givosiran,The serum concentration of Dapagliflozin can be increased when it is combined with Givosiran.,increase,no risk
Dapagliflozin,Gliclazide,Dapagliflozin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Dapagliflozin,Glimepiride,Dapagliflozin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Dapagliflozin,Glipizide,Dapagliflozin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Dapagliflozin,Gliquidone,Dapagliflozin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Dapagliflozin,Glofitamab,The serum concentration of Dapagliflozin can be increased when it is combined with Glofitamab.,increase,no risk
Dapagliflozin,Glyburide,Dapagliflozin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Dapagliflozin,Glycerol phenylbutyrate,The metabolism of Dapagliflozin can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Dapagliflozin,Glymidine,Dapagliflozin may increase the hypoglycemic activities of Glymidine.,increase,no risk
Dapagliflozin,Golimumab,The metabolism of Dapagliflozin can be increased when combined with Golimumab.,increase,no risk
Dapagliflozin,Goserelin,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Goserelin.,decrease,no risk
Dapagliflozin,Grepafloxacin,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Grepafloxacin.,increase,no risk
Dapagliflozin,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Guanadrel,Dapagliflozin may increase the hypotensive activities of Guanadrel.,increase,no risk
Dapagliflozin,Guanethidine,Dapagliflozin may increase the hypotensive activities of Guanethidine.,increase,no risk
Dapagliflozin,Guanfacine,The risk or severity of adverse effects can be increased when Guanfacine is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Guanoxan,Dapagliflozin may increase the hypotensive activities of Guanoxan.,increase,no risk
Dapagliflozin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Halofantrine,The metabolism of Dapagliflozin can be decreased when combined with Halofantrine.,decrease,no risk
Dapagliflozin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Dapagliflozin.,increase,no risk
Dapagliflozin,Halothane,The metabolism of Dapagliflozin can be decreased when combined with Halothane.,decrease,no risk
Dapagliflozin,Histrelin,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Histrelin.,decrease,no risk
Dapagliflozin,Hydralazine,The risk or severity of adverse effects can be increased when Hydralazine is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Hydrochlorothiazide,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Dapagliflozin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Hydroflumethiazide,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Dapagliflozin,Hydromorphone,The metabolism of Dapagliflozin can be decreased when combined with Hydromorphone.,decrease,no risk
Dapagliflozin,Hydroxychloroquine,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Dapagliflozin,Hydroxyprogesterone caproate,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Dapagliflozin,Hydroxyzine,The metabolism of Dapagliflozin can be decreased when combined with Hydroxyzine.,decrease,no risk
Dapagliflozin,Ketamine,The metabolism of Dapagliflozin can be decreased when combined with Ketamine.,decrease,no risk
Dapagliflozin,Ketoconazole,The metabolism of Dapagliflozin can be decreased when combined with Ketoconazole.,decrease,no risk
Dapagliflozin,Ketorolac,The metabolism of Dapagliflozin can be decreased when combined with Ketorolac.,decrease,no risk
Dapagliflozin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Dapagliflozin is combined with Ketotifen.,increase,risk
Dapagliflozin,Obeticholic acid,The metabolism of Dapagliflozin can be decreased when combined with Obeticholic acid.,decrease,no risk
Dapagliflozin,Obinutuzumab,The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Obinutuzumab.,increase,risk
Dapagliflozin,Octreotide,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Octreotide.,decrease,no risk
Dapagliflozin,Ofloxacin,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Ofloxacin.,increase,no risk
Dapagliflozin,Olanzapine,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Olanzapine.,decrease,no risk
Dapagliflozin,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Olmesartan,The risk or severity of adverse effects can be increased when Olmesartan is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Olsalazine,Olsalazine may increase the hypoglycemic activities of Dapagliflozin.,increase,no risk
Dapagliflozin,Omaveloxolone,The serum concentration of Dapagliflozin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dapagliflozin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Opicapone,The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Opicapone.,increase,risk
Dapagliflozin,Opium,The metabolism of Opium can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Oritavancin,The metabolism of Dapagliflozin can be decreased when combined with Oritavancin.,decrease,no risk
Dapagliflozin,Orphenadrine,The metabolism of Dapagliflozin can be decreased when combined with Orphenadrine.,decrease,no risk
Dapagliflozin,Osilodrostat,The metabolism of Dapagliflozin can be decreased when combined with Osilodrostat.,decrease,no risk
Dapagliflozin,Osimertinib,The serum concentration of Dapagliflozin can be decreased when it is combined with Osimertinib.,decrease,no risk
Dapagliflozin,Ospemifene,The metabolism of Dapagliflozin can be decreased when combined with Ospemifene.,decrease,no risk
Dapagliflozin,Oxamniquine,The metabolism of Dapagliflozin can be decreased when combined with Oxamniquine.,decrease,no risk
Dapagliflozin,Oxandrolone,The metabolism of Dapagliflozin can be decreased when combined with Oxandrolone.,decrease,no risk
Dapagliflozin,Oxprenolol,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Oxprenolol.,increase,no risk
Dapagliflozin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Oxybutynin,The metabolism of Dapagliflozin can be decreased when combined with Oxybutynin.,decrease,no risk
Dapagliflozin,Oxycodone,The metabolism of Dapagliflozin can be decreased when combined with Oxycodone.,decrease,no risk
Dapagliflozin,Oxymetholone,Oxymetholone may increase the hypoglycemic activities of Dapagliflozin.,increase,no risk
Dapagliflozin,Oxymorphone,The metabolism of Dapagliflozin can be decreased when combined with Oxymorphone.,decrease,no risk
Dapagliflozin,Quetiapine,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Quetiapine.,decrease,no risk
Dapagliflozin,Quinapril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Quinapril.",increase,risk
Dapagliflozin,Quinethazone,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Quinethazone.,decrease,no risk
Dapagliflozin,Quinidine,The metabolism of Dapagliflozin can be decreased when combined with Quinidine.,decrease,no risk
Dapagliflozin,Quinine,The metabolism of Dapagliflozin can be decreased when combined with Quinine.,decrease,no risk
Dapagliflozin,Quinupramine,Quinupramine may decrease the hypoglycemic activities of Dapagliflozin.,decrease,no risk
Dapagliflozin,Ubidecarenone,The risk or severity of hypoglycemia can be increased when Ubidecarenone is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Udenafil,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Udenafil.,increase,no risk
Dapagliflozin,Ulobetasol,The risk or severity of hyperglycemia can be increased when Ulobetasol is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Vadadustat,The serum concentration of Dapagliflozin can be increased when it is combined with Vadadustat.,increase,no risk
Dapagliflozin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Valdecoxib,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Valdecoxib.,increase,no risk
Dapagliflozin,Valproic acid,The metabolism of Dapagliflozin can be decreased when combined with Valproic acid.,decrease,no risk
Dapagliflozin,Valsartan,The metabolism of Dapagliflozin can be decreased when combined with Valsartan.,decrease,no risk
Dapagliflozin,Vamorolone,The risk or severity of hyperglycemia can be increased when Vamorolone is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Vardenafil,The metabolism of Dapagliflozin can be decreased when combined with Vardenafil.,decrease,no risk
Dapagliflozin,Vemurafenib,The serum concentration of Dapagliflozin can be increased when it is combined with Vemurafenib.,increase,no risk
Dapagliflozin,Venetoclax,The metabolism of Dapagliflozin can be decreased when combined with Venetoclax.,decrease,no risk
Dapagliflozin,Venlafaxine,The metabolism of Dapagliflozin can be decreased when combined with Venlafaxine.,decrease,no risk
Dapagliflozin,Verapamil,The metabolism of Dapagliflozin can be decreased when combined with Verapamil.,decrease,no risk
Dapagliflozin,Vericiguat,The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Vericiguat.,increase,risk
Dapagliflozin,Vernakalant,The metabolism of Dapagliflozin can be decreased when combined with Vernakalant.,decrease,no risk
Dapagliflozin,Vilazodone,The metabolism of Dapagliflozin can be decreased when combined with Vilazodone.,decrease,no risk
Dapagliflozin,Vildagliptin,Dapagliflozin may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Dapagliflozin,Viloxazine,The metabolism of Dapagliflozin can be decreased when combined with Viloxazine.,decrease,no risk
Dapagliflozin,Vinblastine,The metabolism of Dapagliflozin can be decreased when combined with Vinblastine.,decrease,no risk
Dapagliflozin,Vinorelbine,The metabolism of Dapagliflozin can be decreased when combined with Vinorelbine.,decrease,no risk
Dapagliflozin,Voriconazole,The metabolism of Dapagliflozin can be decreased when combined with Voriconazole.,decrease,no risk
Dapagliflozin,Vorinostat,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Vorinostat.,decrease,no risk
Dapagliflozin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Warfarin,The metabolism of Warfarin can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Ximelagatran,The metabolism of Dapagliflozin can be decreased when combined with Ximelagatran.,decrease,no risk
Dapagliflozin,Xylometazoline,The risk or severity of hypoglycemia can be increased when Xylometazoline is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Yohimbine,The metabolism of Dapagliflozin can be decreased when combined with Yohimbine.,decrease,no risk
Dapagliflozin,Zafirlukast,The metabolism of Dapagliflozin can be decreased when combined with Zafirlukast.,decrease,no risk
Dapagliflozin,Ziconotide,The risk or severity of hypoglycemia can be increased when Ziconotide is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Zidovudine,The metabolism of Dapagliflozin can be decreased when combined with Zidovudine.,decrease,no risk
Dapagliflozin,Zileuton,The metabolism of Dapagliflozin can be decreased when combined with Zileuton.,decrease,no risk
Dapagliflozin,Zimelidine,The risk or severity of hypoglycemia can be increased when Zimelidine is combined with Dapagliflozin.,increase,risk
Dapagliflozin,Ziprasidone,The therapeutic efficacy of Dapagliflozin can be decreased when used in combination with Ziprasidone.,decrease,no risk
Dapagliflozin,Zofenopril,"The risk or severity of renal failure, hypotension, and hyperkalemia can be increased when Dapagliflozin is combined with Zofenopril.",increase,risk
Dapagliflozin,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Dapagliflozin.,decrease,no risk
Dapagliflozin,Zonisamide,The therapeutic efficacy of Dapagliflozin can be increased when used in combination with Zonisamide.,increase,no risk
Dapagliflozin,Zopiclone,The metabolism of Dapagliflozin can be decreased when combined with Zopiclone.,decrease,no risk
Dapagliflozin,Zotepine,The metabolism of Zotepine can be decreased when combined with Dapagliflozin.,decrease,no risk
Semuloparin,Gemcitabine,The risk or severity of bleeding can be increased when Semuloparin is combined with Gemcitabine.,increase,risk
Semuloparin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Semuloparin is combined with Gemtuzumab ozogamicin.,increase,risk
Semuloparin,Gentamicin,The therapeutic efficacy of Gentamicin can be decreased when used in combination with Semuloparin.,decrease,no risk
Semuloparin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Semuloparin.,increase,risk
Semuloparin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Semuloparin.,increase,no risk
Semuloparin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Semuloparin.,increase,risk
Semuloparin,Hemin,Hemin may increase the anticoagulant activities of Semuloparin.,increase,no risk
Semuloparin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Semuloparin.,increase,risk
Semuloparin,Hydrochlorothiazide,The therapeutic efficacy of Semuloparin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Semuloparin,Hydroflumethiazide,The therapeutic efficacy of Semuloparin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Semuloparin,Hydroxyprogesterone caproate,The therapeutic efficacy of Semuloparin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Semuloparin,Hydroxyurea,The risk or severity of bleeding can be increased when Semuloparin is combined with Hydroxyurea.,increase,risk
Semuloparin,Kanamycin,The therapeutic efficacy of Kanamycin can be decreased when used in combination with Semuloparin.,decrease,no risk
Semuloparin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Semuloparin.,increase,risk
Semuloparin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Semuloparin.,increase,risk
Semuloparin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Semuloparin is combined with Obeticholic acid.,increase,risk
Semuloparin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Semuloparin is combined with Obinutuzumab.,increase,risk
Semuloparin,Olaparib,The risk or severity of bleeding can be increased when Semuloparin is combined with Olaparib.,increase,risk
Semuloparin,Olive oil,The therapeutic efficacy of Semuloparin can be decreased when used in combination with Olive oil.,decrease,no risk
Semuloparin,Olmesartan,The risk or severity of hyperkalemia can be increased when Semuloparin is combined with Olmesartan.,increase,risk
Semuloparin,Olsalazine,The risk or severity of bleeding can be increased when Semuloparin is combined with Olsalazine.,increase,risk
Semuloparin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Semuloparin is combined with Omacetaxine mepesuccinate.,increase,risk
Semuloparin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Semuloparin.,increase,no risk
Semuloparin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Semuloparin.,increase,risk
Semuloparin,Omega-3-carboxylic acids,The therapeutic efficacy of Semuloparin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Semuloparin,Oritavancin,The therapeutic efficacy of Semuloparin can be decreased when used in combination with Oritavancin.,decrease,no risk
Semuloparin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Semuloparin.,increase,risk
Semuloparin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Semuloparin.,increase,risk
Semuloparin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Semuloparin.,increase,risk
Semuloparin,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Semuloparin.,increase,risk
Semuloparin,Quinestrol,Quinestrol may decrease the anticoagulant activities of Semuloparin.,decrease,no risk
Semuloparin,Quinidine,The therapeutic efficacy of Semuloparin can be increased when used in combination with Quinidine.,increase,no risk
Semuloparin,Quinine,The therapeutic efficacy of Semuloparin can be increased when used in combination with Quinine.,increase,no risk
Semuloparin,Ulipristal,The therapeutic efficacy of Semuloparin can be decreased when used in combination with Ulipristal.,decrease,no risk
Semuloparin,Urokinase,Urokinase may increase the anticoagulant activities of Semuloparin.,increase,no risk
Semuloparin,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Semuloparin is combined with Ursodeoxycholic acid.,increase,risk
Semuloparin,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Semuloparin.,increase,risk
Semuloparin,Valsartan,The risk or severity of hyperkalemia can be increased when Semuloparin is combined with Valsartan.,increase,risk
Semuloparin,Vasopressin,The therapeutic efficacy of Vasopressin can be decreased when used in combination with Semuloparin.,decrease,no risk
Semuloparin,Venlafaxine,The risk or severity of bleeding can be increased when Semuloparin is combined with Venlafaxine.,increase,risk
Semuloparin,Vinblastine,The risk or severity of bleeding can be increased when Semuloparin is combined with Vinblastine.,increase,risk
Semuloparin,Vindesine,The risk or severity of bleeding can be increased when Semuloparin is combined with Vindesine.,increase,risk
Semuloparin,Vinorelbine,The risk or severity of bleeding can be increased when Semuloparin is combined with Vinorelbine.,increase,risk
Semuloparin,Vitamin E,Vitamin E may increase the anticoagulant activities of Semuloparin.,increase,no risk
Semuloparin,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Semuloparin.,decrease,no risk
Semuloparin,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Semuloparin.,increase,risk
Semuloparin,Vorinostat,The risk or severity of bleeding can be increased when Semuloparin is combined with Vorinostat.,increase,risk
Semuloparin,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Semuloparin.,increase,risk
Semuloparin,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Semuloparin.,increase,risk
Semuloparin,Zidovudine,The risk or severity of bleeding can be increased when Semuloparin is combined with Zidovudine.,increase,risk
Semuloparin,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Semuloparin.,increase,risk
Semuloparin,Zofenopril,The risk or severity of hyperkalemia can be increased when Zofenopril is combined with Semuloparin.,increase,risk
Trenonacog alfa,Bemiparin,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Bemiparin.,decrease,no risk
Trenonacog alfa,Betrixaban,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Betrixaban.,decrease,no risk
Trenonacog alfa,Bivalirudin,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Bivalirudin.,decrease,no risk
Trenonacog alfa,Heparin,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Heparin.,decrease,no risk
Trenonacog alfa,Hydrogen peroxide,Hydrogen peroxide may increase the thrombogenic activities of Trenonacog alfa.,increase,no risk
Trenonacog alfa,Urokinase,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Urokinase.,decrease,no risk
Trenonacog alfa,Vorapaxar,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Vorapaxar.,decrease,no risk
Trenonacog alfa,Warfarin,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Warfarin.,decrease,no risk
Trenonacog alfa,Ximelagatran,The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Ximelagatran.,decrease,no risk
Ponatinib,Bendroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Ponatinib.,increase,risk
Ponatinib,Benzatropine,The metabolism of Ponatinib can be decreased when combined with Benzatropine.,decrease,no risk
Ponatinib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Ponatinib is combined with Benzocaine.,increase,risk
Ponatinib,Benzthiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Ponatinib.,increase,risk
Ponatinib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Ponatinib is combined with Benzyl alcohol.,increase,risk
Ponatinib,Bepridil,The metabolism of Ponatinib can be decreased when combined with Bepridil.,decrease,no risk
Ponatinib,Berotralstat,The serum concentration of Berotralstat can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Betamethasone,The metabolism of Ponatinib can be increased when combined with Betamethasone.,increase,no risk
Ponatinib,Betamethasone phosphate,The metabolism of Ponatinib can be increased when combined with Betamethasone phosphate.,increase,no risk
Ponatinib,Betaxolol,The metabolism of Ponatinib can be decreased when combined with Betaxolol.,decrease,no risk
Ponatinib,Betrixaban,The serum concentration of Betrixaban can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Bexarotene,The metabolism of Ponatinib can be increased when combined with Bexarotene.,increase,no risk
Ponatinib,Bezafibrate,The metabolism of Ponatinib can be decreased when combined with Bezafibrate.,decrease,no risk
Ponatinib,Bicalutamide,The metabolism of Ponatinib can be decreased when combined with Bicalutamide.,decrease,no risk
Ponatinib,Bifonazole,The metabolism of Ponatinib can be decreased when combined with Bifonazole.,decrease,no risk
Ponatinib,Bimekizumab,The metabolism of Ponatinib can be increased when combined with Bimekizumab.,increase,no risk
Ponatinib,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Biperiden,The metabolism of Ponatinib can be decreased when combined with Biperiden.,decrease,no risk
Ponatinib,Bisoprolol,The serum concentration of Bisoprolol can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Bivalirudin,The risk or severity of bleeding can be increased when Bivalirudin is combined with Ponatinib.,increase,risk
Ponatinib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Ponatinib.,increase,risk
Ponatinib,Blinatumomab,The risk or severity of adverse effects can be increased when Ponatinib is combined with Blinatumomab.,increase,risk
Ponatinib,Boceprevir,The metabolism of Ponatinib can be decreased when combined with Boceprevir.,decrease,no risk
Ponatinib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Ponatinib.",decrease,no risk
Ponatinib,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Bosentan,The metabolism of Ponatinib can be increased when combined with Bosentan.,increase,no risk
Ponatinib,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Brexpiprazole,The metabolism of Ponatinib can be decreased when combined with Brexpiprazole.,decrease,no risk
Ponatinib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Ponatinib.,decrease,no risk
Ponatinib,Brodalumab,The risk or severity of adverse effects can be increased when Ponatinib is combined with Brodalumab.,increase,risk
Ponatinib,Budesonide,The metabolism of Ponatinib can be increased when combined with Budesonide.,increase,no risk
Ponatinib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Ponatinib is combined with Bupivacaine.,increase,risk
Ponatinib,Buprenorphine,The metabolism of Ponatinib can be decreased when combined with Buprenorphine.,decrease,no risk
Ponatinib,Bupropion,The metabolism of Ponatinib can be decreased when combined with Bupropion.,decrease,no risk
Ponatinib,Buspirone,The metabolism of Ponatinib can be decreased when combined with Buspirone.,decrease,no risk
Ponatinib,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Ponatinib.,increase,risk
Ponatinib,Butacaine,The risk or severity of methemoglobinemia can be increased when Ponatinib is combined with Butacaine.,increase,risk
Ponatinib,Butalbital,The metabolism of Ponatinib can be increased when combined with Butalbital.,increase,no risk
Ponatinib,Butamben,The risk or severity of methemoglobinemia can be increased when Ponatinib is combined with Butamben.,increase,risk
Ponatinib,Galantamine,The metabolism of Ponatinib can be decreased when combined with Galantamine.,decrease,no risk
Ponatinib,Gefitinib,The metabolism of Ponatinib can be decreased when combined with Gefitinib.,decrease,no risk
Ponatinib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Gemfibrozil,The metabolism of Ponatinib can be decreased when combined with Gemfibrozil.,decrease,no risk
Ponatinib,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Ponatinib.,increase,risk
Ponatinib,Gilteritinib,The metabolism of Ponatinib can be decreased when combined with Gilteritinib.,decrease,no risk
Ponatinib,Ginkgo biloba,The metabolism of Ponatinib can be decreased when combined with Ginkgo biloba.,decrease,no risk
Ponatinib,Givosiran,The serum concentration of Ponatinib can be increased when it is combined with Givosiran.,increase,no risk
Ponatinib,Glasdegib,The metabolism of Ponatinib can be decreased when combined with Glasdegib.,decrease,no risk
Ponatinib,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Ponatinib.,increase,risk
Ponatinib,Glecaprevir,The metabolism of Ponatinib can be decreased when combined with Glecaprevir.,decrease,no risk
Ponatinib,Glofitamab,The serum concentration of Ponatinib can be increased when it is combined with Glofitamab.,increase,no risk
Ponatinib,Glyburide,The metabolism of Ponatinib can be decreased when combined with Glyburide.,decrease,no risk
Ponatinib,Glycerol phenylbutyrate,The metabolism of Ponatinib can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Ponatinib,Golimumab,The metabolism of Ponatinib can be increased when combined with Golimumab.,increase,no risk
Ponatinib,Grapefruit,The serum concentration of Ponatinib can be increased when it is combined with Grapefruit.,increase,no risk
Ponatinib,Grazoprevir,Grazoprevir may decrease the excretion rate of Ponatinib which could result in a higher serum level.,decrease,no risk
Ponatinib,Griseofulvin,The metabolism of Ponatinib can be increased when combined with Griseofulvin.,increase,no risk
Ponatinib,Guselkumab,The risk or severity of adverse effects can be increased when Ponatinib is combined with Guselkumab.,increase,risk
Ponatinib,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Ponatinib.,decrease,no risk
Ponatinib,Halofantrine,The metabolism of Ponatinib can be decreased when combined with Halofantrine.,decrease,no risk
Ponatinib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Ponatinib.,increase,risk
Ponatinib,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Ponatinib.,decrease,no risk
Ponatinib,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Ponatinib.,decrease,no risk
Ponatinib,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Ponatinib.,increase,risk
Ponatinib,Hydralazine,The serum concentration of Ponatinib can be increased when it is combined with Hydralazine.,increase,no risk
Ponatinib,Hydrochlorothiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Ponatinib.,increase,risk
Ponatinib,Hydrocodone,The metabolism of Ponatinib can be decreased when combined with Hydrocodone.,decrease,no risk
Ponatinib,Hydrocortamate,The metabolism of Ponatinib can be increased when combined with Hydrocortamate.,increase,no risk
Ponatinib,Hydrocortisone,The metabolism of Ponatinib can be increased when combined with Hydrocortisone.,increase,no risk
Ponatinib,Hydrocortisone acetate,The metabolism of Ponatinib can be increased when combined with Hydrocortisone acetate.,increase,no risk
Ponatinib,Hydrocortisone butyrate,The metabolism of Ponatinib can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Ponatinib,Hydrocortisone cypionate,The metabolism of Ponatinib can be decreased when combined with Hydrocortisone cypionate.,decrease,no risk
Ponatinib,Hydrocortisone phosphate,The metabolism of Ponatinib can be decreased when combined with Hydrocortisone phosphate.,decrease,no risk
Ponatinib,Hydrocortisone succinate,The metabolism of Ponatinib can be increased when combined with Hydrocortisone succinate.,increase,no risk
Ponatinib,Hydroflumethiazide,The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Ponatinib.,increase,risk
Ponatinib,Hydroxychloroquine,The metabolism of Ponatinib can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Ponatinib,Hydroxyprogesterone caproate,The metabolism of Ponatinib can be decreased when combined with Hydroxyprogesterone caproate.,decrease,no risk
Ponatinib,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Ponatinib.,increase,risk
Ponatinib,Hydroxyzine,The metabolism of Ponatinib can be decreased when combined with Hydroxyzine.,decrease,no risk
Ponatinib,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Ponatinib.,decrease,no risk
Ponatinib,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Ponatinib.,decrease,no risk
Ponatinib,Ketamine,The metabolism of Ponatinib can be decreased when combined with Ketamine.,decrease,no risk
Ponatinib,Ketazolam,The serum concentration of Ponatinib can be increased when it is combined with Ketazolam.,increase,no risk
Ponatinib,Ketoconazole,The metabolism of Ponatinib can be decreased when combined with Ketoconazole.,decrease,no risk
Ponatinib,Ketoprofen,The metabolism of Ponatinib can be decreased when combined with Ketoprofen.,decrease,no risk
Ponatinib,Ketorolac,The metabolism of Ponatinib can be decreased when combined with Ketorolac.,decrease,no risk
Ponatinib,Obinutuzumab,The risk or severity of adverse effects can be increased when Ponatinib is combined with Obinutuzumab.,increase,risk
Ponatinib,Ocrelizumab,The risk or severity of adverse effects can be increased when Ponatinib is combined with Ocrelizumab.,increase,risk
Ponatinib,Octreotide,The serum concentration of Ponatinib can be increased when it is combined with Octreotide.,increase,no risk
Ponatinib,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Ponatinib.,increase,risk
Ponatinib,Olanzapine,The metabolism of Ponatinib can be decreased when combined with Olanzapine.,decrease,no risk
Ponatinib,Olaparib,The metabolism of Ponatinib can be decreased when combined with Olaparib.,decrease,no risk
Ponatinib,Oliceridine,The metabolism of Ponatinib can be decreased when combined with Oliceridine.,decrease,no risk
Ponatinib,Olodaterol,The metabolism of Ponatinib can be decreased when combined with Olodaterol.,decrease,no risk
Ponatinib,Olutasidenib,The metabolism of Ponatinib can be increased when combined with Olutasidenib.,increase,no risk
Ponatinib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Omaveloxolone,The serum concentration of Ponatinib can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ponatinib,Ombitasvir,The metabolism of Ponatinib can be decreased when combined with Ombitasvir.,decrease,no risk
Ponatinib,Ondansetron,The metabolism of Ponatinib can be decreased when combined with Ondansetron.,decrease,no risk
Ponatinib,Opium,The metabolism of Ponatinib can be decreased when combined with Opium.,decrease,no risk
Ponatinib,Oritavancin,The metabolism of Ponatinib can be increased when combined with Oritavancin.,increase,no risk
Ponatinib,Orphenadrine,The metabolism of Ponatinib can be decreased when combined with Orphenadrine.,decrease,no risk
Ponatinib,Osilodrostat,The metabolism of Ponatinib can be decreased when combined with Osilodrostat.,decrease,no risk
Ponatinib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Ospemifene,The metabolism of Ponatinib can be decreased when combined with Ospemifene.,decrease,no risk
Ponatinib,Oteseconazole,The serum concentration of Ponatinib can be increased when it is combined with Oteseconazole.,increase,no risk
Ponatinib,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Ponatinib.,increase,risk
Ponatinib,Oxamniquine,The metabolism of Ponatinib can be decreased when combined with Oxamniquine.,decrease,no risk
Ponatinib,Oxcarbazepine,The metabolism of Ponatinib can be increased when combined with Oxcarbazepine.,increase,no risk
Ponatinib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ponatinib is combined with Oxetacaine.,increase,risk
Ponatinib,Oxprenolol,The metabolism of Ponatinib can be decreased when combined with Oxprenolol.,decrease,no risk
Ponatinib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ponatinib is combined with Oxybuprocaine.,increase,risk
Ponatinib,Oxybutynin,The serum concentration of Ponatinib can be increased when it is combined with Oxybutynin.,increase,no risk
Ponatinib,Oxycodone,The metabolism of Ponatinib can be decreased when combined with Oxycodone.,decrease,no risk
Ponatinib,Oxymorphone,The metabolism of Ponatinib can be decreased when combined with Oxymorphone.,decrease,no risk
Ponatinib,Ozanimod,Ponatinib may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Ponatinib,Quetiapine,The metabolism of Ponatinib can be decreased when combined with Quetiapine.,decrease,no risk
Ponatinib,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Quinine,The metabolism of Ponatinib can be decreased when combined with Quinine.,decrease,no risk
Ponatinib,Quinupristin,The metabolism of Ponatinib can be decreased when combined with Quinupristin.,decrease,no risk
Ponatinib,Quizartinib,The metabolism of Ponatinib can be decreased when combined with Quizartinib.,decrease,no risk
Ponatinib,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Ponatinib.,increase,risk
Ponatinib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Udenafil,The metabolism of Ponatinib can be decreased when combined with Udenafil.,decrease,no risk
Ponatinib,Umeclidinium,The metabolism of Ponatinib can be decreased when combined with Umeclidinium.,decrease,no risk
Ponatinib,Upadacitinib,The risk or severity of adverse effects can be increased when Ponatinib is combined with Upadacitinib.,increase,risk
Ponatinib,Urokinase,The risk or severity of bleeding can be increased when Urokinase is combined with Ponatinib.,increase,risk
Ponatinib,Vadadustat,The serum concentration of Ponatinib can be increased when it is combined with Vadadustat.,increase,no risk
Ponatinib,Valbenazine,The metabolism of Ponatinib can be decreased when combined with Valbenazine.,decrease,no risk
Ponatinib,Valoctocogene roxaparvovec,The therapeutic efficacy of Valoctocogene roxaparvovec can be decreased when used in combination with Ponatinib.,decrease,no risk
Ponatinib,Valproic acid,The serum concentration of Ponatinib can be increased when it is combined with Valproic acid.,increase,no risk
Ponatinib,Vandetanib,Vandetanib may decrease the excretion rate of Ponatinib which could result in a higher serum level.,decrease,no risk
Ponatinib,Vardenafil,The metabolism of Ponatinib can be decreased when combined with Vardenafil.,decrease,no risk
Ponatinib,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Ponatinib.,increase,risk
Ponatinib,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Ponatinib.,decrease,no risk
Ponatinib,Vedolizumab,The risk or severity of adverse effects can be increased when Ponatinib is combined with Vedolizumab.,increase,risk
Ponatinib,Velpatasvir,The metabolism of Ponatinib can be decreased when combined with Velpatasvir.,decrease,no risk
Ponatinib,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Venlafaxine,The metabolism of Ponatinib can be decreased when combined with Venlafaxine.,decrease,no risk
Ponatinib,Verapamil,The metabolism of Ponatinib can be decreased when combined with Verapamil.,decrease,no risk
Ponatinib,Vernakalant,The metabolism of Ponatinib can be decreased when combined with Vernakalant.,decrease,no risk
Ponatinib,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ponatinib.,decrease,no risk
Ponatinib,Vilanterol,The risk or severity of adverse effects can be increased when Ponatinib is combined with Vilanterol.,increase,risk
Ponatinib,Vilazodone,The metabolism of Ponatinib can be decreased when combined with Vilazodone.,decrease,no risk
Ponatinib,Viloxazine,The metabolism of Ponatinib can be decreased when combined with Viloxazine.,decrease,no risk
Ponatinib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Vincristine,The excretion of Vincristine can be decreased when combined with Ponatinib.,decrease,no risk
Ponatinib,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Ponatinib.,increase,risk
Ponatinib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Ponatinib.,increase,no risk
Ponatinib,Vinorelbine,The metabolism of Ponatinib can be decreased when combined with Vinorelbine.,decrease,no risk
Ponatinib,Vismodegib,Vismodegib may decrease the excretion rate of Ponatinib which could result in a higher serum level.,decrease,no risk
Ponatinib,Vitamin E,The metabolism of Ponatinib can be increased when combined with Vitamin E.,increase,no risk
Ponatinib,Voclosporin,The risk or severity of adverse effects can be increased when Ponatinib is combined with Voclosporin.,increase,risk
Ponatinib,Vonoprazan,The metabolism of Ponatinib can be decreased when combined with Vonoprazan.,decrease,no risk
Ponatinib,Vorapaxar,The metabolism of Ponatinib can be decreased when combined with Vorapaxar.,decrease,no risk
Ponatinib,Voriconazole,The metabolism of Ponatinib can be decreased when combined with Voriconazole.,decrease,no risk
Ponatinib,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Ponatinib.,increase,risk
Ponatinib,Vortioxetine,The metabolism of Ponatinib can be decreased when combined with Vortioxetine.,decrease,no risk
Ponatinib,Voxelotor,The serum concentration of Ponatinib can be increased when it is combined with Voxelotor.,increase,no risk
Ponatinib,Voxilaprevir,The metabolism of Ponatinib can be decreased when combined with Voxilaprevir.,decrease,no risk
Ponatinib,Warfarin,The metabolism of Ponatinib can be increased when combined with Warfarin.,increase,no risk
Ponatinib,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Ponatinib.,increase,risk
Ponatinib,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Ponatinib.,increase,risk
Ponatinib,Yohimbine,The metabolism of Ponatinib can be decreased when combined with Yohimbine.,decrease,no risk
Ponatinib,Zafirlukast,The serum concentration of Ponatinib can be increased when it is combined with Zafirlukast.,increase,no risk
Ponatinib,Zaleplon,The metabolism of Ponatinib can be decreased when combined with Zaleplon.,decrease,no risk
Ponatinib,Zidovudine,The metabolism of Ponatinib can be decreased when combined with Zidovudine.,decrease,no risk
Ponatinib,Zimelidine,The metabolism of Ponatinib can be decreased when combined with Zimelidine.,decrease,no risk
Ponatinib,Ziprasidone,The metabolism of Ponatinib can be decreased when combined with Ziprasidone.,decrease,no risk
Ponatinib,Zolpidem,The metabolism of Ponatinib can be decreased when combined with Zolpidem.,decrease,no risk
Ponatinib,Zonisamide,The metabolism of Ponatinib can be decreased when combined with Zonisamide.,decrease,no risk
Ponatinib,Zopiclone,The metabolism of Ponatinib can be decreased when combined with Zopiclone.,decrease,no risk
Ponatinib,Zuclopenthixol,The metabolism of Ponatinib can be decreased when combined with Zuclopenthixol.,decrease,no risk
Glesatinib,Voriconazole,The serum concentration of Glesatinib can be increased when it is combined with Voriconazole.,increase,no risk
BIIB015,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with BIIB015.,increase,risk
BIIB015,Obinutuzumab,The risk or severity of adverse effects can be increased when BIIB015 is combined with Obinutuzumab.,increase,risk
BIIB015,Ocrelizumab,The risk or severity of adverse effects can be increased when BIIB015 is combined with Ocrelizumab.,increase,risk
BIIB015,Odesivimab,The risk or severity of adverse effects can be increased when BIIB015 is combined with Odesivimab.,increase,risk
BIIB015,Ofatumumab,The risk or severity of adverse effects can be increased when BIIB015 is combined with Ofatumumab.,increase,risk
BIIB015,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with BIIB015.,increase,risk
BIIB015,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with BIIB015.,increase,risk
BIIB015,Quinestrol,Quinestrol may increase the thrombogenic activities of BIIB015.,increase,no risk
BIIB015,Ublituximab,The risk or severity of adverse effects can be increased when BIIB015 is combined with Ublituximab.,increase,risk
BIIB015,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with BIIB015.,increase,risk
BIIB015,Vedolizumab,The risk or severity of adverse effects can be increased when BIIB015 is combined with Vedolizumab.,increase,risk
Sonepcizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Sonepcizumab.,increase,risk
Sonepcizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Sonepcizumab is combined with Obinutuzumab.,increase,risk
Sonepcizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Sonepcizumab is combined with Ocrelizumab.,increase,risk
Sonepcizumab,Odesivimab,The risk or severity of adverse effects can be increased when Sonepcizumab is combined with Odesivimab.,increase,risk
Sonepcizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Sonepcizumab is combined with Ofatumumab.,increase,risk
Sonepcizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Sonepcizumab.,increase,risk
Sonepcizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sonepcizumab.,increase,risk
Sonepcizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Sonepcizumab.,increase,no risk
Sonepcizumab,Ublituximab,The risk or severity of adverse effects can be increased when Sonepcizumab is combined with Ublituximab.,increase,risk
Sonepcizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Sonepcizumab.,increase,risk
Sonepcizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Sonepcizumab is combined with Vedolizumab.,increase,risk
Motavizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Motavizumab.,increase,risk
Motavizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Motavizumab is combined with Obinutuzumab.,increase,risk
Motavizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Motavizumab is combined with Ocrelizumab.,increase,risk
Motavizumab,Odesivimab,The risk or severity of adverse effects can be increased when Motavizumab is combined with Odesivimab.,increase,risk
Motavizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Motavizumab is combined with Ofatumumab.,increase,risk
Motavizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Motavizumab.,increase,risk
Motavizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Motavizumab.,increase,risk
Motavizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Motavizumab.,increase,no risk
Motavizumab,Ublituximab,The risk or severity of adverse effects can be increased when Motavizumab is combined with Ublituximab.,increase,risk
Motavizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Motavizumab.,increase,risk
Motavizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Motavizumab is combined with Vedolizumab.,increase,risk
Elotuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Elotuzumab.,increase,risk
Elotuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Elotuzumab is combined with Obinutuzumab.,increase,risk
Elotuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Elotuzumab is combined with Ocrelizumab.,increase,risk
Elotuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Elotuzumab is combined with Odesivimab.,increase,risk
Elotuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Elotuzumab is combined with Ofatumumab.,increase,risk
Elotuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Elotuzumab.,increase,risk
Elotuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Elotuzumab.,increase,risk
Elotuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Elotuzumab is combined with Oxetacaine.,increase,risk
Elotuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Elotuzumab is combined with Oxybuprocaine.,increase,risk
Elotuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Elotuzumab.,increase,no risk
Elotuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Elotuzumab is combined with Ublituximab.,increase,risk
Elotuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Elotuzumab.,increase,risk
Elotuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Elotuzumab is combined with Vedolizumab.,increase,risk
AVE9633,Galcanezumab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Galcanezumab.,increase,risk
AVE9633,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with AVE9633.,increase,risk
AVE9633,Gepirone,The serum concentration of Gepirone can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with AVE9633.,decrease,no risk
AVE9633,Glofitamab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Glofitamab.,increase,risk
AVE9633,Golimumab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Golimumab.,increase,risk
AVE9633,Guselkumab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Guselkumab.,increase,risk
AVE9633,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with AVE9633.,increase,risk
AVE9633,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when AVE9633 is combined with Human cytomegalovirus immune globulin.,increase,risk
AVE9633,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with AVE9633.,increase,risk
AVE9633,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when AVE9633 is combined with Human Rho(D) immune globulin.,increase,risk
AVE9633,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when AVE9633 is combined with Human varicella-zoster immune globulin.,increase,risk
AVE9633,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with AVE9633.,increase,risk
AVE9633,Obinutuzumab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Obinutuzumab.,increase,risk
AVE9633,Ocrelizumab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Ocrelizumab.,increase,risk
AVE9633,Odesivimab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Odesivimab.,increase,risk
AVE9633,Ofatumumab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Ofatumumab.,increase,risk
AVE9633,Olaparib,The serum concentration of Olaparib can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with AVE9633.,increase,risk
AVE9633,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with AVE9633.,increase,risk
AVE9633,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Ouabain,The serum concentration of Ouabain can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Oxetacaine,The risk or severity of methemoglobinemia can be increased when AVE9633 is combined with Oxetacaine.,increase,risk
AVE9633,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with AVE9633.,decrease,no risk
AVE9633,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when AVE9633 is combined with Oxybuprocaine.,increase,risk
AVE9633,Quinestrol,Quinestrol may increase the thrombogenic activities of AVE9633.,increase,no risk
AVE9633,Quinidine,The serum concentration of Quinidine can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Quinine,The serum concentration of Quinine can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Ublituximab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Ublituximab.,increase,risk
AVE9633,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with AVE9633.,increase,risk
AVE9633,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Vardenafil,The metabolism of Vardenafil can be decreased when combined with AVE9633.,decrease,no risk
AVE9633,Vedolizumab,The risk or severity of adverse effects can be increased when AVE9633 is combined with Vedolizumab.,increase,risk
AVE9633,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with AVE9633.,decrease,no risk
AVE9633,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Vincristine,The serum concentration of Vincristine can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Vindesine,The serum concentration of Vindesine can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with AVE9633.,decrease,no risk
AVE9633,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Warfarin,The serum concentration of Warfarin can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with AVE9633.,increase,no risk
AVE9633,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with AVE9633.,decrease,no risk
AVE9633,Zopiclone,The metabolism of Zopiclone can be decreased when combined with AVE9633.,decrease,no risk
AVE9633,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with AVE9633.,decrease,no risk
Carotuximab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Carotuximab.,increase,risk
Carotuximab,Obinutuzumab,The risk or severity of adverse effects can be increased when Carotuximab is combined with Obinutuzumab.,increase,risk
Carotuximab,Ocrelizumab,The risk or severity of adverse effects can be increased when Carotuximab is combined with Ocrelizumab.,increase,risk
Carotuximab,Odesivimab,The risk or severity of adverse effects can be increased when Carotuximab is combined with Odesivimab.,increase,risk
Carotuximab,Ofatumumab,The risk or severity of adverse effects can be increased when Carotuximab is combined with Ofatumumab.,increase,risk
Carotuximab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Carotuximab.,increase,risk
Carotuximab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Carotuximab.,increase,risk
Carotuximab,Quinestrol,Quinestrol may increase the thrombogenic activities of Carotuximab.,increase,no risk
Carotuximab,Ublituximab,The risk or severity of adverse effects can be increased when Carotuximab is combined with Ublituximab.,increase,risk
Carotuximab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Carotuximab.,increase,risk
Carotuximab,Vedolizumab,The risk or severity of adverse effects can be increased when Carotuximab is combined with Vedolizumab.,increase,risk
XmAb 2513,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with XmAb 2513.,increase,risk
XmAb 2513,Obinutuzumab,The risk or severity of adverse effects can be increased when XmAb 2513 is combined with Obinutuzumab.,increase,risk
XmAb 2513,Ocrelizumab,The risk or severity of adverse effects can be increased when XmAb 2513 is combined with Ocrelizumab.,increase,risk
XmAb 2513,Odesivimab,The risk or severity of adverse effects can be increased when XmAb 2513 is combined with Odesivimab.,increase,risk
XmAb 2513,Ofatumumab,The risk or severity of adverse effects can be increased when XmAb 2513 is combined with Ofatumumab.,increase,risk
XmAb 2513,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with XmAb 2513.,increase,risk
XmAb 2513,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with XmAb 2513.,increase,risk
XmAb 2513,Quinestrol,Quinestrol may increase the thrombogenic activities of XmAb 2513.,increase,no risk
XmAb 2513,Ublituximab,The risk or severity of adverse effects can be increased when XmAb 2513 is combined with Ublituximab.,increase,risk
XmAb 2513,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with XmAb 2513.,increase,risk
XmAb 2513,Vedolizumab,The risk or severity of adverse effects can be increased when XmAb 2513 is combined with Vedolizumab.,increase,risk
Tucidinostat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Tucidinostat.,increase,risk
Tucidinostat,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Tucidinostat.,increase,risk
Tucidinostat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Tucidinostat.,increase,risk
Tucidinostat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Tucidinostat.,increase,risk
Tucidinostat,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Tucidinostat.,increase,risk
Tucidinostat,Gilteritinib,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Gilteritinib.,increase,risk
Tucidinostat,Glasdegib,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Glasdegib.,increase,risk
Tucidinostat,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Tucidinostat.,increase,risk
Tucidinostat,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Tucidinostat.,increase,risk
Tucidinostat,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Grepafloxacin.,increase,risk
Tucidinostat,Halofantrine,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Halofantrine.,increase,risk
Tucidinostat,Haloperidol,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Haloperidol.,increase,risk
Tucidinostat,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Tucidinostat.,increase,risk
Tucidinostat,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Tucidinostat.,increase,risk
Tucidinostat,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Tucidinostat.,increase,risk
Tucidinostat,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Hydroxyzine.,increase,risk
Tucidinostat,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Tucidinostat.,increase,risk
Tucidinostat,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Tucidinostat.,increase,risk
Tucidinostat,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Tucidinostat.,increase,risk
Tucidinostat,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Tucidinostat.,increase,risk
Tucidinostat,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Tucidinostat.,increase,risk
Tucidinostat,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Tucidinostat.,increase,risk
Tucidinostat,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Tucidinostat.,increase,risk
Tucidinostat,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Tucidinostat.,increase,risk
Tucidinostat,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Tucidinostat.,increase,risk
Tucidinostat,Oxatomide,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Oxatomide.,increase,risk
Tucidinostat,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tucidinostat is combined with Oxetacaine.,increase,risk
Tucidinostat,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tucidinostat is combined with Oxybuprocaine.,increase,risk
Tucidinostat,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Tucidinostat.,increase,risk
Tucidinostat,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Tucidinostat.,increase,risk
Tucidinostat,Quinidine,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Quinidine.,increase,risk
Tucidinostat,Quinine,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Quinine.,increase,risk
Tucidinostat,Quizartinib,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Quizartinib.,increase,risk
Tucidinostat,Valproic acid,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Valproic acid.,increase,risk
Tucidinostat,Vandetanib,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Vandetanib.,increase,risk
Tucidinostat,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Tucidinostat.,increase,risk
Tucidinostat,Vemurafenib,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Vemurafenib.,increase,risk
Tucidinostat,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Tucidinostat.,increase,risk
Tucidinostat,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Tucidinostat.,increase,risk
Tucidinostat,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Tucidinostat.,increase,risk
Tucidinostat,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Tucidinostat is combined with Vorinostat.,increase,risk
Tucidinostat,Ziprasidone,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Ziprasidone.,increase,risk
Tucidinostat,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Tucidinostat.,increase,risk
Tucidinostat,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Tucidinostat is combined with Zuclopenthixol.,increase,risk
Saxagliptin,Benzoic acid,The excretion of Saxagliptin can be decreased when combined with Benzoic acid.,decrease,no risk
Saxagliptin,Benzthiazide,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Benzthiazide.,decrease,no risk
Saxagliptin,Benzydamine,Benzydamine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Benzylpenicillin,The excretion of Saxagliptin can be decreased when combined with Benzylpenicillin.,decrease,no risk
Saxagliptin,Bepotastine,Bepotastine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Bepridil,The risk or severity of hypoglycemia can be increased when Bepridil is combined with Saxagliptin.,increase,risk
Saxagliptin,Berotralstat,The metabolism of Saxagliptin can be decreased when combined with Berotralstat.,decrease,no risk
Saxagliptin,Betamethasone,The risk or severity of hyperglycemia can be increased when Betamethasone is combined with Saxagliptin.,increase,risk
Saxagliptin,Betamethasone phosphate,The risk or severity of hyperglycemia can be increased when Betamethasone phosphate is combined with Saxagliptin.,increase,risk
Saxagliptin,Betaxolol,The therapeutic efficacy of Saxagliptin can be increased when used in combination with Betaxolol.,increase,no risk
Saxagliptin,Bexagliflozin,Bexagliflozin may increase the hypoglycemic activities of Saxagliptin.,increase,no risk
Saxagliptin,Bicisate,Saxagliptin may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Saxagliptin,Bimekizumab,The metabolism of Saxagliptin can be increased when combined with Bimekizumab.,increase,no risk
Saxagliptin,Bismuth subgallate,Saxagliptin may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Saxagliptin,Bismuth subsalicylate,Bismuth subsalicylate may increase the hypoglycemic activities of Saxagliptin.,increase,no risk
Saxagliptin,Bisoprolol,The therapeutic efficacy of Saxagliptin can be increased when used in combination with Bisoprolol.,increase,no risk
Saxagliptin,Bisoxatin,Saxagliptin may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Bleomycin,Bleomycin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Boceprevir,The metabolism of Saxagliptin can be decreased when combined with Boceprevir.,decrease,no risk
Saxagliptin,Bosentan,The therapeutic efficacy of Saxagliptin can be increased when used in combination with Bosentan.,increase,no risk
Saxagliptin,Brexpiprazole,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Saxagliptin,Brivaracetam,Brivaracetam may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Bromazepam,Bromazepam may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Bromocriptine,The risk or severity of hypoglycemia can be increased when Saxagliptin is combined with Bromocriptine.,increase,risk
Saxagliptin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Saxagliptin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Saxagliptin,Budesonide,The risk or severity of hyperglycemia can be increased when Budesonide is combined with Saxagliptin.,increase,risk
Saxagliptin,Bumadizone,Bumadizone may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Bumetanide,The excretion of Saxagliptin can be decreased when combined with Bumetanide.,decrease,no risk
Saxagliptin,Buprenorphine,The metabolism of Saxagliptin can be decreased when combined with Buprenorphine.,decrease,no risk
Saxagliptin,Bupropion,Bupropion may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Buserelin,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Buserelin.,decrease,no risk
Saxagliptin,Buspirone,Buspirone may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Butabarbital,Butabarbital may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Butriptyline,Butriptyline may decrease the hypoglycemic activities of Saxagliptin.,decrease,no risk
Saxagliptin,Gabapentin enacarbil,Saxagliptin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Saxagliptin,Gadobenic acid,Gadobenic acid may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Gadodiamide,Gadodiamide may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Gadofosveset trisodium,Saxagliptin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Saxagliptin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Gadoteric acid,Saxagliptin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Saxagliptin,Gadoteridol,Gadoteridol may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Ganciclovir,The excretion of Saxagliptin can be decreased when combined with Ganciclovir.,decrease,no risk
Saxagliptin,Gatifloxacin,The therapeutic efficacy of Saxagliptin can be increased when used in combination with Gatifloxacin.,increase,no risk
Saxagliptin,Gefapixant,The therapeutic efficacy of Saxagliptin can be increased when used in combination with Gefapixant.,increase,no risk
Saxagliptin,Gefitinib,The metabolism of Saxagliptin can be decreased when combined with Gefitinib.,decrease,no risk
Saxagliptin,Gemcitabine,Gemcitabine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Gemfibrozil,The excretion of Saxagliptin can be decreased when combined with Gemfibrozil.,decrease,no risk
Saxagliptin,Gemifloxacin,The therapeutic efficacy of Saxagliptin can be increased when used in combination with Gemifloxacin.,increase,no risk
Saxagliptin,Gentamicin,Saxagliptin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Gimeracil,Saxagliptin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Saxagliptin,Givosiran,Givosiran may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Gliclazide,Saxagliptin may increase the hypoglycemic activities of Gliclazide.,increase,no risk
Saxagliptin,Glimepiride,Saxagliptin may increase the hypoglycemic activities of Glimepiride.,increase,no risk
Saxagliptin,Glipizide,Saxagliptin may increase the hypoglycemic activities of Glipizide.,increase,no risk
Saxagliptin,Gliquidone,Saxagliptin may increase the hypoglycemic activities of Gliquidone.,increase,no risk
Saxagliptin,Glofitamab,The serum concentration of Saxagliptin can be increased when it is combined with Glofitamab.,increase,no risk
Saxagliptin,Glyburide,Saxagliptin may increase the hypoglycemic activities of Glyburide.,increase,no risk
Saxagliptin,Glycerol phenylbutyrate,Saxagliptin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Saxagliptin,Glymidine,The risk or severity of hypoglycemia can be increased when Saxagliptin is combined with Glymidine.,increase,risk
Saxagliptin,Golimumab,The metabolism of Saxagliptin can be increased when combined with Golimumab.,increase,no risk
Saxagliptin,Golodirsen,Saxagliptin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Saxagliptin,Goserelin,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Goserelin.,decrease,no risk
Saxagliptin,Grepafloxacin,The therapeutic efficacy of Saxagliptin can be increased when used in combination with Grepafloxacin.,increase,no risk
Saxagliptin,Guanethidine,Guanethidine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Guanfacine,Guanfacine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Guanidine,The excretion of Saxagliptin can be decreased when combined with Guanidine.,decrease,no risk
Saxagliptin,Halcinonide,The risk or severity of hyperglycemia can be increased when Halcinonide is combined with Saxagliptin.,increase,risk
Saxagliptin,Halofantrine,The metabolism of Saxagliptin can be decreased when combined with Halofantrine.,decrease,no risk
Saxagliptin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Saxagliptin.,increase,no risk
Saxagliptin,Histrelin,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Histrelin.,decrease,no risk
Saxagliptin,Hydralazine,Hydralazine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Hydrochlorothiazide,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Saxagliptin,Hydrocortisone,The risk or severity of hyperglycemia can be increased when Hydrocortisone is combined with Saxagliptin.,increase,risk
Saxagliptin,Hydrocortisone acetate,The risk or severity of hyperglycemia can be increased when Hydrocortisone acetate is combined with Saxagliptin.,increase,risk
Saxagliptin,Hydrocortisone butyrate,The risk or severity of hyperglycemia can be increased when Hydrocortisone butyrate is combined with Saxagliptin.,increase,risk
Saxagliptin,Hydrocortisone cypionate,The risk or severity of hyperglycemia can be increased when Hydrocortisone cypionate is combined with Saxagliptin.,increase,risk
Saxagliptin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Saxagliptin.,decrease,no risk
Saxagliptin,Hydrocortisone probutate,The risk or severity of hyperglycemia can be increased when Hydrocortisone probutate is combined with Saxagliptin.,increase,risk
Saxagliptin,Hydrocortisone succinate,The risk or severity of hyperglycemia can be increased when Hydrocortisone succinate is combined with Saxagliptin.,increase,risk
Saxagliptin,Hydrocortisone valerate,The risk or severity of hyperglycemia can be increased when Hydrocortisone valerate is combined with Saxagliptin.,increase,risk
Saxagliptin,Hydroflumethiazide,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Saxagliptin,Hydromorphone,Hydromorphone may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Hydroxychloroquine,The therapeutic efficacy of Saxagliptin can be increased when used in combination with Hydroxychloroquine.,increase,no risk
Saxagliptin,Hydroxyethyl Starch,Saxagliptin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Saxagliptin,Hydroxyprogesterone caproate,The therapeutic efficacy of Saxagliptin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Saxagliptin,Hydroxyzine,The metabolism of Saxagliptin can be decreased when combined with Hydroxyzine.,decrease,no risk
Saxagliptin,Kanamycin,Saxagliptin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Ketamine,Ketamine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Ketazolam,Ketazolam may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Ketoconazole,The metabolism of Saxagliptin can be decreased when combined with Ketoconazole.,decrease,no risk
Saxagliptin,Ketoprofen,The excretion of Saxagliptin can be decreased when combined with Ketoprofen.,decrease,no risk
Saxagliptin,Ketorolac,Ketorolac may decrease the excretion rate of Saxagliptin which could result in a higher serum level.,decrease,no risk
Saxagliptin,Ketotifen,The risk or severity of thrombocytopenia can be increased when Saxagliptin is combined with Ketotifen.,increase,risk
Coltuximab ravtansine,Galcanezumab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Galcanezumab.,increase,risk
Coltuximab ravtansine,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Coltuximab ravtansine.,increase,risk
Coltuximab ravtansine,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Coltuximab ravtansine.,decrease,no risk
Coltuximab ravtansine,Glofitamab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Glofitamab.,increase,risk
Coltuximab ravtansine,Golimumab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Golimumab.,increase,risk
Coltuximab ravtansine,Guselkumab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Guselkumab.,increase,risk
Coltuximab ravtansine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Coltuximab ravtansine.,increase,risk
Coltuximab ravtansine,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Human cytomegalovirus immune globulin.,increase,risk
Coltuximab ravtansine,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Coltuximab ravtansine.,increase,risk
Coltuximab ravtansine,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Human Rho(D) immune globulin.,increase,risk
Coltuximab ravtansine,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Human varicella-zoster immune globulin.,increase,risk
Coltuximab ravtansine,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Coltuximab ravtansine.,increase,risk
Coltuximab ravtansine,Obinutuzumab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Obinutuzumab.,increase,risk
Coltuximab ravtansine,Ocrelizumab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Ocrelizumab.,increase,risk
Coltuximab ravtansine,Odesivimab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Odesivimab.,increase,risk
Coltuximab ravtansine,Ofatumumab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Ofatumumab.,increase,risk
Coltuximab ravtansine,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Coltuximab ravtansine.,increase,risk
Coltuximab ravtansine,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Coltuximab ravtansine.,increase,risk
Coltuximab ravtansine,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Coltuximab ravtansine is combined with Oxetacaine.,increase,risk
Coltuximab ravtansine,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Coltuximab ravtansine.,decrease,no risk
Coltuximab ravtansine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Coltuximab ravtansine is combined with Oxybuprocaine.,increase,risk
Coltuximab ravtansine,Quinestrol,Quinestrol may increase the thrombogenic activities of Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Quinine,The serum concentration of Quinine can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Ublituximab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Ublituximab.,increase,risk
Coltuximab ravtansine,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Coltuximab ravtansine.,increase,risk
Coltuximab ravtansine,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Coltuximab ravtansine.,decrease,no risk
Coltuximab ravtansine,Vedolizumab,The risk or severity of adverse effects can be increased when Coltuximab ravtansine is combined with Vedolizumab.,increase,risk
Coltuximab ravtansine,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Coltuximab ravtansine.,decrease,no risk
Coltuximab ravtansine,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Coltuximab ravtansine.,decrease,no risk
Coltuximab ravtansine,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Coltuximab ravtansine.,increase,no risk
Coltuximab ravtansine,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Coltuximab ravtansine.,decrease,no risk
Coltuximab ravtansine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Coltuximab ravtansine.,decrease,no risk
Coltuximab ravtansine,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Coltuximab ravtansine.,decrease,no risk
Teprotumumab,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Teprotumumab.,increase,risk
Teprotumumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Teprotumumab.,increase,risk
Teprotumumab,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Teprotumumab.,increase,risk
Teprotumumab,Gliclazide,The therapeutic efficacy of Gliclazide can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Glimepiride,The therapeutic efficacy of Glimepiride can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Glipizide,The therapeutic efficacy of Glipizide can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Gliquidone,The therapeutic efficacy of Gliquidone can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Glyburide,The therapeutic efficacy of Glyburide can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Glymidine,The therapeutic efficacy of Glymidine can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Golimumab,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Golimumab.,increase,risk
Teprotumumab,Guselkumab,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Guselkumab.,increase,risk
Teprotumumab,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Teprotumumab.,increase,risk
Teprotumumab,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Hydrocortisone acetate.,increase,risk
Teprotumumab,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Hydrocortisone butyrate.,increase,risk
Teprotumumab,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Hydrocortisone succinate.,increase,risk
Teprotumumab,Hydroxychloroquine,The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Teprotumumab.,increase,risk
Teprotumumab,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Teprotumumab.,increase,risk
Teprotumumab,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Obinutuzumab.,increase,risk
Teprotumumab,Ocrelizumab,Ocrelizumab may increase the immunosuppressive activities of Teprotumumab.,increase,no risk
Teprotumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Ofatumumab.,increase,risk
Teprotumumab,Olaparib,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Olaparib.,increase,risk
Teprotumumab,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Teprotumumab.,increase,risk
Teprotumumab,Ozanimod,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Ozanimod.,increase,risk
Teprotumumab,Quinine,The therapeutic efficacy of Quinine can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Teprotumumab.,increase,risk
Teprotumumab,Upadacitinib,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Upadacitinib.,increase,risk
Teprotumumab,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Teprotumumab.,increase,risk
Teprotumumab,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Vedolizumab.,increase,risk
Teprotumumab,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Vilanterol,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Vilanterol.,increase,risk
Teprotumumab,Vildagliptin,The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Teprotumumab.,decrease,no risk
Teprotumumab,Vinblastine,The risk or severity of adverse effects can be increased when Vinblastine is combined with Teprotumumab.,increase,risk
Teprotumumab,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Teprotumumab.,increase,risk
Teprotumumab,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Teprotumumab.,increase,risk
Teprotumumab,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Teprotumumab.,increase,risk
Teprotumumab,Voclosporin,The risk or severity of adverse effects can be increased when Teprotumumab is combined with Voclosporin.,increase,risk
Teprotumumab,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Teprotumumab.,increase,risk
Teprotumumab,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Teprotumumab.,increase,risk
Teprotumumab,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Teprotumumab.,increase,risk
Lucatumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Lucatumumab.,increase,risk
Lucatumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Lucatumumab is combined with Obinutuzumab.,increase,risk
Lucatumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Lucatumumab is combined with Ocrelizumab.,increase,risk
Lucatumumab,Odesivimab,The risk or severity of adverse effects can be increased when Lucatumumab is combined with Odesivimab.,increase,risk
Lucatumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Lucatumumab is combined with Ofatumumab.,increase,risk
Lucatumumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Lucatumumab.,increase,risk
Lucatumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lucatumumab.,increase,risk
Lucatumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Lucatumumab.,increase,no risk
Lucatumumab,Ublituximab,The risk or severity of adverse effects can be increased when Lucatumumab is combined with Ublituximab.,increase,risk
Lucatumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Lucatumumab.,increase,risk
Lucatumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Lucatumumab is combined with Vedolizumab.,increase,risk
Sapacitabine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Sapacitabine is combined with Benzocaine.,increase,risk
Sapacitabine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Sapacitabine is combined with Benzyl alcohol.,increase,risk
Sapacitabine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Sapacitabine is combined with Bupivacaine.,increase,risk
Sapacitabine,Butacaine,The risk or severity of methemoglobinemia can be increased when Sapacitabine is combined with Butacaine.,increase,risk
Sapacitabine,Butamben,The risk or severity of methemoglobinemia can be increased when Sapacitabine is combined with Butamben.,increase,risk
Sapacitabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Sapacitabine is combined with Oxetacaine.,increase,risk
Sapacitabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Sapacitabine is combined with Oxybuprocaine.,increase,risk
Pertuzumab,Galcanezumab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Galcanezumab.,increase,risk
Pertuzumab,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Pertuzumab.,increase,risk
Pertuzumab,Glofitamab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Glofitamab.,increase,risk
Pertuzumab,Golimumab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Golimumab.,increase,risk
Pertuzumab,Guselkumab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Guselkumab.,increase,risk
Pertuzumab,Hepatitis B immune globulin,The risk or severity of adverse effects can be increased when Hepatitis B immune globulin is combined with Pertuzumab.,increase,risk
Pertuzumab,Human cytomegalovirus immune globulin,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Human cytomegalovirus immune globulin.,increase,risk
Pertuzumab,Human immunoglobulin G,The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Pertuzumab.,increase,risk
Pertuzumab,Human Rho(D) immune globulin,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Human Rho(D) immune globulin.,increase,risk
Pertuzumab,Human varicella-zoster immune globulin,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Human varicella-zoster immune globulin.,increase,risk
Pertuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Pertuzumab.,increase,risk
Pertuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Obinutuzumab.,increase,risk
Pertuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Ocrelizumab.,increase,risk
Pertuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Odesivimab.,increase,risk
Pertuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Ofatumumab.,increase,risk
Pertuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Pertuzumab.,increase,risk
Pertuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Pertuzumab.,increase,risk
Pertuzumab,Ouabain,Ouabain may decrease the cardiotoxic activities of Pertuzumab.,decrease,no risk
Pertuzumab,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Pertuzumab is combined with Oxetacaine.,increase,risk
Pertuzumab,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Pertuzumab is combined with Oxybuprocaine.,increase,risk
Pertuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Pertuzumab.,increase,no risk
Pertuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Ublituximab.,increase,risk
Pertuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Pertuzumab.,increase,risk
Pertuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Pertuzumab is combined with Vedolizumab.,increase,risk
Pertuzumab,Vinblastine,The risk or severity of cardiotoxicity can be increased when Vinblastine is combined with Pertuzumab.,increase,risk
Pertuzumab,Vincristine,The risk or severity of cardiotoxicity can be increased when Vincristine is combined with Pertuzumab.,increase,risk
Pertuzumab,Vindesine,The risk or severity of cardiotoxicity can be increased when Vindesine is combined with Pertuzumab.,increase,risk
Pertuzumab,Vinorelbine,The risk or severity of cardiotoxicity can be increased when Vinorelbine is combined with Pertuzumab.,increase,risk
Indisulam,Bexarotene,The metabolism of Indisulam can be decreased when combined with Bexarotene.,decrease,no risk
Indisulam,Bicalutamide,The serum concentration of Bicalutamide can be increased when it is combined with Indisulam.,increase,no risk
Indisulam,Bicisate,Indisulam may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Bimekizumab,The metabolism of Indisulam can be increased when combined with Bimekizumab.,increase,no risk
Indisulam,Bisacodyl,The risk or severity of dehydration can be increased when Indisulam is combined with Bisacodyl.,increase,risk
Indisulam,Bismuth subgallate,Indisulam may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Bisoprolol,Indisulam may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Bisoxatin,The risk or severity of dehydration can be increased when Indisulam is combined with Bisoxatin.,increase,risk
Indisulam,Bleomycin,Indisulam may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Bortezomib,The serum concentration of Bortezomib can be increased when it is combined with Indisulam.,increase,no risk
Indisulam,Bosentan,The metabolism of Indisulam can be increased when combined with Bosentan.,increase,no risk
Indisulam,Bosutinib,The serum concentration of Bosutinib can be increased when it is combined with Indisulam.,increase,no risk
Indisulam,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Indisulam.,increase,no risk
Indisulam,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Indisulam.,decrease,no risk
Indisulam,Brigatinib,The serum concentration of Brigatinib can be increased when it is combined with Indisulam.,increase,no risk
Indisulam,Brivaracetam,Indisulam may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Bromazepam,Indisulam may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Bromocriptine,The therapeutic efficacy of Bromocriptine can be increased when used in combination with Indisulam.,increase,no risk
Indisulam,Budesonide,Indisulam may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Bumetanide,Indisulam may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Indisulam is combined with Bupivacaine.,increase,risk
Indisulam,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Indisulam.,decrease,no risk
Indisulam,Bupropion,Indisulam may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Buspirone,Indisulam may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Busulfan,The serum concentration of Busulfan can be increased when it is combined with Indisulam.,increase,no risk
Indisulam,Butabarbital,Indisulam may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Indisulam,Butacaine,The risk or severity of methemoglobinemia can be increased when Indisulam is combined with Butacaine.,increase,risk
Indisulam,Butamben,The risk or severity of methemoglobinemia can be increased when Indisulam is combined with Butamben.,increase,risk
Indisulam,Butorphanol,The therapeutic efficacy of Indisulam can be decreased when used in combination with Butorphanol.,decrease,no risk
Siplizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Siplizumab.,increase,risk
Siplizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Siplizumab is combined with Obinutuzumab.,increase,risk
Siplizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Siplizumab is combined with Ocrelizumab.,increase,risk
Siplizumab,Odesivimab,The risk or severity of adverse effects can be increased when Siplizumab is combined with Odesivimab.,increase,risk
Siplizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Siplizumab is combined with Ofatumumab.,increase,risk
Siplizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Siplizumab.,increase,risk
Siplizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Siplizumab.,increase,risk
Siplizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Siplizumab.,increase,no risk
Siplizumab,Ublituximab,The risk or severity of adverse effects can be increased when Siplizumab is combined with Ublituximab.,increase,risk
Siplizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Siplizumab.,increase,risk
Siplizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Siplizumab is combined with Vedolizumab.,increase,risk
Rilonacept,Bosentan,The metabolism of Bosentan can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Bosutinib,The metabolism of Bosutinib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Brexpiprazole,The metabolism of Brexpiprazole can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Brigatinib,The metabolism of Brigatinib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Brivaracetam,The metabolism of Brivaracetam can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Brodalumab,The risk or severity of adverse effects can be increased when Rilonacept is combined with Brodalumab.,increase,risk
Rilonacept,Bromazepam,The metabolism of Bromazepam can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Bromotheophylline,The metabolism of Bromotheophylline can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Brompheniramine,The metabolism of Brompheniramine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Rilonacept.,increase,risk
Rilonacept,Bupivacaine,The metabolism of Bupivacaine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Buprenorphine,The metabolism of Buprenorphine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Bupropion,The metabolism of Bupropion can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Buspirone,The metabolism of Buspirone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Busulfan,The metabolism of Busulfan can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Galantamine,The metabolism of Galantamine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Gefitinib,The metabolism of Gefitinib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Rilonacept.,increase,risk
Rilonacept,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Rilonacept.,increase,risk
Rilonacept,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Glasdegib,The metabolism of Glasdegib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Rilonacept.,increase,risk
Rilonacept,Gliclazide,The metabolism of Gliclazide can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Glimepiride,The metabolism of Glimepiride can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Glipizide,The metabolism of Glipizide can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Gliquidone,The metabolism of Gliquidone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Glyburide,The metabolism of Glyburide can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Rilonacept.,increase,risk
Rilonacept,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Guanabenz,The metabolism of Guanabenz can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Guselkumab,The risk or severity of adverse effects can be increased when Rilonacept is combined with Guselkumab.,increase,risk
Rilonacept,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Rilonacept.,decrease,no risk
Rilonacept,Halofantrine,The metabolism of Halofantrine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Haloperidol,The metabolism of Haloperidol can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Halothane,The metabolism of Halothane can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Rilonacept.,decrease,no risk
Rilonacept,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Rilonacept.,decrease,no risk
Rilonacept,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Rilonacept.,increase,risk
Rilonacept,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Rilonacept is combined with Hydrocortisone succinate.,increase,risk
Rilonacept,Hydromorphone,The metabolism of Hydromorphone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Rilonacept.,increase,risk
Rilonacept,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Rilonacept.,decrease,no risk
Rilonacept,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Rilonacept.,decrease,no risk
Rilonacept,Ketamine,The metabolism of Ketamine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Ketorolac,The metabolism of Ketorolac can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Obinutuzumab,The risk or severity of adverse effects can be increased when Rilonacept is combined with Obinutuzumab.,increase,risk
Rilonacept,Ocrelizumab,The risk or severity of adverse effects can be increased when Rilonacept is combined with Ocrelizumab.,increase,risk
Rilonacept,Ofatumumab,The risk or severity of adverse effects can be increased when Rilonacept is combined with Ofatumumab.,increase,risk
Rilonacept,Olanzapine,The metabolism of Olanzapine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Olaparib,The metabolism of Olaparib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Oliceridine,The metabolism of Oliceridine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Olodaterol,The metabolism of Olodaterol can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Ombitasvir,The metabolism of Ombitasvir can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Omeprazole,The metabolism of Omeprazole can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Ondansetron,The metabolism of Ondansetron can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Opium,The metabolism of Opium can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Osimertinib,The metabolism of Osimertinib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Ospemifene,The metabolism of Ospemifene can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Oxaliplatin,The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Rilonacept.,increase,risk
Rilonacept,Oxprenolol,The metabolism of Oxprenolol can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Oxycodone,The metabolism of Oxycodone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Oxymorphone,The metabolism of Oxymorphone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Ozanimod,The risk or severity of adverse effects can be increased when Rilonacept is combined with Ozanimod.,increase,risk
Rilonacept,Quetiapine,The metabolism of Quetiapine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Quinidine,The metabolism of Quinidine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Quinine,The metabolism of Quinine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Quizartinib,The metabolism of Quizartinib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Rilonacept.,increase,risk
Rilonacept,Udenafil,The metabolism of Udenafil can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Umeclidinium,The metabolism of Umeclidinium can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Upadacitinib,The risk or severity of adverse effects can be increased when Rilonacept is combined with Upadacitinib.,increase,risk
Rilonacept,Valbenazine,The metabolism of Valbenazine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Valdecoxib,The metabolism of Valdecoxib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Valproic acid,The metabolism of Valproic acid can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Valsartan,The metabolism of Valsartan can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vandetanib,The metabolism of Vandetanib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vardenafil,The metabolism of Vardenafil can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Rilonacept.,increase,risk
Rilonacept,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Rilonacept.,decrease,no risk
Rilonacept,Vedolizumab,The risk or severity of adverse effects can be increased when Rilonacept is combined with Vedolizumab.,increase,risk
Rilonacept,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Venetoclax,The metabolism of Venetoclax can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Venlafaxine,The metabolism of Venlafaxine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Verapamil,The metabolism of Verapamil can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vernakalant,The metabolism of Vernakalant can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Rilonacept.,decrease,no risk
Rilonacept,Vilanterol,The risk or severity of adverse effects can be increased when Rilonacept is combined with Vilanterol.,increase,risk
Rilonacept,Vilazodone,The metabolism of Vilazodone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vinblastine,The metabolism of Vinblastine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vincristine,The metabolism of Vincristine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vindesine,The metabolism of Vindesine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vinflunine,The metabolism of Vinflunine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Voclosporin,The risk or severity of adverse effects can be increased when Rilonacept is combined with Voclosporin.,increase,risk
Rilonacept,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Voriconazole,The metabolism of Voriconazole can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Vorinostat,The risk or severity of adverse effects can be increased when Vorinostat is combined with Rilonacept.,increase,risk
Rilonacept,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Voxelotor,The metabolism of Voxelotor can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Warfarin,The metabolism of Warfarin can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Ximelagatran,The metabolism of Ximelagatran can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Rilonacept.,increase,risk
Rilonacept,Yohimbine,The metabolism of Yohimbine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zafirlukast,The metabolism of Zafirlukast can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zaleplon,The metabolism of Zaleplon can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zidovudine,The metabolism of Zidovudine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zileuton,The metabolism of Zileuton can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zolpidem,The metabolism of Zolpidem can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zonisamide,The metabolism of Zonisamide can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zopiclone,The metabolism of Zopiclone can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zotepine,The metabolism of Zotepine can be increased when combined with Rilonacept.,increase,no risk
Rilonacept,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Rilonacept.,increase,no risk
Elacestrant,Gefitinib,The serum concentration of Gefitinib can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Glofitamab,The serum concentration of Elacestrant can be increased when it is combined with Glofitamab.,increase,no risk
Elacestrant,Glyburide,The serum concentration of Glyburide can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Haloperidol,The serum concentration of Elacestrant can be increased when it is combined with Haloperidol.,increase,no risk
Elacestrant,Ketoconazole,The serum concentration of Elacestrant can be increased when it is combined with Ketoconazole.,increase,no risk
Elacestrant,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Omaveloxolone,The serum concentration of Elacestrant can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Elacestrant,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Oxaliplatin,The serum concentration of Oxaliplatin can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Elacestrant is combined with Oxetacaine.,increase,risk
Elacestrant,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Elacestrant is combined with Oxybuprocaine.,increase,risk
Elacestrant,Ozanimod,Elacestrant may decrease the excretion rate of Ozanimod which could result in a higher serum level.,decrease,no risk
Elacestrant,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Quinine,The serum concentration of Quinine can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Vadadustat,The serum concentration of Elacestrant can be increased when it is combined with Vadadustat.,increase,no risk
Elacestrant,Vardenafil,The serum concentration of Vardenafil can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Venetoclax,The serum concentration of Elacestrant can be increased when it is combined with Venetoclax.,increase,no risk
Elacestrant,Verapamil,The serum concentration of Elacestrant can be increased when it is combined with Verapamil.,increase,no risk
Elacestrant,Viloxazine,The metabolism of Elacestrant can be decreased when combined with Viloxazine.,decrease,no risk
Elacestrant,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Voriconazole,The serum concentration of Elacestrant can be increased when it is combined with Voriconazole.,increase,no risk
Elacestrant,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Zidovudine,The serum concentration of Zidovudine can be increased when it is combined with Elacestrant.,increase,no risk
Elacestrant,Zimelidine,The serum concentration of Elacestrant can be increased when it is combined with Zimelidine.,increase,no risk
Elacestrant,Ziprasidone,The serum concentration of Elacestrant can be increased when it is combined with Ziprasidone.,increase,no risk
Plecanatide,Gallamine triethiodide,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Gallamine triethiodide.,decrease,no risk
Plecanatide,Glycerin,The risk or severity of adverse effects can be increased when Glycerin is combined with Plecanatide.,increase,risk
Plecanatide,Glycopyrronium,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Glycopyrronium.,decrease,no risk
Plecanatide,Hexafluronium,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Hexafluronium.,decrease,no risk
Plecanatide,Hexocyclium,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Hexocyclium.,decrease,no risk
Plecanatide,Homatropine,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Homatropine.,decrease,no risk
Plecanatide,Homatropine methylbromide,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Homatropine methylbromide.,decrease,no risk
Plecanatide,Hydrochlorothiazide,The risk or severity of dehydration can be increased when Hydrochlorothiazide is combined with Plecanatide.,increase,risk
Plecanatide,Hydrocodone,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Hydrocodone.,decrease,no risk
Plecanatide,Hydroflumethiazide,The risk or severity of dehydration can be increased when Hydroflumethiazide is combined with Plecanatide.,increase,risk
Plecanatide,Hydromorphone,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Hydromorphone.,decrease,no risk
Plecanatide,Hyoscyamine,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Hyoscyamine.,decrease,no risk
Plecanatide,Olanzapine,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Olanzapine.,decrease,no risk
Plecanatide,Oliceridine,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Oliceridine.,decrease,no risk
Plecanatide,Opium,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Opium.,decrease,no risk
Plecanatide,Orphenadrine,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Orphenadrine.,decrease,no risk
Plecanatide,Oxybutynin,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Oxybutynin.,decrease,no risk
Plecanatide,Oxycodone,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Oxycodone.,decrease,no risk
Plecanatide,Oxymorphone,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Oxymorphone.,decrease,no risk
Plecanatide,Oxyphencyclimine,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Oxyphencyclimine.,decrease,no risk
Plecanatide,Oxyphenisatin acetate,The risk or severity of adverse effects can be increased when Plecanatide is combined with Oxyphenisatin acetate.,increase,risk
Plecanatide,Oxyphenonium,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Oxyphenonium.,decrease,no risk
Plecanatide,Quetiapine,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Quetiapine.,decrease,no risk
Plecanatide,Quinethazone,The risk or severity of dehydration can be increased when Quinethazone is combined with Plecanatide.,increase,risk
Plecanatide,Quinidine,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Quinidine.,decrease,no risk
Plecanatide,Umeclidinium,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Umeclidinium.,decrease,no risk
Plecanatide,Vecuronium,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Vecuronium.,decrease,no risk
Plecanatide,Verapamil,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Verapamil.,decrease,no risk
Plecanatide,Xylometazoline,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Xylometazoline.,decrease,no risk
Plecanatide,Ziconotide,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Ziconotide.,decrease,no risk
Plecanatide,Ziprasidone,The therapeutic efficacy of Plecanatide can be decreased when used in combination with Ziprasidone.,decrease,no risk
Plecanatide,Zonisamide,The risk or severity of dehydration can be increased when Zonisamide is combined with Plecanatide.,increase,risk
Namilumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Namilumab.,increase,risk
Namilumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Namilumab.,increase,risk
Namilumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Ocrelizumab is combined with Namilumab.,increase,risk
Namilumab,Odesivimab,The risk or severity of adverse effects can be increased when Namilumab is combined with Odesivimab.,increase,risk
Namilumab,Ofatumumab,The risk or severity of adverse effects can be increased when Ofatumumab is combined with Namilumab.,increase,risk
Namilumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Namilumab.,increase,risk
Namilumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Namilumab.,increase,risk
Namilumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Namilumab.,increase,no risk
Namilumab,Ublituximab,The risk or severity of adverse effects can be increased when Ublituximab is combined with Namilumab.,increase,risk
Namilumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Namilumab.,increase,risk
Namilumab,Vedolizumab,The risk or severity of adverse effects can be increased when Vedolizumab is combined with Namilumab.,increase,risk
Eplivanserin,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Eplivanserin.,increase,risk
Eplivanserin,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gabapentin enacarbil is combined with Eplivanserin.,increase,risk
Eplivanserin,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Eplivanserin.,increase,risk
Eplivanserin,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Eplivanserin is combined with Ganaxolone.",increase,risk
Eplivanserin,Gepirone,The risk or severity of CNS depression can be increased when Eplivanserin is combined with Gepirone.,increase,risk
Eplivanserin,Gilteritinib,The therapeutic efficacy of Eplivanserin can be decreased when used in combination with Gilteritinib.,decrease,no risk
Eplivanserin,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Eplivanserin.,increase,risk
Eplivanserin,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Eplivanserin.,increase,risk
Eplivanserin,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Eplivanserin.,increase,risk
Eplivanserin,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Eplivanserin.,increase,risk
Eplivanserin,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Eplivanserin.,increase,risk
Eplivanserin,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Eplivanserin.,increase,risk
Eplivanserin,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Eplivanserin.,increase,risk
Eplivanserin,Hydrocodone,Eplivanserin may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Eplivanserin,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Eplivanserin.,increase,risk
Eplivanserin,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Eplivanserin.,increase,no risk
Eplivanserin,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Eplivanserin.,increase,risk
Eplivanserin,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Eplivanserin.,increase,risk
Eplivanserin,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Eplivanserin.,increase,risk
Eplivanserin,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Eplivanserin is combined with Oliceridine.",increase,risk
Eplivanserin,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Eplivanserin.,increase,risk
Eplivanserin,Opium,The risk or severity of CNS depression can be increased when Opium is combined with Eplivanserin.,increase,risk
Eplivanserin,Orphenadrine,Eplivanserin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Eplivanserin,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Eplivanserin.,increase,risk
Eplivanserin,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Eplivanserin.,increase,risk
Eplivanserin,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Eplivanserin.,increase,risk
Eplivanserin,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Eplivanserin.,increase,risk
Eplivanserin,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Eplivanserin.,increase,risk
Eplivanserin,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Eplivanserin.,increase,risk
Eplivanserin,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Eplivanserin.,increase,risk
Eplivanserin,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Eplivanserin.,increase,risk
Eplivanserin,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Eplivanserin.,increase,risk
Eplivanserin,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Eplivanserin.,increase,risk
Eplivanserin,Quinupramine,The risk or severity of CNS depression can be increased when Eplivanserin is combined with Quinupramine.,increase,risk
Eplivanserin,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Eplivanserin.,increase,risk
Eplivanserin,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Eplivanserin.,increase,risk
Eplivanserin,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Eplivanserin.,increase,risk
Eplivanserin,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Eplivanserin.,increase,risk
Eplivanserin,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Eplivanserin.,increase,risk
Eplivanserin,Vilazodone,The risk or severity of CNS depression can be increased when Vilazodone is combined with Eplivanserin.,increase,risk
Eplivanserin,Viloxazine,The risk or severity of CNS depression can be increased when Viloxazine is combined with Eplivanserin.,increase,risk
Eplivanserin,Vortioxetine,The risk or severity of CNS depression can be increased when Vortioxetine is combined with Eplivanserin.,increase,risk
Eplivanserin,Warfarin,The risk or severity of adverse effects can be increased when Eplivanserin is combined with Warfarin.,increase,risk
Eplivanserin,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Eplivanserin.,increase,risk
Eplivanserin,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Eplivanserin.,increase,risk
Eplivanserin,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Eplivanserin.,increase,risk
Eplivanserin,Zimelidine,The risk or severity of adverse effects can be increased when Eplivanserin is combined with Zimelidine.,increase,risk
Eplivanserin,Ziprasidone,The risk or severity of adverse effects can be increased when Eplivanserin is combined with Ziprasidone.,increase,risk
Eplivanserin,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Eplivanserin.,increase,risk
Eplivanserin,Zolpidem,Eplivanserin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Eplivanserin,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Eplivanserin.,increase,risk
Eplivanserin,Zopiclone,The risk or severity of adverse effects can be increased when Eplivanserin is combined with Zopiclone.,increase,risk
Eplivanserin,Zotepine,The risk or severity of CNS depression can be increased when Zotepine is combined with Eplivanserin.,increase,risk
Eplivanserin,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Eplivanserin.,increase,risk
Eplivanserin,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Eplivanserin.,increase,risk
Abafungin,Bepridil,The therapeutic efficacy of Abafungin can be increased when used in combination with Bepridil.,increase,no risk
Abafungin,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Abafungin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Abafungin,Olanzapine,Olanzapine can cause a decrease in the absorption of Abafungin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Abafungin,Verapamil,The therapeutic efficacy of Abafungin can be increased when used in combination with Verapamil.,increase,no risk
Abafungin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Abafungin.,increase,no risk
Abafungin,Xylometazoline,The therapeutic efficacy of Abafungin can be increased when used in combination with Xylometazoline.,increase,no risk
Abafungin,Ziconotide,The therapeutic efficacy of Abafungin can be increased when used in combination with Ziconotide.,increase,no risk
Abafungin,Zonisamide,The therapeutic efficacy of Abafungin can be increased when used in combination with Zonisamide.,increase,no risk
Vitespen,Gemtuzumab ozogamicin,The therapeutic efficacy of Vitespen can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
Vitespen,Glatiramer,The therapeutic efficacy of Vitespen can be decreased when used in combination with Glatiramer.,decrease,no risk
Vitespen,Golimumab,The therapeutic efficacy of Vitespen can be decreased when used in combination with Golimumab.,decrease,no risk
Vitespen,Guselkumab,The therapeutic efficacy of Vitespen can be decreased when used in combination with Guselkumab.,decrease,no risk
Vitespen,Hydrocortisone,The therapeutic efficacy of Vitespen can be decreased when used in combination with Hydrocortisone.,decrease,no risk
Vitespen,Hydrocortisone acetate,The therapeutic efficacy of Vitespen can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
Vitespen,Hydrocortisone butyrate,The therapeutic efficacy of Vitespen can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
Vitespen,Hydrocortisone succinate,The therapeutic efficacy of Vitespen can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
Vitespen,Hydroxychloroquine,The therapeutic efficacy of Vitespen can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Vitespen,Hydroxyurea,The therapeutic efficacy of Vitespen can be decreased when used in combination with Hydroxyurea.,decrease,no risk
Vitespen,Obinutuzumab,The therapeutic efficacy of Vitespen can be decreased when used in combination with Obinutuzumab.,decrease,no risk
Vitespen,Ocrelizumab,The therapeutic efficacy of Vitespen can be decreased when used in combination with Ocrelizumab.,decrease,no risk
Vitespen,Ofatumumab,The therapeutic efficacy of Vitespen can be decreased when used in combination with Ofatumumab.,decrease,no risk
Vitespen,Olaparib,The therapeutic efficacy of Vitespen can be decreased when used in combination with Olaparib.,decrease,no risk
Vitespen,Oxaliplatin,The therapeutic efficacy of Vitespen can be decreased when used in combination with Oxaliplatin.,decrease,no risk
Vitespen,Ozanimod,The therapeutic efficacy of Vitespen can be decreased when used in combination with Ozanimod.,decrease,no risk
Vitespen,Ublituximab,The therapeutic efficacy of Vitespen can be decreased when used in combination with Ublituximab.,decrease,no risk
Vitespen,Upadacitinib,The therapeutic efficacy of Vitespen can be decreased when used in combination with Upadacitinib.,decrease,no risk
Vitespen,Vedolizumab,The therapeutic efficacy of Vitespen can be decreased when used in combination with Vedolizumab.,decrease,no risk
Vitespen,Vilanterol,The therapeutic efficacy of Vitespen can be decreased when used in combination with Vilanterol.,decrease,no risk
Vitespen,Vinblastine,The therapeutic efficacy of Vitespen can be decreased when used in combination with Vinblastine.,decrease,no risk
Vitespen,Vincristine,The therapeutic efficacy of Vitespen can be decreased when used in combination with Vincristine.,decrease,no risk
Vitespen,Vindesine,The therapeutic efficacy of Vitespen can be decreased when used in combination with Vindesine.,decrease,no risk
Vitespen,Vinorelbine,The therapeutic efficacy of Vitespen can be decreased when used in combination with Vinorelbine.,decrease,no risk
Vitespen,Voclosporin,The therapeutic efficacy of Vitespen can be decreased when used in combination with Voclosporin.,decrease,no risk
Vitespen,Vorinostat,The therapeutic efficacy of Vitespen can be decreased when used in combination with Vorinostat.,decrease,no risk
Vitespen,Zidovudine,The therapeutic efficacy of Vitespen can be decreased when used in combination with Zidovudine.,decrease,no risk
Bazedoxifene,Gemfibrozil,The metabolism of Bazedoxifene can be decreased when combined with Gemfibrozil.,decrease,no risk
Bazedoxifene,Glecaprevir,The metabolism of Bazedoxifene can be decreased when combined with Glecaprevir.,decrease,no risk
Bazedoxifene,Ketoconazole,The metabolism of Bazedoxifene can be decreased when combined with Ketoconazole.,decrease,no risk
Bazedoxifene,Ombitasvir,The metabolism of Bazedoxifene can be decreased when combined with Ombitasvir.,decrease,no risk
Bazedoxifene,Ospemifene,The risk or severity of adverse effects can be increased when Bazedoxifene is combined with Ospemifene.,increase,risk
Bazedoxifene,Quizartinib,The metabolism of Bazedoxifene can be decreased when combined with Quizartinib.,decrease,no risk
Bazedoxifene,Valproic acid,The metabolism of Bazedoxifene can be decreased when combined with Valproic acid.,decrease,no risk
Bazedoxifene,Zidovudine,The metabolism of Bazedoxifene can be increased when combined with Zidovudine.,increase,no risk
Telavancin,Bromotheophylline,Bromotheophylline may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Telavancin,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Telavancin.,increase,risk
Telavancin,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Telavancin.,increase,risk
Telavancin,Budesonide,Budesonide may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Bumadizone,Bumadizone may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Bumetanide,Bumetanide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Telavancin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Bupivacaine.,increase,risk
Telavancin,Bupropion,Bupropion may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Telavancin.,increase,risk
Telavancin,Buspirone,Buspirone may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Butabarbital,Butabarbital may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Butacaine,The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Butacaine.,increase,risk
Telavancin,Butamben,The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Butamben.,increase,risk
Telavancin,Butriptyline,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Butriptyline.,increase,risk
Telavancin,Gabapentin enacarbil,Telavancin may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Telavancin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Telavancin.,increase,risk
Telavancin,Gadodiamide,Gadodiamide may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Gadofosveset trisodium,Telavancin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Telavancin,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Gadoteric acid,Telavancin may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Telavancin,Gadoteridol,Gadoteridol may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Telavancin.,increase,risk
Telavancin,Ganciclovir,Ganciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Telavancin.,increase,risk
Telavancin,Gemcitabine,Gemcitabine may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Telavancin.,increase,risk
Telavancin,Gentamicin,Telavancin may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Telavancin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Telavancin.,increase,risk
Telavancin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Gilteritinib.,increase,risk
Telavancin,Gimeracil,Telavancin may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Telavancin,Givosiran,Givosiran may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Glasdegib,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Glasdegib.,increase,risk
Telavancin,Glipizide,Glipizide may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Glycerol phenylbutyrate,Telavancin may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Telavancin,Golodirsen,Telavancin may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Telavancin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Telavancin.,increase,risk
Telavancin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Telavancin.,increase,risk
Telavancin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Grepafloxacin.,increase,risk
Telavancin,Guanethidine,Guanethidine may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Guanfacine,Guanfacine may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Halofantrine,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Halofantrine.,increase,risk
Telavancin,Haloperidol,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Haloperidol.,increase,risk
Telavancin,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Telavancin.,decrease,no risk
Telavancin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Telavancin.,increase,risk
Telavancin,Hydralazine,Hydralazine may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Hydrochlorothiazide,Hydrochlorothiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Telavancin,Hydroflumethiazide,Hydroflumethiazide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Telavancin,Hydromorphone,Hydromorphone may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Telavancin.,increase,risk
Telavancin,Hydroxyethyl Starch,Telavancin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Telavancin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Hydroxyzine.,increase,risk
Telavancin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Telavancin.,increase,risk
Telavancin,Kanamycin,Telavancin may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Telavancin,Ketamine,Ketamine may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Ketazolam,Ketazolam may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Telavancin.,increase,risk
Telavancin,Ketoprofen,Ketoprofen may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Ketorolac,Ketorolac may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Octinoxate,Telavancin may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Telavancin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Telavancin.,increase,risk
Telavancin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Telavancin.,increase,risk
Telavancin,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Telavancin.,increase,risk
Telavancin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Telavancin.,increase,risk
Telavancin,Olsalazine,Olsalazine may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Telavancin.,increase,risk
Telavancin,Opium,Telavancin may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Telavancin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Telavancin.,increase,risk
Telavancin,Oseltamivir,Oseltamivir may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Oxacillin,Oxacillin may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Telavancin.,increase,risk
Telavancin,Oxaprozin,Oxaprozin may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Oxatomide,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Oxatomide.,increase,risk
Telavancin,Oxazepam,Oxazepam may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Oxetacaine.,increase,risk
Telavancin,Oxybenzone,Oxybenzone may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Telavancin is combined with Oxybuprocaine.,increase,risk
Telavancin,Oxyphenbutazone,Oxyphenbutazone may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Oxyquinoline,Telavancin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Telavancin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Telavancin.,increase,risk
Telavancin,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Telavancin.,increase,risk
Telavancin,Quinethazone,Quinethazone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Telavancin,Quinidine,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Quinidine.,increase,risk
Telavancin,Quinine,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Quinine.,increase,risk
Telavancin,Quizartinib,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Quizartinib.,increase,risk
Telavancin,Vaborbactam,Telavancin may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Telavancin,Valaciclovir,Valaciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Valbenazine,Telavancin may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Telavancin,Valdecoxib,Valdecoxib may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Valganciclovir,Valganciclovir may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Valproic acid,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Valproic acid.,increase,risk
Telavancin,Vancomycin,Telavancin may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Telavancin,Vandetanib,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Vandetanib.,increase,risk
Telavancin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Telavancin.,increase,risk
Telavancin,Varenicline,Varenicline may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Vemurafenib.,increase,risk
Telavancin,Venlafaxine,Venlafaxine may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Verapamil,Verapamil may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Telavancin.,increase,risk
Telavancin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Telavancin.,decrease,no risk
Telavancin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Telavancin.,increase,risk
Telavancin,Viloxazine,Telavancin may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Telavancin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Telavancin.,increase,risk
Telavancin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Telavancin.,increase,risk
Telavancin,Vortioxetine,Telavancin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Telavancin,Warfarin,Telavancin may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Telavancin,Zaleplon,Zaleplon may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Zanamivir,Zanamivir may decrease the excretion rate of Telavancin which could result in a higher serum level.,decrease,no risk
Telavancin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Ziprasidone.,increase,risk
Telavancin,Zonisamide,Zonisamide may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Telavancin,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Telavancin is combined with Zuclopenthixol.,increase,risk
Ambrisentan,Budesonide,The metabolism of Ambrisentan can be increased when combined with Budesonide.,increase,no risk
Ambrisentan,Bumadizone,The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Bumadizone.,decrease,no risk
Ambrisentan,Bumetanide,Bumetanide may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Bupivacaine,Bupivacaine may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Buprenorphine,The metabolism of Ambrisentan can be decreased when combined with Buprenorphine.,decrease,no risk
Ambrisentan,Buspirone,Buspirone may decrease the antihypertensive activities of Ambrisentan.,decrease,no risk
Ambrisentan,Butriptyline,Butriptyline may decrease the antihypertensive activities of Ambrisentan.,decrease,no risk
Ambrisentan,Gefitinib,The metabolism of Ambrisentan can be decreased when combined with Gefitinib.,decrease,no risk
Ambrisentan,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Ambrisentan.,increase,no risk
Ambrisentan,Gemfibrozil,The excretion of Ambrisentan can be decreased when combined with Gemfibrozil.,decrease,no risk
Ambrisentan,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Ambrisentan.,increase,no risk
Ambrisentan,Glasdegib,The serum concentration of Ambrisentan can be increased when it is combined with Glasdegib.,increase,no risk
Ambrisentan,Glecaprevir,The serum concentration of Ambrisentan can be increased when it is combined with Glecaprevir.,increase,no risk
Ambrisentan,Glofitamab,The serum concentration of Ambrisentan can be increased when it is combined with Glofitamab.,increase,no risk
Ambrisentan,Glyburide,The metabolism of Ambrisentan can be decreased when combined with Glyburide.,decrease,no risk
Ambrisentan,Glycol salicylate,The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Ambrisentan,Golimumab,The metabolism of Ambrisentan can be increased when combined with Golimumab.,increase,no risk
Ambrisentan,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Ambrisentan.,increase,no risk
Ambrisentan,Guanabenz,Guanabenz may decrease the antihypertensive activities of Ambrisentan.,decrease,no risk
Ambrisentan,Guanadrel,Guanadrel may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Guanethidine,Guanethidine may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Guanfacine,Guanfacine may decrease the antihypertensive activities of Ambrisentan.,decrease,no risk
Ambrisentan,Guanoxan,Ambrisentan may increase the hypotensive activities of Guanoxan.,increase,no risk
Ambrisentan,Halofantrine,The metabolism of Ambrisentan can be decreased when combined with Halofantrine.,decrease,no risk
Ambrisentan,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Ambrisentan.,increase,no risk
Ambrisentan,Halothane,Halothane may decrease the antihypertensive activities of Ambrisentan.,decrease,no risk
Ambrisentan,Hydralazine,Hydralazine may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Hydrochlorothiazide,The therapeutic efficacy of Ambrisentan can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Ambrisentan,Hydrocortisone,The metabolism of Ambrisentan can be decreased when combined with Hydrocortisone.,decrease,no risk
Ambrisentan,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Ambrisentan.,decrease,no risk
Ambrisentan,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Ambrisentan.,decrease,no risk
Ambrisentan,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Ambrisentan.,decrease,no risk
Ambrisentan,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Ambrisentan.,decrease,no risk
Ambrisentan,Hydroflumethiazide,The therapeutic efficacy of Ambrisentan can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Ambrisentan,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Ambrisentan.,decrease,no risk
Ambrisentan,Hydroxyzine,The metabolism of Ambrisentan can be decreased when combined with Hydroxyzine.,decrease,no risk
Ambrisentan,Ketoconazole,The metabolism of Ambrisentan can be decreased when combined with Ketoconazole.,decrease,no risk
Ambrisentan,Ketoprofen,The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Ketoprofen.,decrease,no risk
Ambrisentan,Ketorolac,The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Ketorolac.,decrease,no risk
Ambrisentan,Obinutuzumab,Ambrisentan may increase the hypotensive activities of Obinutuzumab.,increase,no risk
Ambrisentan,Olanzapine,Olanzapine may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Olaparib,The metabolism of Olaparib can be decreased when combined with Ambrisentan.,decrease,no risk
Ambrisentan,Olmesartan,Olmesartan may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Olodaterol,Olodaterol may decrease the antihypertensive activities of Ambrisentan.,decrease,no risk
Ambrisentan,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Ambrisentan.,increase,no risk
Ambrisentan,Omaveloxolone,The serum concentration of Ambrisentan can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Ambrisentan,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Ambrisentan.,increase,no risk
Ambrisentan,Ondansetron,The metabolism of Ambrisentan can be decreased when combined with Ondansetron.,decrease,no risk
Ambrisentan,Opicapone,Opicapone may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Orciprenaline,Orciprenaline may decrease the antihypertensive activities of Ambrisentan.,decrease,no risk
Ambrisentan,Osilodrostat,The metabolism of Ambrisentan can be decreased when combined with Osilodrostat.,decrease,no risk
Ambrisentan,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Ambrisentan.,increase,no risk
Ambrisentan,Ouabain,The excretion of Ambrisentan can be decreased when combined with Ouabain.,decrease,no risk
Ambrisentan,Oxaprozin,The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Oxaprozin.,decrease,no risk
Ambrisentan,Oxcarbazepine,The metabolism of Ambrisentan can be increased when combined with Oxcarbazepine.,increase,no risk
Ambrisentan,Oxprenolol,Oxprenolol may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Oxybutynin,The metabolism of Ambrisentan can be decreased when combined with Oxybutynin.,decrease,no risk
Ambrisentan,Oxycodone,The metabolism of Ambrisentan can be decreased when combined with Oxycodone.,decrease,no risk
Ambrisentan,Oxymetazoline,The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Oxymetazoline.,decrease,no risk
Ambrisentan,Oxyphenbutazone,The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Oxyphenbutazone.,decrease,no risk
Ambrisentan,Quetiapine,Quetiapine may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Quinapril,Quinapril may increase the hypotensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Quinidine,The serum concentration of Ambrisentan can be increased when it is combined with Quinidine.,increase,no risk
Ambrisentan,Quinine,The serum concentration of Ambrisentan can be increased when it is combined with Quinine.,increase,no risk
Ambrisentan,Quinupramine,Quinupramine may decrease the antihypertensive activities of Ambrisentan.,decrease,no risk
Ambrisentan,Quizartinib,The serum concentration of Ambrisentan can be increased when it is combined with Quizartinib.,increase,no risk
Ambrisentan,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Ambrisentan.,increase,no risk
Ambrisentan,Udenafil,Udenafil may increase the antihypertensive activities of Ambrisentan.,increase,no risk
Ambrisentan,Umbralisib,The serum concentration of Ambrisentan can be increased when it is combined with Umbralisib.,increase,no risk
Ambrisentan,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Ambrisentan.,increase,no risk
Ambrisentan,Unoprostone,Ambrisentan may increase the hypotensive activities of Unoprostone.,increase,no risk
Idraparinux,Gemcitabine,The risk or severity of bleeding can be increased when Idraparinux is combined with Gemcitabine.,increase,risk
Idraparinux,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Idraparinux is combined with Gemtuzumab ozogamicin.,increase,risk
Idraparinux,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Idraparinux.,increase,risk
Idraparinux,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Idraparinux.,increase,no risk
Idraparinux,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Idraparinux.,increase,risk
Idraparinux,Hemin,Hemin may increase the anticoagulant activities of Idraparinux.,increase,no risk
Idraparinux,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Idraparinux.,increase,risk
Idraparinux,Hydrochlorothiazide,The therapeutic efficacy of Idraparinux can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Idraparinux,Hydroflumethiazide,The therapeutic efficacy of Idraparinux can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Idraparinux,Hydroxyprogesterone caproate,The therapeutic efficacy of Idraparinux can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Idraparinux,Hydroxyurea,The risk or severity of bleeding can be increased when Idraparinux is combined with Hydroxyurea.,increase,risk
Idraparinux,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Idraparinux.,increase,risk
Idraparinux,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Idraparinux.,increase,risk
Idraparinux,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Idraparinux is combined with Obeticholic acid.,increase,risk
Idraparinux,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Idraparinux is combined with Obinutuzumab.,increase,risk
Idraparinux,Olaparib,The risk or severity of bleeding can be increased when Idraparinux is combined with Olaparib.,increase,risk
Idraparinux,Olive oil,The therapeutic efficacy of Idraparinux can be decreased when used in combination with Olive oil.,decrease,no risk
Idraparinux,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Idraparinux.,increase,risk
Idraparinux,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Idraparinux is combined with Omacetaxine mepesuccinate.,increase,risk
Idraparinux,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Idraparinux.,increase,no risk
Idraparinux,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Idraparinux.,increase,risk
Idraparinux,Omega-3-carboxylic acids,The therapeutic efficacy of Idraparinux can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Idraparinux,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Idraparinux.,increase,risk
Idraparinux,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Idraparinux.,increase,risk
Idraparinux,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Idraparinux.,increase,risk
Idraparinux,Quinestrol,Quinestrol may decrease the anticoagulant activities of Idraparinux.,decrease,no risk
Idraparinux,Quinidine,The therapeutic efficacy of Idraparinux can be increased when used in combination with Quinidine.,increase,no risk
Idraparinux,Quinine,The therapeutic efficacy of Idraparinux can be increased when used in combination with Quinine.,increase,no risk
Idraparinux,Ulipristal,The therapeutic efficacy of Idraparinux can be decreased when used in combination with Ulipristal.,decrease,no risk
Idraparinux,Urokinase,Urokinase may increase the anticoagulant activities of Idraparinux.,increase,no risk
Idraparinux,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Idraparinux is combined with Ursodeoxycholic acid.,increase,risk
Idraparinux,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Idraparinux.,increase,risk
Idraparinux,Venlafaxine,The risk or severity of bleeding can be increased when Idraparinux is combined with Venlafaxine.,increase,risk
Idraparinux,Vinblastine,The risk or severity of bleeding can be increased when Idraparinux is combined with Vinblastine.,increase,risk
Idraparinux,Vindesine,The risk or severity of bleeding can be increased when Idraparinux is combined with Vindesine.,increase,risk
Idraparinux,Vinorelbine,The risk or severity of bleeding can be increased when Idraparinux is combined with Vinorelbine.,increase,risk
Idraparinux,Vitamin E,Vitamin E may increase the anticoagulant activities of Idraparinux.,increase,no risk
Idraparinux,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Idraparinux.,decrease,no risk
Idraparinux,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Idraparinux.,increase,risk
Idraparinux,Vorinostat,The risk or severity of bleeding can be increased when Idraparinux is combined with Vorinostat.,increase,risk
Idraparinux,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Idraparinux.,increase,risk
Idraparinux,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Idraparinux.,increase,risk
Idraparinux,Zidovudine,The risk or severity of bleeding can be increased when Idraparinux is combined with Zidovudine.,increase,risk
Idraparinux,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Idraparinux.,increase,risk
Taribavirin,Bacillus calmette-guerin substrain connaught live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be decreased when used in combination with Taribavirin.,decrease,no risk
Taribavirin,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Taribavirin.,decrease,no risk
Taribavirin,Bacillus calmette-guerin substrain tice live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain tice live antigen can be decreased when used in combination with Taribavirin.,decrease,no risk
Taribavirin,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Taribavirin.,decrease,no risk
Taribavirin,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Taribavirin.,decrease,no risk
Taribavirin,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Taribavirin.,decrease,no risk
Taribavirin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Taribavirin.,decrease,no risk
Taribavirin,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Taribavirin.,decrease,no risk
Doxercalciferol,Vamorolone,The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Vamorolone.,decrease,no risk
Doxercalciferol,Vitamin D,The risk or severity of adverse effects can be increased when Doxercalciferol is combined with Vitamin D.,increase,risk
Oxymetholone,Quinine,Oxymetholone may increase the hypoglycemic activities of Quinine.,increase,no risk
Oxymetholone,Vamorolone,The risk or severity of fluid retention can be increased when Vamorolone is combined with Oxymetholone.,increase,risk
Oxymetholone,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Oxymetholone.,decrease,no risk
Oxymetholone,Vildagliptin,Oxymetholone may increase the hypoglycemic activities of Vildagliptin.,increase,no risk
Oxymetholone,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Oxymetholone.,increase,no risk
Oxymetholone,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Oxymetholone.,increase,no risk
Oxymetholone,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Oxymetholone.,decrease,no risk
Armodafinil,Gefitinib,The metabolism of Gefitinib can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Gestrinone,The metabolism of Gestrinone can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Glipizide,The metabolism of Glipizide can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Glyburide,The metabolism of Glyburide can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Grepafloxacin,The metabolism of Grepafloxacin can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Guanabenz,The metabolism of Guanabenz can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Halofantrine,The metabolism of Halofantrine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Haloperidol,The metabolism of Haloperidol can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Halothane,The metabolism of Halothane can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Hydrocortisone,The metabolism of Hydrocortisone can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Hydroxyzine,The metabolism of Hydroxyzine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Ketamine,The metabolism of Ketamine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Olanzapine,The metabolism of Olanzapine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Olaparib,The metabolism of Olaparib can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Armodafinil.,decrease,no risk
Armodafinil,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Ondansetron,The metabolism of Ondansetron can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Osilodrostat,The metabolism of Osilodrostat can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Osimertinib,The metabolism of Osimertinib can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Ospemifene,The metabolism of Ospemifene can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Oxybutynin,The metabolism of Oxybutynin can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Oxycodone,The metabolism of Oxycodone can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Quetiapine,The metabolism of Quetiapine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Quinidine,The metabolism of Quinidine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Quinine,The metabolism of Quinine can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Quizartinib,The metabolism of Quizartinib can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Armodafinil.,decrease,no risk
Armodafinil,Udenafil,The metabolism of Udenafil can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Ulipristal,The metabolism of Ulipristal can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Valbenazine,The metabolism of Valbenazine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Valsartan,The metabolism of Valsartan can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Vandetanib,The metabolism of Vandetanib can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Vardenafil,The metabolism of Vardenafil can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Velpatasvir,The metabolism of Velpatasvir can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Venetoclax,The metabolism of Venetoclax can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Verapamil,The metabolism of Verapamil can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Vinblastine,The metabolism of Vinblastine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Vincristine,The metabolism of Vincristine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Vindesine,The metabolism of Vindesine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Vinflunine,The metabolism of Vinflunine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Vonoprazan,The metabolism of Vonoprazan can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Voxilaprevir,The metabolism of Voxilaprevir can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Warfarin,The metabolism of Warfarin can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Zaleplon,The metabolism of Zaleplon can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Zileuton,The metabolism of Zileuton can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Zolmitriptan,The metabolism of Zolmitriptan can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Armodafinil.,decrease,no risk
Armodafinil,Zotepine,The metabolism of Zotepine can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Armodafinil.,increase,no risk
Armodafinil,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Armodafinil.,decrease,no risk
Etravirine,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Etravirine.,increase,no risk
Etravirine,Gemfibrozil,The metabolism of Etravirine can be decreased when combined with Gemfibrozil.,decrease,no risk
Etravirine,Gestrinone,The metabolism of Gestrinone can be increased when combined with Etravirine.,increase,no risk
Etravirine,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Etravirine.,increase,no risk
Etravirine,Ginkgo biloba,The metabolism of Etravirine can be decreased when combined with Ginkgo biloba.,decrease,no risk
Etravirine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Glipizide,The metabolism of Glipizide can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Glofitamab,The serum concentration of Etravirine can be increased when it is combined with Glofitamab.,increase,no risk
Etravirine,Glyburide,The metabolism of Glyburide can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Golimumab,The metabolism of Etravirine can be increased when combined with Golimumab.,increase,no risk
Etravirine,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Etravirine.,increase,no risk
Etravirine,Halothane,The metabolism of Halothane can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Human adenovirus e serotype 4 strain cl-68578 antigen,The therapeutic efficacy of Human adenovirus e serotype 4 strain cl-68578 antigen can be decreased when used in combination with Etravirine.,decrease,no risk
Etravirine,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Etravirine.,increase,no risk
Etravirine,Ketamine,The metabolism of Ketamine can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Ketoconazole,The metabolism of Etravirine can be decreased when combined with Ketoconazole.,decrease,no risk
Etravirine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Olanzapine,The metabolism of Etravirine can be decreased when combined with Olanzapine.,decrease,no risk
Etravirine,Olaparib,The metabolism of Olaparib can be increased when combined with Etravirine.,increase,no risk
Etravirine,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Etravirine.,decrease,no risk
Etravirine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Etravirine.,decrease,no risk
Etravirine,Omeprazole,The metabolism of Etravirine can be decreased when combined with Omeprazole.,decrease,no risk
Etravirine,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Oritavancin,The metabolism of Etravirine can be decreased when combined with Oritavancin.,decrease,no risk
Etravirine,Osilodrostat,The metabolism of Etravirine can be decreased when combined with Osilodrostat.,decrease,no risk
Etravirine,Osimertinib,The metabolism of Osimertinib can be increased when combined with Etravirine.,increase,no risk
Etravirine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Oxandrolone,The metabolism of Etravirine can be decreased when combined with Oxandrolone.,decrease,no risk
Etravirine,Oxcarbazepine,The metabolism of Etravirine can be decreased when combined with Oxcarbazepine.,decrease,no risk
Etravirine,Quinidine,The metabolism of Quinidine can be increased when combined with Etravirine.,increase,no risk
Etravirine,Quinine,The metabolism of Etravirine can be decreased when combined with Quinine.,decrease,no risk
Etravirine,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Etravirine.,decrease,no risk
Etravirine,Ulipristal,The metabolism of Ulipristal can be increased when combined with Etravirine.,increase,no risk
Etravirine,Vadadustat,The serum concentration of Etravirine can be increased when it is combined with Vadadustat.,increase,no risk
Etravirine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Valproic acid,The metabolism of Etravirine can be decreased when combined with Valproic acid.,decrease,no risk
Etravirine,Valsartan,The metabolism of Etravirine can be decreased when combined with Valsartan.,decrease,no risk
Etravirine,Vandetanib,The metabolism of Vandetanib can be increased when combined with Etravirine.,increase,no risk
Etravirine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Varicella zoster vaccine (live/attenuated),The therapeutic efficacy of Varicella zoster vaccine (live/attenuated) can be decreased when used in combination with Etravirine.,decrease,no risk
Etravirine,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Etravirine.,increase,no risk
Etravirine,Venetoclax,The metabolism of Venetoclax can be increased when combined with Etravirine.,increase,no risk
Etravirine,Verapamil,The metabolism of Etravirine can be decreased when combined with Verapamil.,decrease,no risk
Etravirine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Etravirine.,decrease,no risk
Etravirine,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Viloxazine,The metabolism of Etravirine can be decreased when combined with Viloxazine.,decrease,no risk
Etravirine,Vinblastine,The metabolism of Vinblastine can be increased when combined with Etravirine.,increase,no risk
Etravirine,Vincristine,The metabolism of Vincristine can be increased when combined with Etravirine.,increase,no risk
Etravirine,Vindesine,The metabolism of Vindesine can be increased when combined with Etravirine.,increase,no risk
Etravirine,Vinflunine,The metabolism of Vinflunine can be increased when combined with Etravirine.,increase,no risk
Etravirine,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Etravirine.,increase,no risk
Etravirine,Voclosporin,The metabolism of Voclosporin can be increased when combined with Etravirine.,increase,no risk
Etravirine,Vonoprazan,The metabolism of Etravirine can be decreased when combined with Vonoprazan.,decrease,no risk
Etravirine,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Etravirine.,increase,no risk
Etravirine,Voriconazole,The metabolism of Etravirine can be decreased when combined with Voriconazole.,decrease,no risk
Etravirine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with Etravirine.,decrease,no risk
Etravirine,Warfarin,The metabolism of Warfarin can be increased when combined with Etravirine.,increase,no risk
Etravirine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Yellow fever vaccine,The therapeutic efficacy of Yellow fever vaccine can be decreased when used in combination with Etravirine.,decrease,no risk
Etravirine,Zafirlukast,The metabolism of Etravirine can be decreased when combined with Zafirlukast.,decrease,no risk
Etravirine,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Etravirine.,increase,no risk
Etravirine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Zileuton,The metabolism of Zileuton can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Zimelidine,The metabolism of Etravirine can be decreased when combined with Zimelidine.,decrease,no risk
Etravirine,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Etravirine.,increase,no risk
Etravirine,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Zonisamide,The metabolism of Etravirine can be decreased when combined with Zonisamide.,decrease,no risk
Etravirine,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Etravirine.,decrease,no risk
Etravirine,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Etravirine.,increase,no risk
Etravirine,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Etravirine.,decrease,no risk
Calfactant,Bendroflumethiazide,Bendroflumethiazide may increase the bradycardic activities of Calfactant.,increase,no risk
Calfactant,Bepridil,Bepridil may increase the bradycardic activities of Calfactant.,increase,no risk
Calfactant,Beractant,Calfactant may increase the bradycardic activities of Beractant.,increase,no risk
Calfactant,Betaxolol,Betaxolol may increase the bradycardic activities of Calfactant.,increase,no risk
Calfactant,Bisoprolol,Bisoprolol may increase the bradycardic activities of Calfactant.,increase,no risk
Calfactant,Bretylium,Bretylium may increase the bradycardic activities of Calfactant.,increase,no risk
Calfactant,Galantamine,Galantamine may increase the bradycardic activities of Calfactant.,increase,no risk
Calfactant,Guanfacine,Guanfacine may increase the bradycardic activities of Calfactant.,increase,no risk
Calfactant,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Calfactant.,increase,no risk
Calfactant,Oxprenolol,Oxprenolol may increase the bradycardic activities of Calfactant.,increase,no risk
Calfactant,Verapamil,Verapamil may increase the bradycardic activities of Calfactant.,increase,no risk
Calfactant,Zonisamide,Zonisamide may increase the bradycardic activities of Calfactant.,increase,no risk
Somatotropin,Ofloxacin,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ofloxacin.",increase,risk
Somatotropin,Olanzapine,The metabolism of Olanzapine can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Ondansetron,The metabolism of Ondansetron can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Oxtriphylline,The metabolism of Oxtriphylline can be increased when combined with Somatotropin.,increase,no risk
Somatotropin,Quinestrol,The therapeutic efficacy of Somatotropin can be decreased when used in combination with Quinestrol.,decrease,no risk
Somatotropin,Quinine,Somatotropin may decrease the hypoglycemic activities of Quinine.,decrease,no risk
Cethromycin,Gefitinib,The metabolism of Cethromycin can be decreased when combined with Gefitinib.,decrease,no risk
Cethromycin,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Gilteritinib,The serum concentration of Gilteritinib can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Glofitamab,The serum concentration of Cethromycin can be increased when it is combined with Glofitamab.,increase,no risk
Cethromycin,Glyburide,The metabolism of Cethromycin can be decreased when combined with Glyburide.,decrease,no risk
Cethromycin,Golimumab,The metabolism of Cethromycin can be increased when combined with Golimumab.,increase,no risk
Cethromycin,Grazoprevir,The serum concentration of Grazoprevir can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Halofantrine,The metabolism of Cethromycin can be decreased when combined with Halofantrine.,decrease,no risk
Cethromycin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Hydroxyzine,The metabolism of Cethromycin can be decreased when combined with Hydroxyzine.,decrease,no risk
Cethromycin,Ketoconazole,The metabolism of Cethromycin can be decreased when combined with Ketoconazole.,decrease,no risk
Cethromycin,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Omaveloxolone,The serum concentration of Cethromycin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Cethromycin,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Ondansetron,The metabolism of Cethromycin can be decreased when combined with Ondansetron.,decrease,no risk
Cethromycin,Osilodrostat,The metabolism of Cethromycin can be decreased when combined with Osilodrostat.,decrease,no risk
Cethromycin,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Oxcarbazepine,The metabolism of Cethromycin can be increased when combined with Oxcarbazepine.,increase,no risk
Cethromycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Cethromycin is combined with Oxetacaine.,increase,risk
Cethromycin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Cethromycin is combined with Oxybuprocaine.,increase,risk
Cethromycin,Oxybutynin,The metabolism of Cethromycin can be decreased when combined with Oxybutynin.,decrease,no risk
Cethromycin,Oxycodone,The metabolism of Cethromycin can be decreased when combined with Oxycodone.,decrease,no risk
Cethromycin,Quetiapine,The metabolism of Cethromycin can be decreased when combined with Quetiapine.,decrease,no risk
Cethromycin,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Quinine,The serum concentration of Quinine can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Udenafil,The metabolism of Cethromycin can be decreased when combined with Udenafil.,decrease,no risk
Cethromycin,Umbralisib,The serum concentration of Cethromycin can be increased when it is combined with Umbralisib.,increase,no risk
Cethromycin,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Vadadustat,The serum concentration of Cethromycin can be increased when it is combined with Vadadustat.,increase,no risk
Cethromycin,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Velpatasvir,The serum concentration of Velpatasvir can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Vemurafenib,The serum concentration of Cethromycin can be increased when it is combined with Vemurafenib.,increase,no risk
Cethromycin,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Verapamil,The risk or severity of adverse effects can be increased when Cethromycin is combined with Verapamil.,increase,risk
Cethromycin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Cethromycin.,decrease,no risk
Cethromycin,Viloxazine,The metabolism of Cethromycin can be decreased when combined with Viloxazine.,decrease,no risk
Cethromycin,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Vincristine,The excretion of Vincristine can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Voclosporin,The serum concentration of Voclosporin can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Vorapaxar,The serum concentration of Cethromycin can be increased when it is combined with Vorapaxar.,increase,no risk
Cethromycin,Voriconazole,The metabolism of Cethromycin can be decreased when combined with Voriconazole.,decrease,no risk
Cethromycin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Voxilaprevir,The serum concentration of Voxilaprevir can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Zaleplon,The metabolism of Cethromycin can be decreased when combined with Zaleplon.,decrease,no risk
Cethromycin,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Cethromycin.,increase,no risk
Cethromycin,Zimelidine,The metabolism of Cethromycin can be decreased when combined with Zimelidine.,decrease,no risk
Cethromycin,Ziprasidone,The metabolism of Cethromycin can be decreased when combined with Ziprasidone.,decrease,no risk
Cethromycin,Zonisamide,The serum concentration of Cethromycin can be increased when it is combined with Zonisamide.,increase,no risk
Cethromycin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Cethromycin.,decrease,no risk
Cethromycin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Cethromycin.,decrease,no risk
Annamycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Annamycin is combined with Benzocaine.,increase,risk
Annamycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Annamycin is combined with Benzyl alcohol.,increase,risk
Annamycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Annamycin is combined with Bupivacaine.,increase,risk
Annamycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Annamycin is combined with Butacaine.,increase,risk
Annamycin,Butamben,The risk or severity of methemoglobinemia can be increased when Annamycin is combined with Butamben.,increase,risk
Annamycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Annamycin is combined with Oxetacaine.,increase,risk
Annamycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Annamycin is combined with Oxybuprocaine.,increase,risk
Endostatin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Endostatin is combined with Benzocaine.,increase,risk
Endostatin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Endostatin is combined with Benzyl alcohol.,increase,risk
Endostatin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Endostatin is combined with Bupivacaine.,increase,risk
Endostatin,Butacaine,The risk or severity of methemoglobinemia can be increased when Endostatin is combined with Butacaine.,increase,risk
Endostatin,Butamben,The risk or severity of methemoglobinemia can be increased when Endostatin is combined with Butamben.,increase,risk
Endostatin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Endostatin is combined with Oxetacaine.,increase,risk
Endostatin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Endostatin is combined with Oxybuprocaine.,increase,risk
Endostatin,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Endostatin is combined with Zoledronic acid.,increase,risk
Tezacitabine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Tezacitabine is combined with Benzocaine.,increase,risk
Tezacitabine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Tezacitabine is combined with Benzyl alcohol.,increase,risk
Tezacitabine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Tezacitabine is combined with Bupivacaine.,increase,risk
Tezacitabine,Butacaine,The risk or severity of methemoglobinemia can be increased when Tezacitabine is combined with Butacaine.,increase,risk
Tezacitabine,Butamben,The risk or severity of methemoglobinemia can be increased when Tezacitabine is combined with Butamben.,increase,risk
Tezacitabine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tezacitabine is combined with Oxetacaine.,increase,risk
Tezacitabine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tezacitabine is combined with Oxybuprocaine.,increase,risk
Semaxanib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Semaxanib is combined with Benzocaine.,increase,risk
Semaxanib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Semaxanib is combined with Benzyl alcohol.,increase,risk
Semaxanib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Semaxanib is combined with Bupivacaine.,increase,risk
Semaxanib,Butacaine,The risk or severity of methemoglobinemia can be increased when Semaxanib is combined with Butacaine.,increase,risk
Semaxanib,Butamben,The risk or severity of methemoglobinemia can be increased when Semaxanib is combined with Butamben.,increase,risk
Semaxanib,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Semaxanib is combined with Oxetacaine.,increase,risk
Semaxanib,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Semaxanib is combined with Oxybuprocaine.,increase,risk
Semaxanib,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Semaxanib is combined with Zoledronic acid.,increase,risk
Ravuconazole,Bepridil,The therapeutic efficacy of Ravuconazole can be increased when used in combination with Bepridil.,increase,no risk
Ravuconazole,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ravuconazole,Olanzapine,Olanzapine can cause a decrease in the absorption of Ravuconazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Ravuconazole,Verapamil,The therapeutic efficacy of Ravuconazole can be increased when used in combination with Verapamil.,increase,no risk
Ravuconazole,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Ravuconazole.,increase,no risk
Ravuconazole,Xylometazoline,The therapeutic efficacy of Ravuconazole can be increased when used in combination with Xylometazoline.,increase,no risk
Ravuconazole,Ziconotide,The therapeutic efficacy of Ravuconazole can be increased when used in combination with Ziconotide.,increase,no risk
Ravuconazole,Zonisamide,The therapeutic efficacy of Ravuconazole can be increased when used in combination with Zonisamide.,increase,no risk
Cangrelor,Gemcitabine,The risk or severity of bleeding can be increased when Cangrelor is combined with Gemcitabine.,increase,risk
Cangrelor,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Cangrelor is combined with Gemtuzumab ozogamicin.,increase,risk
Cangrelor,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Cangrelor.,increase,risk
Cangrelor,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Cangrelor.,increase,no risk
Cangrelor,Glucosamine,Glucosamine may increase the antiplatelet activities of Cangrelor.,increase,no risk
Cangrelor,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Cangrelor.,increase,risk
Cangrelor,Hemin,Hemin may increase the anticoagulant activities of Cangrelor.,increase,no risk
Cangrelor,Heparin,The risk or severity of bleeding can be increased when Cangrelor is combined with Heparin.,increase,risk
Cangrelor,Hydrochlorothiazide,The therapeutic efficacy of Cangrelor can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Cangrelor,Hydroflumethiazide,The therapeutic efficacy of Cangrelor can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Cangrelor,Hydroxyprogesterone caproate,The therapeutic efficacy of Cangrelor can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Cangrelor,Hydroxyurea,The risk or severity of bleeding can be increased when Cangrelor is combined with Hydroxyurea.,increase,risk
Cangrelor,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Cangrelor.,increase,risk
Cangrelor,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Cangrelor.,increase,risk
Cangrelor,Obeticholic acid,The risk or severity of adverse effects can be increased when Cangrelor is combined with Obeticholic acid.,increase,risk
Cangrelor,Obinutuzumab,The risk or severity of adverse effects can be increased when Cangrelor is combined with Obinutuzumab.,increase,risk
Cangrelor,Olaparib,The risk or severity of bleeding can be increased when Cangrelor is combined with Olaparib.,increase,risk
Cangrelor,Olive oil,The therapeutic efficacy of Cangrelor can be decreased when used in combination with Olive oil.,decrease,no risk
Cangrelor,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Cangrelor.,increase,risk
Cangrelor,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Cangrelor is combined with Omacetaxine mepesuccinate.,increase,risk
Cangrelor,Omega-3 fatty acids,Omega-3 fatty acids may increase the antiplatelet activities of Cangrelor.,increase,no risk
Cangrelor,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Cangrelor.,increase,risk
Cangrelor,Omega-3-carboxylic acids,The therapeutic efficacy of Cangrelor can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Cangrelor,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Cangrelor.,increase,risk
Cangrelor,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Cangrelor.,increase,risk
Cangrelor,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Cangrelor.,increase,risk
Cangrelor,Quinestrol,Quinestrol may decrease the anticoagulant activities of Cangrelor.,decrease,no risk
Cangrelor,Quinidine,The therapeutic efficacy of Cangrelor can be increased when used in combination with Quinidine.,increase,no risk
Cangrelor,Quinine,The therapeutic efficacy of Cangrelor can be increased when used in combination with Quinine.,increase,no risk
Cangrelor,Ulipristal,The therapeutic efficacy of Cangrelor can be decreased when used in combination with Ulipristal.,decrease,no risk
Cangrelor,Urokinase,Urokinase may increase the anticoagulant activities of Cangrelor.,increase,no risk
Cangrelor,Ursodeoxycholic acid,The risk or severity of adverse effects can be increased when Cangrelor is combined with Ursodeoxycholic acid.,increase,risk
Cangrelor,Valdecoxib,The risk or severity of bleeding and hemorrhage can be increased when Valdecoxib is combined with Cangrelor.,increase,risk
Cangrelor,Venlafaxine,The risk or severity of bleeding can be increased when Cangrelor is combined with Venlafaxine.,increase,risk
Cangrelor,Vinblastine,The risk or severity of bleeding can be increased when Cangrelor is combined with Vinblastine.,increase,risk
Cangrelor,Vindesine,The risk or severity of bleeding can be increased when Cangrelor is combined with Vindesine.,increase,risk
Cangrelor,Vinorelbine,The risk or severity of bleeding can be increased when Cangrelor is combined with Vinorelbine.,increase,risk
Cangrelor,Vitamin E,Vitamin E may increase the antiplatelet activities of Cangrelor.,increase,no risk
Cangrelor,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Cangrelor.,decrease,no risk
Cangrelor,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Cangrelor.,increase,risk
Cangrelor,Vorinostat,The risk or severity of bleeding can be increased when Cangrelor is combined with Vorinostat.,increase,risk
Cangrelor,Vortioxetine,The risk or severity of bleeding can be increased when Vortioxetine is combined with Cangrelor.,increase,risk
Cangrelor,Warfarin,The risk or severity of bleeding can be increased when Cangrelor is combined with Warfarin.,increase,risk
Cangrelor,Ximelagatran,The risk or severity of bleeding can be increased when Cangrelor is combined with Ximelagatran.,increase,risk
Cangrelor,Zidovudine,The risk or severity of bleeding can be increased when Cangrelor is combined with Zidovudine.,increase,risk
Cangrelor,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Cangrelor.,increase,risk
Avasimibe,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Gestrinone,The metabolism of Gestrinone can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Gilteritinib,The metabolism of Gilteritinib can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Glipizide,The metabolism of Glipizide can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Glyburide,The metabolism of Glyburide can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Haloperidol,The metabolism of Haloperidol can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Halothane,The metabolism of Halothane can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Hydromorphone,The metabolism of Hydromorphone can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Ketamine,The metabolism of Ketamine can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Olaparib,The metabolism of Olaparib can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Oliceridine,The serum concentration of Oliceridine can be decreased when it is combined with Avasimibe.,decrease,no risk
Avasimibe,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Omaveloxolone,The therapeutic efficacy of Omaveloxolone can be decreased when used in combination with Avasimibe.,decrease,no risk
Avasimibe,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Osimertinib,The metabolism of Osimertinib can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Quinidine,The metabolism of Quinidine can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Quinine,The metabolism of Quinine can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Ubrogepant,The serum concentration of Ubrogepant can be decreased when it is combined with Avasimibe.,decrease,no risk
Avasimibe,Ulipristal,The metabolism of Ulipristal can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Valproic acid,The metabolism of Valproic acid can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Valsartan,The metabolism of Valsartan can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Vandetanib,The metabolism of Vandetanib can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Vemurafenib,The metabolism of Vemurafenib can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Venetoclax,The metabolism of Venetoclax can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Verapamil,The metabolism of Verapamil can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Vinblastine,The metabolism of Vinblastine can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Vincristine,The metabolism of Vincristine can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Vindesine,The metabolism of Vindesine can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Vinflunine,The metabolism of Vinflunine can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Vinorelbine,The metabolism of Vinorelbine can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Voclosporin,The metabolism of Voclosporin can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Vorapaxar,The metabolism of Vorapaxar can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Voxelotor,The serum concentration of Voxelotor can be decreased when it is combined with Avasimibe.,decrease,no risk
Avasimibe,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Warfarin,The metabolism of Warfarin can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Zileuton,The metabolism of Zileuton can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Ziprasidone,The metabolism of Ziprasidone can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Zotepine,The metabolism of Zotepine can be decreased when combined with Avasimibe.,decrease,no risk
Avasimibe,Zuclopenthixol,The metabolism of Zuclopenthixol can be increased when combined with Avasimibe.,increase,no risk
Avasimibe,Zuranolone,The serum concentration of Zuranolone can be decreased when it is combined with Avasimibe.,decrease,no risk
Diethylnorspermine,Glycol salicylate,The therapeutic efficacy of Diethylnorspermine can be decreased when used in combination with Glycol salicylate.,decrease,no risk
Diethylnorspermine,Guanabenz,Guanabenz may decrease the antihypertensive activities of Diethylnorspermine.,decrease,no risk
Diethylnorspermine,Guanadrel,Guanadrel may increase the hypotensive activities of Diethylnorspermine.,increase,no risk
Diethylnorspermine,Guanethidine,Guanethidine may increase the hypotensive activities of Diethylnorspermine.,increase,no risk
Diethylnorspermine,Guanfacine,Guanfacine may decrease the antihypertensive activities of Diethylnorspermine.,decrease,no risk
Diethylnorspermine,Guanoxan,Diethylnorspermine may increase the hypotensive activities of Guanoxan.,increase,no risk
Diethylnorspermine,Halothane,Halothane may decrease the antihypertensive activities of Diethylnorspermine.,decrease,no risk
Diethylnorspermine,Hydralazine,Hydralazine may increase the hypotensive activities of Diethylnorspermine.,increase,no risk
Diethylnorspermine,Hydrochlorothiazide,The therapeutic efficacy of Diethylnorspermine can be increased when used in combination with Hydrochlorothiazide.,increase,no risk
Diethylnorspermine,Hydroflumethiazide,The therapeutic efficacy of Diethylnorspermine can be increased when used in combination with Hydroflumethiazide.,increase,no risk
Diethylnorspermine,Ketoprofen,The therapeutic efficacy of Diethylnorspermine can be decreased when used in combination with Ketoprofen.,decrease,no risk
Diethylnorspermine,Ketorolac,The therapeutic efficacy of Diethylnorspermine can be decreased when used in combination with Ketorolac.,decrease,no risk
Dotarizine,Butaperazine,The risk or severity of CNS depression can be increased when Dotarizine is combined with Butaperazine.,increase,risk
Dotarizine,Butobarbital,The risk or severity of CNS depression can be increased when Butobarbital is combined with Dotarizine.,increase,risk
Dotarizine,Butorphanol,The risk or severity of CNS depression can be increased when Butorphanol is combined with Dotarizine.,increase,risk
Dotarizine,Butriptyline,The risk or severity of CNS depression can be increased when Dotarizine is combined with Butriptyline.,increase,risk
Dotarizine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Dotarizine.,increase,risk
Dotarizine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Dotarizine is combined with Gabapentin enacarbil.,increase,risk
Dotarizine,Galantamine,Galantamine may increase the bradycardic activities of Dotarizine.,increase,no risk
Dotarizine,Gallamine triethiodide,Dotarizine may increase the neuromuscular blocking activities of Gallamine triethiodide.,increase,no risk
Dotarizine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dotarizine is combined with Ganaxolone.",increase,risk
Dotarizine,Gepirone,The risk or severity of CNS depression can be increased when Dotarizine is combined with Gepirone.,increase,risk
Dotarizine,Gilteritinib,The therapeutic efficacy of Dotarizine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Dotarizine,Gliclazide,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Gliclazide.,increase,risk
Dotarizine,Glimepiride,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Glimepiride.,increase,risk
Dotarizine,Glipizide,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Glipizide.,increase,risk
Dotarizine,Gliquidone,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Gliquidone.,increase,risk
Dotarizine,Glofitamab,The serum concentration of Dotarizine can be increased when it is combined with Glofitamab.,increase,no risk
Dotarizine,Gluconic Acid,The therapeutic efficacy of Gluconic Acid can be decreased when used in combination with Dotarizine.,decrease,no risk
Dotarizine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Dotarizine.,increase,risk
Dotarizine,Glyburide,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Glyburide.,increase,risk
Dotarizine,Glycerin,The therapeutic efficacy of Glycerin can be decreased when used in combination with Dotarizine.,decrease,no risk
Dotarizine,Glymidine,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Glymidine.,increase,risk
Dotarizine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Dotarizine.,increase,risk
Dotarizine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Dotarizine.,increase,risk
Dotarizine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Dotarizine.,increase,risk
Dotarizine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Dotarizine.,increase,risk
Dotarizine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Dotarizine.,increase,risk
Dotarizine,Heparin,The risk or severity of hyperkalemia can be increased when Heparin is combined with Dotarizine.,increase,risk
Dotarizine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Dotarizine.,increase,risk
Dotarizine,Hydrocodone,Dotarizine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Dotarizine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Dotarizine.,increase,risk
Dotarizine,Hydrotalcite,The risk or severity of hypotension can be increased when Hydrotalcite is combined with Dotarizine.,increase,risk
Dotarizine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dotarizine.,increase,no risk
Dotarizine,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Dotarizine.,increase,no risk
Dotarizine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Dotarizine.,increase,risk
Dotarizine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Dotarizine.,increase,risk
Dotarizine,Ketoconazole,The metabolism of Dotarizine can be decreased when combined with Ketoconazole.,decrease,no risk
Dotarizine,Ketoprofen,The risk or severity of hyperkalemia can be increased when Ketoprofen is combined with Dotarizine.,increase,risk
Dotarizine,Ketorolac,The risk or severity of hyperkalemia can be increased when Ketorolac is combined with Dotarizine.,increase,risk
Dotarizine,Octreotide,The serum concentration of the active metabolites of Octreotide can be increased when Octreotide is used in combination with Dotarizine.,increase,no risk
Dotarizine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Dotarizine.,increase,risk
Dotarizine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dotarizine is combined with Oliceridine.",increase,risk
Dotarizine,Olmesartan,The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Dotarizine.,increase,risk
Dotarizine,Omaveloxolone,The serum concentration of Dotarizine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Dotarizine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Dotarizine.,increase,risk
Dotarizine,Opium,The risk or severity of CNS depression can be increased when Dotarizine is combined with Opium.,increase,risk
Dotarizine,Orphenadrine,Dotarizine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Dotarizine,Oteseconazole,The therapeutic efficacy of Oteseconazole can be increased when used in combination with Dotarizine.,increase,no risk
Dotarizine,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Dotarizine.,increase,no risk
Dotarizine,Oxaprozin,The risk or severity of hyperkalemia can be increased when Oxaprozin is combined with Dotarizine.,increase,risk
Dotarizine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Dotarizine.,increase,risk
Dotarizine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Dotarizine.,increase,risk
Dotarizine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Dotarizine.,increase,risk
Dotarizine,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Dotarizine.,increase,no risk
Dotarizine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Dotarizine.,increase,risk
Dotarizine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Dotarizine.,increase,risk
Dotarizine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Dotarizine.,increase,risk
Dotarizine,Oxyphenbutazone,The risk or severity of hyperkalemia can be increased when Oxyphenbutazone is combined with Dotarizine.,increase,risk
Dotarizine,Oxyphenisatin acetate,The therapeutic efficacy of Oxyphenisatin acetate can be decreased when used in combination with Dotarizine.,decrease,no risk
Dotarizine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Dotarizine.,increase,risk
Dotarizine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Dotarizine.,increase,risk
Dotarizine,Quinapril,The risk or severity of hyperkalemia can be increased when Quinapril is combined with Dotarizine.,increase,risk
Dotarizine,Quinidine,Quinidine may increase the arrhythmogenic activities of Dotarizine.,increase,no risk
Dotarizine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Dotarizine.,increase,risk
Dotarizine,Quinupramine,The risk or severity of CNS depression can be increased when Dotarizine is combined with Quinupramine.,increase,risk
Dotarizine,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Dotarizine.,increase,risk
Dotarizine,Vadadustat,The serum concentration of Dotarizine can be increased when it is combined with Vadadustat.,increase,no risk
Dotarizine,Valdecoxib,The risk or severity of hyperkalemia can be increased when Valdecoxib is combined with Dotarizine.,increase,risk
Dotarizine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Dotarizine.,increase,risk
Dotarizine,Valsartan,The risk or severity of hyperkalemia can be increased when Valsartan is combined with Dotarizine.,increase,risk
Dotarizine,Vecuronium,Dotarizine may increase the neuromuscular blocking activities of Vecuronium.,increase,no risk
Dotarizine,Venetoclax,The metabolism of Dotarizine can be decreased when combined with Venetoclax.,decrease,no risk
Dotarizine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Dotarizine.,increase,risk
Dotarizine,Verapamil,Verapamil may increase the arrhythmogenic activities of Dotarizine.,increase,no risk
Dotarizine,Vernakalant,Vernakalant may increase the arrhythmogenic activities of Dotarizine.,increase,no risk
Dotarizine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Dotarizine.,increase,risk
Dotarizine,Vilazodone,The risk or severity of CNS depression can be increased when Dotarizine is combined with Vilazodone.,increase,risk
Dotarizine,Vildagliptin,The risk or severity of hypoglycemia can be increased when Dotarizine is combined with Vildagliptin.,increase,risk
Dotarizine,Viloxazine,The metabolism of Dotarizine can be decreased when combined with Viloxazine.,decrease,no risk
Dotarizine,Voriconazole,The metabolism of Dotarizine can be decreased when combined with Voriconazole.,decrease,no risk
Dotarizine,Vortioxetine,The risk or severity of CNS depression can be increased when Dotarizine is combined with Vortioxetine.,increase,risk
Dotarizine,Warfarin,The risk or severity of adverse effects can be increased when Dotarizine is combined with Warfarin.,increase,risk
Dotarizine,Xylometazoline,Dotarizine may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Dotarizine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Dotarizine.,increase,risk
Dotarizine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Dotarizine.,increase,risk
Dotarizine,Ziconotide,Ziconotide may increase the arrhythmogenic activities of Dotarizine.,increase,no risk
Dotarizine,Zimelidine,The risk or severity of adverse effects can be increased when Dotarizine is combined with Zimelidine.,increase,risk
Dotarizine,Ziprasidone,The risk or severity of adverse effects can be increased when Dotarizine is combined with Ziprasidone.,increase,risk
Dotarizine,Zofenopril,The risk or severity of hyperkalemia can be increased when Dotarizine is combined with Zofenopril.,increase,risk
Dotarizine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Dotarizine.,increase,risk
Dotarizine,Zolpidem,Dotarizine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Dotarizine,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Dotarizine.,increase,no risk
Dotarizine,Zopiclone,The risk or severity of adverse effects can be increased when Dotarizine is combined with Zopiclone.,increase,risk
Dotarizine,Zotepine,The risk or severity of CNS depression can be increased when Dotarizine is combined with Zotepine.,increase,risk
Dotarizine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Dotarizine.,increase,risk
Dotarizine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dotarizine.,increase,risk
Lonafarnib,Galantamine,The metabolism of Galantamine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Ginkgo biloba,The serum concentration of Lonafarnib can be increased when it is combined with Ginkgo biloba.,increase,no risk
Lonafarnib,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Glecaprevir,The serum concentration of Glecaprevir can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Glimepiride,The metabolism of Lonafarnib can be decreased when combined with Glimepiride.,decrease,no risk
Lonafarnib,Glipizide,The metabolism of Lonafarnib can be decreased when combined with Glipizide.,decrease,no risk
Lonafarnib,Gliquidone,The metabolism of Lonafarnib can be decreased when combined with Gliquidone.,decrease,no risk
Lonafarnib,Glofitamab,The serum concentration of Lonafarnib can be increased when it is combined with Glofitamab.,increase,no risk
Lonafarnib,Glyburide,The serum concentration of Lonafarnib can be increased when it is combined with Glyburide.,increase,no risk
Lonafarnib,Golimumab,The metabolism of Lonafarnib can be increased when combined with Golimumab.,increase,no risk
Lonafarnib,Granisetron,The metabolism of Granisetron can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Halothane,The metabolism of Lonafarnib can be decreased when combined with Halothane.,decrease,no risk
Lonafarnib,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Hydromorphone,The metabolism of Lonafarnib can be decreased when combined with Hydromorphone.,decrease,no risk
Lonafarnib,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Ketamine,The metabolism of Ketamine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Ketoconazole,The metabolism of Lonafarnib can be decreased when combined with Ketoconazole.,decrease,no risk
Lonafarnib,Ketorolac,The metabolism of Lonafarnib can be decreased when combined with Ketorolac.,decrease,no risk
Lonafarnib,Olanzapine,The metabolism of Lonafarnib can be decreased when combined with Olanzapine.,decrease,no risk
Lonafarnib,Olaparib,The metabolism of Olaparib can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Olutasidenib,The metabolism of Olutasidenib can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Ombitasvir,The serum concentration of Ombitasvir can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Omeprazole,The metabolism of Omeprazole can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Opium,The metabolism of Opium can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Oritavancin,The metabolism of Lonafarnib can be decreased when combined with Oritavancin.,decrease,no risk
Lonafarnib,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Osimertinib,The metabolism of Osimertinib can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Oxandrolone,The serum concentration of Lonafarnib can be increased when it is combined with Oxandrolone.,increase,no risk
Lonafarnib,Oxcarbazepine,The metabolism of Lonafarnib can be increased when combined with Oxcarbazepine.,increase,no risk
Lonafarnib,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Quazepam,The metabolism of Quazepam can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Quinidine,The metabolism of Quinidine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Quinine,The metabolism of Quinine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Udenafil,The metabolism of Udenafil can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Ulipristal,The metabolism of Ulipristal can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Umeclidinium,The serum concentration of Umeclidinium can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Upadacitinib,The metabolism of Upadacitinib can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vadadustat,The serum concentration of Lonafarnib can be increased when it is combined with Vadadustat.,increase,no risk
Lonafarnib,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Valproic acid,The metabolism of Lonafarnib can be decreased when combined with Valproic acid.,decrease,no risk
Lonafarnib,Valsartan,The serum concentration of Lonafarnib can be increased when it is combined with Valsartan.,increase,no risk
Lonafarnib,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vemurafenib,The serum concentration of Lonafarnib can be increased when it is combined with Vemurafenib.,increase,no risk
Lonafarnib,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Verapamil,The metabolism of Verapamil can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Viloxazine,The metabolism of Lonafarnib can be decreased when combined with Viloxazine.,decrease,no risk
Lonafarnib,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vincristine,The excretion of Vincristine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vindesine,The metabolism of Vindesine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vonoprazan,The metabolism of Vonoprazan can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Voriconazole,The metabolism of Lonafarnib can be decreased when combined with Voriconazole.,decrease,no risk
Lonafarnib,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Lonafarnib.,increase,no risk
Lonafarnib,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Warfarin,The metabolism of Warfarin can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Ximelagatran,The metabolism of Lonafarnib can be decreased when combined with Ximelagatran.,decrease,no risk
Lonafarnib,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zafirlukast,The serum concentration of Lonafarnib can be increased when it is combined with Zafirlukast.,increase,no risk
Lonafarnib,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zileuton,The metabolism of Zileuton can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zimelidine,The metabolism of Lonafarnib can be decreased when combined with Zimelidine.,decrease,no risk
Lonafarnib,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zotepine,The metabolism of Zotepine can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Lonafarnib.,decrease,no risk
Lonafarnib,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Lonafarnib.,increase,no risk
Capravirine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Capravirine.,decrease,no risk
Capravirine,Omaveloxolone,The serum concentration of Capravirine can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Capravirine,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Capravirine.,decrease,no risk
Capravirine,Oxybutynin,The metabolism of Capravirine can be decreased when combined with Oxybutynin.,decrease,no risk
Capravirine,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Capravirine.,decrease,no risk
Capravirine,Quinidine,The metabolism of Capravirine can be decreased when combined with Quinidine.,decrease,no risk
Capravirine,Quinine,The metabolism of Capravirine can be decreased when combined with Quinine.,decrease,no risk
Capravirine,Vadadustat,The serum concentration of Capravirine can be increased when it is combined with Vadadustat.,increase,no risk
Capravirine,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Capravirine.,decrease,no risk
Capravirine,Vemurafenib,The metabolism of Capravirine can be decreased when combined with Vemurafenib.,decrease,no risk
Capravirine,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Capravirine.,decrease,no risk
Capravirine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Capravirine.,decrease,no risk
Capravirine,Zidovudine,The metabolism of Capravirine can be decreased when combined with Zidovudine.,decrease,no risk
Capravirine,Zopiclone,The metabolism of Capravirine can be decreased when combined with Zopiclone.,decrease,no risk
Remacemide,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Remacemide.,increase,risk
Remacemide,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Remacemide is combined with Gabapentin enacarbil.,increase,risk
Remacemide,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Remacemide.,increase,risk
Remacemide,Gamolenic acid,The therapeutic efficacy of Remacemide can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Remacemide,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Remacemide is combined with Ganaxolone.",increase,risk
Remacemide,Ganciclovir,The therapeutic efficacy of Remacemide can be decreased when used in combination with Ganciclovir.,decrease,no risk
Remacemide,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Gestrinone,The metabolism of Gestrinone can be increased when combined with Remacemide.,increase,no risk
Remacemide,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Remacemide.,decrease,no risk
Remacemide,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Remacemide.,increase,risk
Remacemide,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Remacemide.,increase,risk
Remacemide,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Remacemide.,increase,risk
Remacemide,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Remacemide.,increase,risk
Remacemide,Halofantrine,The therapeutic efficacy of Remacemide can be decreased when used in combination with Halofantrine.,decrease,no risk
Remacemide,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Remacemide.,increase,risk
Remacemide,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Remacemide.,increase,risk
Remacemide,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Remacemide.,increase,risk
Remacemide,Hydrocodone,Remacemide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Remacemide,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Remacemide.,increase,risk
Remacemide,Hydroxychloroquine,The therapeutic efficacy of Remacemide can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Remacemide,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Remacemide.,increase,no risk
Remacemide,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Remacemide.,increase,no risk
Remacemide,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Remacemide.,increase,risk
Remacemide,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Remacemide.,increase,risk
Remacemide,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Remacemide.,increase,risk
Remacemide,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Remacemide is combined with Oliceridine.",increase,risk
Remacemide,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Remacemide.,increase,risk
Remacemide,Opium,The risk or severity of CNS depression can be increased when Remacemide is combined with Opium.,increase,risk
Remacemide,Orlistat,Orlistat can cause a decrease in the absorption of Remacemide resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Remacemide,Orphenadrine,Remacemide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Remacemide,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Remacemide.,increase,risk
Remacemide,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Remacemide.,increase,risk
Remacemide,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Remacemide is combined with Oxetacaine.,increase,risk
Remacemide,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Remacemide.,increase,risk
Remacemide,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Remacemide.,increase,risk
Remacemide,Oxtriphylline,Remacemide may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Remacemide,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Remacemide is combined with Oxybuprocaine.,increase,risk
Remacemide,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Remacemide.,increase,risk
Remacemide,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Remacemide.,increase,risk
Remacemide,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Remacemide.,increase,risk
Remacemide,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Remacemide.,increase,risk
Remacemide,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Remacemide.,increase,risk
Remacemide,Quinupramine,The risk or severity of CNS depression can be increased when Remacemide is combined with Quinupramine.,increase,risk
Remacemide,Ulipristal,The metabolism of Ulipristal can be increased when combined with Remacemide.,increase,no risk
Remacemide,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Remacemide.,increase,risk
Remacemide,Valganciclovir,The therapeutic efficacy of Remacemide can be decreased when used in combination with Valganciclovir.,decrease,no risk
Remacemide,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Remacemide.,increase,risk
Remacemide,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Remacemide.,decrease,no risk
Remacemide,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Remacemide.,increase,risk
Remacemide,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Remacemide.,increase,risk
Remacemide,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Remacemide.,increase,risk
Remacemide,Vilazodone,The risk or severity of CNS depression can be increased when Remacemide is combined with Vilazodone.,increase,risk
Remacemide,Viloxazine,The risk or severity of CNS depression can be increased when Remacemide is combined with Viloxazine.,increase,risk
Remacemide,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Remacemide.,decrease,no risk
Remacemide,Vortioxetine,The risk or severity of CNS depression can be increased when Remacemide is combined with Vortioxetine.,increase,risk
Remacemide,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Remacemide.,increase,risk
Remacemide,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Remacemide.,increase,risk
Remacemide,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Remacemide.,increase,no risk
Remacemide,Ziconotide,The risk or severity of CNS depression can be increased when Remacemide is combined with Ziconotide.,increase,risk
Remacemide,Zimelidine,The risk or severity of adverse effects can be increased when Remacemide is combined with Zimelidine.,increase,risk
Remacemide,Ziprasidone,The risk or severity of adverse effects can be increased when Remacemide is combined with Ziprasidone.,increase,risk
Remacemide,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Remacemide.,increase,risk
Remacemide,Zolpidem,Remacemide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Remacemide,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Remacemide.,increase,risk
Remacemide,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Remacemide.,decrease,no risk
Remacemide,Zotepine,The risk or severity of CNS depression can be increased when Remacemide is combined with Zotepine.,increase,risk
Remacemide,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Remacemide.,increase,risk
Remacemide,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Remacemide.,increase,risk
Efaproxiral,Benzocaine,The risk or severity of methemoglobinemia can be increased when Efaproxiral is combined with Benzocaine.,increase,risk
Efaproxiral,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Efaproxiral is combined with Benzyl alcohol.,increase,risk
Efaproxiral,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Efaproxiral is combined with Bupivacaine.,increase,risk
Efaproxiral,Butacaine,The risk or severity of methemoglobinemia can be increased when Efaproxiral is combined with Butacaine.,increase,risk
Efaproxiral,Butamben,The risk or severity of methemoglobinemia can be increased when Efaproxiral is combined with Butamben.,increase,risk
Efaproxiral,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Efaproxiral is combined with Oxetacaine.,increase,risk
Efaproxiral,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Efaproxiral is combined with Oxybuprocaine.,increase,risk
Squalamine,BCG vaccine,The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Squalamine.,decrease,no risk
Squalamine,Benzocaine,The risk or severity of methemoglobinemia can be increased when Squalamine is combined with Benzocaine.,increase,risk
Squalamine,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Squalamine is combined with Benzyl alcohol.,increase,risk
Squalamine,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Squalamine is combined with Bupivacaine.,increase,risk
Squalamine,Butacaine,The risk or severity of methemoglobinemia can be increased when Squalamine is combined with Butacaine.,increase,risk
Squalamine,Butamben,The risk or severity of methemoglobinemia can be increased when Squalamine is combined with Butamben.,increase,risk
Squalamine,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Squalamine is combined with Oxetacaine.,increase,risk
Squalamine,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Squalamine is combined with Oxybuprocaine.,increase,risk
Squalamine,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Squalamine.,decrease,no risk
Squalamine,Warfarin,The risk or severity of bleeding can be increased when Squalamine is combined with Warfarin.,increase,risk
Squalamine,Zoledronic acid,The risk or severity of jaw osteonecrosis and anti-angiogenesis can be increased when Squalamine is combined with Zoledronic acid.,increase,risk
Apolizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Apolizumab.,increase,risk
Apolizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Apolizumab is combined with Obinutuzumab.,increase,risk
Apolizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Apolizumab is combined with Ocrelizumab.,increase,risk
Apolizumab,Odesivimab,The risk or severity of adverse effects can be increased when Apolizumab is combined with Odesivimab.,increase,risk
Apolizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Apolizumab is combined with Ofatumumab.,increase,risk
Apolizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Apolizumab.,increase,risk
Apolizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Apolizumab.,increase,risk
Apolizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Apolizumab.,increase,no risk
Apolizumab,Ublituximab,The risk or severity of adverse effects can be increased when Apolizumab is combined with Ublituximab.,increase,risk
Apolizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Apolizumab.,increase,risk
Apolizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Apolizumab is combined with Vedolizumab.,increase,risk
Cariporide,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Gadobenic acid.,increase,risk
Cariporide,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Cariporide.,increase,risk
Cariporide,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Cariporide.,increase,risk
Cariporide,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Gemifloxacin.,increase,risk
Cariporide,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Cariporide.,increase,risk
Cariporide,Gilteritinib,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Gilteritinib.,increase,risk
Cariporide,Glasdegib,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Glasdegib.,increase,risk
Cariporide,Goserelin,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Goserelin.,increase,risk
Cariporide,Granisetron,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Granisetron.,increase,risk
Cariporide,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Grepafloxacin.,increase,risk
Cariporide,Halofantrine,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Halofantrine.,increase,risk
Cariporide,Haloperidol,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Haloperidol.,increase,risk
Cariporide,Histrelin,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Histrelin.,increase,risk
Cariporide,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Cariporide.,increase,risk
Cariporide,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Cariporide.,increase,risk
Cariporide,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Hydroxyzine.,increase,risk
Cariporide,Hyoscyamine,Hyoscyamine may increase the arrhythmogenic activities of Cariporide.,increase,no risk
Cariporide,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Cariporide.,increase,risk
Cariporide,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Cariporide.,increase,risk
Cariporide,Ofloxacin,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Ofloxacin.,increase,risk
Cariporide,Olanzapine,The risk or severity of QTc prolongation can be increased when Olanzapine is combined with Cariporide.,increase,risk
Cariporide,Olodaterol,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Olodaterol.,increase,risk
Cariporide,Ondansetron,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Ondansetron.,increase,risk
Cariporide,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Cariporide.,increase,risk
Cariporide,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Cariporide.,increase,risk
Cariporide,Oxatomide,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Oxatomide.,increase,risk
Cariporide,Oxprenolol,Oxprenolol may increase the arrhythmogenic activities of Cariporide.,increase,no risk
Cariporide,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Cariporide.,increase,risk
Cariporide,Quetiapine,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Quetiapine.,increase,risk
Cariporide,Quinidine,Quinidine may increase the arrhythmogenic activities of Cariporide.,increase,no risk
Cariporide,Quinine,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Quinine.,increase,risk
Cariporide,Quizartinib,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Quizartinib.,increase,risk
Cariporide,Valproic acid,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Valproic acid.,increase,risk
Cariporide,Vandetanib,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Vandetanib.,increase,risk
Cariporide,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Cariporide.,increase,risk
Cariporide,Vemurafenib,The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Cariporide.,increase,risk
Cariporide,Verapamil,Verapamil may increase the arrhythmogenic activities of Cariporide.,increase,no risk
Cariporide,Vernakalant,Vernakalant may increase the arrhythmogenic activities of Cariporide.,increase,no risk
Cariporide,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Cariporide.,increase,risk
Cariporide,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Cariporide.,increase,risk
Cariporide,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Cariporide.,increase,risk
Cariporide,Xylometazoline,Cariporide may increase the arrhythmogenic activities of Xylometazoline.,increase,no risk
Cariporide,Ziconotide,Ziconotide may increase the arrhythmogenic activities of Cariporide.,increase,no risk
Cariporide,Ziprasidone,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Ziprasidone.,increase,risk
Cariporide,Zonisamide,Zonisamide may increase the arrhythmogenic activities of Cariporide.,increase,no risk
Cariporide,Zuclopenthixol,The risk or severity of QTc prolongation can be increased when Cariporide is combined with Zuclopenthixol.,increase,risk
Lestaurtinib,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Lestaurtinib.,decrease,no risk
Lestaurtinib,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Lestaurtinib.,decrease,no risk
Lestaurtinib,Voriconazole,The serum concentration of Lestaurtinib can be increased when it is combined with Voriconazole.,increase,no risk
Lestaurtinib,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Lestaurtinib.,increase,no risk
Lestaurtinib,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Lestaurtinib.,decrease,no risk
Lestaurtinib,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Lestaurtinib.,decrease,no risk
Lestaurtinib,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Lestaurtinib.,decrease,no risk
Clomethiazole,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Clomethiazole.,increase,risk
Clomethiazole,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Clomethiazole is combined with Gabapentin enacarbil.,increase,risk
Clomethiazole,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Clomethiazole.,increase,risk
Clomethiazole,Gamolenic acid,The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Clomethiazole,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Clomethiazole is combined with Ganaxolone.",increase,risk
Clomethiazole,Ganciclovir,The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Ganciclovir.,decrease,no risk
Clomethiazole,Gepirone,The risk or severity of CNS depression can be increased when Clomethiazole is combined with Gepirone.,increase,risk
Clomethiazole,Gestrinone,The metabolism of Gestrinone can be increased when combined with Clomethiazole.,increase,no risk
Clomethiazole,Glofitamab,The serum concentration of Clomethiazole can be increased when it is combined with Glofitamab.,increase,no risk
Clomethiazole,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Clomethiazole.,increase,risk
Clomethiazole,Golimumab,The metabolism of Clomethiazole can be increased when combined with Golimumab.,increase,no risk
Clomethiazole,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Clomethiazole.,increase,risk
Clomethiazole,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Clomethiazole.,increase,risk
Clomethiazole,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Clomethiazole.,increase,risk
Clomethiazole,Halofantrine,The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Halofantrine.,decrease,no risk
Clomethiazole,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Clomethiazole.,increase,risk
Clomethiazole,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Clomethiazole.,increase,risk
Clomethiazole,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Clomethiazole.,increase,risk
Clomethiazole,Hydrocodone,Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Clomethiazole,Hydrocortisone,The metabolism of Clomethiazole can be increased when combined with Hydrocortisone.,increase,no risk
Clomethiazole,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Clomethiazole.,increase,risk
Clomethiazole,Hydroxychloroquine,The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Clomethiazole,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Clomethiazole.,increase,no risk
Clomethiazole,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Clomethiazole.,increase,no risk
Clomethiazole,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Clomethiazole.,increase,risk
Clomethiazole,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Clomethiazole.,increase,risk
Clomethiazole,Ketoconazole,The metabolism of Clomethiazole can be decreased when combined with Ketoconazole.,decrease,no risk
Clomethiazole,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Clomethiazole.,increase,risk
Clomethiazole,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Clomethiazole is combined with Oliceridine.",increase,risk
Clomethiazole,Omaveloxolone,The serum concentration of Clomethiazole can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Clomethiazole,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Clomethiazole.,increase,risk
Clomethiazole,Opium,The risk or severity of CNS depression can be increased when Clomethiazole is combined with Opium.,increase,risk
Clomethiazole,Orlistat,Orlistat can cause a decrease in the absorption of Clomethiazole resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Clomethiazole,Orphenadrine,Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Clomethiazole,Osilodrostat,The metabolism of Osilodrostat can be decreased when combined with Clomethiazole.,decrease,no risk
Clomethiazole,Ospemifene,The metabolism of Clomethiazole can be decreased when combined with Ospemifene.,decrease,no risk
Clomethiazole,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Clomethiazole.,increase,risk
Clomethiazole,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Clomethiazole.,increase,risk
Clomethiazole,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Clomethiazole is combined with Oxetacaine.,increase,risk
Clomethiazole,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Clomethiazole.,increase,risk
Clomethiazole,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Clomethiazole.,increase,risk
Clomethiazole,Oxtriphylline,Clomethiazole may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Clomethiazole,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Clomethiazole is combined with Oxybuprocaine.,increase,risk
Clomethiazole,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Clomethiazole.,increase,risk
Clomethiazole,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Clomethiazole.,increase,risk
Clomethiazole,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Clomethiazole.,increase,risk
Clomethiazole,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Clomethiazole.,increase,risk
Clomethiazole,Quinidine,The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Quinidine.,decrease,no risk
Clomethiazole,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Clomethiazole.,increase,risk
Clomethiazole,Quinupramine,The risk or severity of CNS depression can be increased when Clomethiazole is combined with Quinupramine.,increase,risk
Clomethiazole,Ulipristal,The metabolism of Ulipristal can be increased when combined with Clomethiazole.,increase,no risk
Clomethiazole,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Clomethiazole.,increase,risk
Clomethiazole,Vadadustat,The serum concentration of Clomethiazole can be decreased when it is combined with Vadadustat.,decrease,no risk
Clomethiazole,Valganciclovir,The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Valganciclovir.,decrease,no risk
Clomethiazole,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Clomethiazole.,increase,risk
Clomethiazole,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Clomethiazole.,increase,risk
Clomethiazole,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Clomethiazole.,decrease,no risk
Clomethiazole,Venetoclax,The metabolism of Clomethiazole can be decreased when combined with Venetoclax.,decrease,no risk
Clomethiazole,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Clomethiazole.,increase,risk
Clomethiazole,Verapamil,The metabolism of Clomethiazole can be decreased when combined with Verapamil.,decrease,no risk
Clomethiazole,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Clomethiazole.,increase,risk
Clomethiazole,Vilazodone,The risk or severity of CNS depression can be increased when Clomethiazole is combined with Vilazodone.,increase,risk
Clomethiazole,Viloxazine,The metabolism of Clomethiazole can be decreased when combined with Viloxazine.,decrease,no risk
Clomethiazole,Voriconazole,The metabolism of Clomethiazole can be decreased when combined with Voriconazole.,decrease,no risk
Clomethiazole,Vortioxetine,The risk or severity of CNS depression can be increased when Clomethiazole is combined with Vortioxetine.,increase,risk
Clomethiazole,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Clomethiazole.,decrease,no risk
Clomethiazole,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Clomethiazole.,increase,risk
Clomethiazole,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Clomethiazole.,increase,risk
Clomethiazole,Zanubrutinib,The metabolism of Zanubrutinib can be decreased when combined with Clomethiazole.,decrease,no risk
Clomethiazole,Ziconotide,The risk or severity of CNS depression can be increased when Clomethiazole is combined with Ziconotide.,increase,risk
Clomethiazole,Zidovudine,The metabolism of Clomethiazole can be decreased when combined with Zidovudine.,decrease,no risk
Clomethiazole,Zimelidine,The risk or severity of adverse effects can be increased when Clomethiazole is combined with Zimelidine.,increase,risk
Clomethiazole,Ziprasidone,The risk or severity of adverse effects can be increased when Clomethiazole is combined with Ziprasidone.,increase,risk
Clomethiazole,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Clomethiazole.,increase,risk
Clomethiazole,Zolpidem,Clomethiazole may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Clomethiazole,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Clomethiazole.,increase,risk
Clomethiazole,Zopiclone,The risk or severity of adverse effects can be increased when Clomethiazole is combined with Zopiclone.,increase,risk
Clomethiazole,Zotepine,The risk or severity of CNS depression can be increased when Clomethiazole is combined with Zotepine.,increase,risk
Clomethiazole,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Clomethiazole.,increase,risk
Clomethiazole,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Clomethiazole.,increase,risk
Sibrotuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Sibrotuzumab.,increase,risk
Sibrotuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Sibrotuzumab is combined with Obinutuzumab.,increase,risk
Sibrotuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Sibrotuzumab is combined with Ocrelizumab.,increase,risk
Sibrotuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Sibrotuzumab is combined with Odesivimab.,increase,risk
Sibrotuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Sibrotuzumab is combined with Ofatumumab.,increase,risk
Sibrotuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Sibrotuzumab.,increase,risk
Sibrotuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Sibrotuzumab.,increase,risk
Sibrotuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Sibrotuzumab.,increase,no risk
Sibrotuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Sibrotuzumab is combined with Ublituximab.,increase,risk
Sibrotuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Sibrotuzumab.,increase,risk
Sibrotuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Sibrotuzumab is combined with Vedolizumab.,increase,risk
Porfiromycin,Benzocaine,The risk or severity of methemoglobinemia can be increased when Porfiromycin is combined with Benzocaine.,increase,risk
Porfiromycin,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Porfiromycin is combined with Benzyl alcohol.,increase,risk
Porfiromycin,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Porfiromycin is combined with Bupivacaine.,increase,risk
Porfiromycin,Butacaine,The risk or severity of methemoglobinemia can be increased when Porfiromycin is combined with Butacaine.,increase,risk
Porfiromycin,Butamben,The risk or severity of methemoglobinemia can be increased when Porfiromycin is combined with Butamben.,increase,risk
Porfiromycin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Porfiromycin is combined with Oxetacaine.,increase,risk
Porfiromycin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Porfiromycin is combined with Oxybuprocaine.,increase,risk
Propentofylline,Gabapentin,Gabapentin may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Propentofylline,Ganaxolone,Ganaxolone may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Propentofylline,Gatifloxacin,The metabolism of Propentofylline can be decreased when combined with Gatifloxacin.,decrease,no risk
Propentofylline,Gemfibrozil,The metabolism of Propentofylline can be decreased when combined with Gemfibrozil.,decrease,no risk
Propentofylline,Gemifloxacin,The metabolism of Propentofylline can be decreased when combined with Gemifloxacin.,decrease,no risk
Propentofylline,Givosiran,The serum concentration of Propentofylline can be increased when it is combined with Givosiran.,increase,no risk
Propentofylline,Glofitamab,The serum concentration of Propentofylline can be increased when it is combined with Glofitamab.,increase,no risk
Propentofylline,Golimumab,The metabolism of Propentofylline can be increased when combined with Golimumab.,increase,no risk
Propentofylline,Grepafloxacin,The metabolism of Propentofylline can be decreased when combined with Grepafloxacin.,decrease,no risk
Propentofylline,Guanabenz,The metabolism of Propentofylline can be decreased when combined with Guanabenz.,decrease,no risk
Propentofylline,Halazepam,The therapeutic efficacy of Halazepam can be decreased when used in combination with Propentofylline.,decrease,no risk
Propentofylline,Haloperidol,The metabolism of Propentofylline can be decreased when combined with Haloperidol.,decrease,no risk
Propentofylline,Human interferon beta,The metabolism of Propentofylline can be decreased when combined with Human interferon beta.,decrease,no risk
Propentofylline,Hydroxyamphetamine,The risk or severity of adverse effects can be increased when Hydroxyamphetamine is combined with Propentofylline.,increase,risk
Propentofylline,Ketazolam,The therapeutic efficacy of Ketazolam can be decreased when used in combination with Propentofylline.,decrease,no risk
Propentofylline,Ketoconazole,The metabolism of Propentofylline can be decreased when combined with Ketoconazole.,decrease,no risk
Propentofylline,Obeticholic acid,The metabolism of Propentofylline can be decreased when combined with Obeticholic acid.,decrease,no risk
Propentofylline,Ofloxacin,The metabolism of Propentofylline can be decreased when combined with Ofloxacin.,decrease,no risk
Propentofylline,Olanzapine,The metabolism of Propentofylline can be decreased when combined with Olanzapine.,decrease,no risk
Propentofylline,Olodaterol,Propentofylline may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Propentofylline,Ondansetron,The metabolism of Propentofylline can be decreased when combined with Ondansetron.,decrease,no risk
Propentofylline,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Propentofylline.,increase,risk
Propentofylline,Orphenadrine,The metabolism of Propentofylline can be decreased when combined with Orphenadrine.,decrease,no risk
Propentofylline,Osilodrostat,The metabolism of Propentofylline can be decreased when combined with Osilodrostat.,decrease,no risk
Propentofylline,Osimertinib,The serum concentration of Propentofylline can be decreased when it is combined with Osimertinib.,decrease,no risk
Propentofylline,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Propentofylline.,decrease,no risk
Propentofylline,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Propentofylline,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Propentofylline.,increase,risk
Propentofylline,Oxtriphylline,The metabolism of Propentofylline can be decreased when combined with Oxtriphylline.,decrease,no risk
Propentofylline,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Propentofylline.,increase,risk
Propentofylline,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Propentofylline.,decrease,no risk
Propentofylline,Quinidine,The serum concentration of Propentofylline can be increased when it is combined with Quinidine.,increase,no risk
Propentofylline,Quinine,The serum concentration of Propentofylline can be increased when it is combined with Quinine.,increase,no risk
Propentofylline,Valproic acid,Valproic acid may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Propentofylline,Vemurafenib,The serum concentration of Propentofylline can be increased when it is combined with Vemurafenib.,increase,no risk
Propentofylline,Verapamil,The metabolism of Propentofylline can be decreased when combined with Verapamil.,decrease,no risk
Propentofylline,Vigabatrin,Vigabatrin may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Propentofylline,Vilanterol,The risk or severity of hypokalemia can be increased when Propentofylline is combined with Vilanterol.,increase,risk
Propentofylline,Viloxazine,The metabolism of Propentofylline can be decreased when combined with Viloxazine.,decrease,no risk
Propentofylline,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Propentofylline.,decrease,no risk
Propentofylline,Warfarin,The metabolism of Propentofylline can be decreased when combined with Warfarin.,decrease,no risk
Propentofylline,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Propentofylline.,decrease,no risk
Propentofylline,Zaleplon,Zaleplon may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Propentofylline,Zileuton,The metabolism of Propentofylline can be decreased when combined with Zileuton.,decrease,no risk
Propentofylline,Zolmitriptan,The metabolism of Propentofylline can be decreased when combined with Zolmitriptan.,decrease,no risk
Propentofylline,Zolpidem,The metabolism of Propentofylline can be decreased when combined with Zolpidem.,decrease,no risk
Propentofylline,Zonisamide,Zonisamide may increase the excretion rate of Propentofylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Propentofylline,Zotepine,The metabolism of Zotepine can be decreased when combined with Propentofylline.,decrease,no risk
Prucalopride,Brivaracetam,Brivaracetam may decrease the excretion rate of Prucalopride which could result in a higher serum level.,decrease,no risk
Prucalopride,Bromazepam,Bromazepam may decrease the excretion rate of Prucalopride which could result in a higher serum level.,decrease,no risk
Prucalopride,Bromocriptine,The metabolism of Prucalopride can be decreased when combined with Bromocriptine.,decrease,no risk
Prucalopride,Bromotheophylline,The risk or severity of dehydration can be increased when Bromotheophylline is combined with Prucalopride.,increase,risk
Prucalopride,Brompheniramine,The therapeutic efficacy of Prucalopride can be decreased when used in combination with Brompheniramine.,decrease,no risk
Prucalopride,Buclizine,The therapeutic efficacy of Prucalopride can be decreased when used in combination with Buclizine.,decrease,no risk
Prucalopride,Budesonide,Budesonide may decrease the excretion rate of Prucalopride which could result in a higher serum level.,decrease,no risk
Prucalopride,Bumadizone,Bumadizone may decrease the excretion rate of Prucalopride which could result in a higher serum level.,decrease,no risk
Prucalopride,Bumetanide,The risk or severity of dehydration can be increased when Bumetanide is combined with Prucalopride.,increase,risk
Prucalopride,Buprenorphine,The metabolism of Prucalopride can be decreased when combined with Buprenorphine.,decrease,no risk
Prucalopride,Bupropion,Bupropion may decrease the excretion rate of Prucalopride which could result in a higher serum level.,decrease,no risk
Prucalopride,Buspirone,Buspirone may decrease the excretion rate of Prucalopride which could result in a higher serum level.,decrease,no risk
Prucalopride,Butabarbital,Butabarbital may decrease the excretion rate of Prucalopride which could result in a higher serum level.,decrease,no risk
Prucalopride,Butalbital,The therapeutic efficacy of Prucalopride can be decreased when used in combination with Butalbital.,decrease,no risk
Prucalopride,Butobarbital,The therapeutic efficacy of Prucalopride can be decreased when used in combination with Butobarbital.,decrease,no risk
Prucalopride,Butorphanol,The therapeutic efficacy of Prucalopride can be decreased when used in combination with Butorphanol.,decrease,no risk
Prucalopride,Butylscopolamine,The therapeutic efficacy of Prucalopride can be decreased when used in combination with Butylscopolamine.,decrease,no risk
Repinotan,Galantamine,The metabolism of Repinotan can be decreased when combined with Galantamine.,decrease,no risk
Repinotan,Gefitinib,The metabolism of Repinotan can be decreased when combined with Gefitinib.,decrease,no risk
Repinotan,Givosiran,The serum concentration of Repinotan can be increased when it is combined with Givosiran.,increase,no risk
Repinotan,Glycerol phenylbutyrate,The metabolism of Repinotan can be decreased when combined with Glycerol phenylbutyrate.,decrease,no risk
Repinotan,Golimumab,The metabolism of Repinotan can be increased when combined with Golimumab.,increase,no risk
Repinotan,Halofantrine,The metabolism of Repinotan can be decreased when combined with Halofantrine.,decrease,no risk
Repinotan,Haloperidol,The serum concentration of Repinotan can be increased when it is combined with Haloperidol.,increase,no risk
Repinotan,Hydroxychloroquine,The metabolism of Repinotan can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Repinotan,Hydroxyzine,The metabolism of Repinotan can be decreased when combined with Hydroxyzine.,decrease,no risk
Repinotan,Ketoconazole,The metabolism of Repinotan can be decreased when combined with Ketoconazole.,decrease,no risk
Repinotan,Olanzapine,The metabolism of Repinotan can be decreased when combined with Olanzapine.,decrease,no risk
Repinotan,Oliceridine,The metabolism of Oliceridine can be decreased when combined with Repinotan.,decrease,no risk
Repinotan,Ondansetron,The metabolism of Repinotan can be decreased when combined with Ondansetron.,decrease,no risk
Repinotan,Opium,The metabolism of Opium can be decreased when combined with Repinotan.,decrease,no risk
Repinotan,Oritavancin,The metabolism of Repinotan can be decreased when combined with Oritavancin.,decrease,no risk
Muraglitazar,Ketamine,The metabolism of Muraglitazar can be decreased when combined with Ketamine.,decrease,no risk
Muraglitazar,Ketoconazole,The metabolism of Muraglitazar can be decreased when combined with Ketoconazole.,decrease,no risk
Muraglitazar,Ketoprofen,The metabolism of Muraglitazar can be decreased when combined with Ketoprofen.,decrease,no risk
Muraglitazar,Ketorolac,The metabolism of Muraglitazar can be decreased when combined with Ketorolac.,decrease,no risk
Muraglitazar,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Muraglitazar.,decrease,no risk
Muraglitazar,Omaveloxolone,The serum concentration of Muraglitazar can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Muraglitazar,Ombitasvir,The metabolism of Muraglitazar can be decreased when combined with Ombitasvir.,decrease,no risk
Muraglitazar,Oxybutynin,The metabolism of Muraglitazar can be decreased when combined with Oxybutynin.,decrease,no risk
Muraglitazar,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Muraglitazar.,decrease,no risk
Muraglitazar,Quinidine,The metabolism of Muraglitazar can be decreased when combined with Quinidine.,decrease,no risk
Muraglitazar,Quinine,The metabolism of Muraglitazar can be decreased when combined with Quinine.,decrease,no risk
Muraglitazar,Quizartinib,The metabolism of Muraglitazar can be decreased when combined with Quizartinib.,decrease,no risk
Muraglitazar,Vadadustat,The serum concentration of Muraglitazar can be increased when it is combined with Vadadustat.,increase,no risk
Muraglitazar,Valproic acid,The metabolism of Muraglitazar can be decreased when combined with Valproic acid.,decrease,no risk
Muraglitazar,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Muraglitazar.,decrease,no risk
Muraglitazar,Vemurafenib,The metabolism of Muraglitazar can be decreased when combined with Vemurafenib.,decrease,no risk
Muraglitazar,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Muraglitazar.,decrease,no risk
Muraglitazar,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Muraglitazar.,decrease,no risk
Muraglitazar,Zidovudine,The metabolism of Muraglitazar can be increased when combined with Zidovudine.,increase,no risk
Muraglitazar,Zopiclone,The metabolism of Muraglitazar can be decreased when combined with Zopiclone.,decrease,no risk
Deramciclane,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Deramciclane.,increase,risk
Deramciclane,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Deramciclane is combined with Gabapentin enacarbil.,increase,risk
Deramciclane,Galantamine,The metabolism of Galantamine can be decreased when combined with Deramciclane.,decrease,no risk
Deramciclane,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Deramciclane.,increase,risk
Deramciclane,Gamolenic acid,The therapeutic efficacy of Deramciclane can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Deramciclane,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Deramciclane is combined with Ganaxolone.",increase,risk
Deramciclane,Ganciclovir,The therapeutic efficacy of Deramciclane can be decreased when used in combination with Ganciclovir.,decrease,no risk
Deramciclane,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Deramciclane.,decrease,no risk
Deramciclane,Gepirone,The risk or severity of CNS depression can be increased when Deramciclane is combined with Gepirone.,increase,risk
Deramciclane,Gestrinone,The metabolism of Gestrinone can be increased when combined with Deramciclane.,increase,no risk
Deramciclane,Gilteritinib,The therapeutic efficacy of Deramciclane can be decreased when used in combination with Gilteritinib.,decrease,no risk
Deramciclane,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Deramciclane.,increase,risk
Deramciclane,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Deramciclane.,increase,risk
Deramciclane,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Deramciclane.,increase,risk
Deramciclane,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Deramciclane.,increase,risk
Deramciclane,Halofantrine,The therapeutic efficacy of Deramciclane can be decreased when used in combination with Halofantrine.,decrease,no risk
Deramciclane,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Deramciclane.,increase,risk
Deramciclane,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Deramciclane.,increase,risk
Deramciclane,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Deramciclane.,increase,risk
Deramciclane,Hydrocodone,Deramciclane may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Deramciclane,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Deramciclane.,increase,risk
Deramciclane,Hydroxychloroquine,The therapeutic efficacy of Deramciclane can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Deramciclane,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Deramciclane.,increase,no risk
Deramciclane,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Deramciclane.,increase,no risk
Deramciclane,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Deramciclane.,increase,risk
Deramciclane,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Deramciclane.,increase,risk
Deramciclane,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Deramciclane.,increase,risk
Deramciclane,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Deramciclane is combined with Oliceridine.",increase,risk
Deramciclane,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Deramciclane.,increase,risk
Deramciclane,Opium,The risk or severity of CNS depression can be increased when Deramciclane is combined with Opium.,increase,risk
Deramciclane,Orlistat,Orlistat can cause a decrease in the absorption of Deramciclane resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Deramciclane,Orphenadrine,Deramciclane may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Deramciclane,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Deramciclane.,increase,risk
Deramciclane,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Deramciclane.,increase,risk
Deramciclane,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Deramciclane is combined with Oxetacaine.,increase,risk
Deramciclane,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Deramciclane.,increase,risk
Deramciclane,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Deramciclane.,increase,risk
Deramciclane,Oxtriphylline,Deramciclane may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Deramciclane,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Deramciclane is combined with Oxybuprocaine.,increase,risk
Deramciclane,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Deramciclane.,increase,risk
Deramciclane,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Deramciclane.,increase,risk
Deramciclane,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Deramciclane.,increase,risk
Deramciclane,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Deramciclane.,increase,risk
Deramciclane,Quinidine,The therapeutic efficacy of Deramciclane can be decreased when used in combination with Quinidine.,decrease,no risk
Deramciclane,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Deramciclane.,increase,risk
Deramciclane,Quinupramine,The risk or severity of CNS depression can be increased when Deramciclane is combined with Quinupramine.,increase,risk
Deramciclane,Ulipristal,The metabolism of Ulipristal can be increased when combined with Deramciclane.,increase,no risk
Deramciclane,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Deramciclane.,decrease,no risk
Deramciclane,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Deramciclane.,increase,risk
Deramciclane,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Deramciclane.,decrease,no risk
Deramciclane,Valganciclovir,The therapeutic efficacy of Deramciclane can be decreased when used in combination with Valganciclovir.,decrease,no risk
Deramciclane,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Deramciclane.,increase,risk
Deramciclane,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Deramciclane.,increase,risk
Deramciclane,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Deramciclane.,increase,risk
Deramciclane,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Deramciclane.,decrease,no risk
Deramciclane,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Deramciclane.,increase,risk
Deramciclane,Vilazodone,The risk or severity of CNS depression can be increased when Deramciclane is combined with Vilazodone.,increase,risk
Deramciclane,Viloxazine,The risk or severity of CNS depression can be increased when Deramciclane is combined with Viloxazine.,increase,risk
Deramciclane,Vortioxetine,The risk or severity of CNS depression can be increased when Deramciclane is combined with Vortioxetine.,increase,risk
Deramciclane,Warfarin,The risk or severity of adverse effects can be increased when Deramciclane is combined with Warfarin.,increase,risk
Deramciclane,Yohimbine,The therapeutic efficacy of Deramciclane can be increased when used in combination with Yohimbine.,increase,no risk
Deramciclane,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Deramciclane.,increase,risk
Deramciclane,Ziconotide,The risk or severity of CNS depression can be increased when Deramciclane is combined with Ziconotide.,increase,risk
Deramciclane,Zimelidine,The risk or severity of adverse effects can be increased when Deramciclane is combined with Zimelidine.,increase,risk
Deramciclane,Ziprasidone,The risk or severity of adverse effects can be increased when Deramciclane is combined with Ziprasidone.,increase,risk
Deramciclane,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Deramciclane.,increase,risk
Deramciclane,Zolpidem,Deramciclane may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Deramciclane,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Deramciclane.,increase,risk
Deramciclane,Zopiclone,The risk or severity of adverse effects can be increased when Deramciclane is combined with Zopiclone.,increase,risk
Deramciclane,Zotepine,The risk or severity of CNS depression can be increased when Deramciclane is combined with Zotepine.,increase,risk
Deramciclane,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Deramciclane.,increase,risk
Deramciclane,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Deramciclane.,increase,risk
Pitavastatin,Gadoxetic acid,The excretion of Gadoxetic acid can be decreased when combined with Pitavastatin.,decrease,no risk
Pitavastatin,Ganciclovir,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ganciclovir is combined with Pitavastatin.",increase,risk
Pitavastatin,Gefitinib,Gefitinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Gemfibrozil,The risk or severity of myopathy and rhabdomyolysis can be increased when Gemfibrozil is combined with Pitavastatin.,increase,risk
Pitavastatin,Gilteritinib,Gilteritinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Ginkgo biloba,The metabolism of Pitavastatin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Pitavastatin,Glasdegib,Glasdegib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Glecaprevir,Glecaprevir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Gliclazide,The metabolism of Pitavastatin can be decreased when combined with Gliclazide.,decrease,no risk
Pitavastatin,Glimepiride,Glimepiride may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Glipizide,Glipizide may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Gliquidone,The metabolism of Pitavastatin can be decreased when combined with Gliquidone.,decrease,no risk
Pitavastatin,Glofitamab,The serum concentration of Pitavastatin can be increased when it is combined with Glofitamab.,increase,no risk
Pitavastatin,Glyburide,Glyburide may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Glycyrrhizic acid,Pitavastatin may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level.,decrease,no risk
Pitavastatin,Golimumab,The metabolism of Pitavastatin can be increased when combined with Golimumab.,increase,no risk
Pitavastatin,Grazoprevir,Grazoprevir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Halofantrine,The metabolism of Pitavastatin can be decreased when combined with Halofantrine.,decrease,no risk
Pitavastatin,Haloperidol,The metabolism of Pitavastatin can be decreased when combined with Haloperidol.,decrease,no risk
Pitavastatin,Halothane,The metabolism of Pitavastatin can be decreased when combined with Halothane.,decrease,no risk
Pitavastatin,Hydrocortisone,The metabolism of Pitavastatin can be increased when combined with Hydrocortisone.,increase,no risk
Pitavastatin,Hydromorphone,The metabolism of Pitavastatin can be decreased when combined with Hydromorphone.,decrease,no risk
Pitavastatin,Hydroxychloroquine,The metabolism of Pitavastatin can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Pitavastatin,Ketamine,The metabolism of Pitavastatin can be decreased when combined with Ketamine.,decrease,no risk
Pitavastatin,Ketoconazole,Ketoconazole may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Ketoprofen,The metabolism of Pitavastatin can be decreased when combined with Ketoprofen.,decrease,no risk
Pitavastatin,Ketorolac,The metabolism of Pitavastatin can be decreased when combined with Ketorolac.,decrease,no risk
Pitavastatin,Ofloxacin,Ofloxacin may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Olanzapine,The metabolism of Pitavastatin can be decreased when combined with Olanzapine.,decrease,no risk
Pitavastatin,Olmesartan,Olmesartan may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Pitavastatin.,decrease,no risk
Pitavastatin,Omaveloxolone,The serum concentration of Pitavastatin can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Pitavastatin,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Pitavastatin.,decrease,no risk
Pitavastatin,Ondansetron,The metabolism of Pitavastatin can be decreased when combined with Ondansetron.,decrease,no risk
Pitavastatin,Oritavancin,The metabolism of Pitavastatin can be decreased when combined with Oritavancin.,decrease,no risk
Pitavastatin,Osimertinib,Osimertinib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Ospemifene,The metabolism of Pitavastatin can be decreased when combined with Ospemifene.,decrease,no risk
Pitavastatin,Oteseconazole,The serum concentration of Pitavastatin can be increased when it is combined with Oteseconazole.,increase,no risk
Pitavastatin,Ouabain,The excretion of Pitavastatin can be decreased when combined with Ouabain.,decrease,no risk
Pitavastatin,Oxandrolone,The metabolism of Pitavastatin can be decreased when combined with Oxandrolone.,decrease,no risk
Pitavastatin,Oxybutynin,The metabolism of Pitavastatin can be decreased when combined with Oxybutynin.,decrease,no risk
Pitavastatin,Ozanimod,The metabolism of Ozanimod can be decreased when combined with Pitavastatin.,decrease,no risk
Pitavastatin,Quinidine,Quinidine may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Quinine,The metabolism of Pitavastatin can be decreased when combined with Quinine.,decrease,no risk
Pitavastatin,Ubidecarenone,The risk or severity of myopathy and rhabdomyolysis can be decreased when Ubidecarenone is combined with Pitavastatin.,decrease,risk
Pitavastatin,Ursodeoxycholic acid,Ursodeoxycholic acid may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Vadadustat,The serum concentration of Pitavastatin can be increased when it is combined with Vadadustat.,increase,no risk
Pitavastatin,Valdecoxib,The metabolism of Pitavastatin can be decreased when combined with Valdecoxib.,decrease,no risk
Pitavastatin,Valproic acid,The metabolism of Pitavastatin can be decreased when combined with Valproic acid.,decrease,no risk
Pitavastatin,Valsartan,The metabolism of Pitavastatin can be decreased when combined with Valsartan.,decrease,no risk
Pitavastatin,Vandetanib,Vandetanib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Vardenafil,The metabolism of Pitavastatin can be decreased when combined with Vardenafil.,decrease,no risk
Pitavastatin,Velpatasvir,Velpatasvir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Vemurafenib,Vemurafenib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Venetoclax,Venetoclax may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Venlafaxine,Venlafaxine may increase the excretion rate of Pitavastatin which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Pitavastatin,Vinblastine,Vinblastine may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Vincristine,Vincristine may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Vismodegib,Vismodegib may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Voriconazole,The metabolism of Pitavastatin can be decreased when combined with Voriconazole.,decrease,no risk
Pitavastatin,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Pitavastatin.,decrease,no risk
Pitavastatin,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Pitavastatin.,decrease,no risk
Pitavastatin,Voxilaprevir,Voxilaprevir may decrease the excretion rate of Pitavastatin which could result in a higher serum level.,decrease,no risk
Pitavastatin,Warfarin,The risk or severity of bleeding can be increased when Pitavastatin is combined with Warfarin.,increase,risk
Pitavastatin,Ximelagatran,The metabolism of Pitavastatin can be decreased when combined with Ximelagatran.,decrease,no risk
Pitavastatin,Zafirlukast,The metabolism of Pitavastatin can be decreased when combined with Zafirlukast.,decrease,no risk
Pitavastatin,Zidovudine,"The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Pitavastatin.",increase,risk
Pitavastatin,Zileuton,The metabolism of Pitavastatin can be decreased when combined with Zileuton.,decrease,no risk
Pitavastatin,Zolpidem,The metabolism of Pitavastatin can be decreased when combined with Zolpidem.,decrease,no risk
Pitavastatin,Zopiclone,The metabolism of Pitavastatin can be decreased when combined with Zopiclone.,decrease,no risk
MLN576,Benzocaine,The risk or severity of methemoglobinemia can be increased when MLN576 is combined with Benzocaine.,increase,risk
MLN576,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when MLN576 is combined with Benzyl alcohol.,increase,risk
MLN576,Bupivacaine,The risk or severity of methemoglobinemia can be increased when MLN576 is combined with Bupivacaine.,increase,risk
MLN576,Butacaine,The risk or severity of methemoglobinemia can be increased when MLN576 is combined with Butacaine.,increase,risk
MLN576,Butamben,The risk or severity of methemoglobinemia can be increased when MLN576 is combined with Butamben.,increase,risk
MLN576,Oxetacaine,The risk or severity of methemoglobinemia can be increased when MLN576 is combined with Oxetacaine.,increase,risk
MLN576,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when MLN576 is combined with Oxybuprocaine.,increase,risk
Tramiprosate,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Tramiprosate.,increase,risk
Tramiprosate,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Tramiprosate is combined with Gabapentin enacarbil.,increase,risk
Tramiprosate,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Tramiprosate.,increase,risk
Tramiprosate,Gamolenic acid,The therapeutic efficacy of Tramiprosate can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Tramiprosate,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Tramiprosate is combined with Ganaxolone.",increase,risk
Tramiprosate,Ganciclovir,The therapeutic efficacy of Tramiprosate can be decreased when used in combination with Ganciclovir.,decrease,no risk
Tramiprosate,Gepirone,The risk or severity of CNS depression can be increased when Tramiprosate is combined with Gepirone.,increase,risk
Tramiprosate,Gestrinone,The metabolism of Gestrinone can be increased when combined with Tramiprosate.,increase,no risk
Tramiprosate,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Tramiprosate.,increase,risk
Tramiprosate,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Tramiprosate.,increase,risk
Tramiprosate,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Tramiprosate.,increase,risk
Tramiprosate,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Tramiprosate.,increase,risk
Tramiprosate,Halofantrine,The therapeutic efficacy of Tramiprosate can be decreased when used in combination with Halofantrine.,decrease,no risk
Tramiprosate,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Tramiprosate.,increase,risk
Tramiprosate,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Tramiprosate.,increase,risk
Tramiprosate,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Tramiprosate.,increase,risk
Tramiprosate,Hydrocodone,Tramiprosate may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Tramiprosate,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Tramiprosate.,increase,risk
Tramiprosate,Hydroxychloroquine,The therapeutic efficacy of Tramiprosate can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Tramiprosate,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Tramiprosate.,increase,no risk
Tramiprosate,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Tramiprosate.,increase,no risk
Tramiprosate,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Tramiprosate.,increase,risk
Tramiprosate,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Tramiprosate.,increase,risk
Tramiprosate,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Tramiprosate.,increase,risk
Tramiprosate,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Tramiprosate is combined with Oliceridine.",increase,risk
Tramiprosate,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Tramiprosate.,increase,risk
Tramiprosate,Opium,The risk or severity of CNS depression can be increased when Tramiprosate is combined with Opium.,increase,risk
Tramiprosate,Orlistat,Orlistat can cause a decrease in the absorption of Tramiprosate resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Tramiprosate,Orphenadrine,Tramiprosate may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Tramiprosate,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Tramiprosate.,increase,risk
Tramiprosate,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Tramiprosate.,increase,risk
Tramiprosate,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Tramiprosate is combined with Oxetacaine.,increase,risk
Tramiprosate,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Tramiprosate.,increase,risk
Tramiprosate,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Tramiprosate.,increase,risk
Tramiprosate,Oxtriphylline,Tramiprosate may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Tramiprosate,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Tramiprosate is combined with Oxybuprocaine.,increase,risk
Tramiprosate,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Tramiprosate.,increase,risk
Tramiprosate,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Tramiprosate.,increase,risk
Tramiprosate,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Tramiprosate.,increase,risk
Tramiprosate,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Tramiprosate.,increase,risk
Tramiprosate,Quinidine,The therapeutic efficacy of Tramiprosate can be decreased when used in combination with Quinidine.,decrease,no risk
Tramiprosate,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Tramiprosate.,increase,risk
Tramiprosate,Quinupramine,The risk or severity of CNS depression can be increased when Tramiprosate is combined with Quinupramine.,increase,risk
Tramiprosate,Ulipristal,The metabolism of Ulipristal can be increased when combined with Tramiprosate.,increase,no risk
Tramiprosate,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Tramiprosate.,increase,risk
Tramiprosate,Valganciclovir,The therapeutic efficacy of Tramiprosate can be decreased when used in combination with Valganciclovir.,decrease,no risk
Tramiprosate,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Tramiprosate.,increase,risk
Tramiprosate,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Tramiprosate.,increase,risk
Tramiprosate,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Tramiprosate.,increase,risk
Tramiprosate,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Tramiprosate.,increase,risk
Tramiprosate,Vilazodone,The risk or severity of CNS depression can be increased when Tramiprosate is combined with Vilazodone.,increase,risk
Tramiprosate,Viloxazine,The risk or severity of CNS depression can be increased when Tramiprosate is combined with Viloxazine.,increase,risk
Tramiprosate,Vortioxetine,The risk or severity of CNS depression can be increased when Tramiprosate is combined with Vortioxetine.,increase,risk
Tramiprosate,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Tramiprosate.,increase,risk
Tramiprosate,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Tramiprosate.,increase,risk
Tramiprosate,Ziconotide,The risk or severity of CNS depression can be increased when Tramiprosate is combined with Ziconotide.,increase,risk
Tramiprosate,Zimelidine,The risk or severity of adverse effects can be increased when Tramiprosate is combined with Zimelidine.,increase,risk
Tramiprosate,Ziprasidone,The risk or severity of adverse effects can be increased when Tramiprosate is combined with Ziprasidone.,increase,risk
Tramiprosate,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Tramiprosate.,increase,risk
Tramiprosate,Zolpidem,Tramiprosate may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Tramiprosate,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Tramiprosate.,increase,risk
Tramiprosate,Zopiclone,The risk or severity of adverse effects can be increased when Tramiprosate is combined with Zopiclone.,increase,risk
Tramiprosate,Zotepine,The risk or severity of CNS depression can be increased when Tramiprosate is combined with Zotepine.,increase,risk
Tramiprosate,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Tramiprosate.,increase,risk
Tramiprosate,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Tramiprosate.,increase,risk
Ocinaplon,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Ocinaplon.,increase,risk
Ocinaplon,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Ocinaplon is combined with Gabapentin enacarbil.,increase,risk
Ocinaplon,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Ocinaplon.,increase,risk
Ocinaplon,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Ocinaplon is combined with Ganaxolone.",increase,risk
Ocinaplon,Gepirone,The risk or severity of CNS depression can be increased when Ocinaplon is combined with Gepirone.,increase,risk
Ocinaplon,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Ocinaplon.,increase,risk
Ocinaplon,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Ocinaplon.,increase,risk
Ocinaplon,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Ocinaplon.,increase,risk
Ocinaplon,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Ocinaplon.,increase,risk
Ocinaplon,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Ocinaplon.,increase,risk
Ocinaplon,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Ocinaplon.,increase,risk
Ocinaplon,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Ocinaplon.,increase,risk
Ocinaplon,Hydrocodone,Ocinaplon may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Ocinaplon,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Ocinaplon.,increase,risk
Ocinaplon,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Ocinaplon.,increase,no risk
Ocinaplon,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Ocinaplon.,increase,risk
Ocinaplon,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Ocinaplon.,increase,risk
Ocinaplon,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Ocinaplon.,increase,risk
Ocinaplon,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Ocinaplon is combined with Oliceridine.",increase,risk
Ocinaplon,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Ocinaplon.,increase,risk
Ocinaplon,Opium,The risk or severity of CNS depression can be increased when Ocinaplon is combined with Opium.,increase,risk
Ocinaplon,Orphenadrine,Ocinaplon may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Ocinaplon,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Ocinaplon.,increase,risk
Ocinaplon,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Ocinaplon.,increase,risk
Ocinaplon,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Ocinaplon.,increase,risk
Ocinaplon,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Ocinaplon.,increase,risk
Ocinaplon,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Ocinaplon.,increase,risk
Ocinaplon,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Ocinaplon.,increase,risk
Ocinaplon,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Ocinaplon.,increase,risk
Ocinaplon,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Ocinaplon.,increase,risk
Ocinaplon,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Ocinaplon.,increase,risk
Ocinaplon,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Ocinaplon.,increase,risk
Ocinaplon,Quinupramine,The risk or severity of CNS depression can be increased when Ocinaplon is combined with Quinupramine.,increase,risk
Ocinaplon,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Ocinaplon.,increase,risk
Ocinaplon,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Ocinaplon.,increase,risk
Ocinaplon,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Ocinaplon.,increase,risk
Ocinaplon,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Ocinaplon.,increase,risk
Ocinaplon,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Ocinaplon.,increase,risk
Ocinaplon,Vilazodone,The risk or severity of CNS depression can be increased when Ocinaplon is combined with Vilazodone.,increase,risk
Ocinaplon,Viloxazine,The risk or severity of CNS depression can be increased when Ocinaplon is combined with Viloxazine.,increase,risk
Ocinaplon,Vortioxetine,The risk or severity of CNS depression can be increased when Ocinaplon is combined with Vortioxetine.,increase,risk
Ocinaplon,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Ocinaplon.,increase,risk
Ocinaplon,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Ocinaplon.,increase,risk
Ocinaplon,Ziconotide,The risk or severity of CNS depression can be increased when Ocinaplon is combined with Ziconotide.,increase,risk
Ocinaplon,Zimelidine,The risk or severity of adverse effects can be increased when Ocinaplon is combined with Zimelidine.,increase,risk
Ocinaplon,Ziprasidone,The risk or severity of adverse effects can be increased when Ocinaplon is combined with Ziprasidone.,increase,risk
Ocinaplon,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Ocinaplon.,increase,risk
Ocinaplon,Zolpidem,Ocinaplon may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Ocinaplon,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Ocinaplon.,increase,risk
Ocinaplon,Zopiclone,The risk or severity of adverse effects can be increased when Ocinaplon is combined with Zopiclone.,increase,risk
Ocinaplon,Zotepine,The risk or severity of CNS depression can be increased when Ocinaplon is combined with Zotepine.,increase,risk
Ocinaplon,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Ocinaplon.,increase,risk
Ocinaplon,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Ocinaplon.,increase,risk
Thrombopoietin,Vinblastine,The risk or severity of peripheral neuropathy can be increased when Thrombopoietin is combined with Vinblastine.,increase,risk
Thrombopoietin,Vincristine,The risk or severity of peripheral neuropathy can be increased when Thrombopoietin is combined with Vincristine.,increase,risk
Thrombopoietin,Vindesine,The risk or severity of peripheral neuropathy can be increased when Thrombopoietin is combined with Vindesine.,increase,risk
Thrombopoietin,Vinflunine,The risk or severity of peripheral neuropathy can be increased when Thrombopoietin is combined with Vinflunine.,increase,risk
Thrombopoietin,Vinorelbine,The risk or severity of peripheral neuropathy can be increased when Thrombopoietin is combined with Vinorelbine.,increase,risk
Etilevodopa,Brexpiprazole,The therapeutic efficacy of Etilevodopa can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Etilevodopa,Bupropion,The risk or severity of adverse effects can be increased when Bupropion is combined with Etilevodopa.,increase,risk
Etilevodopa,Haloperidol,The therapeutic efficacy of Etilevodopa can be decreased when used in combination with Haloperidol.,decrease,no risk
Etilevodopa,Olanzapine,The therapeutic efficacy of Etilevodopa can be decreased when used in combination with Olanzapine.,decrease,no risk
Etilevodopa,Quetiapine,The therapeutic efficacy of Etilevodopa can be decreased when used in combination with Quetiapine.,decrease,no risk
Etilevodopa,Vasopressin,Vasopressin may increase the hypertensive activities of Etilevodopa.,increase,no risk
Etilevodopa,Ziprasidone,The therapeutic efficacy of Etilevodopa can be decreased when used in combination with Ziprasidone.,decrease,no risk
Etilevodopa,Zotepine,The therapeutic efficacy of Etilevodopa can be decreased when used in combination with Zotepine.,decrease,no risk
Etilevodopa,Zuclopenthixol,The therapeutic efficacy of Etilevodopa can be decreased when used in combination with Zuclopenthixol.,decrease,no risk
Astaxanthin,Gemcitabine,The risk or severity of bleeding can be increased when Astaxanthin is combined with Gemcitabine.,increase,risk
Astaxanthin,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Astaxanthin is combined with Gemtuzumab ozogamicin.,increase,risk
Astaxanthin,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Astaxanthin.,increase,risk
Astaxanthin,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Astaxanthin.,increase,no risk
Astaxanthin,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Astaxanthin.,increase,risk
Astaxanthin,Hemin,Hemin may increase the anticoagulant activities of Astaxanthin.,increase,no risk
Astaxanthin,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Astaxanthin.,increase,risk
Astaxanthin,Hydrochlorothiazide,The therapeutic efficacy of Astaxanthin can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Astaxanthin,Hydroflumethiazide,The therapeutic efficacy of Astaxanthin can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Astaxanthin,Hydroxyprogesterone caproate,The therapeutic efficacy of Astaxanthin can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Astaxanthin,Hydroxyurea,The risk or severity of bleeding can be increased when Astaxanthin is combined with Hydroxyurea.,increase,risk
Astaxanthin,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Astaxanthin.,increase,risk
Astaxanthin,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Astaxanthin.,increase,risk
Astaxanthin,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Astaxanthin is combined with Obeticholic acid.,increase,risk
Astaxanthin,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Astaxanthin is combined with Obinutuzumab.,increase,risk
Astaxanthin,Olaparib,The risk or severity of bleeding can be increased when Astaxanthin is combined with Olaparib.,increase,risk
Astaxanthin,Olive oil,The therapeutic efficacy of Astaxanthin can be decreased when used in combination with Olive oil.,decrease,no risk
Astaxanthin,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Astaxanthin.,increase,risk
Astaxanthin,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Astaxanthin is combined with Omacetaxine mepesuccinate.,increase,risk
Astaxanthin,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Astaxanthin.,increase,no risk
Astaxanthin,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Astaxanthin.,increase,risk
Astaxanthin,Omega-3-carboxylic acids,The therapeutic efficacy of Astaxanthin can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Astaxanthin,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Astaxanthin.,increase,risk
Astaxanthin,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Astaxanthin.,increase,risk
Astaxanthin,Oxyphenbutazone,The risk or severity of bleeding and hemorrhage can be increased when Oxyphenbutazone is combined with Astaxanthin.,increase,risk
Astaxanthin,Quinestrol,Quinestrol may decrease the anticoagulant activities of Astaxanthin.,decrease,no risk
Astaxanthin,Quinidine,The therapeutic efficacy of Astaxanthin can be increased when used in combination with Quinidine.,increase,no risk
Astaxanthin,Quinine,The therapeutic efficacy of Astaxanthin can be increased when used in combination with Quinine.,increase,no risk
Bivatuzumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Bivatuzumab.,increase,risk
Bivatuzumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Bivatuzumab is combined with Obinutuzumab.,increase,risk
Bivatuzumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Bivatuzumab is combined with Ocrelizumab.,increase,risk
Bivatuzumab,Odesivimab,The risk or severity of adverse effects can be increased when Bivatuzumab is combined with Odesivimab.,increase,risk
Bivatuzumab,Ofatumumab,The risk or severity of adverse effects can be increased when Bivatuzumab is combined with Ofatumumab.,increase,risk
Bivatuzumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Bivatuzumab.,increase,risk
Bivatuzumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Bivatuzumab.,increase,risk
Bivatuzumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Bivatuzumab.,increase,no risk
Bivatuzumab,Ublituximab,The risk or severity of adverse effects can be increased when Bivatuzumab is combined with Ublituximab.,increase,risk
Bivatuzumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Bivatuzumab.,increase,risk
Bivatuzumab,Vedolizumab,The risk or severity of adverse effects can be increased when Bivatuzumab is combined with Vedolizumab.,increase,risk
Gaboxadol,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Gaboxadol.,increase,risk
Gaboxadol,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Gaboxadol is combined with Gabapentin enacarbil.,increase,risk
Gaboxadol,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Gaboxadol.,increase,risk
Gaboxadol,Gamolenic acid,The therapeutic efficacy of Gaboxadol can be decreased when used in combination with Gamolenic acid.,decrease,no risk
Gaboxadol,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Gaboxadol is combined with Ganaxolone.",increase,risk
Gaboxadol,Ganciclovir,The therapeutic efficacy of Gaboxadol can be decreased when used in combination with Ganciclovir.,decrease,no risk
Gaboxadol,Gepirone,The risk or severity of CNS depression can be increased when Gaboxadol is combined with Gepirone.,increase,risk
Gaboxadol,Gestrinone,The metabolism of Gestrinone can be increased when combined with Gaboxadol.,increase,no risk
Gaboxadol,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Gaboxadol.,increase,risk
Gaboxadol,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Gaboxadol.,increase,risk
Gaboxadol,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Gaboxadol.,increase,risk
Gaboxadol,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Gaboxadol.,increase,risk
Gaboxadol,Halofantrine,The therapeutic efficacy of Gaboxadol can be decreased when used in combination with Halofantrine.,decrease,no risk
Gaboxadol,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Gaboxadol.,increase,risk
Gaboxadol,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Gaboxadol.,increase,risk
Gaboxadol,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Gaboxadol.,increase,risk
Gaboxadol,Hydrocodone,Gaboxadol may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Gaboxadol,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Gaboxadol.,increase,risk
Gaboxadol,Hydroxychloroquine,The therapeutic efficacy of Gaboxadol can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
Gaboxadol,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be increased when combined with Gaboxadol.,increase,no risk
Gaboxadol,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Gaboxadol.,increase,no risk
Gaboxadol,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Gaboxadol.,increase,risk
Gaboxadol,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Gaboxadol.,increase,risk
Gaboxadol,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Gaboxadol.,increase,risk
Gaboxadol,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Gaboxadol is combined with Oliceridine.",increase,risk
Gaboxadol,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Gaboxadol.,increase,risk
Gaboxadol,Opium,The risk or severity of CNS depression can be increased when Gaboxadol is combined with Opium.,increase,risk
Gaboxadol,Orlistat,Orlistat can cause a decrease in the absorption of Gaboxadol resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Gaboxadol,Orphenadrine,Gaboxadol may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Gaboxadol,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Gaboxadol.,increase,risk
Gaboxadol,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Gaboxadol.,increase,risk
Gaboxadol,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Gaboxadol is combined with Oxetacaine.,increase,risk
Gaboxadol,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Gaboxadol.,increase,risk
Gaboxadol,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Gaboxadol.,increase,risk
Gaboxadol,Oxtriphylline,Gaboxadol may increase the excretion rate of Oxtriphylline which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Gaboxadol,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Gaboxadol is combined with Oxybuprocaine.,increase,risk
Gaboxadol,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Gaboxadol.,increase,risk
Gaboxadol,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Gaboxadol.,increase,risk
Gaboxadol,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Gaboxadol.,increase,risk
Gaboxadol,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Gaboxadol.,increase,risk
Gaboxadol,Quinidine,The therapeutic efficacy of Gaboxadol can be decreased when used in combination with Quinidine.,decrease,no risk
Gaboxadol,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Gaboxadol.,increase,risk
Gaboxadol,Quinupramine,The risk or severity of CNS depression can be increased when Gaboxadol is combined with Quinupramine.,increase,risk
Gaboxadol,Ulipristal,The metabolism of Ulipristal can be increased when combined with Gaboxadol.,increase,no risk
Gaboxadol,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Gaboxadol.,increase,risk
Gaboxadol,Valganciclovir,The therapeutic efficacy of Gaboxadol can be decreased when used in combination with Valganciclovir.,decrease,no risk
Gaboxadol,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Gaboxadol.,increase,risk
Gaboxadol,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Gaboxadol.,increase,risk
Gaboxadol,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Gaboxadol.,increase,risk
Gaboxadol,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Gaboxadol.,increase,risk
Gaboxadol,Vilazodone,The risk or severity of CNS depression can be increased when Gaboxadol is combined with Vilazodone.,increase,risk
Gaboxadol,Viloxazine,The risk or severity of CNS depression can be increased when Gaboxadol is combined with Viloxazine.,increase,risk
Gaboxadol,Vortioxetine,The risk or severity of CNS depression can be increased when Gaboxadol is combined with Vortioxetine.,increase,risk
Gaboxadol,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Gaboxadol.,increase,risk
Gaboxadol,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Gaboxadol.,increase,risk
Gaboxadol,Ziconotide,The risk or severity of CNS depression can be increased when Gaboxadol is combined with Ziconotide.,increase,risk
Gaboxadol,Zimelidine,The risk or severity of adverse effects can be increased when Gaboxadol is combined with Zimelidine.,increase,risk
Gaboxadol,Ziprasidone,The risk or severity of adverse effects can be increased when Gaboxadol is combined with Ziprasidone.,increase,risk
Gaboxadol,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Gaboxadol.,increase,risk
Gaboxadol,Zolpidem,Gaboxadol may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Gaboxadol,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Gaboxadol.,increase,risk
Gaboxadol,Zopiclone,The risk or severity of adverse effects can be increased when Gaboxadol is combined with Zopiclone.,increase,risk
Gaboxadol,Zotepine,The risk or severity of CNS depression can be increased when Gaboxadol is combined with Zotepine.,increase,risk
Gaboxadol,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Gaboxadol.,increase,risk
Gaboxadol,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Gaboxadol.,increase,risk
Lerdelimumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Lerdelimumab.,increase,risk
Lerdelimumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Lerdelimumab is combined with Obinutuzumab.,increase,risk
Lerdelimumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Lerdelimumab is combined with Ocrelizumab.,increase,risk
Lerdelimumab,Odesivimab,The risk or severity of adverse effects can be increased when Lerdelimumab is combined with Odesivimab.,increase,risk
Lerdelimumab,Ofatumumab,The risk or severity of adverse effects can be increased when Lerdelimumab is combined with Ofatumumab.,increase,risk
Lerdelimumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Lerdelimumab.,increase,risk
Lerdelimumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lerdelimumab.,increase,risk
Lerdelimumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Lerdelimumab.,increase,no risk
Lerdelimumab,Ublituximab,The risk or severity of adverse effects can be increased when Lerdelimumab is combined with Ublituximab.,increase,risk
Lerdelimumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Lerdelimumab.,increase,risk
Lerdelimumab,Vedolizumab,The risk or severity of adverse effects can be increased when Lerdelimumab is combined with Vedolizumab.,increase,risk
Valomaciclovir,Ofloxacin,The metabolism of Valomaciclovir can be decreased when combined with Ofloxacin.,decrease,no risk
Valomaciclovir,Olodaterol,Valomaciclovir may increase the hyperkalemic activities of Olodaterol.,increase,no risk
Valomaciclovir,Orciprenaline,The risk or severity of adverse effects can be increased when Orciprenaline is combined with Valomaciclovir.,increase,risk
Valomaciclovir,Oxazepam,The therapeutic efficacy of Oxazepam can be decreased when used in combination with Valomaciclovir.,decrease,no risk
Valomaciclovir,Oxcarbazepine,Oxcarbazepine may increase the excretion rate of Valomaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valomaciclovir,Oxprenolol,The risk or severity of adverse effects can be increased when Oxprenolol is combined with Valomaciclovir.,increase,risk
Valomaciclovir,Oxymetazoline,The risk or severity of adverse effects can be increased when Oxymetazoline is combined with Valomaciclovir.,increase,risk
Valomaciclovir,Quazepam,The therapeutic efficacy of Quazepam can be decreased when used in combination with Valomaciclovir.,decrease,no risk
Valomaciclovir,Quinidine,The serum concentration of Valomaciclovir can be increased when it is combined with Quinidine.,increase,no risk
Valomaciclovir,Quinine,The serum concentration of Valomaciclovir can be increased when it is combined with Quinine.,increase,no risk
Valomaciclovir,Valproic acid,Valproic acid may increase the excretion rate of Valomaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valomaciclovir,Vigabatrin,Vigabatrin may increase the excretion rate of Valomaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valomaciclovir,Vilanterol,The risk or severity of hypokalemia can be increased when Valomaciclovir is combined with Vilanterol.,increase,risk
Valomaciclovir,Viloxazine,The serum concentration of Valomaciclovir can be increased when it is combined with Viloxazine.,increase,no risk
Valomaciclovir,Zafirlukast,The serum concentration of Zafirlukast can be decreased when it is combined with Valomaciclovir.,decrease,no risk
Valomaciclovir,Zaleplon,Zaleplon may increase the excretion rate of Valomaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Valomaciclovir,Zonisamide,Zonisamide may increase the excretion rate of Valomaciclovir which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vilanterol,Bacillus calmette-guerin substrain connaught live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain connaught live antigen is combined with Vilanterol.,increase,risk
Vilanterol,Bacillus calmette-guerin substrain russian BCG-I live antigen,The therapeutic efficacy of Bacillus calmette-guerin substrain russian BCG-I live antigen can be decreased when used in combination with Vilanterol.,decrease,no risk
Vilanterol,Bacillus calmette-guerin substrain tice live antigen,The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Vilanterol.,increase,risk
Vilanterol,Bacitracin,Bacitracin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Baclofen,Baclofen may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Balsalazide,The risk or severity of hypertension can be increased when Balsalazide is combined with Vilanterol.,increase,risk
Vilanterol,Baricitinib,The risk or severity of adverse effects can be increased when Vilanterol is combined with Baricitinib.,increase,risk
Vilanterol,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Vilanterol.,increase,risk
Vilanterol,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Vilanterol.,increase,risk
Vilanterol,Beclomethasone dipropionate,The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Vilanterol.,increase,risk
Vilanterol,Bedaquiline,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Bedaquiline.,increase,risk
Vilanterol,Belatacept,The risk or severity of adverse effects can be increased when Belatacept is combined with Vilanterol.,increase,risk
Vilanterol,Belimumab,The risk or severity of adverse effects can be increased when Belimumab is combined with Vilanterol.,increase,risk
Vilanterol,Belinostat,The risk or severity of adverse effects can be increased when Belinostat is combined with Vilanterol.,increase,risk
Vilanterol,Belumosudil,The risk or severity of adverse effects can be increased when Vilanterol is combined with Belumosudil.,increase,risk
Vilanterol,Benazepril,Vilanterol may decrease the antihypertensive activities of Benazepril.,decrease,no risk
Vilanterol,Bendamustine,The risk or severity of adverse effects can be increased when Bendamustine is combined with Vilanterol.,increase,risk
Vilanterol,Bendroflumethiazide,The risk or severity of hypokalemia can be increased when Bendroflumethiazide is combined with Vilanterol.,increase,risk
Vilanterol,Benorilate,The risk or severity of hypertension can be increased when Vilanterol is combined with Benorilate.,increase,risk
Vilanterol,Benoxaprofen,The risk or severity of hypertension can be increased when Benoxaprofen is combined with Vilanterol.,increase,risk
Vilanterol,Benserazide,Vilanterol may decrease the excretion rate of Benserazide which could result in a higher serum level.,decrease,no risk
Vilanterol,Benzatropine,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Benzatropine.,increase,risk
Vilanterol,Benznidazole,Vilanterol may decrease the excretion rate of Benznidazole which could result in a higher serum level.,decrease,no risk
Vilanterol,Benzphetamine,The risk or severity of hypertension can be increased when Benzphetamine is combined with Vilanterol.,increase,risk
Vilanterol,Benzthiazide,The risk or severity of hypokalemia can be increased when Benzthiazide is combined with Vilanterol.,increase,risk
Vilanterol,Benzydamine,The risk or severity of hypertension can be increased when Vilanterol is combined with Benzydamine.,increase,risk
Vilanterol,Benzylpenicilloyl polylysine,Vilanterol may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent.,decrease,no risk
Vilanterol,Bepotastine,Bepotastine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Bepridil,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Bepridil.,increase,risk
Vilanterol,Berotralstat,The metabolism of Vilanterol can be decreased when combined with Berotralstat.,decrease,no risk
Vilanterol,Besifloxacin,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Besifloxacin.,increase,risk
Vilanterol,Betahistine,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Betahistine.,decrease,no risk
Vilanterol,Betamethasone,The risk or severity of adverse effects can be increased when Betamethasone is combined with Vilanterol.,increase,risk
Vilanterol,Betamethasone phosphate,The risk or severity of hypokalemia can be increased when Betamethasone phosphate is combined with Vilanterol.,increase,risk
Vilanterol,Betaxolol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Betaxolol.,decrease,no risk
Vilanterol,Bethanidine,Vilanterol may decrease the antihypertensive activities of Bethanidine.,decrease,no risk
Vilanterol,Bexarotene,The risk or severity of adverse effects can be increased when Bexarotene is combined with Vilanterol.,increase,risk
Vilanterol,Bicisate,Vilanterol may decrease the excretion rate of Bicisate which could result in a higher serum level.,decrease,no risk
Vilanterol,Bilastine,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Bilastine.,increase,risk
Vilanterol,Bimekizumab,The risk or severity of adverse effects can be increased when Vilanterol is combined with Bimekizumab.,increase,risk
Vilanterol,Biperiden,The risk or severity of Tachycardia can be increased when Biperiden is combined with Vilanterol.,increase,risk
Vilanterol,Bismuth subgallate,Vilanterol may decrease the excretion rate of Bismuth subgallate which could result in a higher serum level.,decrease,no risk
Vilanterol,Bisoprolol,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Bisoprolol.,decrease,no risk
Vilanterol,Bisoxatin,Vilanterol may decrease the excretion rate of Bisoxatin which could result in a higher serum level.,decrease,no risk
Vilanterol,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Vilanterol.,increase,risk
Vilanterol,Blinatumomab,The risk or severity of adverse effects can be increased when Blinatumomab is combined with Vilanterol.,increase,risk
Vilanterol,Boceprevir,The serum concentration of Vilanterol can be increased when it is combined with Boceprevir.,increase,no risk
Vilanterol,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Vilanterol.",decrease,no risk
Vilanterol,Bortezomib,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Bortezomib.,increase,risk
Vilanterol,Bosentan,Vilanterol may decrease the antihypertensive activities of Bosentan.,decrease,no risk
Vilanterol,Bosutinib,The risk or severity of adverse effects can be increased when Bosutinib is combined with Vilanterol.,increase,risk
Vilanterol,Brentuximab vedotin,The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vilanterol.,increase,risk
Vilanterol,Bretylium,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Bretylium.,increase,risk
Vilanterol,Brexpiprazole,The therapeutic efficacy of Vilanterol can be decreased when used in combination with Brexpiprazole.,decrease,no risk
Vilanterol,Brivaracetam,Brivaracetam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Brodalumab,The risk or severity of adverse effects can be increased when Vilanterol is combined with Brodalumab.,increase,risk
Vilanterol,Bromazepam,Bromazepam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Bromocriptine,Bromocriptine may increase the hypertensive and vasoconstricting activities of Vilanterol.,increase,no risk
Vilanterol,Bromotheophylline,Bromotheophylline may increase the excretion rate of Vilanterol which could result in a lower serum level and potentially a reduction in efficacy.,increase,no risk
Vilanterol,Brompheniramine,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Brompheniramine.,increase,risk
Vilanterol,Buclizine,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Buclizine.,increase,risk
Vilanterol,Budesonide,The risk or severity of adverse effects can be increased when Budesonide is combined with Vilanterol.,increase,risk
Vilanterol,Bumadizone,The risk or severity of hypertension can be increased when Vilanterol is combined with Bumadizone.,increase,risk
Vilanterol,Bumetanide,The risk or severity of hypokalemia can be increased when Bumetanide is combined with Vilanterol.,increase,risk
Vilanterol,Bupropion,Bupropion may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Buserelin,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Buserelin.,increase,risk
Vilanterol,Buspirone,The risk or severity of hypertension can be increased when Buspirone is combined with Vilanterol.,increase,risk
Vilanterol,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Vilanterol.,increase,risk
Vilanterol,Butabarbital,Butabarbital may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Butriptyline,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Butriptyline.,increase,risk
Vilanterol,Butylscopolamine,The risk or severity of Tachycardia can be increased when Vilanterol is combined with Butylscopolamine.,increase,risk
Vilanterol,Gabapentin enacarbil,Gabapentin enacarbil may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Gadobenic acid,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Gadobenic acid.,increase,risk
Vilanterol,Gadodiamide,Gadodiamide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Gadofosveset trisodium,Gadofosveset trisodium may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Gadopentetic acid,Gadopentetic acid may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Gadoteric acid,Vilanterol may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Vilanterol,Gadoteridol,Gadoteridol may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Galantamine,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Galantamine.,increase,risk
Vilanterol,Gallamine triethiodide,The risk or severity of Tachycardia can be increased when Gallamine triethiodide is combined with Vilanterol.,increase,risk
Vilanterol,Ganciclovir,Ganciclovir may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Gatifloxacin,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Gatifloxacin.,increase,risk
Vilanterol,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Vilanterol.,increase,risk
Vilanterol,Gemfibrozil,Gemfibrozil may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Gemifloxacin,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Gemifloxacin.,increase,risk
Vilanterol,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Vilanterol.,increase,risk
Vilanterol,Gentamicin,Vilanterol may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Vilanterol,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Vilanterol.,increase,risk
Vilanterol,Gilteritinib,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Gilteritinib.,increase,risk
Vilanterol,Gimeracil,Vilanterol may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Vilanterol,Givosiran,Givosiran may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Glasdegib,The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Glasdegib.,increase,risk
Vilanterol,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Vilanterol.,increase,risk
Vilanterol,Glipizide,Glipizide may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Glofitamab,The serum concentration of Vilanterol can be increased when it is combined with Glofitamab.,increase,no risk
Vilanterol,Glycerol phenylbutyrate,Glycerol phenylbutyrate may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Glycopyrronium,The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Vilanterol.,increase,risk
Vilanterol,Golimumab,The risk or severity of adverse effects can be increased when Golimumab is combined with Vilanterol.,increase,risk
Vilanterol,Golodirsen,Vilanterol may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Vilanterol,Goserelin,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Goserelin.,increase,risk
Vilanterol,Granisetron,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Granisetron.,increase,risk
Vilanterol,Grepafloxacin,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Grepafloxacin.,increase,risk
Vilanterol,Guanabenz,Vilanterol may decrease the antihypertensive activities of Guanabenz.,decrease,no risk
Vilanterol,Guanadrel,Vilanterol may decrease the antihypertensive activities of Guanadrel.,decrease,no risk
Vilanterol,Guanethidine,Vilanterol may decrease the antihypertensive activities of Guanethidine.,decrease,no risk
Vilanterol,Guanfacine,Vilanterol may decrease the antihypertensive activities of Guanfacine.,decrease,no risk
Vilanterol,Guanoxan,Vilanterol may decrease the antihypertensive activities of Guanoxan.,decrease,no risk
Vilanterol,Guselkumab,The risk or severity of adverse effects can be increased when Vilanterol is combined with Guselkumab.,increase,risk
Vilanterol,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Vilanterol.,decrease,no risk
Vilanterol,Halofantrine,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Halofantrine.,increase,risk
Vilanterol,Haloperidol,The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Haloperidol.,increase,risk
Vilanterol,Halothane,The risk or severity of hypertension can be increased when Halothane is combined with Vilanterol.,increase,risk
Vilanterol,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Vilanterol.,decrease,no risk
Vilanterol,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Vilanterol.,decrease,no risk
Vilanterol,Hexocyclium,The risk or severity of Tachycardia can be increased when Hexocyclium is combined with Vilanterol.,increase,risk
Vilanterol,Histrelin,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Histrelin.,increase,risk
Vilanterol,Homatropine methylbromide,The risk or severity of Tachycardia can be increased when Homatropine methylbromide is combined with Vilanterol.,increase,risk
Vilanterol,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Vilanterol.,increase,risk
Vilanterol,Hydralazine,Vilanterol may decrease the antihypertensive activities of Hydralazine.,decrease,no risk
Vilanterol,Hydrochlorothiazide,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Hydrochlorothiazide.,increase,risk
Vilanterol,Hydrocortisone,The risk or severity of hypokalemia can be increased when Hydrocortisone is combined with Vilanterol.,increase,risk
Vilanterol,Hydrocortisone acetate,The risk or severity of adverse effects can be increased when Vilanterol is combined with Hydrocortisone acetate.,increase,risk
Vilanterol,Hydrocortisone butyrate,The risk or severity of adverse effects can be increased when Vilanterol is combined with Hydrocortisone butyrate.,increase,risk
Vilanterol,Hydrocortisone cypionate,The risk or severity of hypokalemia can be increased when Hydrocortisone cypionate is combined with Vilanterol.,increase,risk
Vilanterol,Hydrocortisone succinate,The risk or severity of adverse effects can be increased when Vilanterol is combined with Hydrocortisone succinate.,increase,risk
Vilanterol,Hydroflumethiazide,The risk or severity of hypokalemia can be increased when Hydroflumethiazide is combined with Vilanterol.,increase,risk
Vilanterol,Hydromorphone,Hydromorphone may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Hydroxocobalamin,Hydroxocobalamin may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Hydroxychloroquine,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Hydroxychloroquine.,increase,risk
Vilanterol,Hydroxyethyl Starch,Vilanterol may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Vilanterol,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Vilanterol.,increase,risk
Vilanterol,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Hydroxyzine.,increase,risk
Vilanterol,Hyoscyamine,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Hyoscyamine.,increase,risk
Vilanterol,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Vilanterol.,decrease,no risk
Vilanterol,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Vilanterol.,decrease,no risk
Vilanterol,Kanamycin,Vilanterol may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Vilanterol,Ketamine,Ketamine may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Ketazolam,Ketazolam may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Vilanterol,Ketoconazole,The serum concentration of Vilanterol can be increased when it is combined with Ketoconazole.,increase,no risk
Vilanterol,Ketoprofen,The risk or severity of hypertension can be increased when Ketoprofen is combined with Vilanterol.,increase,risk
Vilanterol,Ketorolac,The risk or severity of hypertension can be increased when Ketorolac is combined with Vilanterol.,increase,risk
Adipiplon,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Adipiplon.,increase,risk
Adipiplon,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Adipiplon is combined with Gabapentin enacarbil.,increase,risk
Adipiplon,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Adipiplon.,increase,risk
Adipiplon,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Adipiplon is combined with Ganaxolone.",increase,risk
Adipiplon,Gepirone,The risk or severity of CNS depression can be increased when Adipiplon is combined with Gepirone.,increase,risk
Adipiplon,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Adipiplon.,increase,risk
Adipiplon,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Adipiplon.,increase,risk
Adipiplon,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Adipiplon.,increase,risk
Adipiplon,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Adipiplon.,increase,risk
Adipiplon,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Adipiplon.,increase,risk
Adipiplon,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Adipiplon.,increase,risk
Adipiplon,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Adipiplon.,increase,risk
Adipiplon,Hydrocodone,Adipiplon may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Adipiplon,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Adipiplon.,increase,risk
Adipiplon,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Adipiplon.,increase,no risk
Adipiplon,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Adipiplon.,increase,risk
Adipiplon,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Adipiplon.,increase,risk
Adipiplon,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Adipiplon.,increase,risk
Adipiplon,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Adipiplon is combined with Oliceridine.",increase,risk
Adipiplon,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Adipiplon.,increase,risk
Adipiplon,Opium,The risk or severity of CNS depression can be increased when Adipiplon is combined with Opium.,increase,risk
Adipiplon,Orphenadrine,Adipiplon may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Adipiplon,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Adipiplon.,increase,risk
Adipiplon,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Adipiplon.,increase,risk
Adipiplon,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Adipiplon.,increase,risk
Adipiplon,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Adipiplon.,increase,risk
Adipiplon,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Adipiplon.,increase,risk
Adipiplon,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Adipiplon.,increase,risk
Adipiplon,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Adipiplon.,increase,risk
Adipiplon,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Adipiplon.,increase,risk
Adipiplon,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Adipiplon.,increase,risk
Adipiplon,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Adipiplon.,increase,risk
Adipiplon,Quinupramine,The risk or severity of CNS depression can be increased when Adipiplon is combined with Quinupramine.,increase,risk
Adipiplon,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Adipiplon.,increase,risk
Adipiplon,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Adipiplon.,increase,risk
Adipiplon,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Adipiplon.,increase,risk
Adipiplon,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Adipiplon.,increase,risk
Adipiplon,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Adipiplon.,increase,risk
Adipiplon,Vilazodone,The risk or severity of CNS depression can be increased when Adipiplon is combined with Vilazodone.,increase,risk
Adipiplon,Viloxazine,The risk or severity of CNS depression can be increased when Adipiplon is combined with Viloxazine.,increase,risk
Adipiplon,Vortioxetine,The risk or severity of CNS depression can be increased when Adipiplon is combined with Vortioxetine.,increase,risk
Adipiplon,Yohimbine,The therapeutic efficacy of Adipiplon can be increased when used in combination with Yohimbine.,increase,no risk
Adipiplon,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Adipiplon.,increase,risk
Adipiplon,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Adipiplon.,increase,risk
Adipiplon,Zimelidine,The risk or severity of adverse effects can be increased when Adipiplon is combined with Zimelidine.,increase,risk
Adipiplon,Ziprasidone,The risk or severity of adverse effects can be increased when Adipiplon is combined with Ziprasidone.,increase,risk
Adipiplon,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Adipiplon.,increase,risk
Adipiplon,Zolpidem,Adipiplon may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Adipiplon,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Adipiplon.,increase,risk
Adipiplon,Zopiclone,The risk or severity of adverse effects can be increased when Adipiplon is combined with Zopiclone.,increase,risk
Adipiplon,Zotepine,The risk or severity of CNS depression can be increased when Adipiplon is combined with Zotepine.,increase,risk
Adipiplon,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Adipiplon.,increase,risk
Adipiplon,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Adipiplon.,increase,risk
Dextofisopam,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Dextofisopam.,increase,risk
Dextofisopam,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Dextofisopam is combined with Gabapentin enacarbil.,increase,risk
Dextofisopam,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Dextofisopam.,increase,risk
Dextofisopam,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Dextofisopam is combined with Ganaxolone.",increase,risk
Dextofisopam,Gepirone,The risk or severity of CNS depression can be increased when Dextofisopam is combined with Gepirone.,increase,risk
Dextofisopam,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Dextofisopam.,increase,risk
Dextofisopam,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Dextofisopam.,increase,risk
Dextofisopam,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Dextofisopam.,increase,risk
Dextofisopam,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Dextofisopam.,increase,risk
Dextofisopam,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Dextofisopam.,increase,risk
Dextofisopam,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Dextofisopam.,increase,risk
Dextofisopam,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Dextofisopam.,increase,risk
Dextofisopam,Hydrocodone,Dextofisopam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Dextofisopam,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Dextofisopam.,increase,risk
Dextofisopam,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dextofisopam.,increase,no risk
Dextofisopam,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Dextofisopam.,increase,risk
Dextofisopam,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Dextofisopam.,increase,risk
Dextofisopam,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Dextofisopam.,increase,risk
Dextofisopam,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Dextofisopam is combined with Oliceridine.",increase,risk
Dextofisopam,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Dextofisopam.,increase,risk
Dextofisopam,Opium,The risk or severity of CNS depression can be increased when Dextofisopam is combined with Opium.,increase,risk
Dextofisopam,Orphenadrine,Dextofisopam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Dextofisopam,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Dextofisopam.,increase,risk
Dextofisopam,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Dextofisopam.,increase,risk
Dextofisopam,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Dextofisopam.,increase,risk
Dextofisopam,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Dextofisopam.,increase,risk
Dextofisopam,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Dextofisopam.,increase,risk
Dextofisopam,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Dextofisopam.,increase,risk
Dextofisopam,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Dextofisopam.,increase,risk
Dextofisopam,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Dextofisopam.,increase,risk
Dextofisopam,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Dextofisopam.,increase,risk
Dextofisopam,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Dextofisopam.,increase,risk
Dextofisopam,Quinupramine,The risk or severity of CNS depression can be increased when Dextofisopam is combined with Quinupramine.,increase,risk
Dextofisopam,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Dextofisopam.,increase,risk
Dextofisopam,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Dextofisopam.,increase,risk
Dextofisopam,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Dextofisopam.,increase,risk
Dextofisopam,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Dextofisopam.,increase,risk
Dextofisopam,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Dextofisopam.,increase,risk
Dextofisopam,Vilazodone,The risk or severity of CNS depression can be increased when Dextofisopam is combined with Vilazodone.,increase,risk
Dextofisopam,Viloxazine,The risk or severity of CNS depression can be increased when Dextofisopam is combined with Viloxazine.,increase,risk
Dextofisopam,Vortioxetine,The risk or severity of CNS depression can be increased when Dextofisopam is combined with Vortioxetine.,increase,risk
Dextofisopam,Warfarin,The risk or severity of adverse effects can be increased when Dextofisopam is combined with Warfarin.,increase,risk
Dextofisopam,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Dextofisopam.,increase,risk
Dextofisopam,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Dextofisopam.,increase,risk
Dextofisopam,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Dextofisopam.,increase,risk
Dextofisopam,Zimelidine,The risk or severity of adverse effects can be increased when Dextofisopam is combined with Zimelidine.,increase,risk
Dextofisopam,Ziprasidone,The risk or severity of adverse effects can be increased when Dextofisopam is combined with Ziprasidone.,increase,risk
Dextofisopam,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Dextofisopam.,increase,risk
Dextofisopam,Zolpidem,Dextofisopam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Dextofisopam,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Dextofisopam.,increase,risk
Dextofisopam,Zopiclone,The risk or severity of adverse effects can be increased when Dextofisopam is combined with Zopiclone.,increase,risk
Dextofisopam,Zotepine,The risk or severity of CNS depression can be increased when Dextofisopam is combined with Zotepine.,increase,risk
Dextofisopam,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Dextofisopam.,increase,risk
Dextofisopam,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Dextofisopam.,increase,risk
TG4010,Gemtuzumab ozogamicin,The therapeutic efficacy of TG4010 can be decreased when used in combination with Gemtuzumab ozogamicin.,decrease,no risk
TG4010,Glatiramer,The therapeutic efficacy of TG4010 can be decreased when used in combination with Glatiramer.,decrease,no risk
TG4010,Golimumab,The therapeutic efficacy of TG4010 can be decreased when used in combination with Golimumab.,decrease,no risk
TG4010,Guselkumab,The therapeutic efficacy of TG4010 can be decreased when used in combination with Guselkumab.,decrease,no risk
TG4010,Hydrocortisone,The therapeutic efficacy of TG4010 can be decreased when used in combination with Hydrocortisone.,decrease,no risk
TG4010,Hydrocortisone acetate,The therapeutic efficacy of TG4010 can be decreased when used in combination with Hydrocortisone acetate.,decrease,no risk
TG4010,Hydrocortisone butyrate,The therapeutic efficacy of TG4010 can be decreased when used in combination with Hydrocortisone butyrate.,decrease,no risk
TG4010,Hydrocortisone succinate,The therapeutic efficacy of TG4010 can be decreased when used in combination with Hydrocortisone succinate.,decrease,no risk
TG4010,Hydroxychloroquine,The therapeutic efficacy of TG4010 can be decreased when used in combination with Hydroxychloroquine.,decrease,no risk
TG4010,Hydroxyurea,The therapeutic efficacy of TG4010 can be decreased when used in combination with Hydroxyurea.,decrease,no risk
TG4010,Obinutuzumab,The therapeutic efficacy of TG4010 can be decreased when used in combination with Obinutuzumab.,decrease,no risk
TG4010,Ocrelizumab,The therapeutic efficacy of TG4010 can be decreased when used in combination with Ocrelizumab.,decrease,no risk
TG4010,Ofatumumab,The therapeutic efficacy of TG4010 can be decreased when used in combination with Ofatumumab.,decrease,no risk
TG4010,Olaparib,The therapeutic efficacy of TG4010 can be decreased when used in combination with Olaparib.,decrease,no risk
TG4010,Oxaliplatin,The therapeutic efficacy of TG4010 can be decreased when used in combination with Oxaliplatin.,decrease,no risk
TG4010,Ozanimod,The therapeutic efficacy of TG4010 can be decreased when used in combination with Ozanimod.,decrease,no risk
TG4010,Ublituximab,The therapeutic efficacy of TG4010 can be decreased when used in combination with Ublituximab.,decrease,no risk
TG4010,Upadacitinib,The therapeutic efficacy of TG4010 can be decreased when used in combination with Upadacitinib.,decrease,no risk
TG4010,Vedolizumab,The therapeutic efficacy of TG4010 can be decreased when used in combination with Vedolizumab.,decrease,no risk
TG4010,Vilanterol,The therapeutic efficacy of TG4010 can be decreased when used in combination with Vilanterol.,decrease,no risk
TG4010,Vinblastine,The therapeutic efficacy of TG4010 can be decreased when used in combination with Vinblastine.,decrease,no risk
TG4010,Vincristine,The therapeutic efficacy of TG4010 can be decreased when used in combination with Vincristine.,decrease,no risk
TG4010,Vindesine,The therapeutic efficacy of TG4010 can be decreased when used in combination with Vindesine.,decrease,no risk
TG4010,Vinorelbine,The therapeutic efficacy of TG4010 can be decreased when used in combination with Vinorelbine.,decrease,no risk
TG4010,Voclosporin,The therapeutic efficacy of TG4010 can be decreased when used in combination with Voclosporin.,decrease,no risk
TG4010,Vorinostat,The therapeutic efficacy of TG4010 can be decreased when used in combination with Vorinostat.,decrease,no risk
TG4010,Zidovudine,The therapeutic efficacy of TG4010 can be decreased when used in combination with Zidovudine.,decrease,no risk
Mitemcinal,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Mitemcinal.,decrease,no risk
Mitemcinal,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Hydrocortisone,The serum concentration of Hydrocortisone can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Olaparib,The serum concentration of Olaparib can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Ouabain,The serum concentration of Ouabain can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Mitemcinal is combined with Oxetacaine.,increase,risk
Mitemcinal,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Mitemcinal.,decrease,no risk
Mitemcinal,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Mitemcinal is combined with Oxybuprocaine.,increase,risk
Mitemcinal,Quinidine,The serum concentration of Quinidine can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Quinine,The serum concentration of Quinine can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Vandetanib,The serum concentration of Vandetanib can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Mitemcinal.,decrease,no risk
Mitemcinal,Vemurafenib,The serum concentration of Vemurafenib can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Venetoclax,The serum concentration of Venetoclax can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Mitemcinal.,decrease,no risk
Mitemcinal,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Vindesine,The serum concentration of Vindesine can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Vinorelbine,The serum concentration of Vinorelbine can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Mitemcinal.,decrease,no risk
Mitemcinal,Voxelotor,The serum concentration of Voxelotor can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Warfarin,The serum concentration of Warfarin can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Zanubrutinib,The serum concentration of Zanubrutinib can be increased when it is combined with Mitemcinal.,increase,no risk
Mitemcinal,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Mitemcinal.,decrease,no risk
Mitemcinal,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Mitemcinal.,decrease,no risk
Mitemcinal,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Mitemcinal.,decrease,no risk
Pazopanib,Baricitinib,The risk or severity of adverse effects can be increased when Pazopanib is combined with Baricitinib.,increase,risk
Pazopanib,Basiliximab,The risk or severity of adverse effects can be increased when Basiliximab is combined with Pazopanib.,increase,risk
Pazopanib,Bazedoxifene,The metabolism of Bazedoxifene can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,BCG vaccine,The risk or severity of infection can be increased when BCG vaccine is combined with Pazopanib.,increase,risk
Pazopanib,Beclomethasone dipropionate,The metabolism of Pazopanib can be increased when combined with Beclomethasone dipropionate.,increase,no risk
Pazopanib,Bedaquiline,The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Bedaquiline.,increase,risk
Pazopanib,Belantamab mafodotin,The serum concentration of Pazopanib can be increased when it is combined with Belantamab mafodotin.,increase,no risk
Pazopanib,Belatacept,The risk or severity of adverse effects can be increased when Pazopanib is combined with Belatacept.,increase,risk
Pazopanib,Belimumab,The risk or severity of adverse effects can be increased when Pazopanib is combined with Belimumab.,increase,risk
Pazopanib,Belinostat,The metabolism of Belinostat can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Belumosudil,The serum concentration of Pazopanib can be increased when it is combined with Belumosudil.,increase,no risk
Pazopanib,Belzutifan,The serum concentration of Pazopanib can be decreased when it is combined with Belzutifan.,decrease,no risk
Pazopanib,Bendamustine,The risk or severity of adverse effects can be increased when Pazopanib is combined with Bendamustine.,increase,risk
Pazopanib,Benzatropine,The risk or severity of QTc prolongation can be increased when Benzatropine is combined with Pazopanib.,increase,risk
Pazopanib,Benzocaine,The risk or severity of methemoglobinemia can be increased when Pazopanib is combined with Benzocaine.,increase,risk
Pazopanib,Benzyl alcohol,The risk or severity of methemoglobinemia can be increased when Pazopanib is combined with Benzyl alcohol.,increase,risk
Pazopanib,Benzylpenicillin,The excretion of Benzylpenicillin can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Bepridil,The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Bepridil.,increase,risk
Pazopanib,Berotralstat,The serum concentration of Pazopanib can be increased when it is combined with Berotralstat.,increase,no risk
Pazopanib,Betamethasone,The metabolism of Pazopanib can be increased when combined with Betamethasone.,increase,no risk
Pazopanib,Betamethasone phosphate,The metabolism of Pazopanib can be increased when combined with Betamethasone phosphate.,increase,no risk
Pazopanib,Betaxolol,The metabolism of Pazopanib can be decreased when combined with Betaxolol.,decrease,no risk
Pazopanib,Betrixaban,The serum concentration of Pazopanib can be increased when it is combined with Betrixaban.,increase,no risk
Pazopanib,Bexagliflozin,The metabolism of Bexagliflozin can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Bexarotene,The metabolism of Pazopanib can be increased when combined with Bexarotene.,increase,no risk
Pazopanib,Bezafibrate,The metabolism of Pazopanib can be decreased when combined with Bezafibrate.,decrease,no risk
Pazopanib,Bicalutamide,The metabolism of Pazopanib can be decreased when combined with Bicalutamide.,decrease,no risk
Pazopanib,Bictegravir,The metabolism of Bictegravir can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Bifonazole,The metabolism of Pazopanib can be decreased when combined with Bifonazole.,decrease,no risk
Pazopanib,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Pazopanib.,increase,risk
Pazopanib,Bimekizumab,The metabolism of Pazopanib can be increased when combined with Bimekizumab.,increase,no risk
Pazopanib,Binimetinib,The metabolism of Binimetinib can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Biperiden,The metabolism of Pazopanib can be decreased when combined with Biperiden.,decrease,no risk
Pazopanib,Bismuth subnitrate,Bismuth subnitrate can cause a decrease in the absorption of Pazopanib resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Pazopanib,Bisoprolol,The serum concentration of Pazopanib can be increased when it is combined with Bisoprolol.,increase,no risk
Pazopanib,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Pazopanib.,increase,risk
Pazopanib,Blinatumomab,The risk or severity of adverse effects can be increased when Pazopanib is combined with Blinatumomab.,increase,risk
Pazopanib,Boceprevir,The metabolism of Pazopanib can be decreased when combined with Boceprevir.,decrease,no risk
Pazopanib,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Pazopanib.",decrease,no risk
Pazopanib,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Bosentan,The metabolism of Pazopanib can be increased when combined with Bosentan.,increase,no risk
Pazopanib,Bosutinib,The metabolism of Bosutinib can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Brentuximab vedotin,The metabolism of Brentuximab vedotin can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Pazopanib.,increase,risk
Pazopanib,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Brincidofovir,The serum concentration of Brincidofovir can be increased when it is combined with Pazopanib.,increase,no risk
Pazopanib,Brodalumab,The risk or severity of adverse effects can be increased when Pazopanib is combined with Brodalumab.,increase,risk
Pazopanib,Bromazepam,The metabolism of Pazopanib can be decreased when combined with Bromazepam.,decrease,no risk
Pazopanib,Bromotheophylline,The metabolism of Bromotheophylline can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Pazopanib.,increase,risk
Pazopanib,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Pazopanib.,increase,risk
Pazopanib,Budesonide,The metabolism of Pazopanib can be increased when combined with Budesonide.,increase,no risk
Pazopanib,Bupivacaine,The risk or severity of methemoglobinemia can be increased when Pazopanib is combined with Bupivacaine.,increase,risk
Pazopanib,Buprenorphine,The metabolism of Pazopanib can be decreased when combined with Buprenorphine.,decrease,no risk
Pazopanib,Bupropion,The metabolism of Pazopanib can be decreased when combined with Bupropion.,decrease,no risk
Pazopanib,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Pazopanib.,increase,risk
Pazopanib,Buspirone,The metabolism of Buspirone can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Busulfan,The metabolism of Busulfan can be decreased when combined with Pazopanib.,decrease,no risk
Pazopanib,Butacaine,The risk or severity of methemoglobinemia can be increased when Pazopanib is combined with Butacaine.,increase,risk
Pazopanib,Butalbital,The metabolism of Pazopanib can be increased when combined with Butalbital.,increase,no risk
Pazopanib,Butamben,The risk or severity of methemoglobinemia can be increased when Pazopanib is combined with Butamben.,increase,risk
Pazopanib,Butriptyline,The risk or severity of QTc prolongation can be increased when Pazopanib is combined with Butriptyline.,increase,risk
Ceftaroline fosamil,Gabapentin enacarbil,Ceftaroline fosamil may decrease the excretion rate of Gabapentin enacarbil which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gadobenic acid,Ceftaroline fosamil may decrease the excretion rate of Gadobenic acid which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gadodiamide,Ceftaroline fosamil may decrease the excretion rate of Gadodiamide which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gadofosveset trisodium,Ceftaroline fosamil may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gadopentetic acid,Ceftaroline fosamil may decrease the excretion rate of Gadopentetic acid which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gadoteric acid,Ceftaroline fosamil may decrease the excretion rate of Gadoteric acid which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gadoteridol,Ceftaroline fosamil may decrease the excretion rate of Gadoteridol which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Ganciclovir,Ceftaroline fosamil may decrease the excretion rate of Ganciclovir which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gemcitabine,Ceftaroline fosamil may decrease the excretion rate of Gemcitabine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gemfibrozil,Ceftaroline fosamil may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gentamicin,Ceftaroline fosamil may decrease the excretion rate of Gentamicin which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Gimeracil,Ceftaroline fosamil may decrease the excretion rate of Gimeracil which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Givosiran,The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Givosiran.,increase,risk
Ceftaroline fosamil,Glipizide,Ceftaroline fosamil may decrease the excretion rate of Glipizide which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Glycerol phenylbutyrate,Ceftaroline fosamil may decrease the excretion rate of Glycerol phenylbutyrate which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Golodirsen,Ceftaroline fosamil may decrease the excretion rate of Golodirsen which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Goserelin,Ceftaroline fosamil may decrease the excretion rate of Goserelin which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Guanethidine,Ceftaroline fosamil may decrease the excretion rate of Guanethidine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Guanfacine,Ceftaroline fosamil may decrease the excretion rate of Guanfacine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Haloperidol,Ceftaroline fosamil may decrease the excretion rate of Haloperidol which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Heparin,The therapeutic efficacy of Heparin can be decreased when used in combination with Ceftaroline fosamil.,decrease,no risk
Ceftaroline fosamil,Hydralazine,Ceftaroline fosamil may decrease the excretion rate of Hydralazine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Hydrochlorothiazide,The risk or severity of nephrotoxicity can be increased when Hydrochlorothiazide is combined with Ceftaroline fosamil.,increase,risk
Ceftaroline fosamil,Hydromorphone,Ceftaroline fosamil may decrease the excretion rate of Hydromorphone which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Hydroxocobalamin,Ceftaroline fosamil may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Hydroxyethyl Starch,Ceftaroline fosamil may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Kanamycin,Ceftaroline fosamil may decrease the excretion rate of Kanamycin which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Ketamine,Ceftaroline fosamil may decrease the excretion rate of Ketamine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Ketazolam,Ceftaroline fosamil may decrease the excretion rate of Ketazolam which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Ketoprofen,The risk or severity of nephrotoxicity can be increased when Ketoprofen is combined with Ceftaroline fosamil.,increase,risk
Ceftaroline fosamil,Ketorolac,The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Ceftaroline fosamil.,increase,risk
Ceftaroline fosamil,Octinoxate,Ceftaroline fosamil may decrease the excretion rate of Octinoxate which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Olsalazine,The risk or severity of nephrotoxicity can be increased when Ceftaroline fosamil is combined with Olsalazine.,increase,risk
Ceftaroline fosamil,Opium,Ceftaroline fosamil may decrease the excretion rate of Opium which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Oseltamivir,Ceftaroline fosamil may decrease the excretion rate of Oseltamivir which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Oxacillin,Ceftaroline fosamil may decrease the excretion rate of Oxacillin which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Oxaliplatin,The risk or severity of nephrotoxicity can be increased when Oxaliplatin is combined with Ceftaroline fosamil.,increase,risk
Ceftaroline fosamil,Oxaprozin,The risk or severity of nephrotoxicity can be increased when Oxaprozin is combined with Ceftaroline fosamil.,increase,risk
Ceftaroline fosamil,Oxazepam,Ceftaroline fosamil may decrease the excretion rate of Oxazepam which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Ceftaroline fosamil is combined with Oxetacaine.,increase,risk
Ceftaroline fosamil,Oxybenzone,Ceftaroline fosamil may decrease the excretion rate of Oxybenzone which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Ceftaroline fosamil is combined with Oxybuprocaine.,increase,risk
Ceftaroline fosamil,Oxyphenbutazone,The risk or severity of nephrotoxicity can be increased when Oxyphenbutazone is combined with Ceftaroline fosamil.,increase,risk
Ceftaroline fosamil,Oxyquinoline,Ceftaroline fosamil may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Quetiapine,Ceftaroline fosamil may decrease the excretion rate of Quetiapine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Quinidine,Ceftaroline fosamil may decrease the excretion rate of Quinidine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Urokinase,The therapeutic efficacy of Urokinase can be decreased when used in combination with Ceftaroline fosamil.,decrease,no risk
Ceftaroline fosamil,Vaborbactam,Ceftaroline fosamil may decrease the excretion rate of Vaborbactam which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Valaciclovir,The risk or severity of nephrotoxicity can be increased when Valaciclovir is combined with Ceftaroline fosamil.,increase,risk
Ceftaroline fosamil,Valbenazine,Ceftaroline fosamil may decrease the excretion rate of Valbenazine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Valdecoxib,The risk or severity of nephrotoxicity can be increased when Valdecoxib is combined with Ceftaroline fosamil.,increase,risk
Ceftaroline fosamil,Valganciclovir,Ceftaroline fosamil may decrease the excretion rate of Valganciclovir which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Vancomycin,Ceftaroline fosamil may decrease the excretion rate of Vancomycin which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Varenicline,Ceftaroline fosamil may decrease the excretion rate of Varenicline which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Venlafaxine,Ceftaroline fosamil may decrease the excretion rate of Venlafaxine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Verapamil,Ceftaroline fosamil may decrease the excretion rate of Verapamil which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Ceftaroline fosamil.,decrease,no risk
Ceftaroline fosamil,Vilanterol,Ceftaroline fosamil may decrease the excretion rate of Vilanterol which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Viloxazine,Ceftaroline fosamil may decrease the excretion rate of Viloxazine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Vorapaxar,The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Ceftaroline fosamil.,decrease,no risk
Ceftaroline fosamil,Vortioxetine,Ceftaroline fosamil may decrease the excretion rate of Vortioxetine which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Warfarin,Ceftaroline fosamil may decrease the excretion rate of Warfarin which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Ximelagatran,The therapeutic efficacy of Ximelagatran can be decreased when used in combination with Ceftaroline fosamil.,decrease,no risk
Ceftaroline fosamil,Zaleplon,Ceftaroline fosamil may decrease the excretion rate of Zaleplon which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Zanamivir,Ceftaroline fosamil may decrease the excretion rate of Zanamivir which could result in a higher serum level.,decrease,no risk
Ceftaroline fosamil,Zoledronic acid,The risk or severity of nephrotoxicity and hypocalcemia can be increased when Ceftaroline fosamil is combined with Zoledronic acid.,increase,risk
Ceftaroline fosamil,Zonisamide,Ceftaroline fosamil may decrease the excretion rate of Zonisamide which could result in a higher serum level.,decrease,no risk
Agomelatine,Gabapentin,The risk or severity of CNS depression can be increased when Gabapentin is combined with Agomelatine.,increase,risk
Agomelatine,Gabapentin enacarbil,The risk or severity of CNS depression can be increased when Agomelatine is combined with Gabapentin enacarbil.,increase,risk
Agomelatine,Gallamine triethiodide,The risk or severity of CNS depression can be increased when Gallamine triethiodide is combined with Agomelatine.,increase,risk
Agomelatine,Ganaxolone,"The risk or severity of sedation, somnolence, and CNS depression can be increased when Agomelatine is combined with Ganaxolone.",increase,risk
Agomelatine,Gatifloxacin,The serum concentration of Agomelatine can be increased when it is combined with Gatifloxacin.,increase,no risk
Agomelatine,Gemfibrozil,The metabolism of Agomelatine can be decreased when combined with Gemfibrozil.,decrease,no risk
Agomelatine,Gemifloxacin,The metabolism of Agomelatine can be decreased when combined with Gemifloxacin.,decrease,no risk
Agomelatine,Gepirone,The risk or severity of CNS depression can be increased when Agomelatine is combined with Gepirone.,increase,risk
Agomelatine,Gilteritinib,The therapeutic efficacy of Agomelatine can be decreased when used in combination with Gilteritinib.,decrease,no risk
Agomelatine,Givosiran,The serum concentration of Agomelatine can be increased when it is combined with Givosiran.,increase,no risk
Agomelatine,Gliclazide,The metabolism of Gliclazide can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Glimepiride,The metabolism of Glimepiride can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Glipizide,The metabolism of Glipizide can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Gliquidone,The metabolism of Gliquidone can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Glofitamab,The serum concentration of Agomelatine can be increased when it is combined with Glofitamab.,increase,no risk
Agomelatine,Glutethimide,The risk or severity of CNS depression can be increased when Glutethimide is combined with Agomelatine.,increase,risk
Agomelatine,Glyburide,The metabolism of Glyburide can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Golimumab,The metabolism of Agomelatine can be increased when combined with Golimumab.,increase,no risk
Agomelatine,Granisetron,The risk or severity of CNS depression can be increased when Granisetron is combined with Agomelatine.,increase,risk
Agomelatine,Grepafloxacin,The metabolism of Agomelatine can be decreased when combined with Grepafloxacin.,decrease,no risk
Agomelatine,Guanabenz,The metabolism of Agomelatine can be decreased when combined with Guanabenz.,decrease,no risk
Agomelatine,Guanfacine,The risk or severity of CNS depression can be increased when Guanfacine is combined with Agomelatine.,increase,risk
Agomelatine,Halazepam,The risk or severity of CNS depression can be increased when Halazepam is combined with Agomelatine.,increase,risk
Agomelatine,Haloperidol,The risk or severity of CNS depression can be increased when Haloperidol is combined with Agomelatine.,increase,risk
Agomelatine,Halothane,The risk or severity of CNS depression can be increased when Halothane is combined with Agomelatine.,increase,risk
Agomelatine,Hexafluronium,The risk or severity of CNS depression can be increased when Hexafluronium is combined with Agomelatine.,increase,risk
Agomelatine,Hydrocodone,Agomelatine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.,increase,no risk
Agomelatine,Hydromorphone,The risk or severity of CNS depression can be increased when Hydromorphone is combined with Agomelatine.,increase,risk
Agomelatine,Hydroxyzine,Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Agomelatine.,increase,no risk
Agomelatine,Ketamine,The risk or severity of CNS depression can be increased when Ketamine is combined with Agomelatine.,increase,risk
Agomelatine,Ketazolam,The risk or severity of CNS depression can be increased when Ketazolam is combined with Agomelatine.,increase,risk
Agomelatine,Ketoconazole,The serum concentration of Agomelatine can be increased when it is combined with Ketoconazole.,increase,no risk
Agomelatine,Ketorolac,The metabolism of Ketorolac can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Obeticholic acid,The metabolism of Agomelatine can be decreased when combined with Obeticholic acid.,decrease,no risk
Agomelatine,Olanzapine,The risk or severity of CNS depression can be increased when Olanzapine is combined with Agomelatine.,increase,risk
Agomelatine,Oliceridine,"The risk or severity of hypotension, sedation, death, somnolence, and respiratory depression can be increased when Agomelatine is combined with Oliceridine.",increase,risk
Agomelatine,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Ondansetron,The risk or severity of CNS depression can be increased when Ondansetron is combined with Agomelatine.,increase,risk
Agomelatine,Opium,The risk or severity of CNS depression can be increased when Agomelatine is combined with Opium.,increase,risk
Agomelatine,Orphenadrine,Agomelatine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.,increase,no risk
Agomelatine,Osilodrostat,The serum concentration of Agomelatine can be increased when it is combined with Osilodrostat.,increase,no risk
Agomelatine,Osimertinib,The serum concentration of Agomelatine can be decreased when it is combined with Osimertinib.,decrease,no risk
Agomelatine,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Oxazepam,The risk or severity of CNS depression can be increased when Oxazepam is combined with Agomelatine.,increase,risk
Agomelatine,Oxcarbazepine,The risk or severity of CNS depression can be increased when Oxcarbazepine is combined with Agomelatine.,increase,risk
Agomelatine,Oxitriptan,The risk or severity of CNS depression can be increased when Oxitriptan is combined with Agomelatine.,increase,risk
Agomelatine,Oxprenolol,The risk or severity of CNS depression can be increased when Oxprenolol is combined with Agomelatine.,increase,risk
Agomelatine,Oxtriphylline,The metabolism of Agomelatine can be decreased when combined with Oxtriphylline.,decrease,no risk
Agomelatine,Oxybuprocaine,The risk or severity of CNS depression can be increased when Oxybuprocaine is combined with Agomelatine.,increase,risk
Agomelatine,Oxycodone,The risk or severity of CNS depression can be increased when Oxycodone is combined with Agomelatine.,increase,risk
Agomelatine,Oxymorphone,The risk or severity of CNS depression can be increased when Oxymorphone is combined with Agomelatine.,increase,risk
Agomelatine,Quazepam,The risk or severity of CNS depression can be increased when Quazepam is combined with Agomelatine.,increase,risk
Agomelatine,Quetiapine,The risk or severity of CNS depression can be increased when Quetiapine is combined with Agomelatine.,increase,risk
Agomelatine,Quinidine,The serum concentration of Agomelatine can be increased when it is combined with Quinidine.,increase,no risk
Agomelatine,Quinine,The risk or severity of CNS depression can be increased when Quinine is combined with Agomelatine.,increase,risk
Agomelatine,Quinupramine,The risk or severity of CNS depression can be increased when Agomelatine is combined with Quinupramine.,increase,risk
Agomelatine,Urethane,The risk or severity of CNS depression can be increased when Urethane is combined with Agomelatine.,increase,risk
Agomelatine,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Valproic acid,The risk or severity of CNS depression can be increased when Valproic acid is combined with Agomelatine.,increase,risk
Agomelatine,Valsartan,The metabolism of Valsartan can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Vecuronium,The risk or severity of CNS depression can be increased when Vecuronium is combined with Agomelatine.,increase,risk
Agomelatine,Vemurafenib,The serum concentration of Agomelatine can be increased when it is combined with Vemurafenib.,increase,no risk
Agomelatine,Venlafaxine,The risk or severity of CNS depression can be increased when Venlafaxine is combined with Agomelatine.,increase,risk
Agomelatine,Verapamil,The metabolism of Agomelatine can be decreased when combined with Verapamil.,decrease,no risk
Agomelatine,Vigabatrin,The risk or severity of CNS depression can be increased when Vigabatrin is combined with Agomelatine.,increase,risk
Agomelatine,Vilazodone,The risk or severity of CNS depression can be increased when Agomelatine is combined with Vilazodone.,increase,risk
Agomelatine,Viloxazine,The metabolism of Agomelatine can be decreased when combined with Viloxazine.,decrease,no risk
Agomelatine,Voriconazole,The metabolism of Voriconazole can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Vortioxetine,The risk or severity of CNS depression can be increased when Agomelatine is combined with Vortioxetine.,increase,risk
Agomelatine,Voxelotor,The metabolism of Voxelotor can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Warfarin,The metabolism of Warfarin can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Ximelagatran,The metabolism of Ximelagatran can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Yohimbine,The risk or severity of CNS depression can be increased when Yohimbine is combined with Agomelatine.,increase,risk
Agomelatine,Zafirlukast,The metabolism of Zafirlukast can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Zaleplon,The risk or severity of CNS depression can be increased when Zaleplon is combined with Agomelatine.,increase,risk
Agomelatine,Ziconotide,The risk or severity of CNS depression can be increased when Ziconotide is combined with Agomelatine.,increase,risk
Agomelatine,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Agomelatine.,decrease,no risk
Agomelatine,Zileuton,The metabolism of Agomelatine can be decreased when combined with Zileuton.,decrease,no risk
Agomelatine,Zimelidine,The risk or severity of adverse effects can be increased when Agomelatine is combined with Zimelidine.,increase,risk
Agomelatine,Ziprasidone,The risk or severity of adverse effects can be increased when Agomelatine is combined with Ziprasidone.,increase,risk
Agomelatine,Zolmitriptan,The risk or severity of CNS depression can be increased when Zolmitriptan is combined with Agomelatine.,increase,risk
Agomelatine,Zolpidem,Agomelatine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.,increase,no risk
Agomelatine,Zonisamide,The risk or severity of CNS depression can be increased when Zonisamide is combined with Agomelatine.,increase,risk
Agomelatine,Zopiclone,The risk or severity of adverse effects can be increased when Agomelatine is combined with Zopiclone.,increase,risk
Agomelatine,Zotepine,The risk or severity of CNS depression can be increased when Agomelatine is combined with Zotepine.,increase,risk
Agomelatine,Zuclopenthixol,The risk or severity of CNS depression can be increased when Zuclopenthixol is combined with Agomelatine.,increase,risk
Agomelatine,Zuranolone,The risk or severity of CNS depression can be increased when Zuranolone is combined with Agomelatine.,increase,risk
Midostaurin,Galantamine,The metabolism of Galantamine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Ganaxolone,The metabolism of Ganaxolone can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Gefitinib,The metabolism of Gefitinib can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Gemfibrozil,The metabolism of Gemfibrozil can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Gepirone,The serum concentration of Gepirone can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Gestrinone,The metabolism of Gestrinone can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Gilteritinib,The metabolism of Gilteritinib can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Ginkgo biloba,The metabolism of Midostaurin can be decreased when combined with Ginkgo biloba.,decrease,no risk
Midostaurin,Glasdegib,The serum concentration of Glasdegib can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Glecaprevir,The metabolism of Midostaurin can be decreased when combined with Glecaprevir.,decrease,no risk
Midostaurin,Glofitamab,The serum concentration of Midostaurin can be increased when it is combined with Glofitamab.,increase,no risk
Midostaurin,Glyburide,The metabolism of Glyburide can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Glycerol phenylbutyrate,The metabolism of Midostaurin can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Midostaurin,Golimumab,The metabolism of Midostaurin can be increased when combined with Golimumab.,increase,no risk
Midostaurin,Granisetron,The metabolism of Granisetron can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Grapefruit,The serum concentration of Midostaurin can be increased when it is combined with Grapefruit.,increase,no risk
Midostaurin,Grazoprevir,The metabolism of Grazoprevir can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Grepafloxacin,The metabolism of Grepafloxacin can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Griseofulvin,The metabolism of Midostaurin can be increased when combined with Griseofulvin.,increase,no risk
Midostaurin,Guanfacine,The metabolism of Guanfacine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Halofantrine,The metabolism of Halofantrine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Hydralazine,The serum concentration of Midostaurin can be increased when it is combined with Hydralazine.,increase,no risk
Midostaurin,Hydrocodone,The metabolism of Hydrocodone can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Hydrocortamate,The metabolism of Midostaurin can be increased when combined with Hydrocortamate.,increase,no risk
Midostaurin,Hydrocortisone,The metabolism of Hydrocortisone can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Hydrocortisone succinate,The metabolism of Hydrocortisone succinate can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Hydroxyprogesterone caproate,The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Hydroxyzine,The metabolism of Hydroxyzine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Ketamine,The metabolism of Ketamine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Ketazolam,The metabolism of Ketazolam can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Ketoconazole,The metabolism of Midostaurin can be decreased when combined with Ketoconazole.,decrease,no risk
Midostaurin,Octreotide,The serum concentration of Midostaurin can be increased when it is combined with Octreotide.,increase,no risk
Midostaurin,Olaparib,The metabolism of Olaparib can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Olutasidenib,The therapeutic efficacy of Olutasidenib can be decreased when used in combination with Midostaurin.,decrease,no risk
Midostaurin,Omaveloxolone,The serum concentration of Omaveloxolone can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Opium,The metabolism of Opium can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Oritavancin,The metabolism of Midostaurin can be increased when combined with Oritavancin.,increase,no risk
Midostaurin,Orphenadrine,The metabolism of Orphenadrine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Osilodrostat,The serum concentration of Osilodrostat can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Osimertinib,The metabolism of Osimertinib can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Ospemifene,The metabolism of Ospemifene can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Oxcarbazepine,The metabolism of Midostaurin can be increased when combined with Oxcarbazepine.,increase,no risk
Midostaurin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Midostaurin is combined with Oxetacaine.,increase,risk
Midostaurin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Midostaurin is combined with Oxybuprocaine.,increase,risk
Midostaurin,Oxybutynin,The metabolism of Oxybutynin can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Quazepam,The metabolism of Quazepam can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Quetiapine,The serum concentration of Quetiapine can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Quinidine,The metabolism of Quinidine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Quinine,The metabolism of Quinine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Quinupristin,The metabolism of Midostaurin can be decreased when combined with Quinupristin.,decrease,no risk
Midostaurin,Quizartinib,The serum concentration of Quizartinib can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Udenafil,The metabolism of Udenafil can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Ulipristal,The metabolism of Ulipristal can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Upadacitinib,The metabolism of Upadacitinib can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Vadadustat,The serum concentration of Midostaurin can be increased when it is combined with Vadadustat.,increase,no risk
Midostaurin,Valbenazine,The serum concentration of Valbenazine can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Valdecoxib,The metabolism of Valdecoxib can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Valproic acid,The serum concentration of Midostaurin can be increased when it is combined with Valproic acid.,increase,no risk
Midostaurin,Vamorolone,The serum concentration of Vamorolone can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Vandetanib,The metabolism of Vandetanib can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vardenafil,The metabolism of Vardenafil can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Velpatasvir,The metabolism of Velpatasvir can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vemurafenib,The metabolism of Vemurafenib can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Venetoclax,The metabolism of Venetoclax can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Verapamil,The metabolism of Verapamil can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vilanterol,The serum concentration of Vilanterol can be increased when it is combined with Midostaurin.,increase,no risk
Midostaurin,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Viloxazine,The metabolism of Midostaurin can be decreased when combined with Viloxazine.,decrease,no risk
Midostaurin,Vinblastine,The metabolism of Vinblastine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vincristine,The metabolism of Vincristine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vindesine,The metabolism of Vindesine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vinflunine,The metabolism of Vinflunine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vinorelbine,The metabolism of Vinorelbine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vitamin D,The metabolism of Vitamin D can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vitamin E,The metabolism of Vitamin E can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Voclosporin,The metabolism of Voclosporin can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Vonoprazan,The therapeutic efficacy of Vonoprazan can be decreased when used in combination with Midostaurin.,decrease,no risk
Midostaurin,Vorapaxar,The metabolism of Vorapaxar can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Voriconazole,The serum concentration of Midostaurin can be increased when it is combined with Voriconazole.,increase,no risk
Midostaurin,Vortioxetine,The metabolism of Vortioxetine can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Voxelotor,The serum concentration of Midostaurin can be increased when it is combined with Voxelotor.,increase,no risk
Midostaurin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Warfarin,The metabolism of Warfarin can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Zafirlukast,The serum concentration of Midostaurin can be increased when it is combined with Zafirlukast.,increase,no risk
Midostaurin,Zaleplon,The metabolism of Zaleplon can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Zanubrutinib,The metabolism of Zanubrutinib can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Zidovudine,The metabolism of Zidovudine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Zileuton,The metabolism of Zileuton can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Zimelidine,The metabolism of Midostaurin can be decreased when combined with Zimelidine.,decrease,no risk
Midostaurin,Ziprasidone,The metabolism of Ziprasidone can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Zolpidem,The metabolism of Zolpidem can be increased when combined with Midostaurin.,increase,no risk
Midostaurin,Zonisamide,The metabolism of Zonisamide can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Zopiclone,The metabolism of Zopiclone can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Zotepine,The metabolism of Zotepine can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Midostaurin.,decrease,no risk
Midostaurin,Zuranolone,The serum concentration of Zuranolone can be increased when it is combined with Midostaurin.,increase,no risk
Lexatumumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Lexatumumab.,increase,risk
Lexatumumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Lexatumumab is combined with Obinutuzumab.,increase,risk
Lexatumumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Lexatumumab is combined with Ocrelizumab.,increase,risk
Lexatumumab,Odesivimab,The risk or severity of adverse effects can be increased when Lexatumumab is combined with Odesivimab.,increase,risk
Lexatumumab,Ofatumumab,The risk or severity of adverse effects can be increased when Lexatumumab is combined with Ofatumumab.,increase,risk
Lexatumumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Lexatumumab.,increase,risk
Lexatumumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Lexatumumab.,increase,risk
Lexatumumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Lexatumumab.,increase,no risk
Lexatumumab,Ublituximab,The risk or severity of adverse effects can be increased when Lexatumumab is combined with Ublituximab.,increase,risk
Lexatumumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Lexatumumab.,increase,risk
Lexatumumab,Vedolizumab,The risk or severity of adverse effects can be increased when Lexatumumab is combined with Vedolizumab.,increase,risk
Nemonoxacin,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Galantamine,The risk or severity of QTc prolongation can be increased when Galantamine is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Gilteritinib,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Gilteritinib.,increase,risk
Nemonoxacin,Glasdegib,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Glasdegib.,increase,risk
Nemonoxacin,Gliclazide,The therapeutic efficacy of Gliclazide can be increased when used in combination with Nemonoxacin.,increase,no risk
Nemonoxacin,Glimepiride,The therapeutic efficacy of Glimepiride can be increased when used in combination with Nemonoxacin.,increase,no risk
Nemonoxacin,Glipizide,The therapeutic efficacy of Glipizide can be increased when used in combination with Nemonoxacin.,increase,no risk
Nemonoxacin,Gliquidone,The therapeutic efficacy of Gliquidone can be increased when used in combination with Nemonoxacin.,increase,no risk
Nemonoxacin,Glyburide,The therapeutic efficacy of Glyburide can be increased when used in combination with Nemonoxacin.,increase,no risk
Nemonoxacin,Glycol salicylate,Glycol salicylate may increase the neuroexcitatory activities of Nemonoxacin.,increase,no risk
Nemonoxacin,Glymidine,The therapeutic efficacy of Glymidine can be increased when used in combination with Nemonoxacin.,increase,no risk
Nemonoxacin,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Grepafloxacin.,increase,risk
Nemonoxacin,Guanabenz,The metabolism of Guanabenz can be decreased when combined with Nemonoxacin.,decrease,no risk
Nemonoxacin,Halofantrine,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Halofantrine.,increase,risk
Nemonoxacin,Haloperidol,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Haloperidol.,increase,risk
Nemonoxacin,Hetacillin,The serum concentration of Nemonoxacin can be increased when it is combined with Hetacillin.,increase,no risk
Nemonoxacin,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Hydrocortisone,The risk or severity of tendinopathy can be increased when Hydrocortisone is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Hydrocortisone acetate,The risk or severity of tendinopathy can be increased when Hydrocortisone acetate is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Hydrocortisone butyrate,The risk or severity of tendinopathy can be increased when Hydrocortisone butyrate is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Hydrocortisone cypionate,The risk or severity of tendinopathy can be increased when Hydrocortisone cypionate is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Hydrocortisone succinate,The risk or severity of tendinopathy can be increased when Hydrocortisone succinate is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Hydrotalcite,Hydrotalcite can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nemonoxacin,Hydroxychloroquine,The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Hydroxyzine.,increase,risk
Nemonoxacin,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Ketoconazole,The risk or severity of QTc prolongation can be increased when Ketoconazole is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Ketoprofen,Ketoprofen may increase the neuroexcitatory activities of Nemonoxacin.,increase,no risk
Nemonoxacin,Ketorolac,Ketorolac may increase the neuroexcitatory activities of Nemonoxacin.,increase,no risk
Nemonoxacin,Octreotide,The risk or severity of QTc prolongation can be increased when Octreotide is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Nemonoxacin.,decrease,no risk
Nemonoxacin,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Ondansetron,The risk or severity of QTc prolongation can be increased when Ondansetron is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Orphenadrine,The risk or severity of QTc prolongation can be increased when Orphenadrine is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Oxacillin,The serum concentration of Nemonoxacin can be increased when it is combined with Oxacillin.,increase,no risk
Nemonoxacin,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Oxaprozin,Oxaprozin may increase the neuroexcitatory activities of Nemonoxacin.,increase,no risk
Nemonoxacin,Oxatomide,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Oxatomide.,increase,risk
Nemonoxacin,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Nemonoxacin is combined with Oxetacaine.,increase,risk
Nemonoxacin,Oxtriphylline,The metabolism of Oxtriphylline can be decreased when combined with Nemonoxacin.,decrease,no risk
Nemonoxacin,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Nemonoxacin is combined with Oxybuprocaine.,increase,risk
Nemonoxacin,Oxyphenbutazone,Oxyphenbutazone may increase the neuroexcitatory activities of Nemonoxacin.,increase,no risk
Nemonoxacin,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Quetiapine,The risk or severity of QTc prolongation can be increased when Quetiapine is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Quinapril,Quinapril can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nemonoxacin,Quinidine,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Quinidine.,increase,risk
Nemonoxacin,Quinine,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Quinine.,increase,risk
Nemonoxacin,Quizartinib,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Quizartinib.,increase,risk
Nemonoxacin,Valdecoxib,Valdecoxib may increase the neuroexcitatory activities of Nemonoxacin.,increase,no risk
Nemonoxacin,Valproic acid,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Valproic acid.,increase,risk
Nemonoxacin,Vamorolone,The risk or severity of tendinopathy can be increased when Vamorolone is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Vandetanib,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Vandetanib.,increase,risk
Nemonoxacin,Vardenafil,The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Vemurafenib,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Vemurafenib.,increase,risk
Nemonoxacin,Verapamil,The metabolism of Verapamil can be decreased when combined with Nemonoxacin.,decrease,no risk
Nemonoxacin,Vernakalant,The risk or severity of QTc prolongation can be increased when Vernakalant is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Nemonoxacin.,decrease,no risk
Nemonoxacin,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Vildagliptin,The therapeutic efficacy of Vildagliptin can be increased when used in combination with Nemonoxacin.,increase,no risk
Nemonoxacin,Voriconazole,The risk or severity of QTc prolongation can be increased when Voriconazole is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Vorinostat,The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Voxilaprevir,The metabolism of Voxilaprevir can be decreased when combined with Nemonoxacin.,decrease,no risk
Nemonoxacin,Warfarin,The therapeutic efficacy of Warfarin can be increased when used in combination with Nemonoxacin.,increase,no risk
Nemonoxacin,Zileuton,The metabolism of Zileuton can be decreased when combined with Nemonoxacin.,decrease,no risk
Nemonoxacin,Zinc,Zinc can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nemonoxacin,Zinc acetate,Zinc acetate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nemonoxacin,Zinc ascorbate,Zinc ascorbate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nemonoxacin,Zinc chloride,Zinc chloride can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nemonoxacin,Zinc gluconate,Zinc gluconate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nemonoxacin,Zinc oxide,Zinc oxide can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nemonoxacin,Zinc sulfate,Zinc sulfate can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.,decrease,no risk
Nemonoxacin,"Zinc sulfate, unspecified form","Zinc sulfate, unspecified form can cause a decrease in the absorption of Nemonoxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.",decrease,no risk
Nemonoxacin,Ziprasidone,The risk or severity of QTc prolongation can be increased when Nemonoxacin is combined with Ziprasidone.,increase,risk
Nemonoxacin,Zolmitriptan,The metabolism of Zolmitriptan can be decreased when combined with Nemonoxacin.,decrease,no risk
Nemonoxacin,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Nemonoxacin.,decrease,no risk
Nemonoxacin,Zonisamide,The risk or severity of QTc prolongation can be increased when Zonisamide is combined with Nemonoxacin.,increase,risk
Nemonoxacin,Zotepine,The metabolism of Zotepine can be decreased when combined with Nemonoxacin.,decrease,no risk
Betrixaban,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Betrixaban.,increase,no risk
Betrixaban,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Betrixaban is combined with Gemtuzumab ozogamicin.,increase,risk
Betrixaban,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Betrixaban.,increase,risk
Betrixaban,Gilteritinib,The serum concentration of Betrixaban can be increased when it is combined with Gilteritinib.,increase,no risk
Betrixaban,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Betrixaban.,increase,no risk
Betrixaban,Glasdegib,The serum concentration of Betrixaban can be increased when it is combined with Glasdegib.,increase,no risk
Betrixaban,Glecaprevir,The serum concentration of Betrixaban can be increased when it is combined with Glecaprevir.,increase,no risk
Betrixaban,Glycol salicylate,The risk or severity of bleeding can be increased when Betrixaban is combined with Glycol salicylate.,increase,risk
Betrixaban,Grazoprevir,The serum concentration of Betrixaban can be increased when it is combined with Grazoprevir.,increase,no risk
Betrixaban,Hemin,Hemin may increase the anticoagulant activities of Betrixaban.,increase,no risk
Betrixaban,Heparin,The risk or severity of bleeding can be increased when Heparin is combined with Betrixaban.,increase,risk
Betrixaban,Hydrochlorothiazide,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Betrixaban,Hydroflumethiazide,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Betrixaban,Hydroxyprogesterone caproate,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Betrixaban,Hydroxyurea,The risk or severity of bleeding can be increased when Betrixaban is combined with Hydroxyurea.,increase,risk
Betrixaban,Ketoconazole,The serum concentration of Betrixaban can be increased when it is combined with Ketoconazole.,increase,no risk
Betrixaban,Ketoprofen,The risk or severity of bleeding can be increased when Betrixaban is combined with Ketoprofen.,increase,risk
Betrixaban,Ketorolac,The risk or severity of bleeding can be increased when Betrixaban is combined with Ketorolac.,increase,risk
Betrixaban,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Betrixaban is combined with Obeticholic acid.,increase,risk
Betrixaban,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Betrixaban is combined with Obinutuzumab.,increase,risk
Betrixaban,Olaparib,The risk or severity of bleeding can be increased when Betrixaban is combined with Olaparib.,increase,risk
Betrixaban,Olive oil,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Olive oil.,decrease,no risk
Betrixaban,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Betrixaban.,increase,risk
Betrixaban,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Betrixaban is combined with Omacetaxine mepesuccinate.,increase,risk
Betrixaban,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Betrixaban.,increase,no risk
Betrixaban,Ombitasvir,The serum concentration of Betrixaban can be increased when it is combined with Ombitasvir.,increase,no risk
Betrixaban,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Betrixaban.,increase,no risk
Betrixaban,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Betrixaban.,increase,risk
Betrixaban,Omega-3-carboxylic acids,The therapeutic efficacy of Betrixaban can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Betrixaban,Osimertinib,The serum concentration of Osimertinib can be increased when it is combined with Betrixaban.,increase,no risk
Betrixaban,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Betrixaban.,increase,risk
Betrixaban,Oxaprozin,The risk or severity of bleeding can be increased when Betrixaban is combined with Oxaprozin.,increase,risk
Betrixaban,Oxyphenbutazone,The risk or severity of bleeding can be increased when Betrixaban is combined with Oxyphenbutazone.,increase,risk
Betrixaban,Quinestrol,Quinestrol may decrease the anticoagulant activities of Betrixaban.,decrease,no risk
Betrixaban,Quinidine,The serum concentration of Betrixaban can be increased when it is combined with Quinidine.,increase,no risk
Betrixaban,Quinine,The serum concentration of Betrixaban can be increased when it is combined with Quinine.,increase,no risk
Betrixaban,Quizartinib,The serum concentration of Betrixaban can be increased when it is combined with Quizartinib.,increase,no risk
Betrixaban,Ubrogepant,The serum concentration of Ubrogepant can be increased when it is combined with Betrixaban.,increase,no risk
Betrixaban,Ulipristal,The therapeutic efficacy of Betrixaban can be decreased when used in combination with Ulipristal.,decrease,no risk
Betrixaban,Umbralisib,The serum concentration of Betrixaban can be increased when it is combined with Umbralisib.,increase,no risk
Betrixaban,Umeclidinium,The serum concentration of Betrixaban can be increased when it is combined with Umeclidinium.,increase,no risk
Betrixaban,Urokinase,Urokinase may increase the anticoagulant activities of Betrixaban.,increase,no risk
Betrixaban,Ursodeoxycholic acid,The risk or severity of bleeding and bruising can be increased when Betrixaban is combined with Ursodeoxycholic acid.,increase,risk
Betrixaban,Valdecoxib,The risk or severity of bleeding can be increased when Betrixaban is combined with Valdecoxib.,increase,risk
Betrixaban,Vandetanib,The serum concentration of Betrixaban can be increased when it is combined with Vandetanib.,increase,no risk
Betrixaban,Vardenafil,The serum concentration of Betrixaban can be increased when it is combined with Vardenafil.,increase,no risk
Betrixaban,Velpatasvir,The serum concentration of Betrixaban can be increased when it is combined with Velpatasvir.,increase,no risk
Betrixaban,Vemurafenib,The serum concentration of Betrixaban can be increased when it is combined with Vemurafenib.,increase,no risk
Betrixaban,Venetoclax,The serum concentration of Betrixaban can be increased when it is combined with Venetoclax.,increase,no risk
Betrixaban,Venlafaxine,The risk or severity of bleeding can be increased when Betrixaban is combined with Venlafaxine.,increase,risk
Betrixaban,Verapamil,The serum concentration of Betrixaban can be increased when it is combined with Verapamil.,increase,no risk
Betrixaban,Vinblastine,The serum concentration of Vinblastine can be increased when it is combined with Betrixaban.,increase,no risk
Betrixaban,Vincristine,The serum concentration of Vincristine can be increased when it is combined with Betrixaban.,increase,no risk
Betrixaban,Vindesine,The risk or severity of bleeding can be increased when Betrixaban is combined with Vindesine.,increase,risk
Betrixaban,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Betrixaban.,increase,no risk
Betrixaban,Vinorelbine,The risk or severity of bleeding can be increased when Betrixaban is combined with Vinorelbine.,increase,risk
Betrixaban,Vitamin E,Vitamin E may increase the anticoagulant activities of Betrixaban.,increase,no risk
Betrixaban,Voclosporin,The serum concentration of Betrixaban can be increased when it is combined with Voclosporin.,increase,no risk
Betrixaban,Von Willebrand factor human,The therapeutic efficacy of Von Willebrand factor human can be decreased when used in combination with Betrixaban.,decrease,no risk
Betrixaban,Vorapaxar,The risk or severity of bleeding and hemorrhage can be increased when Vorapaxar is combined with Betrixaban.,increase,risk
Betrixaban,Vorinostat,The risk or severity of bleeding can be increased when Betrixaban is combined with Vorinostat.,increase,risk
Betrixaban,Voxilaprevir,The serum concentration of Betrixaban can be increased when it is combined with Voxilaprevir.,increase,no risk
Betrixaban,Warfarin,The risk or severity of bleeding can be increased when Warfarin is combined with Betrixaban.,increase,risk
Betrixaban,Ximelagatran,The risk or severity of bleeding can be increased when Ximelagatran is combined with Betrixaban.,increase,risk
Betrixaban,Zidovudine,The risk or severity of bleeding can be increased when Betrixaban is combined with Zidovudine.,increase,risk
Betrixaban,Zimelidine,The risk or severity of hemorrhage can be increased when Zimelidine is combined with Betrixaban.,increase,risk
Betrixaban,Zonisamide,The serum concentration of Betrixaban can be increased when it is combined with Zonisamide.,increase,no risk
Reslizumab,Obiltoxaximab,The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with Reslizumab.,increase,risk
Reslizumab,Obinutuzumab,The risk or severity of adverse effects can be increased when Reslizumab is combined with Obinutuzumab.,increase,risk
Reslizumab,Ocrelizumab,The risk or severity of adverse effects can be increased when Reslizumab is combined with Ocrelizumab.,increase,risk
Reslizumab,Odesivimab,The risk or severity of adverse effects can be increased when Reslizumab is combined with Odesivimab.,increase,risk
Reslizumab,Ofatumumab,The risk or severity of adverse effects can be increased when Reslizumab is combined with Ofatumumab.,increase,risk
Reslizumab,Olaratumab,The risk or severity of adverse effects can be increased when Olaratumab is combined with Reslizumab.,increase,risk
Reslizumab,Omalizumab,The risk or severity of adverse effects can be increased when Omalizumab is combined with Reslizumab.,increase,risk
Reslizumab,Quinestrol,Quinestrol may increase the thrombogenic activities of Reslizumab.,increase,no risk
Reslizumab,Ublituximab,The risk or severity of adverse effects can be increased when Reslizumab is combined with Ublituximab.,increase,risk
Reslizumab,Ustekinumab,The risk or severity of adverse effects can be increased when Ustekinumab is combined with Reslizumab.,increase,risk
Reslizumab,Vedolizumab,The risk or severity of adverse effects can be increased when Reslizumab is combined with Vedolizumab.,increase,risk
Panobinostat,Betamethasone,The metabolism of Panobinostat can be increased when combined with Betamethasone.,increase,no risk
Panobinostat,Betamethasone phosphate,The metabolism of Panobinostat can be increased when combined with Betamethasone phosphate.,increase,no risk
Panobinostat,Betaxolol,The metabolism of Betaxolol can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Betrixaban,The serum concentration of Panobinostat can be increased when it is combined with Betrixaban.,increase,no risk
Panobinostat,Bexarotene,The metabolism of Panobinostat can be increased when combined with Bexarotene.,increase,no risk
Panobinostat,Bicalutamide,The metabolism of Panobinostat can be decreased when combined with Bicalutamide.,decrease,no risk
Panobinostat,Bifonazole,The metabolism of Panobinostat can be decreased when combined with Bifonazole.,decrease,no risk
Panobinostat,Bilastine,The risk or severity of QTc prolongation can be increased when Bilastine is combined with Panobinostat.,increase,risk
Panobinostat,Bimekizumab,The metabolism of Panobinostat can be increased when combined with Bimekizumab.,increase,no risk
Panobinostat,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Panobinostat.,increase,no risk
Panobinostat,Bisoprolol,The serum concentration of Panobinostat can be increased when it is combined with Bisoprolol.,increase,no risk
Panobinostat,Bleomycin,The risk or severity of adverse effects can be increased when Bleomycin is combined with Panobinostat.,increase,risk
Panobinostat,Blinatumomab,The risk or severity of adverse effects can be increased when Panobinostat is combined with Blinatumomab.,increase,risk
Panobinostat,Boceprevir,The metabolism of Panobinostat can be decreased when combined with Boceprevir.,decrease,no risk
Panobinostat,"Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)","The therapeutic efficacy of Bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated) can be decreased when used in combination with Panobinostat.",decrease,no risk
Panobinostat,Bortezomib,The metabolism of Bortezomib can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Bosentan,The metabolism of Panobinostat can be increased when combined with Bosentan.,increase,no risk
Panobinostat,Bosutinib,The metabolism of Panobinostat can be decreased when combined with Bosutinib.,decrease,no risk
Panobinostat,Brentuximab vedotin,The serum concentration of Panobinostat can be increased when it is combined with Brentuximab vedotin.,increase,no risk
Panobinostat,Bretylium,The risk or severity of QTc prolongation can be increased when Bretylium is combined with Panobinostat.,increase,risk
Panobinostat,Brexpiprazole,The metabolism of Brexpiprazole can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Brodalumab,The risk or severity of adverse effects can be increased when Panobinostat is combined with Brodalumab.,increase,risk
Panobinostat,Brompheniramine,The risk or severity of QTc prolongation can be increased when Brompheniramine is combined with Panobinostat.,increase,risk
Panobinostat,Buclizine,The risk or severity of QTc prolongation can be increased when Buclizine is combined with Panobinostat.,increase,risk
Panobinostat,Budesonide,The metabolism of Panobinostat can be increased when combined with Budesonide.,increase,no risk
Panobinostat,Bupivacaine,The metabolism of Bupivacaine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Buprenorphine,The metabolism of Buprenorphine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Buserelin,The risk or severity of QTc prolongation can be increased when Buserelin is combined with Panobinostat.,increase,risk
Panobinostat,Buspirone,The metabolism of Buspirone can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Busulfan,The risk or severity of adverse effects can be increased when Busulfan is combined with Panobinostat.,increase,risk
Panobinostat,Butacaine,The risk or severity of methemoglobinemia can be increased when Panobinostat is combined with Butacaine.,increase,risk
Panobinostat,Butalbital,The metabolism of Panobinostat can be increased when combined with Butalbital.,increase,no risk
Panobinostat,Butamben,The risk or severity of methemoglobinemia can be increased when Panobinostat is combined with Butamben.,increase,risk
Panobinostat,Butriptyline,The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Butriptyline.,increase,risk
Panobinostat,Gadobenic acid,The risk or severity of QTc prolongation can be increased when Gadobenic acid is combined with Panobinostat.,increase,risk
Panobinostat,Galantamine,The metabolism of Galantamine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Gatifloxacin,The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Panobinostat.,increase,risk
Panobinostat,Gefitinib,The metabolism of Gefitinib can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Gemcitabine,The risk or severity of adverse effects can be increased when Gemcitabine is combined with Panobinostat.,increase,risk
Panobinostat,Gemifloxacin,The risk or severity of QTc prolongation can be increased when Gemifloxacin is combined with Panobinostat.,increase,risk
Panobinostat,Gemtuzumab ozogamicin,The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Panobinostat.,increase,risk
Panobinostat,Gepirone,The risk or severity of QTc prolongation can be increased when Gepirone is combined with Panobinostat.,increase,risk
Panobinostat,Gilteritinib,The metabolism of Panobinostat can be decreased when combined with Gilteritinib.,decrease,no risk
Panobinostat,Ginkgo biloba,The metabolism of Panobinostat can be decreased when combined with Ginkgo biloba.,decrease,no risk
Panobinostat,Glasdegib,The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Glasdegib.,increase,risk
Panobinostat,Glatiramer,The risk or severity of adverse effects can be increased when Glatiramer is combined with Panobinostat.,increase,risk
Panobinostat,Glecaprevir,The serum concentration of Panobinostat can be increased when it is combined with Glecaprevir.,increase,no risk
Panobinostat,Glofitamab,The serum concentration of Panobinostat can be increased when it is combined with Glofitamab.,increase,no risk
Panobinostat,Glyburide,The metabolism of Panobinostat can be decreased when combined with Glyburide.,decrease,no risk
Panobinostat,Glycerol phenylbutyrate,The metabolism of Panobinostat can be increased when combined with Glycerol phenylbutyrate.,increase,no risk
Panobinostat,Golimumab,The metabolism of Panobinostat can be increased when combined with Golimumab.,increase,no risk
Panobinostat,Goserelin,The risk or severity of QTc prolongation can be increased when Goserelin is combined with Panobinostat.,increase,risk
Panobinostat,Granisetron,The risk or severity of QTc prolongation can be increased when Granisetron is combined with Panobinostat.,increase,risk
Panobinostat,Grapefruit,The serum concentration of Panobinostat can be increased when it is combined with Grapefruit.,increase,no risk
Panobinostat,Grazoprevir,The serum concentration of Panobinostat can be increased when it is combined with Grazoprevir.,increase,no risk
Panobinostat,Grepafloxacin,The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Grepafloxacin.,increase,risk
Panobinostat,Griseofulvin,The metabolism of Panobinostat can be increased when combined with Griseofulvin.,increase,no risk
Panobinostat,Guselkumab,The risk or severity of adverse effects can be increased when Panobinostat is combined with Guselkumab.,increase,risk
Panobinostat,Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen,The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Panobinostat.,decrease,no risk
Panobinostat,Halofantrine,The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Halofantrine.,increase,risk
Panobinostat,Haloperidol,The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Haloperidol.,increase,risk
Panobinostat,Hepatitis A Vaccine,The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Panobinostat.,decrease,no risk
Panobinostat,Hepatitis B Vaccine (Recombinant),The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Panobinostat.,decrease,no risk
Panobinostat,Histrelin,The risk or severity of QTc prolongation can be increased when Histrelin is combined with Panobinostat.,increase,risk
Panobinostat,Human adenovirus e serotype 4 strain cl-68578 antigen,The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl-68578 antigen is combined with Panobinostat.,increase,risk
Panobinostat,Hydralazine,The serum concentration of Panobinostat can be increased when it is combined with Hydralazine.,increase,no risk
Panobinostat,Hydrochlorothiazide,The risk or severity of QTc prolongation can be increased when Hydrochlorothiazide is combined with Panobinostat.,increase,risk
Panobinostat,Hydrocodone,The metabolism of Hydrocodone can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Hydrocortamate,The metabolism of Panobinostat can be increased when combined with Hydrocortamate.,increase,no risk
Panobinostat,Hydrocortisone,The metabolism of Panobinostat can be increased when combined with Hydrocortisone.,increase,no risk
Panobinostat,Hydrocortisone acetate,The metabolism of Panobinostat can be increased when combined with Hydrocortisone acetate.,increase,no risk
Panobinostat,Hydrocortisone butyrate,The metabolism of Panobinostat can be increased when combined with Hydrocortisone butyrate.,increase,no risk
Panobinostat,Hydrocortisone succinate,The metabolism of Panobinostat can be increased when combined with Hydrocortisone succinate.,increase,no risk
Panobinostat,Hydroxychloroquine,The metabolism of Hydroxychloroquine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Hydroxyurea,The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Panobinostat.,increase,risk
Panobinostat,Hydroxyzine,The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Hydroxyzine.,increase,risk
Panobinostat,Hyoscyamine,The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Panobinostat.,increase,risk
Panobinostat,Janssen COVID-19 Vaccine,The therapeutic efficacy of Janssen COVID-19 Vaccine can be decreased when used in combination with Panobinostat.,decrease,no risk
Panobinostat,Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated),The therapeutic efficacy of Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) can be decreased when used in combination with Panobinostat.,decrease,no risk
Panobinostat,Ketazolam,The serum concentration of Panobinostat can be increased when it is combined with Ketazolam.,increase,no risk
Panobinostat,Ketoconazole,The metabolism of Panobinostat can be decreased when combined with Ketoconazole.,decrease,no risk
Panobinostat,Obinutuzumab,The risk or severity of adverse effects can be increased when Panobinostat is combined with Obinutuzumab.,increase,risk
Panobinostat,Ocrelizumab,The risk or severity of adverse effects can be increased when Panobinostat is combined with Ocrelizumab.,increase,risk
Panobinostat,Octreotide,The serum concentration of Panobinostat can be increased when it is combined with Octreotide.,increase,no risk
Panobinostat,Ofatumumab,The risk or severity of adverse effects can be increased when Panobinostat is combined with Ofatumumab.,increase,risk
Panobinostat,Ofloxacin,The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Panobinostat.,increase,risk
Panobinostat,Olanzapine,The metabolism of Olanzapine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Olaparib,The metabolism of Panobinostat can be decreased when combined with Olaparib.,decrease,no risk
Panobinostat,Oliceridine,The serum concentration of Oliceridine can be increased when it is combined with Panobinostat.,increase,no risk
Panobinostat,Olodaterol,The risk or severity of QTc prolongation can be increased when Olodaterol is combined with Panobinostat.,increase,risk
Panobinostat,Olutasidenib,The metabolism of Panobinostat can be increased when combined with Olutasidenib.,increase,no risk
Panobinostat,Omadacycline,The serum concentration of Panobinostat can be increased when it is combined with Omadacycline.,increase,no risk
Panobinostat,Omaveloxolone,The serum concentration of Panobinostat can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Panobinostat,Ombitasvir,The serum concentration of Panobinostat can be increased when it is combined with Ombitasvir.,increase,no risk
Panobinostat,Ondansetron,The metabolism of Ondansetron can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Opium,The metabolism of Opium can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Oritavancin,The metabolism of Panobinostat can be increased when combined with Oritavancin.,increase,no risk
Panobinostat,Orphenadrine,The metabolism of Panobinostat can be decreased when combined with Orphenadrine.,decrease,no risk
Panobinostat,Osilodrostat,The metabolism of Panobinostat can be decreased when combined with Osilodrostat.,decrease,no risk
Panobinostat,Osimertinib,The metabolism of Panobinostat can be decreased when combined with Osimertinib.,decrease,no risk
Panobinostat,Oxaliplatin,The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Panobinostat.,increase,risk
Panobinostat,Oxatomide,The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Oxatomide.,increase,risk
Panobinostat,Oxcarbazepine,The metabolism of Panobinostat can be increased when combined with Oxcarbazepine.,increase,no risk
Panobinostat,Oxetacaine,The risk or severity of methemoglobinemia can be increased when Panobinostat is combined with Oxetacaine.,increase,risk
Panobinostat,Oxprenolol,The metabolism of Oxprenolol can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Oxybuprocaine,The risk or severity of methemoglobinemia can be increased when Panobinostat is combined with Oxybuprocaine.,increase,risk
Panobinostat,Oxybutynin,The serum concentration of Panobinostat can be increased when it is combined with Oxybutynin.,increase,no risk
Panobinostat,Oxycodone,The metabolism of Oxycodone can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Oxymorphone,The metabolism of Oxymorphone can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Oxytocin,The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Panobinostat.,increase,risk
Panobinostat,Ozanimod,The risk or severity of adverse effects can be increased when Panobinostat is combined with Ozanimod.,increase,risk
Panobinostat,Quetiapine,The metabolism of Quetiapine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Quinidine,The serum concentration of Panobinostat can be increased when it is combined with Quinidine.,increase,no risk
Panobinostat,Quinine,The metabolism of Quinine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Quinupristin,The metabolism of Panobinostat can be decreased when combined with Quinupristin.,decrease,no risk
Panobinostat,Quizartinib,The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Quizartinib.,increase,risk
Panobinostat,Ublituximab,The risk or severity of infection can be increased when Ublituximab is combined with Panobinostat.,increase,risk
Panobinostat,Ubrogepant,The serum concentration of Panobinostat can be increased when it is combined with Ubrogepant.,increase,no risk
Panobinostat,Umbralisib,The serum concentration of Panobinostat can be increased when it is combined with Umbralisib.,increase,no risk
Panobinostat,Umeclidinium,The metabolism of Umeclidinium can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Upadacitinib,The risk or severity of adverse effects can be increased when Panobinostat is combined with Upadacitinib.,increase,risk
Panobinostat,Vadadustat,The serum concentration of Panobinostat can be increased when it is combined with Vadadustat.,increase,no risk
Panobinostat,Valbenazine,The metabolism of Valbenazine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Valproic acid,The serum concentration of Panobinostat can be increased when it is combined with Valproic acid.,increase,no risk
Panobinostat,Vandetanib,The serum concentration of Panobinostat can be increased when it is combined with Vandetanib.,increase,no risk
Panobinostat,Vardenafil,The serum concentration of Panobinostat can be increased when it is combined with Vardenafil.,increase,no risk
Panobinostat,Varicella zoster vaccine (live/attenuated),The risk or severity of infection can be increased when Varicella zoster vaccine (live/attenuated) is combined with Panobinostat.,increase,risk
Panobinostat,Varicella zoster vaccine (recombinant),The therapeutic efficacy of Varicella zoster vaccine (recombinant) can be decreased when used in combination with Panobinostat.,decrease,no risk
Panobinostat,Vedolizumab,The risk or severity of adverse effects can be increased when Panobinostat is combined with Vedolizumab.,increase,risk
Panobinostat,Velpatasvir,The serum concentration of Panobinostat can be increased when it is combined with Velpatasvir.,increase,no risk
Panobinostat,Vemurafenib,The serum concentration of Panobinostat can be increased when it is combined with Vemurafenib.,increase,no risk
Panobinostat,Venetoclax,The serum concentration of Panobinostat can be increased when it is combined with Venetoclax.,increase,no risk
Panobinostat,Venlafaxine,The metabolism of Venlafaxine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Verapamil,The serum concentration of Panobinostat can be increased when it is combined with Verapamil.,increase,no risk
Panobinostat,Vernakalant,The metabolism of Vernakalant can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Vibrio cholerae CVD 103-HgR strain live antigen,The therapeutic efficacy of Vibrio cholerae CVD 103-HgR strain live antigen can be decreased when used in combination with Panobinostat.,decrease,no risk
Panobinostat,Vilanterol,The risk or severity of QTc prolongation and ventricular arrhythmias can be increased when Vilanterol is combined with Panobinostat.,increase,risk
Panobinostat,Vilazodone,The metabolism of Vilazodone can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Viloxazine,The metabolism of Panobinostat can be decreased when combined with Viloxazine.,decrease,no risk
Panobinostat,Vinblastine,The metabolism of Panobinostat can be increased when combined with Vinblastine.,increase,no risk
Panobinostat,Vincristine,The risk or severity of adverse effects can be increased when Vincristine is combined with Panobinostat.,increase,risk
Panobinostat,Vindesine,The risk or severity of adverse effects can be increased when Vindesine is combined with Panobinostat.,increase,risk
Panobinostat,Vinflunine,The serum concentration of Vinflunine can be increased when it is combined with Panobinostat.,increase,no risk
Panobinostat,Vinorelbine,The risk or severity of adverse effects can be increased when Vinorelbine is combined with Panobinostat.,increase,risk
Panobinostat,Vitamin E,The metabolism of Panobinostat can be increased when combined with Vitamin E.,increase,no risk
Panobinostat,Voclosporin,The serum concentration of Panobinostat can be increased when it is combined with Voclosporin.,increase,no risk
Panobinostat,Vorapaxar,The serum concentration of Panobinostat can be increased when it is combined with Vorapaxar.,increase,no risk
Panobinostat,Voriconazole,The metabolism of Panobinostat can be decreased when combined with Voriconazole.,decrease,no risk
Panobinostat,Vorinostat,The risk or severity of gastrointestinal bleeding and thrombocytopenia can be increased when Panobinostat is combined with Vorinostat.,increase,risk
Panobinostat,Vortioxetine,The metabolism of Vortioxetine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Voxelotor,The serum concentration of Panobinostat can be increased when it is combined with Voxelotor.,increase,no risk
Panobinostat,Voxilaprevir,The serum concentration of Panobinostat can be increased when it is combined with Voxilaprevir.,increase,no risk
Panobinostat,Warfarin,The metabolism of Panobinostat can be increased when combined with Warfarin.,increase,no risk
Panobinostat,Yellow fever vaccine,The risk or severity of infection can be increased when Yellow fever vaccine is combined with Panobinostat.,increase,risk
Panobinostat,Yohimbine,The metabolism of Yohimbine can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Zafirlukast,The serum concentration of Panobinostat can be increased when it is combined with Zafirlukast.,increase,no risk
Panobinostat,Zidovudine,The risk or severity of adverse effects can be increased when Zidovudine is combined with Panobinostat.,increase,risk
Panobinostat,Zimelidine,The metabolism of Panobinostat can be decreased when combined with Zimelidine.,decrease,no risk
Panobinostat,Ziprasidone,The risk or severity of QTc prolongation can be increased when Panobinostat is combined with Ziprasidone.,increase,risk
Panobinostat,Zolpidem,The metabolism of Zolpidem can be decreased when combined with Panobinostat.,decrease,no risk
Panobinostat,Zonisamide,The serum concentration of Panobinostat can be increased when it is combined with Zonisamide.,increase,no risk
Panobinostat,Zuclopenthixol,The metabolism of Zuclopenthixol can be decreased when combined with Panobinostat.,decrease,no risk
Apixaban,Bexarotene,The metabolism of Apixaban can be decreased when combined with Bexarotene.,decrease,no risk
Apixaban,Bezafibrate,The metabolism of Apixaban can be decreased when combined with Bezafibrate.,decrease,no risk
Apixaban,Bimekizumab,The metabolism of Apixaban can be increased when combined with Bimekizumab.,increase,no risk
Apixaban,Binimetinib,The serum concentration of Binimetinib can be increased when it is combined with Apixaban.,increase,no risk
Apixaban,Bismuth subsalicylate,The risk or severity of bleeding can be increased when Bismuth subsalicylate is combined with Apixaban.,increase,risk
Apixaban,Bisoprolol,The serum concentration of Apixaban can be increased when it is combined with Bisoprolol.,increase,no risk
Apixaban,Bivalirudin,Apixaban may increase the anticoagulant activities of Bivalirudin.,increase,no risk
Apixaban,Blinatumomab,The risk or severity of bleeding can be increased when Apixaban is combined with Blinatumomab.,increase,risk
Apixaban,Boceprevir,The metabolism of Apixaban can be decreased when combined with Boceprevir.,decrease,no risk
Apixaban,Bortezomib,The metabolism of Apixaban can be decreased when combined with Bortezomib.,decrease,no risk
Apixaban,Bosentan,The metabolism of Apixaban can be increased when combined with Bosentan.,increase,no risk
Apixaban,Bosutinib,The metabolism of Apixaban can be decreased when combined with Bosutinib.,decrease,no risk
Apixaban,Brentuximab vedotin,The serum concentration of Brentuximab vedotin can be increased when it is combined with Apixaban.,increase,no risk
Apixaban,Brigatinib,The metabolism of Brigatinib can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Brivaracetam,The metabolism of Apixaban can be decreased when combined with Brivaracetam.,decrease,no risk
Apixaban,Budesonide,The metabolism of Apixaban can be increased when combined with Budesonide.,increase,no risk
Apixaban,Bumadizone,The risk or severity of bleeding and hemorrhage can be increased when Bumadizone is combined with Apixaban.,increase,risk
Apixaban,Buprenorphine,Buprenorphine may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Bupropion,The metabolism of Apixaban can be decreased when combined with Bupropion.,decrease,no risk
Apixaban,Buspirone,The metabolism of Apixaban can be decreased when combined with Buspirone.,decrease,no risk
Apixaban,Busulfan,The risk or severity of bleeding can be increased when Apixaban is combined with Busulfan.,increase,risk
Apixaban,Gefitinib,Gefitinib may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Gemcitabine,The serum concentration of Gemcitabine can be increased when it is combined with Apixaban.,increase,no risk
Apixaban,Gemfibrozil,The metabolism of Apixaban can be decreased when combined with Gemfibrozil.,decrease,no risk
Apixaban,Gemtuzumab ozogamicin,The risk or severity of bleeding can be increased when Apixaban is combined with Gemtuzumab ozogamicin.,increase,risk
Apixaban,Gestrinone,The risk or severity of adverse effects can be increased when Gestrinone is combined with Apixaban.,increase,risk
Apixaban,Gilteritinib,Gilteritinib may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Ginkgo biloba,Ginkgo biloba may increase the anticoagulant activities of Apixaban.,increase,no risk
Apixaban,Glasdegib,Glasdegib may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Glecaprevir,Glecaprevir may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Gliclazide,The metabolism of Apixaban can be decreased when combined with Gliclazide.,decrease,no risk
Apixaban,Glimepiride,The metabolism of Apixaban can be decreased when combined with Glimepiride.,decrease,no risk
Apixaban,Glipizide,The metabolism of Apixaban can be decreased when combined with Glipizide.,decrease,no risk
Apixaban,Gliquidone,The metabolism of Apixaban can be decreased when combined with Gliquidone.,decrease,no risk
Apixaban,Glofitamab,The serum concentration of Apixaban can be increased when it is combined with Glofitamab.,increase,no risk
Apixaban,Glyburide,The metabolism of Apixaban can be decreased when combined with Glyburide.,decrease,no risk
Apixaban,Glycol salicylate,The risk or severity of bleeding and hemorrhage can be increased when Glycol salicylate is combined with Apixaban.,increase,risk
Apixaban,Golimumab,The metabolism of Apixaban can be increased when combined with Golimumab.,increase,no risk
Apixaban,Grazoprevir,Grazoprevir may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Halofantrine,The metabolism of Apixaban can be decreased when combined with Halofantrine.,decrease,no risk
Apixaban,Haloperidol,The serum concentration of Haloperidol can be increased when it is combined with Apixaban.,increase,no risk
Apixaban,Halothane,The metabolism of Apixaban can be decreased when combined with Halothane.,decrease,no risk
Apixaban,Hemin,Hemin may increase the anticoagulant activities of Apixaban.,increase,no risk
Apixaban,Heparin,Apixaban may increase the anticoagulant activities of Heparin.,increase,no risk
Apixaban,Hydrochlorothiazide,The therapeutic efficacy of Apixaban can be decreased when used in combination with Hydrochlorothiazide.,decrease,no risk
Apixaban,Hydrocortisone,The metabolism of Apixaban can be increased when combined with Hydrocortisone.,increase,no risk
Apixaban,Hydrocortisone acetate,The metabolism of Hydrocortisone acetate can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Hydrocortisone butyrate,The metabolism of Hydrocortisone butyrate can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Hydrocortisone cypionate,The metabolism of Hydrocortisone cypionate can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Hydrocortisone phosphate,The metabolism of Hydrocortisone phosphate can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Hydroflumethiazide,The therapeutic efficacy of Apixaban can be decreased when used in combination with Hydroflumethiazide.,decrease,no risk
Apixaban,Hydromorphone,The metabolism of Apixaban can be decreased when combined with Hydromorphone.,decrease,no risk
Apixaban,Hydroxychloroquine,The metabolism of Apixaban can be decreased when combined with Hydroxychloroquine.,decrease,no risk
Apixaban,Hydroxyprogesterone caproate,The therapeutic efficacy of Apixaban can be decreased when used in combination with Hydroxyprogesterone caproate.,decrease,no risk
Apixaban,Hydroxyurea,The risk or severity of bleeding can be increased when Apixaban is combined with Hydroxyurea.,increase,risk
Apixaban,Hydroxyzine,The metabolism of Apixaban can be decreased when combined with Hydroxyzine.,decrease,no risk
Apixaban,Ketamine,The metabolism of Apixaban can be decreased when combined with Ketamine.,decrease,no risk
Apixaban,Ketoconazole,The metabolism of Apixaban can be decreased when combined with Ketoconazole.,decrease,no risk
Apixaban,Ketoprofen,The risk or severity of bleeding and hemorrhage can be increased when Ketoprofen is combined with Apixaban.,increase,risk
Apixaban,Ketorolac,The risk or severity of bleeding and hemorrhage can be increased when Ketorolac is combined with Apixaban.,increase,risk
Apixaban,Obeticholic acid,The risk or severity of bleeding and bruising can be increased when Apixaban is combined with Obeticholic acid.,increase,risk
Apixaban,Obinutuzumab,The risk or severity of bleeding and hemorrhage can be increased when Apixaban is combined with Obinutuzumab.,increase,risk
Apixaban,Olanzapine,The metabolism of Apixaban can be decreased when combined with Olanzapine.,decrease,no risk
Apixaban,Olaparib,The metabolism of Olaparib can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Olive oil,The therapeutic efficacy of Apixaban can be decreased when used in combination with Olive oil.,decrease,no risk
Apixaban,Olodaterol,The metabolism of Olodaterol can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Olsalazine,The risk or severity of bleeding can be increased when Olsalazine is combined with Apixaban.,increase,risk
Apixaban,Omacetaxine mepesuccinate,The risk or severity of bleeding can be increased when Apixaban is combined with Omacetaxine mepesuccinate.,increase,risk
Apixaban,Omadacycline,The serum concentration of Omadacycline can be increased when it is combined with Apixaban.,increase,no risk
Apixaban,Omaveloxolone,The serum concentration of Apixaban can be decreased when it is combined with Omaveloxolone.,decrease,no risk
Apixaban,Ombitasvir,The metabolism of Ombitasvir can be decreased when combined with Apixaban.,decrease,no risk
Apixaban,Omega-3 fatty acids,Omega-3 fatty acids may increase the anticoagulant activities of Apixaban.,increase,no risk
Apixaban,Omega-3-acid ethyl esters,The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Apixaban.,increase,risk
Apixaban,Omega-3-carboxylic acids,The therapeutic efficacy of Apixaban can be increased when used in combination with Omega-3-carboxylic acids.,increase,no risk
Apixaban,Omeprazole,The metabolism of Apixaban can be decreased when combined with Omeprazole.,decrease,no risk
Apixaban,Ondansetron,The metabolism of Apixaban can be decreased when combined with Ondansetron.,decrease,no risk
Apixaban,Oritavancin,The metabolism of Apixaban can be decreased when combined with Oritavancin.,decrease,no risk
Apixaban,Osilodrostat,The metabolism of Apixaban can be decreased when combined with Osilodrostat.,decrease,no risk
Apixaban,Osimertinib,Osimertinib may decrease the excretion rate of Apixaban which could result in a higher serum level.,decrease,no risk
Apixaban,Ospemifene,The metabolism of Apixaban can be decreased when combined with Ospemifene.,decrease,no risk
Apixaban,Oteseconazole,The serum concentration of Apixaban can be increased when it is combined with Oteseconazole.,increase,no risk
Apixaban,Oxaliplatin,The risk or severity of hemorrhage can be increased when Oxaliplatin is combined with Apixaban.,increase,risk
Apixaban,Oxandrolone,The metabolism of Apixaban can be decreased when combined with Oxandrolone.,decrease,no risk
Apixaban,Oxaprozin,The risk or severity of bleeding and hemorrhage can be increased when Oxaprozin is combined with Apixaban.,increase,risk
Apixaban,Oxcarbazepine,The metabolism of Apixaban can be increased when combined with Oxcarbazepine.,increase,no risk
Apixaban,Oxybutynin,The metabolism of Apixaban can be decreased when combined with Oxybutynin.,decrease,no risk
